×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

Data Dictionary

Entering terms or keywords in the Data Dictionary search above provides a definition, and entering specific terms within the data archive provides data location.

Results for "ID"
TermDefinitionCodePhaseTableCRF
ID Record ID "crfname","","indexes","adni_aal_idx=TBLID,FLDID,TRANSNID","notnullcols","ID,USERID,USERDATE,USERNUM,TBLID,FLDID,TRANSNID,REASONID,CHANGE" ADNI1 AAL N/A
USERID N/A N/A ADNI1,ADNIGO AAL N/A
USERID2 N/A N/A ADNI1,ADNIGO AAL N/A
TBLID N/A N/A ADNI1,ADNIGO AAL N/A
FLDID N/A N/A ADNI1,ADNIGO AAL N/A
TRANSNID N/A N/A ADNI1,ADNIGO AAL N/A
RECID N/A N/A ADNI1,ADNIGO AAL N/A
OLDVID N/A N/A ADNI1,ADNIGO AAL N/A
NEWVID N/A N/A ADNI1,ADNIGO AAL N/A
REASONID N/A N/A ADNI1,ADNIGO AAL N/A
ID Record ID "crfname","","indexes","adni_aalfld_idx=FLDNAME","notnullcols","ID,USERID,USERDATE,FLDNAME" ADNI1 AALFLD N/A
USERID N/A N/A ADNI1,ADNIGO AALFLD N/A
USERID2 N/A N/A ADNI1,ADNIGO AALFLD N/A
ID Record ID "crfname","","indexes","","notnullcols","ID,USERID,USERDATE,TDATE,TDATENUM,TLOGID,STATUS,USERNUM,TBLID" ADNI1,ADNIGO AALMETA N/A
USERID N/A N/A ADNI1,ADNIGO AALMETA N/A
USERID2 N/A N/A ADNI1,ADNIGO AALMETA N/A
TLOGID N/A N/A ADNI1,ADNIGO AALMETA N/A
RID Participant roster ID N/A ADNI1,ADNIGO AALMETA N/A
TBLID N/A N/A ADNI1,ADNIGO AALMETA N/A
RECID N/A N/A ADNI1,ADNIGO AALMETA N/A
ID Record ID "crfname","","indexes","adni_aalreason_idx=REASON","notnullcols","ID,USERID,USERDATE,TYPE,REASON" ADNI1 AALREASON N/A
USERID N/A N/A ADNI1,ADNIGO AALREASON N/A
USERID2 N/A N/A ADNI1,ADNIGO AALREASON N/A
ID Record ID "crfname","","indexes","adni_aaltbl_idx=TBLNAME","notnullcols","ID,USERID,USERDATE,TBLNAME" ADNI1 AALTBL N/A
USERID N/A N/A ADNI1,ADNIGO AALTBL N/A
USERID N/A N/A ADNI1,ADNIGO AALVALUE N/A
USERID2 N/A N/A ADNI1,ADNIGO AALTBL N/A
ID Record ID "crfname","","indexes","adni_aaluser_idx=USERNAME","notnullcols","ID,USERID,USERDATE,USERNAME" ADNI1 AALUSER N/A
USERID N/A N/A ADNI1,ADNIGO AALUSER N/A
USERID2 N/A N/A ADNI1,ADNIGO AALUSER N/A
ID Record ID "crfname","","indexes","adni_aalvalue_idx=VALUE","notnullcols","ID,USERID,USERDATE,VALUE" ADNI1 AALVALUE N/A
USERID2 N/A N/A ADNI1,ADNIGO AALVALUE N/A
ID Record ID "crfname","ADAS-Cognitive Behavior","indexes","adni_adas_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 ADAS ADAS-Cognitive Behavior
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 ADAS ADAS-Cognitive Behavior
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 ADAS ADAS-Cognitive Behavior
USERID N/A N/A ADNI1,ADNIGO,ADNI2 ADAS ADAS-Cognitive Behavior
COIDEA Check each step completed correctly. 1=Fold a letter.; 2=Put letter in envelope.; 3=Seal envelope.; 4=Address envelope.; 5=Indicate where stamp goes.; 6=None completed correctly ADNI1 ADAS ADAS-Cognitive Behavior
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 ADAS ADAS-Cognitive Behavior
ID Record ID "crfname","ADAS Sub-Scores and Total Scores","indexes","adni_adasscores_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 ADASSCORES ADAS Sub-Scores and Total Scores
RID Participant roster ID N/A ADNI1 ADASSCORES ADAS Sub-Scores and Total Scores
SITEID Site ID N/A ADNI1 ADASSCORES ADAS Sub-Scores and Total Scores
USERID N/A N/A ADNI1 ADASSCORES ADAS Sub-Scores and Total Scores
Q6 Ideational Praxis 0..5 ADNI1 ADASSCORES ADAS Sub-Scores and Total Scores
USERID2 N/A N/A ADNI1 ADASSCORES ADAS Sub-Scores and Total Scores
ID Record ID "crfname","Additional Comments","indexes","adni_addcomm_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 ADDCOMM Additional Comments
RID Participant roster ID N/A ADNI1 ADDCOMM Additional Comments
SITEID Site ID N/A ADNI1 ADDCOMM Additional Comments
USERID N/A N/A ADNI1 ADDCOMM Additional Comments
USERID2 N/A N/A ADNI1 ADDCOMM Additional Comments
RID Participant roster ID -4 ADNI1 ADNIMERGE Key ADNI tables merged into one table
PTID Participant ID -4 ADNI1 ADNIMERGE Key ADNI tables merged into one table
MidTemp UCSF Med Temp -4 ADNI1 ADNIMERGE Key ADNI tables merged into one table
MidTemp_bl UCSF Med Temp at baseline -4 ADNI1 ADNIMERGE Key ADNI tables merged into one table
ID Record ID "crfname","Diagnosis and Symptoms Checklist","indexes","adni_adsxlist_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 ADSXLIST Diagnosis and Symptoms Checklist
RID Participant roster ID N/A ADNI1,ADNIGO ADSXLIST Diagnosis and Symptoms Checklist
SITEID Site ID N/A ADNI1,ADNIGO ADSXLIST Diagnosis and Symptoms Checklist
USERID N/A N/A ADNI1,ADNIGO ADSXLIST Diagnosis and Symptoms Checklist
USERID2 N/A N/A ADNI1,ADNIGO ADSXLIST Diagnosis and Symptoms Checklist
ID Record ID "crfname","ApoE Genotyping - Draw Data","indexes","adni_apoe_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 APOE ApoE Genotyping - Draw Data
RID Participant roster ID N/A ADNI1 APOE ApoE Genotyping - Draw Data
SITEID Site ID N/A ADNI1 APOE ApoE Genotyping - Draw Data
USERID N/A N/A ADNI1 APOE ApoE Genotyping - Draw Data
USERID2 N/A N/A ADNI1 APOE ApoE Genotyping - Draw Data
ID Record ID "crfname","ApoE Genotyping - Results","indexes","adni_apoeres_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 APOERES ApoE Genotyping - Results
SITEID Site ID N/A ADNI1,ADNIGO APOERES ApoE Genotyping - Results
RID Participant roster ID N/A ADNI1,ADNIGO APOERES ApoE Genotyping - Results
USERID N/A N/A ADNI1,ADNIGO APOERES ApoE Genotyping - Results
USERID2 N/A N/A ADNI1,ADNIGO APOERES ApoE Genotyping - Results
ID Record ID "crfname","","indexes","adni_arm_idx=PTNO","notnullcols","ID,USERID,USERDATE,RID,SITEID,PTNO,TYPE" ADNI1 ARM N/A
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 ARM N/A
SITEID Site ID N/A ADNI1,ADNIGO ARM N/A
TYPE ID Type S=Study Participant;P=Phantom;V=Volunteer ADNI1,ADNIGO,ADNI2 ARM N/A
LASTNAME ID Assigner's Last Name N/A ADNI1,ADNIGO,ADNI2 ARM N/A
USERID N/A N/A ADNI1,ADNIGO,ADNI2 ARM N/A
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 ARM N/A
ID Record ID -4 ADNI1 AVGJACOB Average Jacobian - Temporal (Paul Thompson's Lab)
RID Participant roster ID -4 ADNI1 AVGJACOB Average Jacobian - Temporal (Paul Thompson's Lab)
SITEID Site ID -4 ADNI1 AVGJACOB Average Jacobian - Temporal (Paul Thompson's Lab)
IMAGEUID imageUID -4 ADNI1 AVGJACOB Average Jacobian - Temporal (Paul Thompson's Lab)
USERID N/A -4 ADNI1 AVGJACOB Average Jacobian - Temporal (Paul Thompson's Lab)
RID Participant roster ID -4 ADNI1 BACEAPPBETA Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta
SPECIMENID Specimen ID -4 ADNI1 BACEAPPBETA Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta
GLOBALSPECID Global Spec ID -4 ADNI1 BACEAPPBETA Biomarkers Consortium ADNI CSF BACE activity and sAPPbeta
USERID N/A N/A ADNI1 BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGPMR11 Cingulum_Post_R/Cingulum_Mid_R N/A ADNI1 BAINMRC Banner Alzheimer's Institute NMRC Summaries
ID Record ID "crfname","Biomarker Samples","indexes","adni_biomark_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 BIOMARK Biomarker Samples
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 BIOMARK Biomarker Samples
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 BIOMARK Biomarker Samples
USERID N/A N/A ADNI1,ADNIGO,ADNI2 BIOMARK Biomarker Samples
BIFAST Overnight fast from midnight? 1=Yes;0=No ADNI1,ADNIGO BIOMARK Biomarker Samples
BILPSPCOM If Spine Film performed, but no CSF was collected, provide explanation N/A ADNI1,ADNIGO BIOMARK Biomarker Samples
ID Record ID "crfname","Diagnostic Summary - Baseline Changes","indexes","adni_blchange_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 BLCHANGE Diagnostic Summary - Baseline Changes
RID Participant roster ID N/A ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
SITEID Site ID N/A ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
USERID N/A N/A ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
BCSTROKE 10. Did subject have a stroke? 1=Yes; 0=No ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
BCDELIR 11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)? 1=Yes; 0=No ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
BCEXTCIR 12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance? 1=Yes; 0=No ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
USERID2 N/A N/A ADNI1,ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
ID Record ID "crfname","Baseline Symptoms Checklist","indexes","adni_blscheck_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 BLSCHECK Baseline Symptoms Checklist
RID Participant roster ID N/A ADNI1,ADNIGO BLSCHECK Baseline Symptoms Checklist
SITEID Site ID N/A ADNI1,ADNIGO BLSCHECK Baseline Symptoms Checklist
USERID N/A N/A ADNI1,ADNIGO BLSCHECK Baseline Symptoms Checklist
USERID2 N/A N/A ADNI1,ADNIGO BLSCHECK Baseline Symptoms Checklist
USERID N/A N/A ADNI1 BSI Boundary Shift Integral Summaries (Nick Fox's lab)
ID Record ID "crfname","Clinical Dementia Rating","indexes","adni_cdr_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 CDR Clinical Dementia Rating
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 CDR Clinical Dementia Rating
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 CDR Clinical Dementia Rating
USERID N/A N/A ADNI1,ADNIGO,ADNI2 CDR Clinical Dementia Rating
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 CDR Clinical Dementia Rating
ID Record ID "crfname","Cells For Immortalization Speciman Collection","indexes","adni_cellimort_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 CELLIMORT Cells For Immortalization Speciman Collection
RID Participant roster ID N/A ADNI1 CELLIMORT Cells For Immortalization Speciman Collection
SITEID Site ID N/A ADNI1 CELLIMORT Cells For Immortalization Speciman Collection
USERID N/A N/A ADNI1 CELLIMORT Cells For Immortalization Speciman Collection
USERID2 N/A N/A ADNI1 CELLIMORT Cells For Immortalization Speciman Collection
ID Record ID "crfname","Clinician Review","indexes","adni_clirev_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 CLIREV Clinician Review
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 CLIREV Clinician Review
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 CLIREV Clinician Review
USERID N/A N/A ADNI1,ADNIGO,ADNI2 CLIREV Clinician Review
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 CLIREV Clinician Review
CLIDATE Approval Date N/A ADNI1,ADNIGO,ADNI2 CLIREV Clinician Review
ID Record ID "crfname","Method of CSF Collection","indexes","adni_csfmeth_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 CSFMETH Method of CSF Collection
RID Participant roster ID N/A ADNI1,ADNIGO CSFMETH Method of CSF Collection
SITEID Site ID N/A ADNI1,ADNIGO CSFMETH Method of CSF Collection
TUBEMIN If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in collection tube 0..1440 ADNI1 CSFMETH Method of CSF Collection
USERID2 N/A N/A ADNI1,ADNIGO CSFMETH Method of CSF Collection
ID Record ID "crfname","","indexes","adni_datadic_ind=FLDNAME,TBLNAME","notnullcols","ID,FLDNAME,TBLNAME" ADNI1 DATADIC N/A
OBJID N/A N/A ADNI1,ADNIGO DATADIC N/A
COLID N/A N/A ADNI1,ADNIGO DATADIC N/A
GRID N/A N/A ADNI1,ADNIGO DATADIC N/A
ID Record ID "crfname","Eligibility Confirmation","indexes","adni_eligconf_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 ELIGCONF Eligibility Confirmation
RID Participant roster ID N/A ADNI1 ELIGCONF Eligibility Confirmation
SITEID Site ID N/A ADNI1 ELIGCONF Eligibility Confirmation
USERID N/A N/A ADNI1 ELIGCONF Eligibility Confirmation
USERID2 N/A N/A ADNI1 ELIGCONF Eligibility Confirmation
ID Record ID "crfname","Enrollment Tracking","indexes","adni_enrolltr_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 ENROLLTR Enrollment Tracking
RID Participant roster ID N/A ADNI1 ENROLLTR Enrollment Tracking
SITEID Site ID N/A ADNI1 ENROLLTR Enrollment Tracking
USERID N/A N/A ADNI1 ENROLLTR Enrollment Tracking
USERID2 N/A N/A ADNI1 ENROLLTR Enrollment Tracking
ID Record ID "crfname","Exclusion Criteria","indexes","adni_exclusio_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 EXCLUSIO Exclusion Criteria
RID Participant roster ID N/A ADNI1 EXCLUSIO Exclusion Criteria
SITEID Site ID N/A ADNI1 EXCLUSIO Exclusion Criteria
USERID N/A N/A ADNI1 EXCLUSIO Exclusion Criteria
EXNIMAG 2. Does the participant's screening/baseline MRI scans have evidence of infection, infarction, or other focal lesions? Participants with multiple lacunes or lacunes in a critical memory structure are excluded. 1=Yes; 0=No ADNI1 EXCLUSIO Exclusion Criteria
EXRESID 8. Does the participant reside in a skilled nursing facility? 1=Yes; 0=No ADNI1 EXCLUSIO Exclusion Criteria
USERID2 N/A N/A ADNI1 EXCLUSIO Exclusion Criteria
ID Record ID "crfname","Inclusion/Exclusion Exceptions Log","indexes","adni_excptlog_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 EXCPTLOG Inclusion/Exclusion Exceptions Log
RID Participant roster ID N/A ADNI1 EXCPTLOG Inclusion/Exclusion Exceptions Log
SITEID Site ID N/A ADNI1 EXCPTLOG Inclusion/Exclusion Exceptions Log
USERID N/A N/A ADNI1 EXCPTLOG Inclusion/Exclusion Exceptions Log
EXCBIDT If Fluroscopy or LP spine film, indicate [anticipated] date performed: N/A ADNI1 EXCPTLOG Inclusion/Exclusion Exceptions Log
USERID2 N/A N/A ADNI1 EXCPTLOG Inclusion/Exclusion Exceptions Log
ID Record ID "crfname","Functional Assessment Questionnaire","indexes","adni_faq_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 FAQ Functional Assessment Questionnaire
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 FAQ Functional Assessment Questionnaire
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 FAQ Functional Assessment Questionnaire
USERID N/A N/A ADNI1,ADNIGO,ADNI2 FAQ Functional Assessment Questionnaire
FAQGAME 4. Playing a game of skill such as bridge or chess, working on a hobby. 0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3) ADNI1,ADNIGO,ADNI2,ADNI3 FAQ Functional Assessment Questionnaire
FAQREM 9. Remembering appointments, family occasions, holidays, medications. 0=Normal (0);1=Never did, but could do now (0);2=Never did, would have difficulty now (1);3=Has difficulty, but does by self (1);4=Requires assistance (2);5=Dependent (3) ADNI1,ADNIGO,ADNI2,ADNI3 FAQ Functional Assessment Questionnaire
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 FAQ Functional Assessment Questionnaire
ID Record ID "crfname","Family History Questionnaire","indexes","adni_fhq_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 FHQ Family History Questionnaire
RID Participant roster ID N/A ADNI1 FHQ Family History Questionnaire
SITEID Site ID N/A ADNI1 FHQ Family History Questionnaire
FHQPROV Indicate below who provided the information collected for this questionnaire: 1=Participant only; 2=Study Partner only; 3=Both Participant and Study Partner ADNI1 FHQ Family History Questionnaire
USERID2 N/A N/A ADNI1 FHQ Family History Questionnaire
RID Participant roster ID N/A ADNI1 FLAIRQC FLAIR QC
ID Record ID "crfname","","indexes","adni_formver_idx=TBLNAME,FLDNAME,VERSION,VERTYPE","notnullcols","ID,USERID,USERDATE,TBLNAME,FLDNAME,VERSION,VERTYPE" ADNI1 FORMVER N/A
USERID N/A N/A ADNI1 FORMVER N/A
USERID2 N/A N/A ADNI1 FORMVER N/A
ID Record ID "crfname","Geriatric Depression Scale","indexes","adni_gdscale_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 GDSCALE Geriatric Depression Scale
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 GDSCALE Geriatric Depression Scale
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 GDSCALE Geriatric Depression Scale
USERID N/A N/A ADNI1,ADNIGO,ADNI2 GDSCALE Geriatric Depression Scale
GDAFRAID 6. Are you afraid that something bad is going to happen to you? 1=Yes(1); 0=No(0) ADNI1,ADNIGO,ADNI2 GDSCALE Geriatric Depression Scale
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 GDSCALE Geriatric Depression Scale
ID Record ID "crfname","Homocysteine - Results","indexes","adni_hcres_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 HCRES Homocysteine - Results
RID Participant roster ID N/A ADNI1,ADNIGO HCRES Homocysteine - Results
SITEID Site ID N/A ADNI1,ADNIGO HCRES Homocysteine - Results
USERID N/A N/A ADNI1,ADNIGO HCRES Homocysteine - Results
ID Record ID "crfname","Inclusion Criteria","indexes","adni_inclusio_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 INCLUSIO Inclusion Criteria
SITEID Site ID N/A ADNI1 INCLUSIO Inclusion Criteria
INCMCOMP 2. NL - Is participant free of memory complaints, verified by an informant, aside from those normal with age?
MCI - Does the subject have memory complaints and memory difficulties that are verified by an informant?
AD - Does the subject have memory complaints that are verified by an informant?		 1=Yes;0=No ADNI1 INCLUSIO Inclusion Criteria
INCIMAG 16. Is the participant willing to undergo MRI 1.5 Tesla neuroimaging (PET and MRI 3 Tesla are optional) and provide DNA for ApoE assessments and banking as well as plasma samples at protocol specified time points? 1=Yes; 0=No ADNI1 INCLUSIO Inclusion Criteria
USERID2 N/A N/A ADNI1 INCLUSIO Inclusion Criteria
RID Participant roster ID -4 ADNI1 INVENTORY Inventory
STUDYID_LONI -4 -4 ADNI1 INVENTORY Inventory
USERID N/A -4 ADNI1 ISOPROSTANE Baseleine isoprostanes data. ADNI Biomarker Core laboratory
ID Record ID "crfname","Laboratory Data","indexes","adni_labdata_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 LABDATA Laboratory Data
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
AXT117 Test AXT117; Thyroid Stim. Hormone N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
HMT60 Test HMT60; Lymphocyte, Plasmacytoid N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
HMT84 Test HMT84; Lymphocyte, Plasmacytoid N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
RCT19 Test RCT19; Triglycerides (GPO) N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
SLT3 Test SLT3; Rapid Plasma Reagin N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
ID Record ID "crfname","Clinical Laboratory Tests","indexes","adni_labtests_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 LABTESTS Clinical Laboratory Tests
SITEID Site ID N/A ADNI1 LABTESTS Clinical Laboratory Tests
USERID N/A N/A ADNI1 LABTESTS Clinical Laboratory Tests
USERID2 N/A N/A ADNI1 LABTESTS Clinical Laboratory Tests
ID Record ID "crfname","CSF - Local Lab Results","indexes","adni_loclab_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 LOCLAB CSF - Local Lab Results
USERID N/A N/A ADNI1,ADNIGO LOCLAB CSF - Local Lab Results
ID Record ID "crfname","","indexes","","notnullcols","ID,USERID,USERDATE,SID,TYPE" ADNI1,ADNIGO LOGGING N/A
ID Record ID "crfname","Medical History","indexes","adni_medhist_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 MEDHIST Medical History
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 MEDHIST Medical History
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 MEDHIST Medical History
USERID N/A N/A ADNI1,ADNIGO,ADNI2 MEDHIST Medical History
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 MEDHIST Medical History
ID Record ID "crfname","Mini Mental State Exam","indexes","adni_mmse_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 MMSE Mini Mental State Exam
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 MMSE Mini Mental State Exam
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 MMSE Mini Mental State Exam
USERID N/A N/A ADNI1,ADNIGO,ADNI2 MMSE Mini Mental State Exam
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 MMSE Mini Mental State Exam
ID Record ID "crfname","Modified Hachinski","indexes","adni_modhach_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 MODHACH Modified Hachinski
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 MODHACH Modified Hachinski
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 MODHACH Modified Hachinski
USERID N/A N/A ADNI1,ADNIGO,ADNI2 MODHACH Modified Hachinski
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 MODHACH Modified Hachinski
ID Record ID "crfname","3T MRI Scan Information","indexes","adni_mri3meta_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRI3META 3T MRI Scan Information
RID Participant roster ID N/A ADNI1 MRI3META 3T MRI Scan Information
SITEID Site ID N/A ADNI1 MRI3META 3T MRI Scan Information
USERID N/A N/A ADNI1 MRI3META 3T MRI Scan Information
USERID2 N/A N/A ADNI1 MRI3META 3T MRI Scan Information
ID Record ID "crfname","MRI B1 Calibration","indexes","adni_mrib1calib_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIB1CALIB MRI B1 Calibration
RID Participant roster ID N/A ADNI1 MRIB1CALIB MRI B1 Calibration
SITEID Site ID N/A ADNI1 MRIB1CALIB MRI B1 Calibration
USERID N/A N/A ADNI1 MRIB1CALIB MRI B1 Calibration
LONISID LONI Study ID N/A ADNI1 MRIB1CALIB MRI B1 Calibration
USERID2 N/A N/A ADNI1 MRIB1CALIB MRI B1 Calibration
ID Record ID "crfname","1.5T MRI Scan Information","indexes","adni_mrimeta_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIMETA 1.5T MRI Scan Information
RID Participant roster ID N/A ADNI1,ADNIGO MRIMETA 1.5T MRI Scan Information
SITEID Site ID N/A ADNI1,ADNIGO MRIMETA 1.5T MRI Scan Information
USERID N/A N/A ADNI1,ADNIGO MRIMETA 1.5T MRI Scan Information
USERID2 N/A N/A ADNI1,ADNIGO MRIMETA 1.5T MRI Scan Information
ID Record ID "crfname","MRI MPRAGE Process","indexes","adni_mrimppro_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIMPPRO MRI MPRAGE Process
RID Participant roster ID N/A ADNI1 MRIMPPRO MRI MPRAGE Process
SITEID Site ID N/A ADNI1 MRIMPPRO MRI MPRAGE Process
USERID N/A N/A ADNI1 MRIMPPRO MRI MPRAGE Process
LONISID LONI Study ID N/A ADNI1 MRIMPPRO MRI MPRAGE Process
LONIUID LONI Unique Series ID selected for processing. This field identifies which scan the MRI Core has selected to be the preferred scan to be used for processing. MPRAGE Rankings: The MPRAGE rankings are done in a qualitative manner.A scan with a 1 ranking is considered a high quality scan. A 2 ranking is considered a medium quality scan. 3 ranking is a low quality scan.3 is the lowest ranking a scan can receive and still be considered a passing scan. Anything below 3 would be a failure for quality. The rankings are found in the MRIMPRANK table in the RANK field. Choosing MPRAGES: For scans ranked 2 and 3 the scan ranked 2 (whatever is the lower ranking of the two) should always be the "preferred/chosen" MPRAGE. If the rankings are tied in ranking the QC-er would chose the "sharper of the two". If the two scans are identical the first MPRAGE was always chosen. N/A ADNI1 MRIMPPRO MRI MPRAGE Process
USERID2 N/A N/A ADNI1 MRIMPPRO MRI MPRAGE Process
ID Record ID "crfname","MRI MPRAGE Ranking","indexes","adni_mrimprank_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIMPRANK MRI MPRAGE Ranking
RID Participant roster ID N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
SITEID Site ID N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
USERID N/A N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
LONISID LONI Study ID N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
LONIUID LONI Unique Series ID N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
RANK MPRAGE Rankings: The MPRAGE rankings are done in a qualitative manner.A scan with a 1 ranking is considered a high quality scan. A 2 ranking is considered a medium quality scan. 3 ranking is a low quality scan.3 is the lowest ranking a scan can receive and still be considered a passing scan. Anything below 3 would be a failure for quality. Choosing MPRAGES: For scans ranked 2 and 3 the scan ranked 2 (whatever is the lower ranking of the two) should always be the "preferred/chosen"MPRAGE. If the rankings are tied in ranking the QC-er would chose the"sharper of the two". If the two scans are identical the first MPRAGE was always chosen. The preferred scan is indicated by the LONIUID field in the MRIMPPRO table. N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
USERID2 N/A N/A ADNI1 MRIMPRANK MRI MPRAGE Ranking
ID Record ID "crfname","Archive MRI Subject Inclusion","indexes","adni_mrincl1_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRINCL1 Archive MRI Subject Inclusion
RID Participant roster ID N/A ADNI1,ADNIGO MRINCL1 Archive MRI Subject Inclusion
SITEID Site ID N/A ADNI1,ADNIGO MRINCL1 Archive MRI Subject Inclusion
USERID N/A N/A ADNI1,ADNIGO MRINCL1 Archive MRI Subject Inclusion
LONISID LONI Study ID N/A ADNI1,ADNIGO MRINCL1 Archive MRI Subject Inclusion
USERID2 N/A N/A ADNI1,ADNIGO MRINCL1 Archive MRI Subject Inclusion
ID Record ID "crfname","MRI Subject Inclusion","indexes","adni_mrinclusio_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRINCLUSIO MRI Subject Inclusion
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 MRINCLUSIO MRI Subject Inclusion
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 MRINCLUSIO MRI Subject Inclusion
USERID N/A N/A ADNI1,ADNIGO,ADNI2 MRINCLUSIO MRI Subject Inclusion
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 MRINCLUSIO MRI Subject Inclusion
LONISID LONI Study ID N/A ADNI1,ADNIGO,ADNI2 MRINCLUSIO MRI Subject Inclusion
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 VITALS Vital Signs
IMAGEUID N/A N/A ADNI1 UWOVENT University of Western Ontario (Bartha Lab) Ventricular Volumes
ID Record ID "crfname","Vital Signs","indexes","adni_vitals_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 VITALS Vital Signs
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 VITALS Vital Signs
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 VITALS Vital Signs
USERID N/A N/A ADNI1,ADNIGO,ADNI2 VITALS Vital Signs
ID Record ID "indexes","adni_uwovent_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 UWOVENT University of Western Ontario (Bartha Lab) Ventricular Volumes
RID Participant roster ID N/A ADNI1 UWOVENT University of Western Ontario (Bartha Lab) Ventricular Volumes
SITEID Site ID N/A ADNI1 UWOVENT University of Western Ontario (Bartha Lab) Ventricular Volumes
USERID N/A N/A ADNI1 UWOVENT University of Western Ontario (Bartha Lab) Ventricular Volumes
ID Record ID "crfname","MRI Phantom","indexes","adni_mriphantom_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIPHANTOM MRI Phantom
RID Participant roster ID N/A ADNI1 MRIPHANTOM MRI Phantom
SITEID Site ID N/A ADNI1 MRIPHANTOM MRI Phantom
USERID -4 -4 ADNI1 UPENNBIOMK3 UPENN Longitudinal Biomarker Data (3 yr)
USERID -4 -4 ADNI1 UPENNBIOMK2 UPENN Longitudinal Biomarker Data
PTAU181P CSF pTau181p concentration data for BASELINE, YEAR1 and YEAR 2 will bequarantined temporarily due to our discovery that for some individualsamples there appears to be greater analytical variability than shouldbe the case. We are working with the manufacturer of the immunoassayreagents we use for the CSF biomarker measurements, Innogenetics, andhave worked out a procedural change that eliminates this extraneousnoise. Once the retesting analyses are completed the new data will beuploaded with accompanying description.ADNI Biomarker Core laboratory at UPenn N/A ADNI1 UPENNBIOMK UPENN Biomarker Data
SITEID Site ID N/A ADNI1 UPENNBIOMK UPENN Biomarker Data
USERID N/A N/A ADNI1 UPENNBIOMK UPENN Biomarker Data
USERID2 N/A N/A ADNI1 UPENNBIOMK UPENN Biomarker Data
USERID N/A N/A ADNI1 MRIPHANTOM MRI Phantom
ID Record ID "crfname","UPENN Biomarker Data","indexes","adni_upennbiomk_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 UPENNBIOMK UPENN Biomarker Data
RID Participant roster ID N/A ADNI1 UPENNBIOMK UPENN Biomarker Data
USERID N/A -4 ADNI1 UCSFSNTVOL UCSF SNT Hippocampal Volumes
LONISID LONI Study ID N/A ADNI1 MRIPHANTOM MRI Phantom
LONIPSID Phantom - LONI Study ID N/A ADNI1 MRIPHANTOM MRI Phantom
USERID2 N/A N/A ADNI1 MRIPHANTOM MRI Phantom
ID Record ID "crfname","MRI Protocol","indexes","adni_mriprot_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIPROT MRI Protocol
RID Participant roster ID N/A ADNI1 MRIPROT MRI Protocol
SITEID Site ID N/A ADNI1 MRIPROT MRI Protocol
USERID N/A N/A ADNI1 MRIPROT MRI Protocol
LONISID LONI Study ID N/A ADNI1 MRIPROT MRI Protocol
LONIUID LONI Unique Series ID N/A ADNI1 MRIPROT MRI Protocol
USERID2 N/A N/A ADNI1 MRIPROT MRI Protocol
ID Record ID "crfname","MRI Quality","indexes","adni_mriquality_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRIQUALITY MRI Quality
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 MRIQUALITY MRI Quality
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 MRIQUALITY MRI Quality
USERID N/A N/A ADNI1,ADNIGO,ADNI2 MRIQUALITY MRI Quality
LONISID LONI Study ID N/A ADNI1,ADNIGO,ADNI2 MRIQUALITY MRI Quality
LONIUID LONI Unique Series ID N/A ADNI1,ADNIGO,ADNI2 MRIQUALITY MRI Quality
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 MRIQUALITY MRI Quality
ID Record ID "crfname","MRI Clinical Read","indexes","adni_mriread_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 MRIREAD MRI Clinical Read
RID Participant roster ID N/A ADNI1 MRIREAD MRI Clinical Read
SITEID Site ID N/A ADNI1 MRIREAD MRI Clinical Read
USERID N/A N/A ADNI1 MRIREAD MRI Clinical Read
USERID2 N/A N/A ADNI1 MRIREAD MRI Clinical Read
ID Record ID "crfname","MRI Serial","indexes","adni_mriserial_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 MRISERIAL MRI Serial
RID Participant roster ID N/A ADNI1 MRISERIAL MRI Serial
SITEID Site ID N/A ADNI1 MRISERIAL MRI Serial
USERID N/A N/A ADNI1 MRISERIAL MRI Serial
LONISID LONI Study ID N/A ADNI1 MRISERIAL MRI Serial
LONIUID LONI Unique Series ID N/A ADNI1 MRISERIAL MRI Serial
BLLONIUID LONI Unique Series ID for the baseline scan. N/A ADNI1 MRISERIAL MRI Serial
USERID2 N/A N/A ADNI1 MRISERIAL MRI Serial
ID Record ID "crfname","Neuropsychological Battery","indexes","adni_neurobat_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 NEUROBAT Neuropsychological Battery
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 NEUROBAT Neuropsychological Battery
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 NEUROBAT Neuropsychological Battery
USERID N/A N/A ADNI1,ADNIGO,ADNI2 NEUROBAT Neuropsychological Battery
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 NEUROBAT Neuropsychological Battery
ID Record ID "crfname","Neurological Exam","indexes","adni_neuroexm_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 NEUROEXM Neurological Exam
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 NEUROEXM Neurological Exam
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 NEUROEXM Neurological Exam
USERID N/A N/A ADNI1,ADNIGO,ADNI2 NEUROEXM Neurological Exam
NXGAIDES Details N/A ADNI1,ADNIGO,ADNI2 NEUROEXM Neurological Exam
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 NEUROEXM Neurological Exam
ID Record ID "crfname","Neuropsychiatric Inventory Q","indexes","adni_npiq_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 NPIQ Neuropsychiatric Inventory Q
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 NPIQ Neuropsychiatric Inventory Q
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 NPIQ Neuropsychiatric Inventory Q
USERID N/A N/A ADNI1,ADNIGO,ADNI2 NPIQ Neuropsychiatric Inventory Q
NPID Does {P} act as if he/she is sad or in low spirits? Does he/she cry? 0=No;1=Yes;2=N/A ADNI1,ADNIGO,ADNI2 NPIQ Neuropsychiatric Inventory Q
NPIDSEV Severity Ratings 1=1 - Mild (noticeable, but not a significant change).; 2=2 - Moderate (significant, but not a dramatic change).; 3=3 - Severe (very marked or prominent. A dramatic change). ADNI1,ADNIGO,ADNI2 NPIQ Neuropsychiatric Inventory Q
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 NPIQ Neuropsychiatric Inventory Q
ID Record ID "crfname","Diagnostic Summary","indexes","adni_pdxconv_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 PDXCONV Diagnostic Summary
RID Participant roster ID N/A ADNI1 PDXCONV Diagnostic Summary
SITEID Site ID N/A ADNI1 PDXCONV Diagnostic Summary
USERID N/A N/A ADNI1 PDXCONV Diagnostic Summary
DXCONFID Physician Confidence in Diagnosis: 1=Uncertain; 2=Mildly Confident; 3=Moderately Confident; 4=Highly Confident ADNI1 PDXCONV Diagnostic Summary
USERID2 N/A N/A ADNI1 PDXCONV Diagnostic Summary
ID Record ID "crfname","PET Scan Information","indexes","adni_petmeta_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 PETMETA PET Scan Information
RID Participant roster ID N/A ADNI1 PETMETA PET Scan Information
SITEID Site ID N/A ADNI1 PETMETA PET Scan Information
USERID N/A N/A ADNI1 PETMETA PET Scan Information
PMCONSENT Did the participant consent to quantitative scan? 1=Yes;0=No ADNI1 PETMETA PET Scan Information
PMGLUCOM Provide an explanation if blood glucose was measured after the FDG injection N/A ADNI1 PETMETA PET Scan Information
PMSCANCOM Provide an explanation if start time is not within the allowable window N/A ADNI1 PETMETA PET Scan Information
PMPROTID Predefined acquisition protocol ID N/A ADNI1 PETMETA PET Scan Information
PMWITHTIME If No, provide the time difference N/A ADNI1 PETMETA PET Scan Information
PMCOUNTIME If No, provide the time difference N/A ADNI1 PETMETA PET Scan Information
USERID2 N/A N/A ADNI1 PETMETA PET Scan Information
ID Record ID "crfname","PET QC Tracking","indexes","adni_petqc_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 PETQC PET QC Tracking
RID Participant roster ID N/A ADNI1 PETQC PET QC Tracking
SITEID Site ID N/A ADNI1 PETQC PET QC Tracking
USERID N/A N/A ADNI1 PETQC PET QC Tracking
LONIUID LONI Unique Series ID N/A ADNI1 PETQC PET QC Tracking
USERID2 N/A N/A ADNI1 PETQC PET QC Tracking
ID Record ID "crfname","Physical Exam","indexes","adni_physical_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 PHYSICAL Physical Exam
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 PHYSICAL Physical Exam
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 PHYSICAL Physical Exam
USERID N/A N/A ADNI1,ADNIGO,ADNI2 PHYSICAL Physical Exam
PXSKIDES Details N/A ADNI1,ADNIGO,ADNI2 PHYSICAL Physical Exam
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 PHYSICAL Physical Exam
ID Record ID "crfname","PIB Scan Information","indexes","adni_pibmeta_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 PIBMETA PIB Scan Information
RID Participant roster ID N/A ADNI1 PIBMETA PIB Scan Information
SITEID Site ID N/A ADNI1 PIBMETA PIB Scan Information
USERID N/A N/A ADNI1 PIBMETA PIB Scan Information
PBRESTIME Time of residual PIB assay N/A ADNI1 PIBMETA PIB Scan Information
PBRESID Residual left in syringe N/A ADNI1 PIBMETA PIB Scan Information
PBSCANCOM Provide an explanation if start time is not within the allowable window N/A ADNI1 PIBMETA PIB Scan Information
PBPROTID Predefined acquisition protocol ID N/A ADNI1 PIBMETA PIB Scan Information
USERID2 N/A N/A ADNI1 PIBMETA PIB Scan Information
ID Record ID "crfname","PIB QC Tracking","indexes","adni_pibqc_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 PIBQC PIB QC Tracking
RID Participant roster ID N/A ADNI1 PIBQC PIB QC Tracking
SITEID Site ID N/A ADNI1 PIBQC PIB QC Tracking
USERID N/A N/A ADNI1 PIBQC PIB QC Tracking
LONIUID LONI Unique Series ID N/A ADNI1 PIBQC PIB QC Tracking
USERID2 N/A N/A ADNI1 PIBQC PIB QC Tracking
ID Record ID "crfname","Participant Demographic Information","indexes","adni_ptdemog_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 PTDEMOG Participant Demographic Information
RID Participant roster ID N/A ADNI1 PTDEMOG Participant Demographic Information
SITEID Site ID N/A ADNI1 PTDEMOG Participant Demographic Information
USERID N/A N/A ADNI1 PTDEMOG Participant Demographic Information
PTHOME 8. Type of Participant residence 1=House; 2=Condo/Co-op (owned); 3=Apartment (rented); 4=Mobile Home; 5=Retirement Community; 6=Assisted Living; 7=Skilled Nursing Facility; 8=Other (specify) ADNI1 PTDEMOG Participant Demographic Information
USERID2 N/A N/A ADNI1 PTDEMOG Participant Demographic Information
ID Record ID "crfname","","indexes","adni_qc_idx=QAID,RECNO","notnullcols","ID,QAID,RECNO,USERID,USERDATE" ADNI1 QC N/A
QAID N/A N/A ADNI1,ADNIGO QC N/A
USERID N/A N/A ADNI1,ADNIGO QC N/A
USERID2 N/A N/A ADNI1,ADNIGO QC N/A
ID Record ID -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
RID Participant roster ID -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
RBMID RBM Sample ID -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
BNP Brain Natriuretic Peptide -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
CPEPTIDE C-peptide -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
EGF Epidermal Growth Factor -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
EGFR Epidermal Growth Factor Receptor -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
FABP Fatty Acid-Binding Protein- heart -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
GLP1TO Glucagon-like Peptide 1- total -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
KIM1 Kidney Injury Molecule-1 -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
LOX Lectin-Like Oxidized LDL Receptor 1 -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
MYLDPIF1 Myeloid Progenitor Inhibitory Factor 1 -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
MPO Myeloperoxidase -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
PAP Prostatic Acid Phosphatase -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
PPP Pancreatic Polypeptide -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
PYY Peptide YY -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
SAP Serum Amyloid P-Component -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
SOD1 Superoxide Dismutase 1- Soluble -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
TSH Thyroid-Stimulating Hormone -4 ADNI1 RBMQC Rules Based Medicine Plasma Multiplex QC Data
ID Record ID N/A ADNI1 RBMRAW Rules Based Medicine Plasma Multiplex Raw Data
RID Participant roster ID N/A ADNI1 RBMRAW Rules Based Medicine Plasma Multiplex Raw Data
RBMID Sample ID from RBM N/A ADNI1 RBMRAW Rules Based Medicine Plasma Multiplex Raw Data
OUTLIER Is analval considered an outlier (see primer for details) 0=no; 1=yes ADNI1 RBMRAW Rules Based Medicine Plasma Multiplex Raw Data
ID Record ID "crfname","Adverse Events/Hospitalizations - Log","indexes","adni_recadv_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 RECADV Adverse Events/Hospitalizations - Log
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 RECADV Adverse Events/Hospitalizations - Log
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 RECADV Adverse Events/Hospitalizations - Log
USERID N/A N/A ADNI1,ADNIGO,ADNI2 RECADV Adverse Events/Hospitalizations - Log
AEHINHOS Did this event occur while the participant was being hospitalized for another event? 1=Yes; 0=No ADNI1,ADNIGO RECADV Adverse Events/Hospitalizations - Log
AEHPRO If Yes, did this event prolong hospitalization? 1=Yes; 0=No ADNI1,ADNIGO RECADV Adverse Events/Hospitalizations - Log
AEHHOSP If No, did this event require hospitalization? 3=No; 2=Yes - Outpatient; 1=Yes - Inpatient ADNI1,ADNIGO RECADV Adverse Events/Hospitalizations - Log
AEHOUTDT If Outpatient, provide the date of visit N/A ADNI1,ADNIGO RECADV Adverse Events/Hospitalizations - Log
AEHDEATH Did this event result in death? 1=Yes; 0=No ADNI1,ADNIGO RECADV Adverse Events/Hospitalizations - Log
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 RECADV Adverse Events/Hospitalizations - Log
ID Record ID "crfname","Documentation of Baseline Symptoms Log","indexes","adni_recbllog_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 RECBLLOG Documentation of Baseline Symptoms Log
RID Participant roster ID N/A ADNI1,ADNIGO RECBLLOG Documentation of Baseline Symptoms Log
SITEID Site ID N/A ADNI1,ADNIGO RECBLLOG Documentation of Baseline Symptoms Log
USERID N/A N/A ADNI1,ADNIGO RECBLLOG Documentation of Baseline Symptoms Log
USERID2 N/A N/A ADNI1,ADNIGO RECBLLOG Documentation of Baseline Symptoms Log
ID Record ID "crfname","Concurrent Medications Log","indexes","adni_reccmeds_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 RECCMEDS Concurrent Medications Log
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 RECCMEDS Concurrent Medications Log
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 RECCMEDS Concurrent Medications Log
USERID N/A N/A ADNI1,ADNIGO,ADNI2 RECCMEDS Concurrent Medications Log
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 RECCMEDS Concurrent Medications Log
ID Record ID "crfname","Family History Questionnaire Subtable","indexes","adni_recfhq_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 RECFHQ Family History Questionnaire Subtable
RID Participant roster ID N/A ADNI1 RECFHQ Family History Questionnaire Subtable
SITEID Site ID N/A ADNI1 RECFHQ Family History Questionnaire Subtable
USERID N/A N/A ADNI1 RECFHQ Family History Questionnaire Subtable
USERID2 N/A N/A ADNI1 RECFHQ Family History Questionnaire Subtable
ID Record ID "crfname","Medical History","indexes","adni_recmhist_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 RECMHIST Medical History
RID Participant roster ID N/A ADNI1 RECMHIST Medical History
SITEID Site ID N/A ADNI1 RECMHIST Medical History
USERID N/A N/A ADNI1 RECMHIST Medical History
USERID2 N/A N/A ADNI1 RECMHIST Medical History
ID Record ID "crfname","Registry","indexes","adni_registry_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 REGISTRY Registry
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 REGISTRY Registry
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 REGISTRY Registry
USERID N/A N/A ADNI1,ADNIGO,ADNI2 REGISTRY Registry
RGPREVID If Yes, what was the participant's initial ID number? N/A ADNI1,ADNIGO,ADNI2,ADNI3 REGISTRY Registry
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 REGISTRY Registry
ID Record ID "crfname","Roster","indexes","adni_roster_idx2=ENTRY,PTID;adni_roster_idx=RID,ENTRY","notnullcols","ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID" ADNI1 ROSTER Roster
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 ROSTER Roster
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 ROSTER Roster
USERID N/A N/A ADNI1,ADNIGO,ADNI2 ROSTER Roster
PTID Participant ID N/A ADNI1,ADNIGO,ADNI2,ADNI3 ROSTER Roster
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 ROSTER Roster
ID Record ID "crfname","","indexes","","notnullcols","" ADNI1,ADNIGO SITES_VWX N/A
RID Participant roster ID -4 ADNI1 STROKESUM Stroke Summary
SIDE Side -4 ADNI1 STROKESUM Stroke Summary
IMAGE.ID_1 IMAGE ID of the screening scan -4 ADNI1 TBM Thompson Lab - Cross-sectional and longitudinal tensor-based morphometry Version 2.0
IMAGE.ID_2 IMAGE ID of the follow-up scan; see VISCODE -4 ADNI1 TBM Thompson Lab - Cross-sectional and longitudinal tensor-based morphometry Version 2.0
RID Participant roster ID -4 ADNI1 TOMM40 TOMM40 PolyT variable length polymorphism
ID Record ID "crfname","Early Discontinuation and Withdrawal","indexes","adni_treatdis_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNI1 TREATDIS Early Discontinuation and Withdrawal
RID Participant roster ID N/A ADNI1,ADNIGO,ADNI2 TREATDIS Early Discontinuation and Withdrawal
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 TREATDIS Early Discontinuation and Withdrawal
USERID N/A N/A ADNI1,ADNIGO,ADNI2 TREATDIS Early Discontinuation and Withdrawal
WDPARTCOM Please provide any additional information regarding the withdrawal. If individual procedures are being discontinued for different reasons, please provide an explanation. N/A ADNI1,ADNIGO,ADNI2 TREATDIS Early Discontinuation and Withdrawal
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 TREATDIS Early Discontinuation and Withdrawal
USERID N/A N/A ADNI1 UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
ID Record ID "crfname","Jagust Lab (UCB) - PET ROI analysis","indexes","adni_ucbpet_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 UCBPET Jagust Lab (UCB) - PET ROI analysis
RID Participant roster ID N/A ADNI1 UCBPET Jagust Lab (UCB) - PET ROI analysis
SITEID Site ID N/A ADNI1 UCBPET Jagust Lab (UCB) - PET ROI analysis
USERID N/A N/A ADNI1 UCBPET Jagust Lab (UCB) - PET ROI analysis
IMAGEUID imageUID N/A ADNI1 UCBPET Jagust Lab (UCB) - PET ROI analysis
USERID2 N/A N/A ADNI1 UCBPET Jagust Lab (UCB) - PET ROI analysis
USERID N/A -4 ADNI1 UCSFATRPHY UCSF (Colin Studholme) Regional Atrophy Rates
RID Participant roster ID N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
SITEID Site ID N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
LONISID1 The LONI study UID for the image used as prior information. N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
LONIUID1 The LONI Series UID for the image used as prior information. N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
IMAGEUID1 The ImageUID for the image used as prior information. N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
LONISID2 The LONI study UID for the image processed N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
LONIUID2 The LONI series UID for the image processed. N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
IMAGEUID2 The ImageUID for the image processed. N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
SUPRQC QC rating of the superior cortex. Fail affects the following regions: LeftPrecentral (ST51), RightPrecentral (ST110), LeftPostcentral (ST49), RightPostcentral (ST108), LeftSuperiorParietal (ST57), RightSuperiorParietal (ST116), LeftCuneus (ST23), RightCuneus (ST82), LeftParacentral (ST43), RightParacentral (ST102), LeftCaudalMiddleFrontal (ST15), RightCaudalMiddleFrontal (ST74), LeftCerebralWM (ST20), RightCerebralWM (ST79) Pass=Pass; Fail=Fail ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST101SV Volume (WM Parcellation) of RightPallidum N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST114CV Volume (Cortical Parcellation) of RightRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST114SA Surface Area of RightRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST114TA Cortical Thickness Average of RightRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST114TS Cortical Thickness Standard Deviation of RightRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST15CV Volume (Cortical Parcellation) of LeftCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST15SA Surface Area of LeftCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST15TA Cortical Thickness Average of LeftCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST15TS Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST21SV Volume (WM Parcellation) of LeftChoroidPlexus N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST40CV Volume (Cortical Parcellation) of LeftMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST40SA Surface Area of LeftMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST40TA Cortical Thickness Average of LeftMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST40TS Cortical Thickness Standard Deviation of LeftMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST42SV Volume (WM Parcellation) of LeftPallidum N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST4SV Volume (WM Parcellation) of CorpusCallosumMidAnterior N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST55CV Volume (Cortical Parcellation) of LeftRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST55SA Surface Area of LeftRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST55TA Cortical Thickness Average of LeftRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST55TS Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST5SV Volume (WM Parcellation) of CorpusCallosumMidPosterior N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST74CV Volume (Cortical Parcellation) of RightCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST74SA Surface Area of RightCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST74TA Cortical Thickness Average of RightCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST74TS Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST80SV Volume (WM Parcellation) of RightChoroidPlexus N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST99CV Volume (Cortical Parcellation) of RightMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST99SA Surface Area of RightMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST99TA Cortical Thickness Average of RightMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ST99TS Cortical Thickness Standard Deviation of RightMiddleTemporal N/A ADNI1 UCSFFRESFR Longitudinal FreeSurfer
ID Record ID "crfname","Banner Alzheimer's Institute NMRC Summaries","indexes","adni_bainmrc_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNI1 BAINMRC Banner Alzheimer's Institute NMRC Summaries
SITEID Site ID N/A ADNI1 BAINMRC Banner Alzheimer's Institute NMRC Summaries
USERID2 N/A N/A ADNI1 BAINMRC Banner Alzheimer's Institute NMRC Summaries
BILPFLCOM If Fluoroscopy performed, but no CSF was collected, provide explanation N/A ADNI1,ADNIGO BIOMARK Biomarker Samples
USERID2 N/A N/A ADNI1,ADNIGO,ADNI2 BIOMARK Biomarker Samples
USERID N/A N/A ADNI1,ADNIGO CSFMETH Method of CSF Collection
USERID N/A N/A ADNI1 FHQ Family History Questionnaire
USERID2 N/A N/A ADNI1,ADNIGO HCRES Homocysteine - Results
RID Participant roster ID N/A ADNI1 INCLUSIO Inclusion Criteria
USERID N/A N/A ADNI1 INCLUSIO Inclusion Criteria
SITEID Site ID N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
USERID N/A N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
RCT8 Test RCT8; Serum Uric Acid N/A ADNI1,ADNIGO,ADNI2 LABDATA Laboratory Data
RID Participant roster ID N/A ADNI1 LABTESTS Clinical Laboratory Tests
RID Participant roster ID N/A ADNI1,ADNIGO LOCLAB CSF - Local Lab Results
SITEID Site ID N/A ADNI1,ADNIGO LOCLAB CSF - Local Lab Results
USERID2 N/A N/A ADNI1,ADNIGO LOCLAB CSF - Local Lab Results
USERID N/A N/A ADNI1,ADNIGO LOGGING N/A
USERID2 N/A N/A ADNI1,ADNIGO LOGGING N/A
SID N/A N/A ADNI1,ADNIGO LOGGING N/A
LONISID LONI Study ID -4 ADNI1 MAYOADIRL_MRI_FMRI Jack Lab - Default Mode Network connectivity
LONIUID LONI Series ID -4 ADNI1 MAYOADIRL_MRI_FMRI Jack Lab - Default Mode Network connectivity
ID Record ID "crfname","","indexes","adnigo_aal_idx=TBLID,FLDID,TRANSNID","notnullcols","ID,USERID,USERDATE,USERNUM,TBLID,FLDID,TRANSNID,REASONID,CHANGE" ADNIGO AAL N/A
ID Record ID "crfname","","indexes","adnigo_aalfld_idx=FLDNAME","notnullcols","ID,USERID,USERDATE,FLDNAME" ADNIGO AALFLD N/A
ID Record ID "crfname","","indexes","adnigo_aalreason_idx=REASON","notnullcols","ID,USERID,USERDATE,TYPE,REASON" ADNIGO AALREASON N/A
ID Record ID "crfname","","indexes","adnigo_aaltbl_idx=TBLNAME","notnullcols","ID,USERID,USERDATE,TBLNAME" ADNIGO AALTBL N/A
ID Record ID "crfname","","indexes","adnigo_aaluser_idx=USERNAME","notnullcols","ID,USERID,USERDATE,USERNAME" ADNIGO AALUSER N/A
ID Record ID "crfname","","indexes","adnigo_aalvalue_idx=VALUE","notnullcols","ID,USERID,USERDATE,VALUE" ADNIGO AALVALUE N/A
ID Record ID "crfname","ADAS-Cognitive Behavior","indexes","adnigo_adas_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO ADAS ADAS-Cognitive Behavior
Q6UNABLE 6. Ideational Praxis 1=Not done (for reasons other than physical/cognitive); 2=Participant refused; 3=Participant unable for physical reasons; 4=Participant unable for cognitive reasons ADNIGO,ADNI2 ADAS ADAS-Cognitive Behavior
Q6TASK 1=Fold a letter; 2=Put letter in envelope; 3=Seal envelope; 4=Address envelope; 5=Indicate where stamp goes; 0=None completed correctly ADNIGO ADAS ADAS-Cognitive Behavior
ID Record ID "crfname","Visit Comments","indexes","adnigo_addcomm_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO ADDCOMM Visit Comments
RID Participant roster ID N/A ADNIGO,ADNI2 ADDCOMM Visit Comments
SITEID Site ID N/A ADNIGO,ADNI2 ADDCOMM Visit Comments
USERID N/A N/A ADNIGO,ADNI2 ADDCOMM Visit Comments
USERID2 N/A N/A ADNIGO,ADNI2 ADDCOMM Visit Comments
ID Record ID "crfname","Diagnosis and Symptoms Checklist","indexes","adnigo_adsxlist_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO ADSXLIST Diagnosis and Symptoms Checklist
ID Record ID "crfname","ApoE / GWAS / RNA Genotyping","indexes","adnigo_apoe_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO APOE ApoE / GWAS / RNA Genotyping
RID Participant roster ID N/A ADNIGO APOE ApoE / GWAS / RNA Genotyping
SITEID Site ID N/A ADNIGO APOE ApoE / GWAS / RNA Genotyping
USERID N/A N/A ADNIGO APOE ApoE / GWAS / RNA Genotyping
USERID2 N/A N/A ADNIGO APOE ApoE / GWAS / RNA Genotyping
ID Record ID "crfname","ApoE Genotyping - Results","indexes","adnigo_apoeres_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO APOERES ApoE Genotyping - Results
ID Record ID "crfname","","notnullcols","ID,USERID,USERDATE,RID,SITEID,PTNO,TYPE" ADNIGO ARM N/A
ID Record ID "crfname","AV-45 24-48 Hour Follow-Up","indexes","adnigo_av45follow_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO AV45FOLLOW AV-45 24-48 Hour Follow-Up
RID Participant roster ID N/A ADNIGO AV45FOLLOW AV-45 24-48 Hour Follow-Up
SITEID Site ID N/A ADNIGO AV45FOLLOW AV-45 24-48 Hour Follow-Up
USERID N/A N/A ADNIGO AV45FOLLOW AV-45 24-48 Hour Follow-Up
USERID2 N/A N/A ADNIGO AV45FOLLOW AV-45 24-48 Hour Follow-Up
ID Record ID "crfname","AV-45 PET Scan Information","indexes","adnigo_av45meta_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO AV45META AV-45 PET Scan Information
RID Participant roster ID N/A ADNIGO AV45META AV-45 PET Scan Information
SITEID Site ID N/A ADNIGO AV45META AV-45 PET Scan Information
USERID N/A N/A ADNIGO AV45META AV-45 PET Scan Information
USERID2 N/A N/A ADNIGO AV45META AV-45 PET Scan Information
PMSCANCOM Target start time is 50 min AV-45 post-injection. Provide an explanation if start time is not between 48 and 52 min post-injection. N/A ADNIGO AV45META AV-45 PET Scan Information
PMPROTID Predefined Acquisition Protocol ID N/A ADNIGO AV45META AV-45 PET Scan Information
ID Record ID "crfname","AV-45 PET QC Tracking","indexes","adnigo_av45qc_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO AV45QC AV-45 PET QC Tracking
RID Participant roster ID N/A ADNIGO AV45QC AV-45 PET QC Tracking
SITEID Site ID N/A ADNIGO AV45QC AV-45 PET QC Tracking
USERID N/A N/A ADNIGO AV45QC AV-45 PET QC Tracking
USERID2 N/A N/A ADNIGO AV45QC AV-45 PET QC Tracking
LONIUID LONI Unique Series ID N/A ADNIGO AV45QC AV-45 PET QC Tracking
ID Record ID "crfname","AV-45 Pre and Post Injection Vitals","indexes","adnigo_av45vitals_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO AV45VITALS AV-45 Pre and Post Injection Vitals
RID Participant roster ID N/A ADNIGO AV45VITALS AV-45 Pre and Post Injection Vitals
SITEID Site ID N/A ADNIGO AV45VITALS AV-45 Pre and Post Injection Vitals
USERID N/A N/A ADNIGO AV45VITALS AV-45 Pre and Post Injection Vitals
USERID2 N/A N/A ADNIGO AV45VITALS AV-45 Pre and Post Injection Vitals
ID Record ID "crfname","Key Background Medications","indexes","adnigo_backmeds_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO BACKMEDS Key Background Medications
RID Participant roster ID N/A ADNIGO,ADNI2 BACKMEDS Key Background Medications
SITEID Site ID N/A ADNIGO,ADNI2 BACKMEDS Key Background Medications
USERID N/A N/A ADNIGO,ADNI2 BACKMEDS Key Background Medications
USERID2 N/A N/A ADNIGO,ADNI2 BACKMEDS Key Background Medications
ID Record ID "crfname","Biomarker Samples","indexes","adnigo_biomark_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO BIOMARK Biomarker Samples
ID Record ID "crfname","","indexes","adnigo_blacklist_idx=TBLNAME,LABEL","notnullcols","ID,USERID,USERDATE" ADNIGO BLACKLIST N/A
USERID N/A N/A ADNIGO BLACKLIST N/A
USERID2 N/A N/A ADNIGO BLACKLIST N/A
ID Record ID "crfname","Diagnostic Summary - Baseline Changes","indexes","adnigo_blchange_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO BLCHANGE Diagnostic Summary - Baseline Changes
ID Record ID "crfname","Baseline Symptoms Checklist","indexes","adnigo_blscheck_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO BLSCHECK Baseline Symptoms Checklist
ID Record ID "crfname","Clinical Dementia Rating","indexes","adnigo_cdr_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO CDR Clinical Dementia Rating
ID Record ID "crfname","Immortalization Cell Collection","indexes","adnigo_cellimort_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO CELLIMORT Immortalization Cell Collection
RID Participant roster ID N/A ADNIGO CELLIMORT Immortalization Cell Collection
SITEID Site ID N/A ADNIGO CELLIMORT Immortalization Cell Collection
USERID N/A N/A ADNIGO CELLIMORT Immortalization Cell Collection
USERID2 N/A N/A ADNIGO CELLIMORT Immortalization Cell Collection
ID Record ID "crfname","Clinician Verification","indexes","adnigo_clielg_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO CLIELG Clinician Verification
RID Participant roster ID N/A ADNIGO,ADNI2 CLIELG Clinician Verification
SITEID Site ID N/A ADNIGO,ADNI2 CLIELG Clinician Verification
USERID N/A N/A ADNIGO,ADNI2 CLIELG Clinician Verification
USERID2 N/A N/A ADNIGO,ADNI2 CLIELG Clinician Verification
CEMRI Does Screening MRI have evidence of infection, infarction, other focal lesions, or multiple lacunes in critical memory structures? 1=Yes; 0=No ADNIGO CLIELG Clinician Verification
ID Record ID "crfname","Clinician Review","indexes","adnigo_clirev_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO CLIREV Clinician Review
ID Record ID "crfname","Method of CSF Collection","indexes","adnigo_csfmeth_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO CSFMETH Method of CSF Collection
TUBEMIN If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in polystyrene collection tube 0..1440 ADNIGO CSFMETH Method of CSF Collection
REASON If no, please provide reason why CSF was not collected: 1=Illness;2=Participant unavailable;3=Participant Unwilling;8=Administrative Problems;4=Withdrawn consent;5=Other (specify) ADNIGO CSFMETH Method of CSF Collection
ID Record ID "crfname","","indexes","adnigo_datadic_ind=FLDNAME,TBLNAME","notnullcols","ID,FLDNAME,TBLNAME" ADNIGO DATADIC N/A
ID Record ID "crfname","Diagnostic Summary","indexes","adnigo_dxsum_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO DXSUM Diagnostic Summary
USERID2 N/A N/A ADNIGO,ADNI2 VIOLOG Protocol Deviations Log
RID Participant roster ID N/A ADNIGO,ADNI2 DXSUM Diagnostic Summary
SITEID Site ID N/A ADNIGO,ADNI2 DXSUM Diagnostic Summary
USERID N/A N/A ADNIGO,ADNI2 DXSUM Diagnostic Summary
USERID2 N/A N/A ADNIGO,ADNI2 DXSUM Diagnostic Summary
ID Record ID "crfname","Vital Signs","indexes","adnigo_vitals_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO VITALS Vital Signs
ID Record ID "crfname","Everyday Cognition - Participant Self-Report","indexes","adnigo_ecogpt_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO ECOGPT Everyday Cognition - Participant Self-Report
RID Participant roster ID N/A ADNIGO,ADNI2 ECOGPT Everyday Cognition - Participant Self-Report
SITEID Site ID N/A ADNIGO,ADNI2 ECOGPT Everyday Cognition - Participant Self-Report
USERID N/A N/A ADNIGO,ADNI2 ECOGPT Everyday Cognition - Participant Self-Report
USERID2 N/A N/A ADNIGO,ADNI2 ECOGPT Everyday Cognition - Participant Self-Report
VALIDITY 2. Validity of the information collected from the participant (based on research assistant's observations and interactions with the participant while they were completing the ECog): 1=1- Appeared Valid--The participant did not express any confusion or ask for any clarification in completing the ECog.;2=2- Questionable Validity--The participant needed to have the instructions repeated, and/or needed help in understanding a few of the items.; 3=3- Appeared Invalid--The participant was clearly confused about the content of many of the questions or how to complete the form in general.;4=No information collected from participant ADNIGO,ADNI2 ECOGPT Everyday Cognition - Participant Self-Report
ID Record ID "crfname","Functional Assessment Questionnaire","indexes","adnigo_faq_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO FAQ Functional Assessment Questionnaire
ID Record ID "crfname","Family History","indexes","adnigo_fhq_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO FHQ Family History
RID Participant roster ID N/A ADNIGO,ADNI2 FHQ Family History
SITEID Site ID N/A ADNIGO,ADNI2 FHQ Family History
USERID N/A N/A ADNIGO,ADNI2 FHQ Family History
USERID2 N/A N/A ADNIGO,ADNI2 FHQ Family History
FHQPROV Indicate below who provided the information collected for this questionnaire: 1=Participant only; 2=Study Partner only; 3=Both Participant and Study Partner ADNIGO,ADNI2 FHQ Family History
ID Record ID "crfname","Geriatric Depression Scale","indexes","adnigo_gdscale_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO GDSCALE Geriatric Depression Scale
ID Record ID "crfname","Other Genetic Samples","indexes","adnigo_gensamples_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO GENSAMPLES Other Genetic Samples
RID Participant roster ID N/A ADNIGO GENSAMPLES Other Genetic Samples
SITEID Site ID N/A ADNIGO GENSAMPLES Other Genetic Samples
USERID N/A N/A ADNIGO GENSAMPLES Other Genetic Samples
USERID2 N/A N/A ADNIGO GENSAMPLES Other Genetic Samples
ID Record ID "crfname","Homocysteine - Results","indexes","adnigo_hcres_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO HCRES Homocysteine - Results
ID Record ID "crfname","","indexes","adnigo_imgdcm_idx=FILEID,VERFILEID,SCANID","notnullcols","ID,USERID,USERDATE" ADNIGO IMGDCM N/A
USERID N/A N/A ADNIGO IMGDCM N/A
USERID2 N/A N/A ADNIGO IMGDCM N/A
FILEID N/A N/A ADNIGO IMGDCM N/A
VERFILEID N/A N/A ADNIGO IMGDCM N/A
SCANID N/A N/A ADNIGO IMGDCM N/A
STUDYUID N/A N/A ADNIGO IMGDCM N/A
SERIESUID N/A N/A ADNIGO IMGDCM N/A
ID Record ID "crfname","","indexes","","notnullcols","ID,USERID,USERDATE" ADNIGO IMGDCMSTAT N/A
USERID N/A N/A ADNIGO IMGDCMSTAT N/A
USERID2 N/A N/A ADNIGO IMGDCMSTAT N/A
FILEID N/A N/A ADNIGO IMGDCMSTAT N/A
VERFILEID N/A N/A ADNIGO IMGDCMSTAT N/A
SCANID N/A N/A ADNIGO IMGDCMSTAT N/A
ID Record ID "crfname","","indexes","","notnullcols","ID,USERID,USERDATE,RID,SITEID,VISCODE" ADNIGO IMGFILE N/A
USERID N/A N/A ADNIGO IMGFILE N/A
USERID2 N/A N/A ADNIGO IMGFILE N/A
RID Participant roster ID N/A ADNIGO IMGFILE N/A
SITEID Site ID N/A ADNIGO IMGFILE N/A
ID Record ID "crfname","","indexes","","notnullcols","ID,USERID,USERDATE" ADNIGO IMGFSTAT N/A
USERID N/A N/A ADNIGO IMGFSTAT N/A
USERID2 N/A N/A ADNIGO IMGFSTAT N/A
FILEID N/A N/A ADNIGO IMGFSTAT N/A
VERFILEID N/A N/A ADNIGO IMGFSTAT N/A
ID Record ID "crfname","","indexes","","notnullcols","ID,USERID,USERDATE" ADNIGO IMGFVERS N/A
USERID N/A N/A ADNIGO IMGFVERS N/A
USERID2 N/A N/A ADNIGO IMGFVERS N/A
FILEID N/A N/A ADNIGO IMGFVERS N/A
ID Record ID "crfname","Laboratory Data","indexes","adnigo_labdata_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO LABDATA Laboratory Data
ID Record ID "crfname","Screening Laboratory Tests","indexes","adnigo_labtests_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO LABTESTS Screening Laboratory Tests
RID Participant roster ID N/A ADNIGO,ADNI2 LABTESTS Screening Laboratory Tests
SITEID Site ID N/A ADNIGO,ADNI2 LABTESTS Screening Laboratory Tests
USERID N/A N/A ADNIGO,ADNI2 LABTESTS Screening Laboratory Tests
USERID2 N/A N/A ADNIGO,ADNI2 LABTESTS Screening Laboratory Tests
ID Record ID "crfname","CSF - Local Lab Results","indexes","adnigo_loclab_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO LOCLAB CSF - Local Lab Results
ID Record ID "crfname","Medical History","indexes","adnigo_medhist_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO MEDHIST Medical History
MH16CSMOK 16c. If no longer smoking, provide period of time since stopped smoking (years) 0..99 ADNIGO,ADNI2 MEDHIST Medical History
ID Record ID "crfname","Mini Mental State Exam","indexes","adnigo_mmse_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO MMSE Mini Mental State Exam
ID Record ID "crfname","MoCA","indexes","adnigo_moca_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO MOCA MoCA
RID Participant roster ID N/A ADNIGO,ADNI2 MOCA MoCA
SITEID Site ID N/A ADNIGO,ADNI2 MOCA MoCA
USERID N/A N/A ADNIGO,ADNI2 MOCA MoCA
USERID2 N/A N/A ADNIGO,ADNI2 MOCA MoCA
REPEAT2 Repeat Sentence: The cat always hid under the couch when dogs were in the room. 1=Correct; 0=Incorrect ADNIGO,ADNI2 MOCA MoCA
ID Record ID "crfname","Modified Hachinski","indexes","adnigo_modhach_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO MODHACH Modified Hachinski
ID Record ID "crfname","Monitor Eligibility","indexes","adnigo_monelg_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO MONELG Monitor Eligibility
RID Participant roster ID N/A ADNIGO,ADNI2 MONELG Monitor Eligibility
SITEID Site ID N/A ADNIGO,ADNI2 MONELG Monitor Eligibility
USERID N/A N/A ADNIGO,ADNI2 MONELG Monitor Eligibility
USERID2 N/A N/A ADNIGO,ADNI2 MONELG Monitor Eligibility
ID Record ID "crfname","Monitor Review","indexes","adnigo_monrev_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO MONREV Monitor Review
RID Participant roster ID N/A ADNIGO MONREV Monitor Review
SITEID Site ID N/A ADNIGO MONREV Monitor Review
USERID N/A N/A ADNIGO MONREV Monitor Review
USERID2 N/A N/A ADNIGO MONREV Monitor Review
ID Record ID "crfname","3T MRI Scan Information","indexes","adnigo_mri3gometa_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO MRI3GOMETA 3T MRI Scan Information
RID Participant roster ID N/A ADNIGO MRI3GOMETA 3T MRI Scan Information
SITEID Site ID N/A ADNIGO MRI3GOMETA 3T MRI Scan Information
USERID N/A N/A ADNIGO MRI3GOMETA 3T MRI Scan Information
USERID2 N/A N/A ADNIGO MRI3GOMETA 3T MRI Scan Information
EYEKEEP4 Did the subject keep their eyes open (MRI Tech: ask the subject right after the scan) 1=Yes; 0=No; 2=N/A not a Philips Scanner ADNIGO MRI3GOMETA 3T MRI Scan Information
EYEKEEP6 Did the subject keep their eyes open (MRI Tech: ask the subject right after the scan) 1=Yes; 0=No;2=N/A not a Siemens Scanner ADNIGO MRI3GOMETA 3T MRI Scan Information
ID Record ID "crfname","1.5T MRI Scan Information","indexes","adnigo_mrimeta_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO MRIMETA 1.5T MRI Scan Information
ID Record ID "crfname","Archive MRI Subject Inclusion","indexes","adnigo_mrincl1_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO MRINCL1 Archive MRI Subject Inclusion
ID Record ID "crfname","MRI Subject Inclusion","indexes","adnigo_mrinclusio_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO MRINCLUSIO MRI Subject Inclusion
ID Record ID "crfname","MRI Quality","indexes","adnigo_mriquality_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO MRIQUALITY MRI Quality
ID Record ID "crfname","Neuropsychological Battery","indexes","adnigo_neurobat_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO NEUROBAT Neuropsychological Battery
ID Record ID "crfname","Neurological Exam","indexes","adnigo_neuroexm_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO NEUROEXM Neurological Exam
ID Record ID "crfname","Neuropsychiatric Inventory Q","indexes","adnigo_npiq_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO NPIQ Neuropsychiatric Inventory Q
ID Record ID "crfname","","indexes","adnigo_packets_idx=TBLNAME,VISCODE,Q4A_WHITE,GROUPID","notnullcols","ID,TBLNAME,VISCODE,Q4A_WHITE,GROUPID" ADNIGO PACKETS N/A
OBJID N/A N/A ADNIGO PACKETS N/A
ORDERID N/A N/A ADNIGO PACKETS N/A
GROUPID N/A N/A ADNIGO PACKETS N/A
ID Record ID "crfname","FDG PET Scan Information","indexes","adnigo_petmeta_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO PETMETA FDG PET Scan Information
RID Participant roster ID N/A ADNIGO,ADNI2 PETMETA FDG PET Scan Information
SITEID Site ID N/A ADNIGO,ADNI2 PETMETA FDG PET Scan Information
USERID N/A N/A ADNIGO,ADNI2 PETMETA FDG PET Scan Information
USERID2 N/A N/A ADNIGO,ADNI2 PETMETA FDG PET Scan Information
PMGLUCOM Provide an explanation if blood glucose was measured after the FDG injection: N/A ADNIGO,ADNI2,ADNI3 PETMETA FDG PET Scan Information
PMSCANCOM Target start time is 30 min FDG post-injection. Provide an explanation if start time is not between 28 and 32 min post-injection. N/A ADNIGO,ADNI2 PETMETA FDG PET Scan Information
PMPROTID Predefined Acquisition Protocol ID: N/A ADNIGO,ADNI2 PETMETA FDG PET Scan Information
ID Record ID "crfname","FDG PET QC Tracking","indexes","adnigo_petqc_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO PETQC FDG PET QC Tracking
RID Participant roster ID N/A ADNIGO,ADNI2 PETQC FDG PET QC Tracking
SITEID Site ID N/A ADNIGO,ADNI2 PETQC FDG PET QC Tracking
USERID N/A N/A ADNIGO,ADNI2 PETQC FDG PET QC Tracking
USERID2 N/A N/A ADNIGO,ADNI2 PETQC FDG PET QC Tracking
LONIUID LONI Unique Series ID N/A ADNIGO,ADNI2 PETQC FDG PET QC Tracking
ID Record ID "crfname","Physical Exam","indexes","adnigo_physical_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO PHYSICAL Physical Exam
ID Record ID "crfname","","indexes","adnigo_pipeconf_idx=IDX,PIPELINE","notnullcols","ID,USERID,USERDATE,IDX,PIPELINE" ADNIGO PIPECONF N/A
USERID N/A N/A ADNIGO PIPECONF N/A
USERID2 N/A N/A ADNIGO PIPECONF N/A
IDX N/A N/A ADNIGO PIPECONF N/A
ID Record ID "crfname","Participant Demographics","indexes","adnigo_ptdemog_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO PTDEMOG Participant Demographics
RID Participant roster ID N/A ADNIGO,ADNI2 PTDEMOG Participant Demographics
SITEID Site ID N/A ADNIGO,ADNI2 PTDEMOG Participant Demographics
USERID N/A N/A ADNIGO,ADNI2 PTDEMOG Participant Demographics
USERID2 N/A N/A ADNIGO,ADNI2 PTDEMOG Participant Demographics
PTHOME 8. Type of Participant residence 1=House; 2=Condo/Co-op (owned); 3=Apartment (rented); 4=Mobile Home; 5=Retirement Community; 6=Assisted Living; 7=Skilled Nursing Facility; 8=Other (specify) ADNIGO,ADNI2 PTDEMOG Participant Demographics
RID Participant roster ID N/A ADNIGO,ADNI2 VIOLOG Protocol Deviations Log
ID Record ID "crfname","","indexes","adnigo_qc_idx=QAID,RECNO","notnullcols","ID,QAID,RECNO,USERID,USERDATE" ADNIGO QC N/A
ID Record ID "crfname","Diagnosis and Symptoms Log","indexes","adnigo_recadsx_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO RECADSX Diagnosis and Symptoms Log
RID Participant roster ID N/A ADNIGO RECADSX Diagnosis and Symptoms Log
SITEID Site ID N/A ADNIGO RECADSX Diagnosis and Symptoms Log
USERID N/A N/A ADNIGO RECADSX Diagnosis and Symptoms Log
USERID2 N/A N/A ADNIGO RECADSX Diagnosis and Symptoms Log
ID Record ID "crfname","Adverse Events/Hospitalizations - Log","indexes","adnigo_recadv_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO RECADV Adverse Events/Hospitalizations - Log
ID Record ID "crfname","Documentation of Baseline Symptoms Log","indexes","adnigo_recbllog_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO RECBLLOG Documentation of Baseline Symptoms Log
ID Record ID "crfname","Concurrent Medications Log","indexes","adnigo_reccmeds_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO RECCMEDS Concurrent Medications Log
CMMEDID medlist ID N/A ADNIGO,ADNI2 RECCMEDS Concurrent Medications Log
CMUNITSID N/A N/A ADNIGO RECCMEDS Concurrent Medications Log
CMFREQID N/A N/A ADNIGO RECCMEDS Concurrent Medications Log
CMROUTEID N/A N/A ADNIGO RECCMEDS Concurrent Medications Log
ID Record ID "crfname","Family History Siblings Log","indexes","adnigo_recfhq_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO RECFHQ Family History Siblings Log
RID Participant roster ID N/A ADNIGO,ADNI2 RECFHQ Family History Siblings Log
SITEID Site ID N/A ADNIGO,ADNI2 RECFHQ Family History Siblings Log
USERID N/A N/A ADNIGO,ADNI2 RECFHQ Family History Siblings Log
USERID2 N/A N/A ADNIGO,ADNI2 RECFHQ Family History Siblings Log
ID Record ID "crfname","Medical History Details Log","indexes","adnigo_recmhist_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO RECMHIST Medical History Details Log
RID Participant roster ID N/A ADNIGO,ADNI2 RECMHIST Medical History Details Log
SITEID Site ID N/A ADNIGO,ADNI2 RECMHIST Medical History Details Log
USERID N/A N/A ADNIGO,ADNI2 RECMHIST Medical History Details Log
USERID2 N/A N/A ADNIGO,ADNI2 RECMHIST Medical History Details Log
ID Record ID "crfname","Registry","indexes","adnigo_registry_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO REGISTRY Registry
ID Record ID "crfname","Roster","indexes","adnigo_roster_idx=RID,ENTRY;adnigo_roster_idx2=ENTRY,PTID","notnullcols","ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID" ADNIGO ROSTER Roster
SITEID Site ID N/A ADNIGO,ADNI2 VIOLOG Protocol Deviations Log
ID Record ID "crfname","","indexes","adnigo_visits_idx=VISCODE","notnullcols","ID,VISCODE" ADNIGO VISITS N/A
ID Record ID "crfname","Early Discontinuation and Withdrawal","indexes","adnigo_treatdis_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" ADNIGO TREATDIS Early Discontinuation and Withdrawal
USERID N/A N/A ADNIGO,ADNI2 VIOLOG Protocol Deviations Log
ID Record ID "crfname","Protocol Deviations Log","indexes","adnigo_violog_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" ADNIGO VIOLOG Protocol Deviations Log
SITEID Site ID N/A ADNI2 AV45FOLLOW Florbetapir F18 24-48 Hour Follow-Up
SITEID Site ID N/A ADNI2 AV45META Florbetapir F18 PET Scan Information
SITEID Site ID N/A ADNI2 MRIMETA MRI Scan Information
SITEID Site ID N/A ADNI2 AV45QC Florbetapir F18 PET QC Tracking
SITEID Site ID N/A ADNI2 BLSCHECK Pre-Existing Symptoms Checklist
SITEID Site ID N/A ADNI2 GENETIC Genetic Sample Collection
SITEID Site ID N/A ADNI2 ECOGSP Everyday Cognition - Study Partner Report
RID Participant roster ID N/A ADNI2 GENETIC Genetic Sample Collection
RID Participant roster ID N/A ADNI2 BLCHANGE Diagnostic Summary Clinical Status
RID Participant roster ID N/A ADNI2 AV45VITALS Florbetapir F18 Pre and Post Injection Vitals
RID Participant roster ID N/A ADNI2 AV45FOLLOW Florbetapir F18 24-48 Hour Follow-Up
RID Participant roster ID N/A ADNI2 NPSTATUS Neuropathology Status
RID Participant roster ID N/A ADNI2 NPI Neuropsychiatric Inventory
ID Record ID 'crfname','Cognitive Change Index','indexes','adni2_cci_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 CCI Cognitive Change Index
RID Participant roster ID N/A ADNI2 RECBLLOG Pre-Existing Symptoms Log
TUBEMIN If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in polystyrene collection tube 0..1440 ADNI2 BIOMARK Biomarker Samples
RID Participant roster ID N/A ADNI2 AV45META Florbetapir F18 PET Scan Information
AMYLRESNM Name: N/A ADNI2 RORR Return of Research Results
SPRESPONSE Study partner: N/A ADNI2 RORR Return of Research Results
CLRESPONSE Treating clinician: N/A ADNI2 RORR Return of Research Results
PREDISC Pre-disclosure: N/A ADNI2 RORR Return of Research Results
Q6TASK 1=Fold the paper; 2=Put the paper in the envelope; 3=Seal envelope; 4=Address envelope; 5=Indicate where stamp goes; 0=None completed correctly ADNI2 ADAS ADAS-Cognitive Behavior
POSTDISC Post-disclosure: N/A ADNI2 RORR Return of Research Results
FMRESPONSE Family member: N/A ADNI2 RORR Return of Research Results
FRRESPONSE Friend: N/A ADNI2 RORR Return of Research Results
ID Record ID 'crfname','Laboratory Data','indexes','adni2_labdata_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 LABDATA Laboratory Data
AMLYLRESQU Qualifications (e.g., degrees, specialty area): N/A ADNI2 RORR Return of Research Results
AMLYRESTR Training (e.g., specific training in interpretation of amyloid imaging, such as Amyvid training course): N/A ADNI2 RORR Return of Research Results
AMLYRESEXP Experience: N/A ADNI2 RORR Return of Research Results
PMSCANCOM Target start time is 50 min Florbetapir F18 post-injection. Provide an explanation if start time is not between 48 and 52 min post-injection. N/A ADNI2 AV45META Florbetapir F18 PET Scan Information
NPII2 2. Does {P} rapidly change moods from one to another, being fine one minute and angry the next? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPIH1 1. Does {P} act impulsively without appearing to consider the consequences? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPIE5 5. Does {P} avoid certain places or situations that make him.her more nervous such as riding in the car, meeting with friends, or being in crowds? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPIDTOT D. Depression/Dysphoria: Item score 0..12 ADNI2,ADNI3 NPI Neuropsychiatric Inventory
NPID9B 9b. Severity Ratings 1=1: Mild; 2=2: Moderate; 3=3: Marked ADNI2 NPI Neuropsychiatric Inventory
NPID9C 9c. Caregiver Distress 0=Not at all; 1=Minimally; 2=Mildly; 3=Moderately; 4=Severely; 5=Very severely or extremely ADNI2 NPI Neuropsychiatric Inventory
NPID9A 9a. Frequency Ratings 1=1: Occasionally; 2=2: Often; 3=3: Frequently; 4=4: Very frequently ADNI2 NPI Neuropsychiatric Inventory
NPID8 8. Does {P} show any other signs of depression or sadness? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID7 7. Does {P} express a wish for death or talk about killing him/herself? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID6 6. Does {P} say he/she is a burden to the family or that the family would be better off without him/her? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID4 4. Does {P} say that he/she is a bad person or deserves to be punished? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID5 5. Does {P} seem very discouraged or say that he/ she has not future? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID3 3. Does {P} put him/herself down or say that he/she feels like a failure? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID1 1. Does {P} have periods of tearfulness or sobbing that seem to indicate sadness? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID2 2. Does {P} say or act as if he/she is sad or low in spirits? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPID D: Depression/Dysphoria 0=No; 1=Yes ADNI2 NPI Neuropsychiatric Inventory
NPDECNO If No, provide reason for nonparticipation: N/A ADNI2 NPSTATUS Neuropathology Status
NPDECIDE Has a definitive decision about brain donation been made? 1=Yes; 0=No ADNI2 NPSTATUS Neuropathology Status
MMREASON If No, please provide reason why the scan was not conducted: 1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;6=Other (specify) ADNI2,ADNI3 MRIMETA MRI Scan Information
LONIUID LONI Unique Series ID N/A ADNI2 AV45QC Florbetapir F18 PET QC Tracking
ID Record ID 'crfname','Vital Signs','indexes','adni2_vitals_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 VITALS Vital Signs
ID Record ID 'crfname','Early Discontinuation and Withdrawal','indexes','adni2_treatdis_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 TREATDIS Early Discontinuation and Withdrawal
ID Record ID 'crfname','Registry','indexes','adni2_registry_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 REGISTRY Registry
ID Record ID 'crfname','Medical History Details Log','indexes','adni2_recmhist_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 RECMHIST Medical History Details Log
ID Record ID 'crfname','Pre-Existing Symptoms Log','indexes','adni2_recbllog_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 RECBLLOG Pre-Existing Symptoms Log
ID Record ID 'crfname','Adverse Events/Hospitalizations - Log','indexes','adni2_recadv_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 RECADV Adverse Events/Hospitalizations - Log
ID Record ID 'crfname','FDG PET QC Tracking','indexes','adni2_petqc_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 PETQC FDG PET QC Tracking
ID Record ID 'crfname','Physical Exam','indexes','adni2_physical_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 PHYSICAL Physical Exam
ID Record ID 'crfname','FDG PET Scan Information','indexes','adni2_petmeta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 PETMETA FDG PET Scan Information
ID Record ID 'crfname','Neuropsychiatric Inventory','indexes','adni2_npi_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 NPI Neuropsychiatric Inventory
ID Record ID 'crfname','Neuropsychiatric Inventory Q','indexes','adni2_npiq_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 NPIQ Neuropsychiatric Inventory Q
ID Record ID 'crfname','Neuropathology Status','indexes','adni2_npstatus_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 NPSTATUS Neuropathology Status
ID Record ID 'crfname','Neurological Exam','indexes','adni2_neuroexm_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 NEUROEXM Neurological Exam
ID Record ID 'crfname','MRI Quality','indexes','adni2_mriquality_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 MRIQUALITY MRI Quality
ID Record ID 'crfname','Neuropsychological Battery','indexes','adni2_neurobat_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 NEUROBAT Neuropsychological Battery
ID Record ID 'crfname','MRI Subject Inclusion','indexes','adni2_mrinclusio_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 MRINCLUSIO MRI Subject Inclusion
ID Record ID 'crfname','Monitor Eligibility','indexes','adni2_monelg_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 MONELG Monitor Eligibility
ID Record ID 'crfname','Medical History','indexes','adni2_medhist_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 MEDHIST Medical History
ID Record ID 'crfname','Mini Mental State Exam','indexes','adni2_mmse_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 MMSE Mini Mental State Exam
ID Record ID 'crfname','Screening Laboratory Tests','indexes','adni2_labtests_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 LABTESTS Screening Laboratory Tests
ID Record ID 'crfname','Geriatric Depression Scale','indexes','adni2_gdscale_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 GDSCALE Geriatric Depression Scale
ID Record ID 'crfname','Genetic Sample Collection','indexes','adni2_genetic_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 GENETIC Genetic Sample Collection
ID Record ID 'crfname','Family History','indexes','adni2_fhq_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 FHQ Family History
ID Record ID 'crfname','Everyday Cognition - Participant Self-Report','indexes','adni2_ecogpt_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 ECOGPT Everyday Cognition - Participant Self-Report
ID Record ID 'crfname','Florbetapir F18 PET Scan Information','indexes','adni2_av45meta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 AV45META Florbetapir F18 PET Scan Information
ID Record ID 'crfname','Florbetapir F18 24-48 Hour Follow-Up','indexes','adni2_av45follow_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 AV45FOLLOW Florbetapir F18 24-48 Hour Follow-Up
ID Record ID 'crfname','Visit Comments','indexes','adni2_addcomm_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 ADDCOMM Visit Comments
ID Record ID 'crfname','ADAS-Cognitive Behavior','indexes','adni2_adas_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 ADAS ADAS-Cognitive Behavior
ID Record ID 'crfname','Return of Research Results','indexes','adni2_rorr_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 RORR Return of Research Results
RID Participant roster ID N/A ADNI2 RORR Return of Research Results
SITEID Site ID N/A ADNI2 RORR Return of Research Results
USERID N/A N/A ADNI2 RORR Return of Research Results
USERID2 N/A N/A ADNI2 AECHECK Adverse Event Checklist
USERID N/A N/A ADNI2 AECHECK Adverse Event Checklist
EYEKEEP Did the participant keep their eyes open (MRI Tech: ask the subject right after the scan) 1=Yes; 0=No; 2=N/A Scanner manufacturer is GE ADNI2 MRIMETA MRI Scan Information
REASON If no, please provide reason why the LP was not conducted 1=Illness;2=Participant unavailable;3=Participant Unwilling;8=Administrative Problems;4=Withdrawn consent;6=Not called for by protocol at this visit;7=Collection done on a different date for this visit;5=Other (specify) ADNI2 BIOMARK Biomarker Samples
RID Participant roster ID N/A ADNI2 CCI Cognitive Change Index
SITEID Site ID N/A ADNI2 CCI Cognitive Change Index
CEMRI 1. Does Screening MRI have evidence of infection, infarction, other focal lesions, or multiple lacunes in critical memory structures? 1=Yes; 0=No ADNI2 CLIELG Clinician Verification
USERID N/A N/A ADNI2 CCI Cognitive Change Index
AEHCOMM Comments:
If SAE provide full narrative. Include any and all treatment (medication, surgery, long term care). If SAE is resolved with sequelae, provide details.		 N/A ADNI2 RECADV Adverse Events/Hospitalizations - Log
PTRESPONSE Participant: N/A ADNI2 RORR Return of Research Results
BCDELIR 11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)? 1=Yes; 0=No ADNI2 BLCHANGE Diagnostic Summary Clinical Status
SITEID Site ID N/A ADNI2 RECBLLOG Pre-Existing Symptoms Log
SITEID Site ID N/A ADNI2 NPSTATUS Neuropathology Status
SITEID Site ID N/A ADNI2 NPI Neuropsychiatric Inventory
SITEID Site ID N/A ADNI2 AV45VITALS Florbetapir F18 Pre and Post Injection Vitals
SITEID Site ID N/A ADNI2 BLCHANGE Diagnostic Summary Clinical Status
RID Participant roster ID N/A ADNI2 BLSCHECK Pre-Existing Symptoms Checklist
RID Participant roster ID N/A ADNI2 AV45QC Florbetapir F18 PET QC Tracking
RID Participant roster ID N/A ADNI2 ECOGSP Everyday Cognition - Study Partner Report
RID Participant roster ID N/A ADNI2 MRIMETA MRI Scan Information
ID Record ID 'crfname','MRI Scan Information','indexes','adni2_mrimeta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 MRIMETA MRI Scan Information
ID Record ID 'crfname','Modified Hachinski','indexes','adni2_modhach_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 MODHACH Modified Hachinski
ID Record ID 'crfname','MoCA','indexes','adni2_moca_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 MOCA MoCA
OTRESPONSE Other recipient: N/A ADNI2 RORR Return of Research Results
ID Record ID 'crfname','Functional Assessment Questionnaire','indexes','adni2_faq_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 FAQ Functional Assessment Questionnaire
ID Record ID 'crfname','Everyday Cognition - Study Partner Report','indexes','adni2_ecogsp_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 ECOGSP Everyday Cognition - Study Partner Report
ID Record ID 'crfname','Diagnostic Summary','indexes','adni2_dxsum_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 DXSUM Diagnostic Summary
ID Record ID 'crfname','Clinician Review','indexes','adni2_clirev_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 CLIREV Clinician Review
ID Record ID 'crfname','Clinician Verification','indexes','adni2_clielg_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 CLIELG Clinician Verification
ID Record ID 'crfname','Clinical Dementia Rating','indexes','adni2_cdr_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 CDR Clinical Dementia Rating
ID Record ID 'crfname','Pre-Existing Symptoms Checklist','indexes','adni2_blscheck_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 BLSCHECK Pre-Existing Symptoms Checklist
ID Record ID 'crfname','Diagnostic Summary Clinical Status','indexes','adni2_blchange_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 BLCHANGE Diagnostic Summary Clinical Status
ID Record ID 'crfname','Key Background Medications','indexes','adni2_backmeds_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 BACKMEDS Key Background Medications
ID Record ID 'crfname','Florbetapir F18 Pre and Post Injection Vitals','indexes','adni2_av45vitals_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 AV45VITALS Florbetapir F18 Pre and Post Injection Vitals
ID Record ID 'crfname','Florbetapir F18 PET QC Tracking','indexes','adni2_av45qc_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 AV45QC Florbetapir F18 PET QC Tracking
ID Record ID 'crfname','','indexes','adni2_arm_idx=PTNO','notnullcols','ID,USERID,USERDATE,RID,PTNO,TYPE' ADNI2 ARM N/A
USERID2 N/A N/A ADNI2 RORR Return of Research Results
PMPROTID Predefined Acquisition Protocol ID N/A ADNI2 AV45META Florbetapir F18 PET Scan Information
NPIJ6 6. Has {P} fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
NPIH4 4. Does {P} say crude things or make sexual remarks that they would not usually have said? 1=Yes; 0=No ADNI2 NPI Neuropsychiatric Inventory
USERID2 N/A N/A ADNI2 CCI Cognitive Change Index
BCSTROKE 10. Did subject have a stroke? 1=Yes; 0=No ADNI2 BLCHANGE Diagnostic Summary Clinical Status
BCREASON If No, please provide reason why the Buffy Coat was not extracted 1=Biomarker not collected;2=Inadequate biomarker sample;3=Withdrawn consent;4=Other (specify) ADNI2,ADNI3 GENETIC Genetic Sample Collection
BCEXTCIR 12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance? 1=Yes; 0=No ADNI2 BLCHANGE Diagnostic Summary Clinical Status
ID Record ID 'crfname','Roster','indexes','adni2_roster_idx=RID,ENTRY;adni2_roster_idx2=ENTRY,PTID','notnullcols','ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID' ADNI2 ROSTER Roster
ID Record ID 'crfname','Family History Siblings Log','indexes','adni2_recfhq_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 RECFHQ Family History Siblings Log
ID Record ID 'crfname','Concurrent Medications Log','indexes','adni2_reccmeds_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 RECCMEDS Concurrent Medications Log
ID Record ID 'crfname','Participant Demographics','indexes','adni2_ptdemog_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 PTDEMOG Participant Demographics
SITEID Site ID N/A ADNI2 AECHECK Adverse Event Checklist
AEHADMDT If hospitalized, provide Admission Date N/A ADNI2 RECADV Adverse Events/Hospitalizations - Log
USERID N/A N/A ADNI2 AV45META Florbetapir F18 PET Scan Information
USERID N/A N/A ADNI2 AV45QC Florbetapir F18 PET QC Tracking
USERID N/A N/A ADNI2 AV45VITALS Florbetapir F18 Pre and Post Injection Vitals
USERID N/A N/A ADNI2 AV45FOLLOW Florbetapir F18 24-48 Hour Follow-Up
USERID N/A N/A ADNI2 MRIMETA MRI Scan Information
USERID N/A N/A ADNI2 GENETIC Genetic Sample Collection
USERID N/A N/A ADNI2 RECBLLOG Pre-Existing Symptoms Log
USERID N/A N/A ADNI2 NPSTATUS Neuropathology Status
USERID N/A N/A ADNI2 BLSCHECK Pre-Existing Symptoms Checklist
USERID N/A N/A ADNI2 NPI Neuropsychiatric Inventory
USERID N/A N/A ADNI2 BLCHANGE Diagnostic Summary Clinical Status
USERID N/A N/A ADNI2 ECOGSP Everyday Cognition - Study Partner Report
USERID2 N/A N/A ADNI2 NPSTATUS Neuropathology Status
USERID2 N/A N/A ADNI2 ECOGSP Everyday Cognition - Study Partner Report
USERID2 N/A N/A ADNI2 MRIMETA MRI Scan Information
USERID2 N/A N/A ADNI2 AV45FOLLOW Florbetapir F18 24-48 Hour Follow-Up
USERID2 N/A N/A ADNI2 AV45META Florbetapir F18 PET Scan Information
USERID2 N/A N/A ADNI2 AV45QC Florbetapir F18 PET QC Tracking
USERID2 N/A N/A ADNI2 AV45VITALS Florbetapir F18 Pre and Post Injection Vitals
USERID2 N/A N/A ADNI2 BLCHANGE Diagnostic Summary Clinical Status
USERID2 N/A N/A ADNI2 GENETIC Genetic Sample Collection
USERID2 N/A N/A ADNI2 BLSCHECK Pre-Existing Symptoms Checklist
USERID2 N/A N/A ADNI2 RECBLLOG Pre-Existing Symptoms Log
USERID2 N/A N/A ADNI2 NPI Neuropsychiatric Inventory
ID Record ID 'crfname','Biomarker Samples','indexes','adni2_biomark_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 BIOMARK Biomarker Samples
RID Participant roster ID N/A ADNI2 AECHECK Adverse Event Checklist
BLREASON If no, please provide reason why blood was not collected 1=Illness;2=Participant unavailable;3=Participant Unwilling;7=Administrative Problems;4=Withdrawn consent;5=Collection done on a different date for this visit;6=Other (specify) ADNI2 BIOMARK Biomarker Samples
NOCSF If no CSF was collected, provide explanation N/A ADNI2,ADNI3 BIOMARK Biomarker Samples
NEELDEOTH accident N/A ADNI2 BIOMARK Biomarker Samples
ID Record ID 'crfname','Adverse Event Checklist','indexes','adni2_aecheck_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 AECHECK Adverse Event Checklist
ID Record ID 'crfname','Tau AV-1451 PET Scan Information','indexes','adni2_taumeta_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 TAUMETA Tau AV-1451 PET Scan Information
RID Participant roster ID N/A ADNI2 TAUMETA Tau AV-1451 PET Scan Information
SITEID Site ID N/A ADNI2 TAUMETA Tau AV-1451 PET Scan Information
USERID N/A N/A ADNI2 TAUMETA Tau AV-1451 PET Scan Information
USERID2 N/A N/A ADNI2 TAUMETA Tau AV-1451 PET Scan Information
TAUSCANDIF If scan start time is not between 73 and 77 min post-injection, provide explanation N/A ADNI2 TAUMETA Tau AV-1451 PET Scan Information
TAUPROTID Predefined Acquisition Protocol Name N/A ADNI2 TAUMETA Tau AV-1451 PET Scan Information
ID Record ID 'crfname','Tau AV-1451 Follow-up Phone Contact','indexes','adni2_tauphone_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 TAUPHONE Tau AV-1451 Follow-up Phone Contact
RID Participant roster ID N/A ADNI2 TAUPHONE Tau AV-1451 Follow-up Phone Contact
SITEID Site ID N/A ADNI2 TAUPHONE Tau AV-1451 Follow-up Phone Contact
USERID N/A N/A ADNI2 TAUPHONE Tau AV-1451 Follow-up Phone Contact
USERID2 N/A N/A ADNI2 TAUPHONE Tau AV-1451 Follow-up Phone Contact
ID Record ID 'crfname','Tau AV-1451 PET QC','indexes','adni2_tauqc_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 TAUQC Tau AV-1451 PET QC
RID Participant roster ID N/A ADNI2 TAUQC Tau AV-1451 PET QC
SITEID Site ID N/A ADNI2 TAUQC Tau AV-1451 PET QC
USERID N/A N/A ADNI2 TAUQC Tau AV-1451 PET QC
USERID2 N/A N/A ADNI2 TAUQC Tau AV-1451 PET QC
LONIUID LONI Unique Series ID N/A ADNI2,ADNI3 TAUQC Tau AV-1451 PET QC
ID Record ID 'crfname','Cogstate Brief Battery','indexes','adni2_cbbcomp_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 CBBCOMP Cogstate Brief Battery
RID Participant roster ID N/A ADNI2 CBBCOMP Cogstate Brief Battery
SITEID Site ID N/A ADNI2 CBBCOMP Cogstate Brief Battery
USERID N/A N/A ADNI2 CBBCOMP Cogstate Brief Battery
USERID2 N/A N/A ADNI2 CBBCOMP Cogstate Brief Battery
ID Record ID 'crfname','ECG','indexes','adni2_ecg_idx=RID,VISCODE,ENTRY','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE' ADNI2 ECG ECG
RID Participant roster ID N/A ADNI2 ECG ECG
SITEID Site ID N/A ADNI2 ECG ECG
USERID N/A N/A ADNI2 ECG ECG
USERID2 N/A N/A ADNI2 ECG ECG
ID Record ID 'crfname','Tau AV-1451 PET Eligibility','indexes','adni2_otelgtau_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 OTELGTAU Tau AV-1451 PET Eligibility
RID Participant roster ID N/A ADNI2 OTELGTAU Tau AV-1451 PET Eligibility
SITEID Site ID N/A ADNI2 OTELGTAU Tau AV-1451 PET Eligibility
USERID N/A N/A ADNI2 OTELGTAU Tau AV-1451 PET Eligibility
USERID2 N/A N/A ADNI2 OTELGTAU Tau AV-1451 PET Eligibility
ID Record ID 'crfname','Participant Transfers','indexes','adni2_transfer_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 TRANSFER Participant Transfers
RID Participant roster ID N/A ADNI2 TRANSFER Participant Transfers
SITEID Site ID N/A ADNI2 TRANSFER Participant Transfers
USERID N/A N/A ADNI2 TRANSFER Participant Transfers
USERID2 N/A N/A ADNI2 TRANSFER Participant Transfers
SITEIDA Site conducting visits PRIOR to transfer: select distinct id, sitecode || ': ' || siteinits || ' - '|| sitename as label from adni2_sites_vwx order by label ADNI2 TRANSFER Participant Transfers
SITEIDB Site conducting visits AFTER transfer: select distinct id, sitecode || ': ' || siteinits || ' - '|| sitename as label from adni2_sites_vwx order by label ADNI2 TRANSFER Participant Transfers
SITEIDTMP Temporary site: select distinct id, sitecode || ': ' || siteinits || ' - '|| sitename as label from adni2_sites_vwx order by label ADNI2 TRANSFER Participant Transfers
ID Record ID 'crfname','Protocol Deviations Log','indexes','adni2_violog_idx=RID,VISCODE,ENTRY,RECNO','notnullcols','ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO' ADNI2 VIOLOG Protocol Deviations Log
ID N/A N/A ADNI3 ADAS ADAS-Cognitive Behavior
RID N/A N/A ADNI3 ADAS ADAS-Cognitive Behavior
SITEID N/A N/A ADNI3 ADAS ADAS-Cognitive Behavior
Q6SCORE ADAS Score Component Q6 Ideational Praxis 0..5 ADNI3 ADAS ADAS-Cognitive Behavior
Q6UNABLE Task 6. Ideational Praxis 0=Conducted;1=Not done (for reasons other than physical/cognitive);2=Participant refused;3=Participant unable for physical reasons;4=Participant unable for cognitive reasons ADNI3 ADAS ADAS-Cognitive Behavior
Q6TASK 6. Ideational Praxis 0=None completed correctly;1=a. Fold the paper;2=b. Put the paper in the envelope;3=c. Seal envelope;4=d. Address envelope;5=e. Show me where the stamp goes ADNI3 ADAS ADAS-Cognitive Behavior
ID N/A N/A ADNI3 ADDCOMM Visit Comments
RID N/A N/A ADNI3 ADDCOMM Visit Comments
SITEID N/A N/A ADNI3 ADDCOMM Visit Comments
AERELPAN Related to COVID-19 pandemic disruption 1=Definitely;2=Probably;3=Possibly;4=Unlikely;5=Not related ADNI3 ADVERSE Adverse Events Log
AERELCOVID Related to COVID-19 illness 1=Definitely (Confirmed COVID-19 test);2=Probably;3=Possibly;4=Unlikely;5=Not related ADNI3 ADVERSE Adverse Events Log
AERELAES If yes, provide related adverse event number(s): N/A ADNI3 ADVERSE Adverse Events Log
AEHCOMM Provide a full description of event: N/A ADNI3 ADVERSE Adverse Events Log
ID N/A N/A ADNI3 AMYMETA Amyloid PET Scan Information
RID N/A N/A ADNI3 AMYMETA Amyloid PET Scan Information
SITEID N/A N/A ADNI3 AMYMETA Amyloid PET Scan Information
VISCODE N/A N/A ADNI3 AMYMETA Amyloid PET Scan Information
USERDATE N/A N/A ADNI3 AMYMETA Amyloid PET Scan Information
USERDATE2 N/A N/A ADNI3 AMYMETA Amyloid PET Scan Information
DONE Was the scan conducted? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
NDREASON If No, reason not done 1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn consent;7=Not called for by protocol;8=Software/scanner error;99=Other (specify) ADNI3 AMYMETA Amyloid PET Scan Information
NDSPECIFY If Other, specify N/A ADNI3 AMYMETA Amyloid PET Scan Information
RADTRACER If scan not done, was radiotracer administered? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
TRACERTYPE Amyloid Imaging radiotracer used 1=Florbetaben (Neuraceq);2=Florbetapir (Amyvid) ADNI3 AMYMETA Amyloid PET Scan Information
SCANDATE Scan Date/Dose Date N/A ADNI3 AMYMETA Amyloid PET Scan Information
EXAMINIT Technologist Initials N/A ADNI3 AMYMETA Amyloid PET Scan Information
QCTIME Time of today's Scanner QC N/A ADNI3 AMYMETA Amyloid PET Scan Information
ASSAYTIME Time of dose assay N/A ADNI3 AMYMETA Amyloid PET Scan Information
DOSEFLRBTBN Florbetaben (Neuraceq): Injected dose assay N/A ADNI3 AMYMETA Amyloid PET Scan Information
DOSEFLRBTPR Florbetapir (Amyvid): Injected dose assay N/A ADNI3 AMYMETA Amyloid PET Scan Information
INJTIME Time of injection N/A ADNI3 AMYMETA Amyloid PET Scan Information
SCANTIME Emission Scan Start Time N/A ADNI3 AMYMETA Amyloid PET Scan Information
SCANDIFF Provide an explanation if start time is not at optimal start time for amyloid imaging compound. N/A ADNI3 AMYMETA Amyloid PET Scan Information
VARIAT Any variations from protocol during uptake? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
VARIATSPEC If Yes, describe N/A ADNI3 AMYMETA Amyloid PET Scan Information
RECON Select reconstruction used 1=3D or LOR Ramla (Philips);2=FORE/2D-OSEM (Siemens);4=3D-OSEM (Siemens);5=3D Iterative (VPHD / GE);6=FORE Iterative (GE) ADNI3 AMYMETA Amyloid PET Scan Information
SHARP For Phillips scanners: was "smooth" parameter set to "sharp"? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
ARCHIVE Data archived locally? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
LONI Data transferred to LONI? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
TRANDATE Transfer Date N/A ADNI3 AMYMETA Amyloid PET Scan Information
COMM Comments N/A ADNI3 AMYMETA Amyloid PET Scan Information
ID N/A N/A ADNI3 AMYQC Amyloid PET QC
RID N/A N/A ADNI3 AMYQC Amyloid PET QC
SITEID N/A N/A ADNI3 AMYQC Amyloid PET QC
VISCODE N/A N/A ADNI3 AMYQC Amyloid PET QC
USERDATE N/A N/A ADNI3 AMYQC Amyloid PET QC
USERDATE2 N/A N/A ADNI3 AMYQC Amyloid PET QC
SCANDATE Scan Date N/A ADNI3 AMYQC Amyloid PET QC
LONIUPDT Date uploaded to LONI N/A ADNI3 AMYQC Amyloid PET QC
LONIUID LONI Unique Series ID N/A ADNI3 AMYQC Amyloid PET QC
REVDT Date Reviewed N/A ADNI3 AMYQC Amyloid PET QC
REVINIT Reviewer Initials N/A ADNI3 AMYQC Amyloid PET QC
ALLFRAME Were all frames acceptable? 0=No;1=Yes ADNI3 AMYQC Amyloid PET QC
UNUSABL If No, indicate which frames were unacceptable N/A ADNI3 AMYQC Amyloid PET QC
UNRSN If No, indicate why frames were unacceptable 1=Subject motion;2=Other ADNI3 AMYQC Amyloid PET QC
UNRSNSPEC If Other, Specify N/A ADNI3 AMYQC Amyloid PET QC
SCANQLTY Scan Pass QC? 0=No;1=Yes ADNI3 AMYQC Amyloid PET QC
REPROCREQ Reprocessing requested? 0=No;1=Yes ADNI3 AMYQC Amyloid PET QC
PROCERR If Yes, select processing error(s) 1=Incorrect reconstruction algorithm;2=Incorrect filtering;3=Incorrect slice thickness;4=Incorrect voxel size;5=Attenuation Error;6=Normalization Error;7=Inadequate counts;8=Inadequate field of view;9=Incorrect acquisition protocol;10=Unfixable image artifact (e.g. attenuation, normalization, etc.);99=Other (specify) ADNI3 AMYQC Amyloid PET QC
PROCERRSPEC If Other, Specify N/A ADNI3 AMYQC Amyloid PET QC
RESCANREQ Rescan requested? 0=No;1=Yes ADNI3 AMYQC Amyloid PET QC
COMM Comments N/A ADNI3 AMYQC Amyloid PET QC
ID N/A N/A ADNI3 BACKMEDS Key Background Medications
RID N/A N/A ADNI3 BACKMEDS Key Background Medications
SITEID N/A N/A ADNI3 BACKMEDS Key Background Medications
ONLINEID Online ID N/A ADNI3 CBBCOMP Cogstate Brief Battery
ID N/A N/A ADNI3 BHR Brain Health Registry
RID N/A N/A ADNI3 BHR Brain Health Registry
SITEID N/A N/A ADNI3 BHR Brain Health Registry
EXAMDATE If Yes, date brochure provided N/A ADNI3 BHR Brain Health Registry
WRITTEN If Yes, was the ADNI Online ID written down on the participant's brochure? 0=No;1=Yes ADNI3 BHR Brain Health Registry
ID N/A N/A ADNI3 BIOMARK Biomarker Samples
RID N/A N/A ADNI3 BIOMARK Biomarker Samples
SITEID N/A N/A ADNI3 BIOMARK Biomarker Samples
BLREASON If no, please provide reason why blood was not collected 1=Illness;2=Participant unavailable;3=Participant Unwilling;4=Withdrawn consent;5=Collection done on a different date for this visit;6=Other (specify);7=Administrative Problems ADNI3 BIOMARK Biomarker Samples
REASON If no, please provide reason why the LP was not conducted 1=Illness;2=Participant unavailable;3=Participant Unwilling;4=Withdrawn consent;5=Other (specify);6=Not called for by protocol at this visit;7=Collection done on a different date for this visit;8=Administrative Problems ADNI3 BIOMARK Biomarker Samples
TUBEMIN If collected in polystyrene and shipped in polypropylene, please provide estimated amount of time CSF remained in polystyrene collection tube N/A ADNI3 BIOMARK Biomarker Samples
ID N/A N/A ADNI3 BIOMARKQC Biomarker Samples Tracking and QC
RID N/A N/A ADNI3 BIOMARKQC Biomarker Samples Tracking and QC
SITEID N/A N/A ADNI3 BIOMARKQC Biomarker Samples Tracking and QC
ID N/A N/A ADNI3 BLCHANGE Diagnostic Summary Clinical Status
RID N/A N/A ADNI3 BLCHANGE Diagnostic Summary Clinical Status
SITEID N/A N/A ADNI3 BLCHANGE Diagnostic Summary Clinical Status
BCSTROKE 10. Did subject have a stroke? 0=No;1=Yes ADNI3 BLCHANGE Diagnostic Summary Clinical Status
BCDELIR 11. Is there evidence of a delirium (medication effect, toxic or metabolic encephalopathy)? 0=No;1=Yes ADNI3 BLCHANGE Diagnostic Summary Clinical Status
BCEXTCIR 12. Has extenuating circumstance (such as a physical health problem, change in residence, charge in support network, death of a family member, etc.) contributed to a change in the subject's cognitive or functional performance? 0=No;1=Yes ADNI3 BLCHANGE Diagnostic Summary Clinical Status
ID N/A N/A ADNI3 CBBCOMP Cogstate Brief Battery
RID N/A N/A ADNI3 CBBCOMP Cogstate Brief Battery
SITEID N/A N/A ADNI3 CBBCOMP Cogstate Brief Battery
ID N/A N/A ADNI3 CCI Cognitive Change Index
RID N/A N/A ADNI3 CCI Cognitive Change Index
SITEID N/A N/A ADNI3 CCI Cognitive Change Index
ID N/A N/A ADNI3 CDR Clinical Dementia Rating
RID N/A N/A ADNI3 CDR Clinical Dementia Rating
SITEID N/A N/A ADNI3 CDR Clinical Dementia Rating
SPID Study Partner ID: N/A ADNI3 CDR Clinical Dementia Rating
ID N/A N/A ADNI3 CLIELG Clinician Verification
RID N/A N/A ADNI3 CLIELG Clinician Verification
SITEID N/A N/A ADNI3 CLIELG Clinician Verification
ID N/A N/A ADNI3 CONSENTS Consent Tracking
RID N/A N/A ADNI3 CONSENTS Consent Tracking
SITEID N/A N/A ADNI3 CONSENTS Consent Tracking
MRIDET Reason for nonconsent: N/A ADNI3 CONSENTS Consent Tracking
AMY 3d. Consent to Amyloid PET scan procedures 0=No;1=Yes;2=n/a ADNI3 CONSENTS Consent Tracking
SITEID N/A N/A ADNI3 DXSUM Diagnostic Summary
ID N/A N/A ADNI3 DXSUM Diagnostic Summary
RID N/A N/A ADNI3 DXSUM Diagnostic Summary
ID N/A N/A ADNI3 DEVLOG Protocol Deviations Log
RID N/A N/A ADNI3 DEVLOG Protocol Deviations Log
SITEID N/A N/A ADNI3 DEVLOG Protocol Deviations Log
ID N/A N/A ADNI3 ECOGPT Everyday Cognition - Participant Self-Report
RID N/A N/A ADNI3 ECOGPT Everyday Cognition - Participant Self-Report
SITEID N/A N/A ADNI3 ECOGPT Everyday Cognition - Participant Self-Report
VALIDITY 2. Validity of the information collected from the participant (based on research assistant's observations and interactions with the participant while they were completing the ECog): 1=1- Appeared Valid--The participant did not express any confusion or ask for any clarification in completing the ECog.;2=2- Questionable Validity--The participant needed to have the instructions repeated, and/or needed help in understanding a few of the items.;3=3- Appeared Invalid--The participant was clearly confused about the content of many of the questions or how to complete the form in general.;4=No information collected from participant ADNI3 ECOGPT Everyday Cognition - Participant Self-Report
ID N/A N/A ADNI3 ECOGSP Everyday Cognition - Study Partner Report
RID N/A N/A ADNI3 ECOGSP Everyday Cognition - Study Partner Report
SITEID N/A N/A ADNI3 ECOGSP Everyday Cognition - Study Partner Report
SPID Study Partner ID: N/A ADNI3 ECOGSP Everyday Cognition - Study Partner Report
ID N/A N/A ADNI3 FAMHXPAR Family History - Parents
RID N/A N/A ADNI3 FAMHXPAR Family History - Parents
SITEID N/A N/A ADNI3 FAMHXPAR Family History - Parents
MOTHDEM Did/Does the biological mother have dementia? 0=No;1=Yes ADNI3 FAMHXPAR Family History - Parents
MOTHAD If yes, did/does biological mother have Alzheimer's Disease? 0=No;1=Yes ADNI3 FAMHXPAR Family History - Parents
MOTHSXAGE At what approximate age did mother's symptoms start? N/A ADNI3 FAMHXPAR Family History - Parents
FATHDEM Did/Does the biological father have dementia? 0=No;1=Yes ADNI3 FAMHXPAR Family History - Parents
FATHAD If yes, did/does biological father have Alzheimer's Disease? 0=No;1=Yes ADNI3 FAMHXPAR Family History - Parents
FATHSXAGE At what approximate age did father's symptoms start? N/A ADNI3 FAMHXPAR Family History - Parents
ID N/A N/A ADNI3 FAMHXSIB Family History - Sibling Log
RID N/A N/A ADNI3 FAMHXSIB Family History - Sibling Log
SITEID N/A N/A ADNI3 FAMHXSIB Family History - Sibling Log
SIBDEMENT Did/Does this sibling have dementia? 0=No;1=Yes ADNI3 FAMHXSIB Family History - Sibling Log
SIBAD If yes, did/does sibling have Alzheimer's Disease? 0=No;1=Yes ADNI3 FAMHXSIB Family History - Sibling Log
SIBSXAGE At what approximate age did symptoms start? N/A ADNI3 FAMHXSIB Family History - Sibling Log
ID N/A N/A ADNI3 FAQ Functional Assessment Questionnaire
RID N/A N/A ADNI3 FAQ Functional Assessment Questionnaire
SITEID N/A N/A ADNI3 FAQ Functional Assessment Questionnaire
SPID Study Partner ID: N/A ADNI3 FAQ Functional Assessment Questionnaire
ID N/A N/A ADNI3 FCI Financial Capacity Instrument Short Form (FCI-SF)
RID N/A N/A ADNI3 FCI Financial Capacity Instrument Short Form (FCI-SF)
SITEID N/A N/A ADNI3 FCI Financial Capacity Instrument Short Form (FCI-SF)
ID N/A N/A ADNI3 GDSCALE Geriatric Depression Scale
RID N/A N/A ADNI3 GDSCALE Geriatric Depression Scale
SITEID N/A N/A ADNI3 GDSCALE Geriatric Depression Scale
GDAFRAID 6. Are you afraid that something bad is going to happen to you? 0=No (0);1=Yes (1) ADNI3 GDSCALE Geriatric Depression Scale
ID N/A N/A ADNI3 GENETIC Genetic Sample Collection
RID N/A N/A ADNI3 GENETIC Genetic Sample Collection
SITEID N/A N/A ADNI3 GENETIC Genetic Sample Collection
ID N/A N/A ADNI3 GUID Global Unique Identifier (GUID)
RID N/A N/A ADNI3 GUID Global Unique Identifier (GUID)
SITEID N/A N/A ADNI3 GUID Global Unique Identifier (GUID)
VISCODE N/A N/A ADNI3 GUID Global Unique Identifier (GUID)
USERDATE N/A N/A ADNI3 GUID Global Unique Identifier (GUID)
USERDATE2 N/A N/A ADNI3 GUID Global Unique Identifier (GUID)
DONE Was assessment/procedure done? 0=No;1=Yes ADNI3 GUID Global Unique Identifier (GUID)
NDREASON If No, reason not done 1=Participant Unable for Cognitive Reasons;2=Participant Unable for Other Reasons (Physical, auditory, etc.);3=Participant/Study Partner Refused;4=Equipment related issue;7=Site Error;8=Other Reason;9=Unknown ADNI3 GUID Global Unique Identifier (GUID)
GUID Enter ADNI GUID N/A ADNI3 GUID Global Unique Identifier (GUID)
COMM Comments N/A ADNI3 GUID Global Unique Identifier (GUID)
ID N/A N/A ADNI3 LABTESTS Screening Laboratory Tests
RID N/A N/A ADNI3 LABTESTS Screening Laboratory Tests
SITEID N/A N/A ADNI3 LABTESTS Screening Laboratory Tests
ID N/A N/A ADNI3 LOCLAB CSF - Local Lab Results
RID N/A N/A ADNI3 LOCLAB CSF - Local Lab Results
SITEID N/A N/A ADNI3 LOCLAB CSF - Local Lab Results
ID N/A N/A ADNI3 MMSE Mini Mental State Exam (MMSE)
RID N/A N/A ADNI3 MMSE Mini Mental State Exam (MMSE)
SITEID N/A N/A ADNI3 MMSE Mini Mental State Exam (MMSE)
ID N/A N/A ADNI3 MOCA MoCA
RID N/A N/A ADNI3 MOCA MoCA
SITEID N/A N/A ADNI3 MOCA MoCA
REPEAT2 Repeat Sentence: The cat always hid under the couch when dogs were in the room. 0=Incorrect;1=Correct ADNI3 MOCA MoCA
ID N/A N/A ADNI3 MODHACH Modified Hachinski
RID N/A N/A ADNI3 MODHACH Modified Hachinski
SITEID N/A N/A ADNI3 MODHACH Modified Hachinski
ID N/A N/A ADNI3 MONELG Monitor Eligibility
RID N/A N/A ADNI3 MONELG Monitor Eligibility
SITEID N/A N/A ADNI3 MONELG Monitor Eligibility
ID N/A N/A ADNI3 MONREV Monitor Review
RID N/A N/A ADNI3 MONREV Monitor Review
SITEID N/A N/A ADNI3 MONREV Monitor Review
ID N/A N/A ADNI3 MRIMETA MRI Scan Information
RID N/A N/A ADNI3 MRIMETA MRI Scan Information
SITEID N/A N/A ADNI3 MRIMETA MRI Scan Information
EYEKEEP Did the participant keep their eyes open (MRI Tech: ask the subject right after the scan) 0=No;1=Yes;2=N/A Scanner manufacturer is GE ADNI3 MRIMETA MRI Scan Information
ID N/A N/A ADNI3 NEUROBAT Neuropsychological Battery
RID N/A N/A ADNI3 NEUROBAT Neuropsychological Battery
SITEID N/A N/A ADNI3 NEUROBAT Neuropsychological Battery
ID N/A N/A ADNI3 NEUROEXM Neurological Exam
RID N/A N/A ADNI3 NEUROEXM Neurological Exam
SITEID N/A N/A ADNI3 NEUROEXM Neurological Exam
NXGAIDES Details: Gait N/A ADNI3 NEUROEXM Neurological Exam
NPIJ6 6. Has {P} fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPII2 2. Does {P} rapidly change moods from one to another, being fine one minute and angry the next? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPIH4 4. Does {P} say crude things or make sexual remarks that they would not usually have said? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPIH1 1. Does {P} act impulsively without appearing to consider the consequences? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPIE5 5. Does {P} avoid certain places or situations that make him.her more nervous such as riding in the car, meeting with friends, or being in crowds? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
ID N/A N/A ADNI3 INITHEALTH Initial Health Assessment
RID N/A N/A ADNI3 INITHEALTH Initial Health Assessment
SITEID N/A N/A ADNI3 INITHEALTH Initial Health Assessment
SPID Study Partner ID: N/A ADNI3 NPI Neuropsychiatric Inventory
NPID9C 9c. Caregiver Distress 0=Not at all;1=Minimally;2=Mildly;3=Moderately;4=Severely;5=Very severely or extremely ADNI3 NPI Neuropsychiatric Inventory
NPID9B 9b. Severity Ratings 1=1: Mild;2=2: Moderate;3=3: Marked ADNI3 NPI Neuropsychiatric Inventory
NPID9A 9a. Frequency Ratings 1=1: Occasionally;2=2: Often;3=3: Frequently;4=4: Very frequently ADNI3 NPI Neuropsychiatric Inventory
NPID8 8. Does {P} show any other signs of depression or sadness? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID7 7. Does {P} express a wish for death or talk about killing him/herself? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID6 6. Does {P} say he/she is a burden to the family or that the family would be better off without him/her? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID5 5. Does {P} seem very discouraged or say that he/ she has not future? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID4 4. Does {P} say that he/she is a bad person or deserves to be punished? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID3 3. Does {P} put him/herself down or say that he/she feels like a failure? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID2 2. Does {P} say or act as if he/she is sad or low in spirits? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID1 1. Does {P} have periods of tearfulness or sobbing that seem to indicate sadness? 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
NPID D: Depression/Dysphoria 0=No;1=Yes ADNI3 NPI Neuropsychiatric Inventory
ID N/A N/A ADNI3 NPIQ Neuropsychiatric Inventory Q
RID N/A N/A ADNI3 NPIQ Neuropsychiatric Inventory Q
SITEID N/A N/A ADNI3 NPIQ Neuropsychiatric Inventory Q
SPID Study Partner ID: N/A ADNI3 NPIQ Neuropsychiatric Inventory Q
NPID D. Depression/Dysphoria: Does {P} act as if he/she is sad or in low spirits? Does he/she cry? 0=No;1=Yes;2=N/A ADNI3 NPIQ Neuropsychiatric Inventory Q
NPIDSEV D. Depression/Dysphoria: Severity Ratings 1=1 - Mild (noticeable, but not a significant change).;2=2 - Moderate (significant, but not a dramatic change).;3=3 - Severe (very marked or prominent. A dramatic change). ADNI3 NPIQ Neuropsychiatric Inventory Q
ID N/A N/A ADNI3 NPSTATUS Neuropathology Status
RID N/A N/A ADNI3 NPSTATUS Neuropathology Status
SITEID N/A N/A ADNI3 NPSTATUS Neuropathology Status
NPDECIDE Has a definitive decision about brain donation been made? 0=No;1=Yes ADNI3 NPSTATUS Neuropathology Status
ID N/A N/A ADNI3 OTDISC Other Discontinuations and Withdrawals
RID N/A N/A ADNI3 OTDISC Other Discontinuations and Withdrawals
SITEID N/A N/A ADNI3 OTDISC Other Discontinuations and Withdrawals
OTAE If Adverse Event, provide Adverse Event number(s) N/A ADNI3 OTDISC Other Discontinuations and Withdrawals
ID N/A N/A ADNI3 PETMETA FDG PET Scan Information
RID N/A N/A ADNI3 PETMETA FDG PET Scan Information
SITEID N/A N/A ADNI3 PETMETA FDG PET Scan Information
SCANDIFF Provide an explanation if start time is not between 30-32 mins post-injection. N/A ADNI3 PETMETA FDG PET Scan Information
PROTID Predefined Acquisition Protocol Name N/A ADNI3 PETMETA FDG PET Scan Information
ID N/A N/A ADNI3 PETQC FDG PET QC
RID N/A N/A ADNI3 PETQC FDG PET QC
SITEID N/A N/A ADNI3 PETQC FDG PET QC
LONIUID LONI Unique Series ID N/A ADNI3 PETQC FDG PET QC
ID N/A N/A ADNI3 PHYSICAL Physical Exam
RID N/A N/A ADNI3 PHYSICAL Physical Exam
SITEID N/A N/A ADNI3 PHYSICAL Physical Exam
PXSKIDES Details: Skin and Appendages N/A ADNI3 PHYSICAL Physical Exam
ID N/A N/A ADNI3 PTDEMOG Participant Demographics
RID N/A N/A ADNI3 PTDEMOG Participant Demographics
SITEID N/A N/A ADNI3 PTDEMOG Participant Demographics
PTHOME 8. Type of Participant residence 1=House;2=Condo/Co-op (owned);3=Apartment (rented);4=Mobile Home;5=Retirement Community;6=Assisted Living;7=Skilled Nursing Facility;8=Other (specify) ADNI3 PTDEMOG Participant Demographics
ID N/A N/A ADNI3 RECCMEDS Concurrent Medications Log
ID N/A N/A ADNI3 REGISTRY Registry
RID N/A N/A ADNI3 REGISTRY Registry
SITEID N/A N/A ADNI3 REGISTRY Registry
RGREASON If visit is not done, or telephone visit is done in place of an In-clinic visit, provide reason. 1=Illness;2=Participant unavailable;3=Participant unwilling;4=Administrative problems;5=Withdrawn Consent;6=Other (specify);10=COVID-19 Participant's Illness;11=COVID-19 Participant - pandemic disruptions;12=COVID-19 Site closure due to pandemic ADNI3 REGISTRY Registry
ID N/A N/A ADNI3 RORR Return of Research Results
RID N/A N/A ADNI3 RORR Return of Research Results
SITEID N/A N/A ADNI3 RORR Return of Research Results
RECIPOTH 7f. Were the research results returned to another individual (Other, Specify) 0=No;1=Yes ADNI3 RORR Return of Research Results
AMYLRESNM 10a. If amyloid imaging results were returned, please indicate who read the scan and the individual's qualifications for interpreting amyloid imaging: Enter Name: N/A ADNI3 RORR Return of Research Results
AMLYLRESQU 10b. If amyloid imaging results: Qualifications (e.g., degrees, specialty area): N/A ADNI3 RORR Return of Research Results
AMLYRESTR 10c. If amyloid imaging results: Training (e.g., specific training in interpretation of amyloid imaging, such as Amyvid training course): N/A ADNI3 RORR Return of Research Results
AMLYRESEXP 10d. If amyloid imaging results: Experience: N/A ADNI3 RORR Return of Research Results
PTRESPONSE 11a. How did recipient respond to the information provided? Participant: N/A ADNI3 RORR Return of Research Results
FMRESPONSE 11b. How did recipient respond to the information provided? Family member: N/A ADNI3 RORR Return of Research Results
FRRESPONSE 11c. How did recipient respond to the information provided? Friend: N/A ADNI3 RORR Return of Research Results
SPRESPONSE 11d. How did recipient respond to the information provided? Study partner: N/A ADNI3 RORR Return of Research Results
CLRESPONSE 11e. How did recipient respond to the information provided? Treating clinician: N/A ADNI3 RORR Return of Research Results
OTRESPONSE 11f. How did recipient respond to the information provided? Other recipient: N/A ADNI3 RORR Return of Research Results
PREDISC 12a. What kind of pre- and post-disclosure support and monitoring was provided to the participant and his or her family? Pre-disclosure: N/A ADNI3 RORR Return of Research Results
POSTDISC 12b. What kind of pre- and post-disclosure support and monitoring was provided to the participant and his or her family? Post-disclosure: N/A ADNI3 RORR Return of Research Results
ID N/A crfname,Roster,indexes,adni2_roster_idx=RID,ENTRY;adni2_roster_idx2=ENTRY,PTID,notnullcols,ID,RID,SITEID,ENTRY,USERID,USERDATE,PTID ADNI3 ROSTER Roster
RID N/A N/A ADNI3 ROSTER Roster
SITEID N/A N/A ADNI3 ROSTER Roster
ID N/A crfname,,indexes,,notnullcols, ADNI3 SITES_VWX N/A
ID N/A N/A ADNI3 SOURCEUP Source Doc Upload
RID N/A N/A ADNI3 SOURCEUP Source Doc Upload
SITEID N/A N/A ADNI3 SOURCEUP Source Doc Upload
ID N/A N/A ADNI3 SPCONSENT Study Partner Consent
RID N/A N/A ADNI3 SPCONSENT Study Partner Consent
SITEID N/A N/A ADNI3 SPCONSENT Study Partner Consent
SPID Study Partner ID Number: N/A ADNI3 SPCONSENT Study Partner Consent
ID N/A N/A ADNI3 SPINFO Study Partner Information
RID N/A N/A ADNI3 SPINFO Study Partner Information
SITEID N/A N/A ADNI3 SPINFO Study Partner Information
INFSPID Study Partner ID Number: N/A ADNI3 SPINFO Study Partner Information
INFOTHER If Paid caregiver or Other, specify: N/A ADNI3 SPINFO Study Partner Information
ID N/A N/A ADNI3 STUDYSUM Study Visits Summary
RID N/A N/A ADNI3 STUDYSUM Study Visits Summary
SITEID N/A N/A ADNI3 STUDYSUM Study Visits Summary
SDPRIMAE If Adverse Event, provide Adverse Event number N/A ADNI3 STUDYSUM Study Visits Summary
AENUM If Adverse Event, provide Adverse Event number N/A ADNI3 STUDYSUM Study Visits Summary
ID N/A N/A ADNI3 SUBJECT Participant Registration
RID N/A N/A ADNI3 SUBJECT Participant Registration
SITEID N/A N/A ADNI3 SUBJECT Participant Registration
ID N/A N/A ADNI3 TAUMETA Tau AV-1451 PET Scan Information
RID N/A N/A ADNI3 TAUMETA Tau AV-1451 PET Scan Information
SITEID N/A N/A ADNI3 TAUMETA Tau AV-1451 PET Scan Information
SCANDIFF If scan start time is not 75-77 min post-injection, provide explanation N/A ADNI3 TAUMETA Tau AV-1451 PET Scan Information
PROTID Predefined Acquisition Protocol Name N/A ADNI3 TAUMETA Tau AV-1451 PET Scan Information
ID N/A N/A ADNI3 TAUQC Tau AV-1451 PET QC
RID N/A N/A ADNI3 TAUQC Tau AV-1451 PET QC
SITEID N/A N/A ADNI3 TAUQC Tau AV-1451 PET QC
ID N/A N/A ADNI3 TRANSFER Participant Transfers
RID N/A N/A ADNI3 TRANSFER Participant Transfers
SITEID N/A N/A ADNI3 TRANSFER Participant Transfers
SITEIDA Site conducting visits PRIOR to transfer: N/A ADNI3 TRANSFER Participant Transfers
SITEIDB Site conducting visits AFTER transfer: N/A ADNI3 TRANSFER Participant Transfers
SITEIDTMP Temporary site: N/A ADNI3 TRANSFER Participant Transfers
ID N/A crfname,,indexes,adni2_visits_idx=VISCODE,notnullcols,ID,VISCODE ADNI3 VISITS N/A
ID N/A N/A ADNI3 VITALS Vital Signs
RID N/A N/A ADNI3 VITALS Vital Signs
SITEID N/A N/A ADNI3 VITALS Vital Signs
PROTID Predefined Acquisition Protocol Name N/A ADNI3 AMYMETA Amyloid PET Scan Information
MOTION Participant motion problems 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
OTHERVAR Other protocol variations 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
ID N/A N/A ADNI3 NPI Neuropsychiatric Inventory
RID N/A N/A ADNI3 NPI Neuropsychiatric Inventory
SITEID N/A N/A ADNI3 NPI Neuropsychiatric Inventory
EARLYADD Does the study include an 'early add-on' scan (0-20) min? 0=No;1=Yes ADNI3 AMYMETA Amyloid PET Scan Information
EARLYTIME If yes, Early add on sequence start time: [H H M M] N/A ADNI3 AMYMETA Amyloid PET Scan Information
EARLYNO If no, why? 1=Not a participating site in the early add on sequence study;2=Subject did not consent to the early add on sequence study;3=Administrative problems;4=Software/scanner error;5=Withdrawn consent;99=Other ADNI3 AMYMETA Amyloid PET Scan Information
EARLYOTHER If other, specify N/A ADNI3 AMYMETA Amyloid PET Scan Information
TARGETCOMM Target start time for the early add on sequence is at the point of injection. If more than 10 seconds after the time of Florbetapir F 18 (AV-45) injection, please explain. N/A ADNI3 AMYMETA Amyloid PET Scan Information
SITEID N/A N/A ADNI3 RECCMEDS Concurrent Medications Log
RID N/A N/A ADNI3 RECCMEDS Concurrent Medications Log
PDCOVID Was deviation related to COVID-19 0=No;1=Yes, COVID-19 participant's illness;2=Yes, COVID-19 pandemic disruption ADNI3 DEVLOG Protocol Deviations Log
TRTENDDT When did treatment end? N/A ADNI3 STUDIES Treatment Trials
ID N/A N/A ADNI3 STUDIES Treatment Trials
RID N/A N/A ADNI3 STUDIES Treatment Trials
SITEID N/A N/A ADNI3 STUDIES Treatment Trials
ID N/A N/A ADNI3 ADVERSE Adverse Events Log
RID N/A N/A ADNI3 ADVERSE Adverse Events Log
SITEID N/A N/A ADNI3 ADVERSE Adverse Events Log
TXREC This Participant received an Anti-Amyloid treatment. The use of an Anti-Amyloid treatment requires discontinuation of the study medication. 1=Yes - I confirm this participant has received an Anti-Amyloid Treatment. ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXNAME Treatment Name 1=Aducanumab ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
STARTDATE Treatment Start Date N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
ENDDATE Treatment End Date N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXDOSE Dose N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXUNITS Units 1=milligram (mg) / milliliter (mL);99=other (OT) ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXUNITO If other, specify N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXFREQNC Frequency 1=every 4 weeks (q4w);99=other (OT) ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXFREQNCO If other, specify N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXROUTE Route 1=intravenous (iv);99=other (OT) ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
TXROUTEO If other, specify N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
COMM Comments N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
ID N/A N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
RID N/A N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
SITEID N/A N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
VISCODE N/A N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
USERDATE N/A N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
USERDATE2 N/A N/A ADNI3 ANTIAMYTX Anti-Amyloid Treatment Information
VISCODE2 Translated visit code -4 ADNI3 AMYMETA Amyloid PET Scan Information
VISCODE2 Translated visit code -4 ADNI3 AMYQC Amyloid PET QC
VISCODE2 Translated visit code -4 ADNI3 GUID Global Unique Identifier (GUID)
ProtocolID Study reference (i.e., ADNI2 or ADNI3). -4 ADNI3 CBBRESULTS Cogstate Battery Results
RID Participant roster ID -4 ADNI3 CBBRESULTS Cogstate Battery Results
SessionID Identification number for the session. -4 ADNI3 CBBRESULTS Cogstate Battery Results
SessionCompletionPass Session completion criteria. (i) Yes = all tests in session met completion criteria. If a test is attempted multiple times within the session, TestCompletionPass must = Yes for at least one of the attempts. (ii) No = at least one test in the session did not meet completion criteria. If a test is attempted multiple times within the session, TestCompletionPass = No for all attempts. (iii) If one or more tests in the battery do not have any data for the real test (and therefore, the test does not appear in the extract), SessionCompletionPass = No. -4 ADNI3 CBBRESULTS Cogstate Battery Results
SessionPerformancePass Session performance criteria. (i) Yes = all tests in the session met the performance check. If a test is attempted multiple times within the session, TestPerformancePass must = Yes for the most recent attempt that passed completion. (ii) No = at least one test in the session did not meet performance check. If a test is attempted multiple times within the session, TestPerformancePass = No for the most recent attempt that passed completion. (iii) If TestCompletionPass = No for all attempts for a particular test, SessionPerformancePass = No. (iv) If one or more tests in the battery do not have any data for the real test (and therefore, the test does not appear in the extract), SessionPerformancePass = No. -4 ADNI3 CBBRESULTS Cogstate Battery Results
SessionIntegrityPass Session integrity criteria. (i) Yes = all tests in the session met the integrity check. If a test is attempted multiple times within the session, TestIntegrityPass must = Yes for the most recent attempt that passed completion. (ii) No = at least one test in the session did not meet the integrity check. If a test is attempted multiple times within the session, TestIntegrityPass = No for the most recent attempt that passed completion. (iii) If TestCompletionPass = No for all attempts of a test that contributes to the integrity checks, SessionIntegrityPass = No. (iv) If one or more tests in the battery that contribute to the integrity checks do not have any data for the real test (and therefore, the test does not appear in the extract), SessionIntegrityPass = No. -4 ADNI3 CBBRESULTS Cogstate Battery Results
TestCompletionScore The completion score for the test [(TotalTrials/required correct responses) x 100; required correct responses is 35 for Detection, 30 for Identification, 80 for One Card Learning and 31 for One Back]. -4 ADNI3 CBBRESULTS Cogstate Battery Results
TestCompletionPass Test completion criteria (Yes = met completion check; No = did not meet completion check). -4 ADNI3 CBBRESULTS Cogstate Battery Results
TestPerformancePass Test performance criteria (Yes = met performance check; No = did not meet performance check). -4 ADNI3 CBBRESULTS Cogstate Battery Results
TestIntegrityPass Test integrity criteria (Yes = met integrity check; No = did not meet integrity check). -4 ADNI3 CBBRESULTS Cogstate Battery Results
TotalMaxOut Number of MaxOut responses (i.e., when a response is not provided within the maximum trial duration). -4 ADNI3 CBBRESULTS Cogstate Battery Results
TotalResponses Number of responses provided. -4 ADNI3 CBBRESULTS Cogstate Battery Results
Psyattstdscr The score on the Psychomotor Function/Attention composite, incorporating ReactionTime as the outcome measure for the Detection and Identification tests, relative to age-matched normative data. -4 ADNI3 CBBRESULTS Cogstate Battery Results
RID Participant roster ID N/A ADNI3 EMBICDCB Embic Corporation – Digital Cognitive Biomarkers
RID Participant roster ID -4 N/A ADMCBARCELONAPURINE AD Metabolomics Consortium Barcelona Purines
Uric.acid Uric acid -4 N/A ADMCBARCELONAPURINE AD Metabolomics Consortium Barcelona Purines
CA Cholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
CA.Status Status of Cholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
CDCA Chenodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
CDCA.Status Status of Chenodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
DCA Deoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
DCA.Status Status of Deoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GCA Glycocholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GCA.Status Status of Glycocholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GCDCA Glycochenodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GCDCA.Status Status of Glycochenodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GDCA Glycodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GDCA.Status Status of Glycodeoxycholic acid -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GLCA Glycolithocholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GLCA.Status Status of Glycolithocholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GLCAS Glycolithocholic acid sulphate [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GLCAS.Status Status of Glycolithocholic acid sulphate -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GUDCA Glycoursodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
GUDCA.Status Status of Glycoursodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
HDCA Hyodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
HDCA.Status Status of Hyodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Injection.Number Generated by the Biocrates MetIDQ software for every sample on a plate indicating whether a sample was injected more than once. All study samples were injected only once for every plate. Therefore, all Injection Numbers for study samples is 1. QC samples are injected three times for every plate resulting in a 1, 2, or 3 listing. -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
LCA Lithocholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
LCA.Status Status of Lithocholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Material For this study the samples are serum -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
MCA.a. -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
MCA.a.Status -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
MCA.b. -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
MCA.b.Status -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
MCA.o. -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
MCA.o.Status -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
RID Participant roster ID -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Run.Number Generated by the Biocrates MetIDQ software for every plate indicating the run number for a particular plate. For this study, all plates were injected only once. Therefore, all Run Numbers are 1. -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Sample.Type Study samples are Sample. Biocrates QCs are QC Level 1, 2 or 3. -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Sample.Volume The volume of sample injected in microliters -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Species Species of sample -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TCA Taurocholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TCA.Status Status of Taurocholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TCDCA Taurochenodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TCDCA.Status Status of Taurochenodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TDCA Taurodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TDCA.Status Status of Taurodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TLCA Taurolithocholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TLCA.Status Status of Taurolithocholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TLCAS Taurolithocholic acid sulphate [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TLCAS.Status Status of Taurolithocholic acid sulphate result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TMCA.a.b. -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TMCA.a.b.Status -4 -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TUDCA Tauroursodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
TUDCA.Status Status ofTauroursodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
UDCA Ursodeoxycholic acid [M] -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
UDCA.Status Status of Ursodeoxycholic acid result -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
Well.Position Well number in the 96-well plate from which the sample was injected -4 N/A ADMCBA AD Metabolomics Consortium Bile Acids
ST80SD Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST80MIN Min CBF value for FreeSurfer ROI: Right-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST80MD Median CBF value for FreeSurfer ROI: Right-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST80MAX Max CBF value for FreeSurfer ROI: Right-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST80AVG Mean CBF value for FreeSurfer ROI: Right-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST80CT Count of CBF voxels in FreeSurfer ROI: Right-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
Customer.Sample.Identification -4 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C14.0 lysoPhosphatidylcholine a C14:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C16.0 lysoPhosphatidylcholine a C16:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C16.1 lysoPhosphatidylcholine a C16:1 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C17.0 lysoPhosphatidylcholine a C17:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C18.0 lysoPhosphatidylcholine a C18:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C18.1 lysoPhosphatidylcholine a C18:1 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C18.2 lysoPhosphatidylcholine a C18:2 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C20.3 lysoPhosphatidylcholine a C20:3 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C20.4 lysoPhosphatidylcholine a C20:4 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C24.0 lysoPhosphatidylcholine a C24:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C26.0 lysoPhosphatidylcholine a C26:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C26.1 lysoPhosphatidylcholine a C26:1 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C28.0 lysoPhosphatidylcholine a C28:0 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C28.1 lysoPhosphatidylcholine a C28:1 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
OTHERSPECID -4 -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
Plate.Bar.Code Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
RID Participant roster ID -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
Sample.Bar.Code Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
Sample.Identification Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System. -4 N/A ADMCDUKEP180FIAADNI2GO ADMC Duke p180 Flow Injection Analysis [ADNI GO,2]
lysoPC.a.C14.0 lysoPhosphatidylcholine a C14:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C16.0 lysoPhosphatidylcholine a C16:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C16.1 lysoPhosphatidylcholine a C16:1 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C17.0 lysoPhosphatidylcholine a C17:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C18.0 lysoPhosphatidylcholine a C18:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C18.1 lysoPhosphatidylcholine a C18:1 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C18.2 lysoPhosphatidylcholine a C18:2 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C20.3 lysoPhosphatidylcholine a C20:3 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C20.4 lysoPhosphatidylcholine a C20:4 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C24.0 lysoPhosphatidylcholine a C24:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C26.0 lysoPhosphatidylcholine a C26:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C26.1 lysoPhosphatidylcholine a C26:1 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C28.0 lysoPhosphatidylcholine a C28:0 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
lysoPC.a.C28.1 lysoPhosphatidylcholine a C28:1 -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
Plate.Bar.Code Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
RID Participant roster ID. NOTE: 9999999 denotes pooled sample. -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
Sample.Bar.Code Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
Sample.Identification Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System. -4 N/A ADMCDUKEP180FIA AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis
Ac.Orn Acetylornithine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
ADDV -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
ADMA Asymmetric dimethylarginine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Ala Alanine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
alpha.AAA alpha-Aminoadipic acid -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Arg Arginine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Asn Asparagine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Asp Aspartic Acid -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
c4.OH.Pro c4-OH-proline -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Carnosine Carnosine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Cit Citrulline -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
CONDITION -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Creatinine Creatinine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Customer.Sample.Identification -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
DER -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
DOPA Dihydroxyphenylalanine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Dopamine Dopamine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
DRAWDTE -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
DRAWTIME -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Gln Glutamine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Glu Glutamic Acid -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Gly Glycine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
GRP -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
His Histidine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Histamine Histamine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Ile Isoleucine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Injection.Number -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Kynurenine Kynurenine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Lys Lysine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Material For this study the samples are serum -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Met Methionine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Met.SO Methionine-Sulfoxide -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Nitro.Tyr Nitrotyrosine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Orn Ornithine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
OTHERSPECID -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
PEA Phenylethylamine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Phe Phenylalanine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Plate.Bar.Code Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
PRIM -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Pro Proline -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
PROT -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Putrescine Putrescine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
RECDTE -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
RID Participant roster ID -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Run.Number -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Sample.Bar.Code Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Sample.Identification Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System. -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Sample.Type -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Sample.Volume The volume of sample injected in microliters -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Sarcosine Sarcosine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
SDMA Symmetric dimethylarginine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Ser Serine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Serotonin Serotonin -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
SITE -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Species Species of sample origin -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Spermidine Spermidine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Spermine Spermine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
t4.OH.Pro trans isomer of 4-hydroxyproline -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Taurine Taurine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Thr Threonine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Trp Tryptophan -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Tyr Tyrosine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Val Valine -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
VISCODE Visit code -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
VOL -4 -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Well.Position Well number in the 96-well plate from which the sample was injected -4 N/A ADMCDUKEP180UPLCADNI2GO ADMC Duke p180 Ultra Performance Liquid Chromatography [ADNI GO,2]
Ac.Orn Acetylornithine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
ADMA Asymmetric dimethylarginine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Ala Alanine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
alpha.AAA alpha-Aminoadipic acid -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Arg Arginine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Asn Asparagine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Asp Aspartic Acid -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
c4.OH.Pro c4-OH-proline -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Carnosine Carnosine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Cit Citrulline -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Creatinine Creatinine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
DOPA Dihydroxyphenylalanine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Dopamine Dopamine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Gln Glutamine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Glu Glutamic Acid -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Gly Glycine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
His Histidine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Histamine Histamine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Ile Isoleucine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Kynurenine Kynurenine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Lys Lysine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Material For this study the samples are serum -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Met Methionine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Met.SO Methionine-Sulfoxide -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Nitro.Tyr Nitrotyrosine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Orn Ornithine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
PEA Phenylethylamine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Phe Phenylalanine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Plate.Bar.Code Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Pro Proline -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Putrescine Putrescine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
RID Participant roster ID. NOTE: 9999999 denotes pooled sample. -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Sample.Bar.Code Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Sample.Identification Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System. -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Sample.Volume The volume of sample injected in microliters -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Sarcosine Sarcosine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
SDMA Symmetric dimethylarginine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Ser Serine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Serotonin Serotonin -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Species Species of sample origin -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Spermidine Spermidine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Spermine Spermine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
t4.OH.Pro trans isomer of 4-hydroxyproline -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Taurine Taurine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Thr Threonine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Trp Tryptophan -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Tyr Tyrosine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Val Valine -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
Well.Position Well number in the 96-well plate from which the sample was injected -4 N/A ADMCDUKEP180UPLC AD Metabolomics Consortium Duke Biocrates P180 Kit Ultra Performance Liquid Chromatography
ACONITIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ADIPIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ALLANTOIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ARACHIDIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ARACHIDONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ASPARTIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
BEHENIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
BENZOIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
CAPRIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
CAPRYLIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
CITRIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
CONDURITOL.BETA.EPOXIDE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
FUMARIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
GLUCONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
GLUTAMIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
GLYCERIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
GLYCEROL.3.GALACTOSIDE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
GLYCOLIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
HEPTADECANOIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
HEXURONIC.ACID2 -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
HISTIDINE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
HYDROXYPROLINE.DIPEPTIDE.NIST -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ISOCITRIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ISODEOXYTETRONIC.ACID.NIST -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ISOHEXONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ISOTHREONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
LACTIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
LAURIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
LINOLEIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
MALEIMIDE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
MALIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
METHIONINE.SULFOXIDE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
MYRISTIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
OLEIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PALMITIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PALMITOLEIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PARABANIC.ACID.NIST -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PELARGONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PIPECOLINIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PSEUDO.URIDINE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
PYRUVIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
QUINIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
RIBONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
RID Participant roster ID -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
SALICYLIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
SHIKIMIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
STEARIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
SUCCINIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
TARTARIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
THREONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
UDP.GLUCURONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
URIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
URIDINE -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X2.3.DIHYDROXYBUTANOIC.ACID.NIST -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X2.DEOXYTETRONIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X2.HYDROXYBUTANOIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X2.HYDROXYGLUTARIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X2.HYDROXYHIPPURIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X2.HYDROXYVALERIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X3.AMINOISOBUTYRIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
X3.HYDROXYBUTYRIC.ACID -4 -4 N/A ADMCGCTOF ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1]
ADIPIC_ACID Adipic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
ALLOLCA Allolithocholic acid (Isoallolithocholic acid) -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
APOCA Apocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
BUDCA 3-Ursodeoxycholic Acid (Isoursodeoxycholic acid) -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C10_0 Decanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C11_0 Undecanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C11_1_CIS_10 Undecylenic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C12_0 Dodecanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C13_0 Tridecanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C14_0 Myristic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C15_0 Pentadecanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C16_0 Palmitic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C16_1_CIS_9 Palmitoleic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C17_0 Heptadecanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C17_1_CIS_10 10Z-Heptadecenoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C18_0 Stearic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C18_1_CIS_9 Oleic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C18_2_CIS_9_12 Linoleic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C18_3_CIS_6_9_12 Gamma-Linolenic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C18_3_CIS_9_12_15 Alpha-Linolenic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C19_2_CIS_10_13 10,13-Nonadecadienoic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C1_0 Formic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C20_2_CIS_11_14 Eicosadienoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C20_3_CIS_8_11_14 8,11,14-Eicosatrienoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C20_4_CIS_5_8_11_14 Arachidonic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C20_5_CIS_5_8_11_14_17 Eicosapentaenoic acid (EPA) -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C22_4_CIS_7_10_13_16 docosatetraenoic acid (Adrenic acid) -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C22_5_CIS_4_7_10_13_16 Docosapentaenoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C22_5_CIS_7_10_13_16_19 Docosapentaenoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C22_6_CIS_4_7_10_13_16_19 Docosahexaenoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C2_0 Acetic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C3_0 Propionic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C4_0 Butyric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C5_0 Valeric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C6_0 Hexanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C7_0 Heptanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C8_0 Caprylic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
C9_0 Pelargonic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
CA Cholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
CDCA Chenodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
CIS_ACONITIC_ACID cis-Aconitic_acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
CITRIC_ACID Citric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
DCA Deoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
DEHYDROLCA Dehydrolithocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GCA Glycocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GCDCA Glycochenodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GDCA Glycodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GHCA Glycohyocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GHDCA Glycohyodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GLCA Glycolithocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GLYCERIC_ACID Glyceric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GLYCOLIC_ACID Glycolic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
GUDCA Glycoursodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
HCA Muricholic Acid\Hyocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
HDCA Hyodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
HIPPURIC_ACID Hippuric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
INDOLEACETIC_ACID Indoleacetic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
ISOBUTYRIC_ACID Isobutyric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
ISOCITRIC_ACID Isocitric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
ISOLCA Isolithocholic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
LCA Lithocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
LCA_3S Lithocholic Acid 3-Sulfate -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
L_ALPHA_AMINOBUTYRIC_ACID L-Alpha aminobutyric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
L_ASPARTIC_ACID L-Aspartic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
L_HISTIDINE L-Histidine -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
L_MALIC_ACID L-Malic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
METHYLSUCCINIC_ACID Methylsuccinic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
MUROCA Murocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
NORCA Norcholic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
NORDCA 3,12-Dihydroxynorcholanate\23-Nordeoxycholic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
OXOGLUTARIC_ACID Oxoglutaric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
PYROGLUTAMIC_ACID Pyroglutamic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
RID Participant roster ID -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
SAMPLE_ID -4 -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
SUBERIC_ACID Suberic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
SUCCINIC_ACID Succinic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
TAMCA Tauro--muricholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
TCA Taurocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
TCDCA Taurochenodeoxycholic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
TDCA Taurodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
TUDCA Tauroursodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
UCA Ursocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
UDCA Ursodeoxycholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
VID -4 -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X12_KETOLCA 12-Ketolithocholic acid /12-Ketodeoxycholic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X2_HYDROXYBUTYRIC_ACID 2-Hydroxybutyric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X3_DHCA 3-Dehydrocholic Acid/ 3-Oxocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X3_HYDROXYBUTYRIC_ACID 3-Hydroxybutyric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X3_HYDROXYISOVALERIC_ACID 3-Hydroxyisovaleric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X3_INDOLEPROPIONIC_ACID 3-Indolepropionic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X3_METHYL_2_OXOVALERIC_ACID 3-Methyl-2-oxovaleric acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X7_DHCA 7-Dehydrocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X7_KETOLCA Nutriacholic acid / 7-Ketolithocholic Acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
X__2_METHYLPENTANOIC_ACID ()-2-Methylpentanoic acid -4 N/A ADMCGUTMETABOLITESLONG ADMC U Hawaii UPLC-MS/MS Gut Metabolites Serum Longitudinal
Glutamic.acid -4 -4 N/A ADMCHIVALMETAB Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples
RID Participant roster ID -4 N/A ADMCHIVALMETAB Targeted UHPLC-MS analysis of High-Value Metabolites in Serum Samples
AC.12.0. AC(12:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.12.1. AC(12:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.13.0. AC(13:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.14.0. AC(14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.14.0..OH AC(14:0)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.14.1. AC(14:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.14.1..OH AC(14:1)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.14.2. AC(14:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.15.0...A. AC(15:0) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.15.0...B. AC(15:0) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.16.0. AC(16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.16.0..OH AC(16:0)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.16.1. AC(16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.16.1..OH AC(16:1)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.17.0...A. AC(17:0) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.17.0...B. AC(17:0) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.18.0. AC(18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.18.0..OH AC(18:0)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.18.1. AC(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.18.1..OH AC(18:1)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.18.2. AC(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.18.3. AC(18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.20.3...A. AC(20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.20.3...B. AC(20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.20.3..OH AC(20:3)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.20.4. AC(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.20.5. AC(20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.22.5. AC(22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.22.5..OH AC(22:5)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.22.6. AC(22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.24.0. AC(24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.24.1. AC(24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.24.1..OH AC(24:1)-OH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.26.0. AC(26:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
AC.26.1. AC(26:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CA CA. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.14.0. CE(14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.15.0. CE(15:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.16.0. CE(16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.16.1. CE(16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.16.2. CE(16:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.17.0. CE(17:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.17.1. CE(17:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.18.0. CE(18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.18.1. CE(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.18.2. CE(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.18.2....OH. CE(18:2) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.18.3. CE(18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.0. CE(20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.1. CE(20:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.2. CE(20:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.3. CE(20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.4. CE(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.4....OH. CE(20:4) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.20.5. CE(20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.22.0. CE(22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.22.1. CE(22:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.22.4. CE(22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.22.5. CE(22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.22.6. CE(22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.22.6....OH. CE(22:6) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.24.0. CE(24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.24.1. CE(24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.24.4. CE(24:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.24.5. CE(24:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CE.24.6. CE(24:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.16.0. Cer(d16:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.18.0. Cer(d16:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.20.0. Cer(d16:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.22.0. Cer(d16:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.23.0. Cer(d16:1/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.24.0. Cer(d16:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D16.1.24.1. Cer(d16:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.16.0. Cer(d17:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.18.0. Cer(d17:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.20.0. Cer(d17:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.22.0. Cer(d17:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.23.0. Cer(d17:1/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.24.0. Cer(d17:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D17.1.24.1. Cer(d17:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.14.0. Cer(d18:1/14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.16.0. Cer(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.18.0. Cer(d18:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.19.0. Cer(d18:1/19:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.20.0. Cer(d18:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.21.0. Cer(d18:1/21:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.22.0. Cer(d18:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.23.0. Cer(d18:1/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.24.0. Cer(d18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.24.1. Cer(d18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.1.26.0. Cer(d18:1/26:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.14.0. Cer(d18:2/14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.16.0. Cer(d18:2/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.18.0. Cer(d18:2/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.20.0. Cer(d18:2/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.21.0. Cer(d18:2/21:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.22.0. Cer(d18:2/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.23.0. Cer(d18:2/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.24.0. Cer(d18:2/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.24.1. Cer(d18:2/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D18.2.26.0. Cer(d18:2/26:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.16.0. Cer(d19:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.18.0. Cer(d19:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.20.0. Cer(d19:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.22.0. Cer(d19:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.23.0. Cer(d19:1/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.24.0. Cer(d19:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.24.1. Cer(d19:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D19.1.26.0. Cer(d19:1/26:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D20.1.22.0. Cer(d20:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D20.1.23.0. Cer(d20:1/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D20.1.24.0. Cer(d20:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.D20.1.24.1. Cer(d20:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.0.20.0. Cer(m18:0/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.0.22.0. Cer(m18:0/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.0.23.0. Cer(m18:0/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.0.24.0. Cer(m18:0/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.0.24.1. Cer(m18:0/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.1.18.0. Cer(m18:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.1.20.0. Cer(m18:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.1.22.0. Cer(m18:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.1.23.0. Cer(m18:1/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.1.24.0. Cer(m18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER.M18.1.24.1. Cer(m18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CER1P.D18.1.16.0. Cer1P(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
COH COH. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
COHORT Cohort. ADNI1 longitudinal or ADNI2/GO -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DE.16.0. DE(16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DE.18.1. DE(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DE.18.2. DE(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DE.20.4. DE(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DE.20.5. DE(20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DE.22.6. DE(22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DEDE.18.2. deDE(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DEDE.20.4. deDE(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.14.0_16.0. DG(14:0_16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.14.0_18.2. DG(14:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_16.0. DG(16:0_16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_16.1. DG(16:0_16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_18.1. DG(16:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_18.2. DG(16:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_20.4. DG(16:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_22.5. DG(16:0_22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.0_22.6. DG(16:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.16.1_18.1. DG(16:1_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.0_18.1. DG(18:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.0_18.2. DG(18:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.0_20.4. DG(18:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_18.1. DG(18:1_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_18.2. DG(18:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_18.3. DG(18:1_18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_20.3. DG(18:1_20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_20.4. DG(18:1_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_20.5. DG(18:1_20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_22.5. DG(18:1_22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.1_22.6. DG(18:1_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.2_18.2. DG(18:2_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.2_20.4. DG(18:2_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DG.18.2_22.6. DG(18:2_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DHCER.D18.0.16.0. dhCer(d18:0/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DHCER.D18.0.18.0. dhCer(d18:0/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DHCER.D18.0.20.0. dhCer(d18:0/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DHCER.D18.0.22.0. dhCer(d18:0/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DHCER.D18.0.24.0. dhCer(d18:0/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DHCER.D18.0.24.1. dhCer(d18:0/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DIMETHYL.CE.18.1. dimethyl-CE(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DIMETHYL.CE.18.2. dimethyl-CE(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DIMETHYL.CE.20.4. dimethyl-CE(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DIMETHYL.CE.22.6. dimethyl-CE(22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
DXCA dxCA. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
EXAMDATE Examination Date -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.14.0. FA(14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.16.0. FA(16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.16.1. FA(16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.17.0. FA(17:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.17.1. FA(17:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.18.0. FA(18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.18.1. FA(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.18.2. FA(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.18.3. FA(18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.20.2. FA(20:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.20.3. FA(20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.20.4. FA(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.20.5. FA(20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.22.4. FA(22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.22.5. FA(22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
FA.22.6. FA(22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM1.D18.1.16.0. GM1(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM3.D18.1.16.0. GM3(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM3.D18.1.18.0. GM3(d18:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM3.D18.1.20.0. GM3(d18:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM3.D18.1.22.0. GM3(d18:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM3.D18.1.24.0. GM3(d18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GM3.D18.1.24.1. GM3(d18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D16.1.16.0. Hex2Cer(d16:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D16.1.24.1. Hex2Cer(d16:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.1.16.0. Hex2Cer(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.1.20.0. Hex2Cer(d18:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.1.22.0. Hex2Cer(d18:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.1.24.0. Hex2Cer(d18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.1.24.1. Hex2Cer(d18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.2.16.0. Hex2Cer(d18:2/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX2CER.D18.2.24.1. Hex2Cer(d18:2/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX3CER.D18.1.16.0. Hex3Cer(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX3CER.D18.1.18.0. Hex3Cer(d18:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX3CER.D18.1.20.0. Hex3Cer(d18:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX3CER.D18.1.22.0. Hex3Cer(d18:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX3CER.D18.1.24.0. Hex3Cer(d18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEX3CER.D18.1.24.1. Hex3Cer(d18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D16.1.18.0. HexCer(d16:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D16.1.20.0. HexCer(d16:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D16.1.22.0. HexCer(d16:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D16.1.24.0. HexCer(d16:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.1.16.0. HexCer(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.1.18.0. HexCer(d18:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.1.20.0. HexCer(d18:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.1.22.0. HexCer(d18:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.1.24.0. HexCer(d18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.1.24.1. HexCer(d18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.2.18.0. HexCer(d18:2/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.2.20.0. HexCer(d18:2/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.2.22.0. HexCer(d18:2/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
HEXCER.D18.2.24.0. HexCer(d18:2/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.14.0...SN1. LPC(14:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.14.0...SN2. LPC(14:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.15.0...SN1. LPC(15:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.15.0...SN2. LPC(15:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.15.MHDA...SN1....LPC.17.0...SN2. LPC(15-MHDA) [sn1] / LPC(17:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.15.MHDA...SN1...104_SN1. LPC(15-MHDA) [sn1] [104_sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.15.MHDA...SN2. LPC(15-MHDA) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.16.0...SN1. LPC(16:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.16.0...SN2. LPC(16:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.16.1...SN1. LPC(16:1) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.16.1...SN2. LPC(16:1) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.17.0...SN1. LPC(17:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.17.1...A...SN1...104_SN1. LPC(17:1) (a) [sn1] [104_sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.17.1...SN1...A....LPC.17.1...SN2...B. LPC(17:1) [sn1] (a) / LPC(17:1) [sn2] (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.17.1...SN1...B. LPC(17:1) [sn1] (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.17.1...SN2...A. LPC(17:1) [sn2] (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.0...SN1. LPC(18:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.0...SN2. LPC(18:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.1...SN1. LPC(18:1) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.1...SN2. LPC(18:1) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.2....OH. LPC(18:2) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.2...SN1. LPC(18:2) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.2...SN2. LPC(18:2) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.3...A...SN1...104_SN1. LPC(18:3) (a) [sn1] [104_sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.3...SN1...A..LPC.18.3...SN2...B. LPC(18:3) [sn1] (a)/LPC(18:3) [sn2] (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.3...SN1...B. LPC(18:3) [sn1] (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.18.3...SN2...A. LPC(18:3) [sn2] (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.0...A...SN1...104_SN1. LPC(19:0) (a) [sn1] [104_sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.0...SN1...A....LPC.19.0...SN2...B. LPC(19:0) [sn1] (a) / LPC(19:0) [sn2] (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.0...SN1...B. LPC(19:0) [sn1] (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.0...SN2...A. LPC(19:0) [sn2] (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.1...A. LPC(19:1) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.1...B. LPC(19:1) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.19.1...C. LPC(19:1) (c). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.0...SN1. LPC(20:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.0...SN2. LPC(20:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.1...SN1. LPC(20:1) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.1...SN2. LPC(20:1) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.2...SN1. LPC(20:2) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.2...SN2. LPC(20:2) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.3...SN1. LPC(20:3) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.3...SN2. LPC(20:3) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.4....OH. LPC(20:4) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.4...SN1. LPC(20:4) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.4...SN2. LPC(20:4) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.5...SN1. LPC(20:5) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.20.5...SN2. LPC(20:5) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.0...SN1. LPC(22:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.0...SN2. LPC(22:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.1...SN1. LPC(22:1) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.1...SN2. LPC(22:1) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.4...SN1. LPC(22:4) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.4...SN2. LPC(22:4) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.5...N3...SN1...104_SN1. LPC(22:5) (n3) [sn1] [104_sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.5...SN1...N3..LPC.22.5...SN2...N6. LPC(22:5) [sn1] (n3)/LPC(22:5) [sn2] (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.5...SN1...N6. LPC(22:5) [sn1] (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.5...SN2...N3. LPC(22:5) [sn2] (n3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.6....OH. LPC(22:6) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.6...SN1. LPC(22:6) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.22.6...SN2. LPC(22:6) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.24.0...SN1. LPC(24:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.24.0...SN2. LPC(24:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.26.0...SN1. LPC(26:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.26.0...SN2. LPC(26:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.16.0. LPC(O-16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.18.0. LPC(O-18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.18.1. LPC(O-18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.20.0. LPC(O-20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.20.1. LPC(O-20:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.22.0. LPC(O-22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.22.1. LPC(O-22:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.24.0. LPC(O-24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.24.1. LPC(O-24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.O.24.2. LPC(O-24:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.P.16.0. LPC(P-16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.P.17.0...A. LPC(P-17:0) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.P.17.0...B. LPC(P-17:0) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.P.18.0. LPC(P-18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.P.18.1. LPC(P-18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPC.P.20.0. LPC(P-20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.16.0...SN1. LPE(16:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.16.0...SN2. LPE(16:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.18.0...SN1. LPE(18:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.18.0...SN2. LPE(18:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.18.1...SN1. LPE(18:1) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.18.1...SN2. LPE(18:1) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.18.2...SN1. LPE(18:2) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.18.2...SN2. LPE(18:2) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.20.4...SN1. LPE(20:4) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.20.4...SN2. LPE(20:4) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.22.6...SN1. LPE(22:6) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.22.6...SN2. LPE(22:6) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.P.16.0. LPE(P-16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.P.18.0. LPE(P-18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.P.18.1. LPE(P-18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPE.P.20.0. LPE(P-20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.18.0...SN1. LPI(18:0) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.18.0...SN2. LPI(18:0) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.18.1...SN1. LPI(18:1) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.18.1...SN2. LPI(18:1) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.18.2...SN1. LPI(18:2) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.18.2...SN2. LPI(18:2) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.20.4...SN1. LPI(20:4) [sn1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
LPI.20.4...SN2. LPI(20:4) [sn2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.CE.18.0. methyl-CE(18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.CE.18.1. methyl-CE(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.CE.18.2. methyl-CE(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.CE.20.4. methyl-CE(20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.CE.22.6. methyl-CE(22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.DE.18.1. methyl-DE(18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
METHYL.DE.18.2. methyl-DE(18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PA.34.1. PA(34:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PA.36.1. PA(36:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PA.36.2. PA(36:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PA.36.3. PA(36:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PA.36.4. PA(36:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PA.40.6. PA(40:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.14.0_16.0. PC(14:0_16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.14.0_20.4. PC(14:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.14.0_22.6. PC(14:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.0_20.3. PC(15:0_20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.0_20.4. PC(15:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.0_22.6. PC(15:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.MHDA_18.1. PC(15-MHDA_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.MHDA_18.2. PC(15-MHDA_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.MHDA_20.4. PC(15-MHDA_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.15.MHDA_22.6. PC(15-MHDA_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_16.0. PC(16:0_16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_18.0. PC(16:0_18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_18.1. PC(16:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_18.2. PC(16:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_18.3...A. PC(16:0_18:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_18.3...B. PC(16:0_18:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_20.3...A. PC(16:0_20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_20.3...B. PC(16:0_20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_20.4. PC(16:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_20.5. PC(16:0_20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.0_22.6. PC(16:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.1_18.2. PC(16:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.1_20.4. PC(16:1_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.16.1_22.6. PC(16:1_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.17.0_18.1. PC(17:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.17.0_18.2. PC(17:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.17.0_20.4. PC(17:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.17.0_22.6. PC(17:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.17.1_18.2. PC(17:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_18.1. PC(18:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_18.2. PC(18:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_20.3. PC(18:0_20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_20.4. PC(18:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_22.4. PC(18:0_22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_22.5...N3..PC.20.1_20.4. PC(18:0_22:5) (n3)/PC(20:1_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_22.5...N6. PC(18:0_22:5) (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.0_22.6. PC(18:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.1_18.1. PC(18:1_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.1_18.2. PC(18:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.1_20.3. PC(18:1_20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.1_22.6...A. PC(18:1_22:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.1_22.6...B. PC(18:1_22:6) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.2_18.2. PC(18:2_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.18.2_20.5. PC(18:2_20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.20.0_20.4. PC(20:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.28.0. PC(28:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.31.0...A. PC(31:0) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.31.0...B. PC(31:0) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.32.1. PC(32:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.32.2. PC(32:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.33.0...A. PC(33:0) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.33.0...B. PC(33:0) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.33.1. PC(33:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.33.2. PC(33:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.34.2....OH. PC(34:2) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.34.5. PC(34:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.35.5. PC(35:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.36.4....OH. PC(36:4) [+OH]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.36.6...A. PC(36:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.38.2. PC(38:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.38.4...B. PC(38:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.38.5...A. PC(38:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.38.5...B. PC(38:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.38.6...A. PC(38:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.38.7..C. PC(38:7)(c). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.39.5..A. PC(39:5)(a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.39.5..B. PC(39:5)(b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.40.7...A. PC(40:7) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.40.8. PC(40:8). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.44.12. PC(44:12). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.16.0.16.0. PC(O-16:0/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.16.0.20.3. PC(O-16:0/20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.16.0.20.4. PC(O-16:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.16.0.22.6. PC(O-16:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.18.0.18.1. PC(O-18:0/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.18.0.18.2. PC(O-18:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.18.0.20.4. PC(O-18:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.18.0.22.6. PC(O-18:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.18.1.18.1. PC(O-18:1/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.18.1.18.2. PC(O-18:1/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.32.1. PC(O-32:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.32.2. PC(O-32:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.34.1. PC(O-34:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.34.2. PC(O-34:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.34.4. PC(O-34:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.35.4. PC(O-35:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.36.0. PC(O-36:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.36.5. PC(O-36:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.38.5. PC(O-38:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.O.40.5. PC(O-40:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.15.0.20.4...A. PC(P-15:0/20:4) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.15.0.20.4...B. PC(P-15:0/20:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.14.0. PC(P-16:0/14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.16.0. PC(P-16:0/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.16.1. PC(P-16:0/16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.18.0. PC(P-16:0/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.18.1. PC(P-16:0/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.18.2. PC(P-16:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.18.3. PC(P-16:0/18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.20.4. PC(P-16:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.20.5. PC(P-16:0/20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.16.0.22.6. PC(P-16:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.17.0.20.4...A. PC(P-17:0/20:4) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.17.0.20.4...B. PC(P-17:0/20:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.18.0.18.2. PC(P-18:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.18.0.20.4. PC(P-18:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.18.0.22.5. PC(P-18:0/22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.18.0.22.6. PC(P-18:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.18.1.18.1. PC(P-18:1/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.18.1.22.6. PC(P-18:1/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.20.0.20.4. PC(P-20:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.35.2..A. PC(P-35:2)(a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.35.2..B. PC(P-35:2)(b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.36.3. PC(P-36:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.38.5...A. PC(P-38:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PC.P.38.5...B. PC(P-38:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.15.MHDA_18.1. PE(15-MHDA_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.15.MHDA_18.2. PE(15-MHDA_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.15.MHDA_20.4. PE(15-MHDA_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.15.MHDA_22.6. PE(15-MHDA_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_16.0. PE(16:0_16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_16.1. PE(16:0_16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_18.1. PE(16:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_18.2. PE(16:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_18.3...A. PE(16:0_18:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_18.3...B. PE(16:0_18:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_20.3. PE(16:0_20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_20.4. PE(16:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_20.5. PE(16:0_20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.0_22.6. PE(16:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.1_18.2. PE(16:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.16.1_20.4. PE(16:1_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.17.0_18.1. PE(17:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.17.0_18.2. PE(17:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.17.0_20.4. PE(17:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.17.0_22.6. PE(17:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_18.1. PE(18:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_18.2. PE(18:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_20.3...A. PE(18:0_20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_20.3...B. PE(18:0_20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_20.4. PE(18:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_22.4. PE(18:0_22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_22.5...N3. PE(18:0_22:5) (n3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_22.5...N6. PE(18:0_22:5) (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.0_22.6. PE(18:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.1_18.1. PE(18:1_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.1_18.2. PE(18:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.1_22.6...A. PE(18:1_22:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.18.1_22.6...B. PE(18:1_22:6) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.20.0_20.4. PE(20:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.36.0. PE(36:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.38.5...A. PE(38:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.38.5...B. PE(38:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.16.0.18.2. PE(O-16:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.16.0.20.3. PE(O-16:0/20:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.16.0.20.4. PE(O-16:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.16.0.22.4. PE(O-16:0/22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.16.0.22.6. PE(O-16:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.18.0.20.4. PE(O-18:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.18.0.22.5. PE(O-18:0/22:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.18.0.22.6. PE(O-18:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.18.1.18.2. PE(O-18:1/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.18.1.22.6. PE(O-18:1/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.34.1. PE(O-34:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.36.5. PE(O-36:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.38.5...A. PE(O-38:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.O.38.5...B. PE(O-38:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.15.0.20.4...A. PE(P-15:0/20:4) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.15.0.20.4...B. PE(P-15:0/20:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.15.0.22.6...A. PE(P-15:0/22:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.15.0.22.6...B. PE(P-15:0/22:6) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.18.1. PE(P-16:0/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.18.2. PE(P-16:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.18.3. PE(P-16:0/18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.20.3...A. PE(P-16:0/20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.20.3...B. PE(P-16:0/20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.20.4. PE(P-16:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.20.5. PE(P-16:0/20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.22.4. PE(P-16:0/22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.22.5...N3. PE(P-16:0/22:5) (n3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.22.5...N6. PE(P-16:0/22:5) (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.16.0.22.6. PE(P-16:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.17.0.20.4...A. PE(P-17:0/20:4) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.17.0.20.4...B. PE(P-17:0/20:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.17.0.22.6...A. PE(P-17:0/22:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.17.0.22.6...B. PE(P-17:0/22:6) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.18.1. PE(P-18:0/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.18.2. PE(P-18:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.18.3. PE(P-18:0/18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.20.3...A. PE(P-18:0/20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.20.3...B. PE(P-18:0/20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.20.4. PE(P-18:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.20.5. PE(P-18:0/20:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.22.4. PE(P-18:0/22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.22.5...N3. PE(P-18:0/22:5) (n3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.22.5...N6. PE(P-18:0/22:5) (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.0.22.6. PE(P-18:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.18.1...A. PE(P-18:1/18:1) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.18.1...B. PE(P-18:1/18:1) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.18.2...A. PE(P-18:1/18:2) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.18.2...B. PE(P-18:1/18:2) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.18.3. PE(P-18:1/18:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.20.3...A. PE(P-18:1/20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.20.3...B. PE(P-18:1/20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.20.4...A. PE(P-18:1/20:4) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.20.4...B. PE(P-18:1/20:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.20.5...A. PE(P-18:1/20:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.20.5...B. PE(P-18:1/20:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.22.4. PE(P-18:1/22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.22.5...A. PE(P-18:1/22:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.22.5...B. PE(P-18:1/22:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.22.6...A. PE(P-18:1/22:6) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.18.1.22.6...B. PE(P-18:1/22:6) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.19.0.20.4...A. PE(P-19:0/20:4) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.19.0.20.4...B. PE(P-19:0/20:4) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.20.0.18.1. PE(P-20:0/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.20.0.18.2. PE(P-20:0/18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.20.0.20.4. PE(P-20:0/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.20.0.22.6. PE(P-20:0/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.20.1.20.4. PE(P-20:1/20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PE.P.20.1.22.6. PE(P-20:1/22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PG.34.1. PG(34:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PG.36.1. PG(36:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PG.36.2. PG(36:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI..38.5...B. PI (38:5) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.15.MHDA_18.1..PI.17.0_18.1. PI(15-MHDA_18:1)/PI(17:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.15.MHDA_18.2..PI.17.0_18.2. PI(15-MHDA_18:2)/PI(17:0_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.15.MHDA_20.4..PI.17.0_20.4. PI(15-MHDA_20:4)/PI(17:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.16.0.16.0. PI(16:0/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.16.0_16.1. PI(16:0_16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.16.0_20.3...A. PI(16:0_20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.16.0_20.3...B. PI(16:0_20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.16.0_20.4. PI(16:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_18.1. PI(18:0_18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_20.2. PI(18:0_20:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_20.3...A. PI(18:0_20:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_20.3...B. PI(18:0_20:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_20.4. PI(18:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_22.4. PI(18:0_22:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_22.5...N3. PI(18:0_22:5) (n3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_22.5...N6. PI(18:0_22:5) (n6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.0_22.6. PI(18:0_22:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.18.1_18.2. PI(18:1_18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.20.0_20.4. PI(20:0_20:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.34.0. PI(34:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.34.1. PI(34:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.36.2. PI(36:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.37.6. PI(37:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.38.5...A. PI(38:5) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.38.6. PI(38:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PI.39.6. PI(39:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PIP1.38.4. PIP1(38:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PS.36.1. PS(36:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PS.36.2. PS(36:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PS.38.3. PS(38:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PS.38.4. PS(38:4). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PS.40.5. PS(40:5). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
PS.40.6. PS(40:6). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
RID Participant roster ID -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
S1P.D16.1. S1P(d16:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
S1P.D18.0. S1P(d18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
S1P.D18.1. S1P(d18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
S1P.D18.2. S1P(d18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SAMPLE.ID -4 -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.34.3. SM(34:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.35.2...B. SM(35:2) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.37.1. SM(37:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.37.2. SM(37:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.38.3...A. SM(38:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.38.3...B. SM(38:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.40.3...A. SM(40:3) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.40.3...B. SM(40:3) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.41.0. SM(41:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.41.1...A. SM(41:1) (a). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.43.1. SM(43:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.43.2...B. SM(43:2) (b). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.43.2...C. SM(43:2) (c). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.44.1. SM(44:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.44.2. SM(44:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.44.3. SM(44:3). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D16.1.19.0. SM(d16:1/19:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D16.1.23.0..SM.D17.1.22.0. SM(d16:1/23:0)/SM(d17:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D16.1.24.1. SM(d16:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D17.1.14.0. SM(d17:1/14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D17.1.16.0. SM(d17:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D17.1.24.1. SM(d17:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.0.14.0. SM(d18:0/14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.0.16.0. SM(d18:0/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.0.22.0. SM(d18:0/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.14.0..SM.D16.1.16.0. SM(d18:1/14:0)/SM(d16:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.16.0. SM(d18:1/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.17.0..SM.D17.1.18.0. SM(d18:1/17:0)/SM(d17:1/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.18.0..SM.D16.1.20.0. SM(d18:1/18:0)/SM(d16:1/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.20.0..SM.D16.1.22.0. SM(d18:1/20:0)/SM(d16:1/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.22.0..SM.D16.1.24.0. SM(d18:1/22:0)/SM(d16:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.23.0..SM.D17.1.24.0. SM(d18:1/23:0)/SM(d17:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.24.0. SM(d18:1/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.1.24.1. SM(d18:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.14.0. SM(d18:2/14:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.16.0. SM(d18:2/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.17.0. SM(d18:2/17:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.18.0. SM(d18:2/18:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.18.1. SM(d18:2/18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.20.0. SM(d18:2/20:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.22.0. SM(d18:2/22:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.23.0. SM(d18:2/23:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D18.2.24.0. SM(d18:2/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SM.D19.1.24.1. SM(d19:1/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SPH.D18.1. Sph(d18:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SPH.D18.2. Sph(d18:2). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SULFATIDE..D18.1..16.0. Sulfatide (d18:1:/16:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SULFATIDE..D18.1..16.0.OH.. Sulfatide (d18:1:/16:0(OH)). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SULFATIDE..D18.1..24.0. Sulfatide (d18:1:/24:0). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SULFATIDE..D18.1..24.0.OH.. Sulfatide (d18:1:/24:0(OH)). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SULFATIDE..D18.1..24.1. Sulfatide (d18:1:/24:1). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
SULFATIDE..D18.1..24.1.OH.. Sulfatide (d18:1:/24:1(OH)). Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.0...NL.16.0. TG(48:0) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.0...NL.18.0. TG(48:0) [NL-18:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.0...SIM. TG(48:0) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.1...NL.16.1. TG(48:1) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.1...NL.18.1. TG(48:1) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.1...SIM. TG(48:1) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.2...NL.14.0. TG(48:2) [NL-14:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.2...NL.14.1. TG(48:2) [NL-14:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.2...NL.16.1. TG(48:2) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.2...NL.18.2. TG(48:2) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.2...SIM. TG(48:2) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.3...NL.14.0. TG(48:3) [NL-14:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.3...NL.16.1. TG(48:3) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.3...NL.18.3. TG(48:3) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.48.3...SIM. TG(48:3) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.49.1...NL.16.1. TG(49:1) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.49.1...NL.17.1. TG(49:1) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.0...NL.18.0. TG(50:0) [NL-18:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.0...SIM. TG(50:0) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.1...NL.14.0. TG(50:1) [NL-14:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.1...NL.16.0. TG(50:1) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.1...NL.18.1. TG(50:1) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.1...SIM. TG(50:1) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.2...NL.14.0. TG(50:2) [NL-14:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.2...NL.16.1. TG(50:2) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.2...NL.18.1. TG(50:2) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.2...NL.18.2. TG(50:2) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.2...SIM. TG(50:2) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.3...NL.14.0. TG(50:3) [NL-14:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.3...NL.14.1. TG(50:3) [NL-14:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.3...NL.16.1. TG(50:3) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.3...NL.18.2. TG(50:3) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.3...NL.18.3. TG(50:3) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.3...SIM. TG(50:3) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.4...NL.14.0. TG(50:4) [NL-14:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.4...NL.18.3. TG(50:4) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.4...NL.20.4. TG(50:4) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.50.4...SIM. TG(50:4) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.0...NL.16.0. TG(51:0) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.1...NL.17.0. TG(51:1) [NL-17:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.1...SIM. TG(51:1) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.2...NL.15.0. TG(51:2) [NL-15:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.2...NL.17.0. TG(51:2) [NL-17:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.2...NL.17.1. TG(51:2) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.51.2...SIM. TG(51:2) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.1...NL.18.0. TG(52:1) [NL-18:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.1...NL.18.1. TG(52:1) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.1...SIM. TG(52:1) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.2...NL.16.0. TG(52:2) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.2...NL.18.2. TG(52:2) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.2...SIM. TG(52:2) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.3...NL.16.1. TG(52:3) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.3...NL.18.2. TG(52:3) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.3...SIM. TG(52:3) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.4...NL.16.1. TG(52:4) [NL-16:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.4...NL.18.2. TG(52:4) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.4...NL.18.3. TG(52:4) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.4...SIM. TG(52:4) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.5...NL.18.3. TG(52:5) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.5...NL.20.4. TG(52:5) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.5...NL.20.5. TG(52:5) [NL-20:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.52.5...SIM. TG(52:5) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.53.2...NL.17.1. TG(53:2) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.53.2...NL.18.1. TG(53:2) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.53.2...SIM. TG(53:2) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.0...NL.18.0. TG(54:0) [NL-18:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.0...SIM. TG(54:0) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.1...NL.18.1. TG(54:1) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.1...SIM. TG(54:1) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.2...NL.18.0. TG(54:2) [NL-18:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.2...NL.20.1. TG(54:2) [NL-20:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.2...SIM. TG(54:2) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.3...NL.18.1. TG(54:3) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.3...NL.18.2. TG(54:3) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.3...SIM. TG(54:3) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.4...NL.18.2. TG(54:4) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.4...NL.20.3. TG(54:4) [NL-20:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.4...SIM. TG(54:4) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.5...NL.18.3. TG(54:5) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.5...NL.20.4. TG(54:5) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.5...SIM. TG(54:5) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.6...NL.18.3. TG(54:6) [NL-18:3]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.6...NL.20.4. TG(54:6) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.6...NL.20.5. TG(54:6) [NL-20:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.6...NL.22.6. TG(54:6) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.6...SIM. TG(54:6) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.7...NL.20.5. TG(54:7) [NL-20:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.7...NL.22.6. TG(54:7) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.54.7...SIM. TG(54:7) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.6...NL.20.4. TG(56:6) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.6...NL.22.5. TG(56:6) [NL-22:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.6...SIM. TG(56:6) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.7...NL.20.4. TG(56:7) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.7...NL.20.5. TG(56:7) [NL-20:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.7...NL.22.5. TG(56:7) [NL-22:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.7...NL.22.6. TG(56:7) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.7...SIM. TG(56:7) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.8...NL.20.4. TG(56:8) [NL-20:4]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.8...NL.20.5. TG(56:8) [NL-20:5]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.8...NL.22.6. TG(56:8) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.8...SIM. TG(56:8) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.9...NL.22.6. TG(56:9) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.56.9...SIM. TG(56:9) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.58.10...NL.22.6. TG(58:10) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.58.10...SIM. TG(58:10) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.58.8...NL.22.6. TG(58:8) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.58.8...SIM. TG(58:8) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.58.9...NL.22.6. TG(58:9) [NL-22:6]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.58.9...SIM. TG(58:9) [SIM]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.1...NL.15.0. TG(O-50:1) [NL-15:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.1...NL.16.0. TG(O-50:1) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.1...NL.17.1. TG(O-50:1) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.1...NL.18.1. TG(O-50:1) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.2...NL.18.1. TG(O-50:2) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.2...NL.18.2. TG(O-50:2) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.50.3...NL.18.2. TG(O-50:3) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.52.0...NL.16.0. TG(O-52:0) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.52.1...NL.16.0. TG(O-52:1) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.52.1...NL.18.1. TG(O-52:1) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.52.2...NL.16.0. TG(O-52:2) [NL-16:0]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.52.2...NL.17.1. TG(O-52:2) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.52.2...NL.18.1. TG(O-52:2) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.54.2...NL.17.1. TG(O-54:2) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.54.2...NL.18.1. TG(O-54:2) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.54.3...NL.17.1. TG(O-54:3) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.54.3...NL.18.1. TG(O-54:3) [NL-18:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.54.4...NL.17.1. TG(O-54:4) [NL-17:1]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
TG.O.54.4...NL.18.2. TG(O-54:4) [NL-18:2]. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
UBIQUINONE Ubiquinone. Lipid metabolite [nM] -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
VID -4 -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matr
VISCODE Visit code -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
VISCODE2 Translated visit code -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
GUSPECID -4 -4 N/A ADMCLIPIDOMICSMEIKLELABLONG ADMC Lipidomics Meikle Lab Longitudinal Data Matrix
CA Cholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
CDCA Chenodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
CUSTOMER.SAMPLE.IDENTIFICATION This is the number listed on every tube of the study samples -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
DCA Deoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
GCA Glycocholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
GCDCA Glycochenodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
GDCA Glycodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
GLCA Glycolithocholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
GUDCA Glycoursodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
HDCA Hyodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
INJECTION.NUMBER Generated by the Biocrates MetIDQ software for every sample on a plate indicating whether a sample was injected more than once. All study samples were injected only once for every plate. Therefore, all Injection Numbers for study samples is 1. QC samples are injected three times for every plate resulting in a 1, 2, or 3 listing. -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
LCA Lithocholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
MATERIAL For this study the samples are serum -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
MCA.A. ?-Muricholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
MCA.B. Muricholic acid, beta [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
MCA.O. Muricholic acid, omega [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
PLATE.BAR.CODE Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
RID Participant roster ID -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
RUN.NUMBER Generated by the Biocrates MetIDQ software for every plate indicating the run number for a particular plate. For this study, all plates were injected only once. Therefore, all Run Numbers are 1. -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
SAMPLE.BAR.CODE Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
SAMPLE.IDENTIFICATION Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
SAMPLE.TYPE Study samples are Sample. Biocrates QCs are QC Level 1, 2 or 3. -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
SAMPLE.VOLUME The volume of sample injected in microliters -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
SPECIES Species of sample -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
TCA Taurocholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
TCDCA Taurochenodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
TDCA Taurodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
TLCA Taurolithocholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
TMCA.A.B. Tauromuricholic acid (alpha+beta) [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
TUDCA Tauroursodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
UDCA Ursodeoxycholic acid [M] -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
WELL.POSITION Well number in the 96-well plate from which the sample was injected -4 N/A ADMCM2OVEBA ADMC M2OVE-AD ADNIGO-2 Bile Acids
LPC.16.0 LPtdCho 16:0/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.16.1 LPtdCho 16:1/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.18.0 LPtdCho 18:0/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.18.1 LPtdCho 18:1/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.18.2 LPtdCho 18:2/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.18.3 LysoPtdCho 18:3 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.20.4 LPtdCho 20:4/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.20.5 LysoPtdCho 20:5 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.22.4 LysoPtdCho 22:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
LPC.22.6 LPtdCho 22:6/OH -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_18.0 PtdCho 16:0/18:0 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_18.1 PtdCho 16:0/18:1 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_18.2 PtdCho 16:0/18:2 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_18.3 PtdCho 16:0/18:3 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_20.4 PtdCho 16:0/20:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_20.5 PtdCho 16:0/20:5 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_22.4 PtdCho 16:0/22:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.0_22.6 PtdCho 16:0/22:6 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.16.1_22.6 PtdCho 16:1/22:6 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_18.0 PtdCho 18:0/18:0 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_18.1 PtdCho 18:0/18:1 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_18.2 PtdCho 18:0/18:2 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_18.3 PtdCho 18:0/18:3 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_20.4 PtdCho 18:0/20:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_20.5 PtdCho 18:0/20:5 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_22.4 PtdCho 18:0/22:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.0_22.6 PtdCho 18:0/22:6 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_18.1 PtdCho 18:1/18:1 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_18.2 PtdCho 18:1/18:2 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_18.3 PtdCho 18:1/18:3 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_20.4 PtdCho 18:1/20:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_20.5 PtdCho 18:1/20:5 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_22.4 PtdCho 18:1/22:4 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PC.18.1_22.6 PtdCho 18:1/22:6 -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
RECNO Record number (2 indicates replicate sample) -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
RID Participant roster ID -4 N/A ADMCPDINESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho) Flow Injection Negative Ionization LC-MS/MS Internal Standard Ratios
PE.16.0_18.3 PtdEtn 16:0/18:3 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0_22.6 PtdEtn 16:0/22:6 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0_20.5 PtdEtn 18:0/20:5 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0_22.4 PtdEtn 18:0/22:4 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0_18.2 PlsEtn 16:0/18:2 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0_22.4 PlsEtn 16:0/22:4 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0_22.6 PlsEtn 16:0/22:6 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0_20.5 PlsEtn 18:0/20:5 -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
RECNO Record number (2 indicates replicate sample) -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
RID Participant roster ID -4 N/A ADMCPDIPEISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
BATCH.ID MS Batch identifier -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
C13.PE.16.0_22.6 C13.PE.16.0_22.6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
C13.PE.P.16.0_22.6 C13.PE.P.16.0_22.6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
COMMENTS -4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PDI.ID Phenomenome sample ID -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0_18.3 PtdEtn 16:0/18:3 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.16.0_22.6 PtdEtn 16:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.18.0_20.5 PtdEtn 18:0/20:5 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.18.0_22.4 PtdEtn 18:0/22:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.P.16.0_18.2 PlsEtn 16:0/18:2 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.P.16.0_22.4 PlsEtn 16:0/22:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.P.16.0_22.6 PlsEtn 16:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
PE.P.18.0_20.5 PlsEtn 18:0/20:5 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Peak Heights
RID Participant roster ID -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
C13.PE.16.0.22.6 13C Labeled PtdEtn 16:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
C13.PE.P.16.0.22.6 13C Labeled PlsEtn 16:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.18.0 PtdEtn 16:0/18:0 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.18.1 PtdEtn 16:0/18:1 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.18.2 PtdEtn 16:0/18:2 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.18.3 PtdEtn 16:0/18:3 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.20.4 PtdEtn 16:0/20:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.20.5 PtdEtn 16:0/20:5 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.22.4 PtdEtn 16:0/22:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.22.6 PtdEtn 16:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.16.0.24.6 PtdEtn 16:0/24:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.18.1 PtdEtn 18:0/18:1 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.18.2 PtdEtn 18:0/18:2 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.18.3 PtdEtn 18:0/18:3 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.20.4 PtdEtn 18:0/20:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.20.5 PtdEtn 18:0/20:5 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.22.4 PtdEtn 18:0/22:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.22.6 PtdEtn 18:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.18.0.24.6 PtdEtn 18:0/24:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.18.0 PlsEtn 16:0/18:0 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.18.1 PlsEtn 16:0/18:1 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.18.2 PlsEtn 16:0/18:2 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.18.3 PlsEtn 16:0/18:3 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.20.4 PlsEtn 16:0/20:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.20.5 PlsEtn 16:0/20:5 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.22.4 PlsEtn 16:0/22:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.16.0.22.6 PlsEtn 16:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.18.0 PlsEtn 18:0/18:0 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.18.1 PlsEtn 18:0/18:1 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.18.2 PlsEtn 18:0/18:2 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.18.3 PlsEtn 18:0/18:3 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.20.4 PlsEtn 18:0/20:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.20.5 PlsEtn 18:0/20:5 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.22.4 PlsEtn 18:0/22:4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
PE.P.18.0.22.6 PlsEtn 18:0/22:6 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
SAMPLE.TYPE -4 -4 N/A ADMCPDIPEPEAKHEIGHTS AD Metabolomics Consortium Phenomenome Phosphatidylethanolamine (PtdEtn), Plasmenylethanolamine (PlsEtn) Flow Injection LC-MS/MS Internal Standard Ratios
LPC.16.0 LPtdCho 16:0/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
LPC.16.1 LPtdCho 16:1/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
LPC.18.0 LPtdCho 18:0/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
LPC.18.1 LPtdCho 18:1/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
LPC.18.2 LPtdCho 18:2/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
LPC.20.4 LPtdCho 20:4/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
LPC.22.6 LPtdCho 22:6/OH -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.34.0 diacyl-PtdCho 16:0/18:0; 14:0/20:0 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.34.1 diacyl PtdCho 16:0/18:1; 14:0/20:1; 16:1/18:0 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.34.2 diacyl PtdCho 16:0/18:2; 14:0/20:2; 16:1/18:1 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.34.3 diacyl-PtdCho 16:0/18:3; 14:0/20:3; 16:1/18:2 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.36.2 diacyl PtdCho 18:0/18:2; 18:1/18:1; 14:0/22:2; 16:0/20:2; 16:1/20:1 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.36.3 diacyl PtdCho 18:0/18:3, 18:1/18:2; 14:0/22:3; 16:0/20:3; 16:1/20:2 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.36.4 diacyl PtdCho 16:0/20:4; 18:1/18:3; 14:0/22:4; 18:2/18:2; 16:1/20:3 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.36.5 diacyl PtdCho 16:0/20:5; 14:0/22:5; 18:2/18:3; 18:2/18:3 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.36.6 diacyl PtdCho 14:0/22:6; 16:1/20:5; 18:3/18:3 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.38.0 diacyl PtdCho 18:0/20:0;16:0/22:0 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.38.4 diacyl PtdCho 16:0/22:4, 18:0/20:4; 14:0/24:4; 18:1/20:3 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.38.5 diacyl PtdCho 18:0/20:5, 18:1/20:4; 14:0/24:5; 16:0/22:5; 16:1/22:4 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.38.6 diacyl PtdCho 16:0/22:6, 18:1/20:5; 14:0/24:6; 18:2/20:4 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.38.7 diacyl PtdCho 16:1/22:6; 14:1/24:6; 18:2/20:5 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.40.1 diacyl PtdCho 18:0/22:1; 18:1/22:0; 16:0/24:1; 16:1/24:0 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.40.2 diacyl PtdCho 18:1/22:1; 18:0/22:2; 16:0/24:2; 16:1/24:1 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.40.4 diacyl PtdCho 18:0/22:4; 16:0/24:4; 16:1/24:3; 20:0/20:4 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.40.5 diacyl PtdCho 18:1/22:4; 16:0/24:5; 18:0/22:5; 20:0/20:5; 20:1/20:4 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.40.6 diacyl PtdCho 18:0/22:6; 16:0/24:6; 18:1/22:5 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
PC.40.7 diacyl PtdCho 18:1/22:6; 16:0/24:6 -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
RECNO Record number (2 indicates replicate sample) -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
RID Participant roster ID -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
SM.34.1 SphMyelin (d18:1/16:0), SphMyelin (d18:0/16:1) -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
SM.36.1 SphMyelin (d18:1/18:0), SphMyelin (d18:0/18:1) -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
SM.36.2 SphMyelin (d18:1/18:1) -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
SM.42.1 SphMyelin (d18:1/24:0) -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
SM.42.2 SphMyelin (d18:1/24:1) -4 N/A ADMCPDIPESIPCISRATIOS AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios
ST74SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST74MIN Min CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST74MD Median CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST74MAX Max CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST74CT Count of CBF voxels in FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST74AVG Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
TMPMIDR08 Temporal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDR06 Temporal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDR05 Temporal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDR04 Temporal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDR03 Temporal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDR02 Globally normalized CMRgl from Temporal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDR01 Globally normalized CMRgl from Temporal_mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL07 Temporal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL06 Temporal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL05 Temporal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL04 Temporal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL03 Temporal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL02 Globally normalized CMRgl from Temporal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
TMPMIDL01 Globally normalized CMRgl from Temporal _mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
AMINOCAPROIC_ACID -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
DHA 22:6, docosahexaenoic acid N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
GUSPECID -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
HDL_TG Triglycerides in HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
HIS Histidine N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_C Total cholesterol in IDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_CE Cholesterol esters in IDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_CE_PCT -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_C_PCT -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_FC Free cholesterol in IDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_FC_PCT -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_L Total lipids in IDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_P Concentration of IDL particles N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_PL Phospholipids in IDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_PL_PCT -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_TG Triglycerides in IDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
IDL_TG_PCT -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
LA 18:2, linoleic acid N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
LDL_TG Triglycerides in LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_HDL_L Total lipids in large HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_HDL_PL Phospholipids in large HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_HDL_TG Triglycerides in large HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_LDL_L Total lipids in large LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_LDL_PL Phospholipids in large LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_LDL_TG Triglycerides in large LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_VLDL_L Total lipids in large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_VLDL_PL Phospholipids in large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
L_VLDL_TG Triglycerides in large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
MUFA Monounsaturated fatty acids; 16:1, 18:1 N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_HDL_L Total lipids in medium HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_HDL_PL Phospholipids in medium HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_HDL_TG Triglycerides in medium HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_LDL_L Total lipids in medium LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_LDL_PL Phospholipids in medium LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_LDL_TG Triglycerides in medium LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_VLDL_L Total lipids in medium VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_VLDL_PL Phospholipids in medium VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
M_VLDL_TG Triglycerides in medium VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
N_METHYL_2_PYRROLIDONE -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
PHOSPHATIDYLC -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
POLYSACCHARIDES -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
PUFA Polyunsaturated fatty acids N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
RID Participant roster ID -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
SFA Saturated fatty acids N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_HDL_L Total lipids in small HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_HDL_PL Phospholipids in small HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_HDL_TG Triglycerides in small HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_LDL_L Total lipids in small LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_LDL_PL Phospholipids in small LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_LDL_TG Triglycerides in small LDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_VLDL_L Total lipids in small VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_VLDL_PL Phospholipids in small VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
S_VLDL_TG Triglycerides in small VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
UNEXPECTED_AMINO_ACID_SIGNALS -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
UNIDENTIFIED_MACROMOLECULES -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
UNIDENTIFIED_SMALL_MOLECULE_A -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
UNIDENTIFIED_SMALL_MOLECULE_B -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
UNIDENTIFIED_SMALL_MOLECULE_C -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
VID -4 -4 N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
VLDL_TG Triglycerides in VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XL_HDL_L Total lipids in very large HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XL_HDL_PL Phospholipids in very large HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XL_HDL_TG Triglycerides in very large HDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XL_VLDL_L Total lipids in very large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XL_VLDL_PL Phospholipids in very large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XL_VLDL_TG Triglycerides in very large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XS_VLDL_L Total lipids in very small VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XS_VLDL_PL Phospholipids in very small VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XS_VLDL_TG Triglycerides in very small VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XXL_VLDL_L Total lipids in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XXL_VLDL_PL Phospholipids in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
XXL_VLDL_TG Triglycerides in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALELONG ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites Longitudinal
RID Participant roster ID -4 N/A ADRC_EMORY_DDE DDE Analysis Summary
TG_56_8_NL_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
VISCODE2 Translated visit code -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
VISCODE Visit code -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
UOM UOM -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
TOTAL Total (g/g) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
SPECIMEN_TYPE Specimen Type -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
SPECIMEN_QUANTITY Specimen Quantity -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
SPECIMEN_BAR_CODE Specimen Bar Code -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
SEQUENCE_NUMBER Sequence Number -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
SATURES Satures (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
RID Participant roster ID -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
POSITION Position -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
ORIGPROT Original study protocol -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
N6 n-6 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
N3 n-3 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
MONO Mono (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
MASSE_MG masse (mg) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
LAB_NUMBER Lab number -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
KIT_NUMBER Kit Number -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
EXAMDATE Examination Date -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
COLPROT Study protocol of data collection -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C226N3 C22:6 n-3 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C225N6 C22:5 n-6 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C225N3 C22:5 n-3 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C224N6 C22:4 n-6 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C205PLUSC226N3 C20:5 + C22:6 n-3 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C205PLUSC225PLUSC226N3 C20:5 + C22:5 +C22:6 n-3 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C205N3 C20:5 n-3 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C204N6 C20:4 n-6 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C203N6 C20:3 n-6 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C201N9 C20:1 n-9 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C183N3PLUSC200 C18:3 n-3 + C20:0 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C182N6 C18:2 n-6 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
RID Participant roster ID -4 N/A ALIQUOT_LIST Aliquot count in the LDMS database
VID Visit number from sample tube -4 N/A ALIQUOT_LIST Aliquot count in the LDMS database
VIALID -4 -4 N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
UBIQUINONE Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_O_52_2_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_O_52_0_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_O_50_1_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SUBJID Participant ADSP subject_key -4 N/A ADSP_PHC_COGN ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores
IMAGEUID -4 -4 N/A BAIMRINMRC Banner Alzheimer's Institute MRI NMRC Summaries
RID Participant roster ID -4 N/A BAIMRINMRC Banner Alzheimer's Institute MRI NMRC Summaries
LONIUID -4 -4 N/A BAIMRINMRC Banner Alzheimer's Institute MRI NMRC Summaries
RID N/A N/A N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDR06 Occipital_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDR05 Occipital_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDR04 Occipital_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDR03 Occipital_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDR02 Globally normalized CMRgl from Occipital_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDR01 Globally normalized CMRgl from Occipital_mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL11 Occipital_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL06 Occipital_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL05 Occipital_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL04 Occipital_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL03 Occipital_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL02 Globally normalized CMRgl from Occipital_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
OCCMIDL01 Globally normalized CMRgl from Occipital_mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
INDTEPNDX Individualized Temporal index NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
IMAGEUID N/A N/A N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
INDGLBNDX Individualized Global Index NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDR06 Frontal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDR05 Frontal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDR04 Frontal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDR03 Frontal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDR02 Globally normalized CMRgl from Frontal_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDR01 Globally normalized CMRgl from Frontal_mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDOR02 Globally normalized CMRgl from Frontal_Mid_Orb_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDOL02 Globally normalized CMRgl from Frontal_Mid_Orb_Right NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDL06 Frontal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDL05 Frontal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDL04 Frontal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDL03 Frontal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDL02 Globally normalized CMRgl from Frontal_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
FRTMIDL01 Globally normalized CMRgl from Frontal_mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGPSTR12 Cingulum_Post_R/Cingulum_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMIDR02 Globally normalized CMRgl from Cingulum_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMIDR01 Globally normalized CMRgl from Cingulum_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMIDL02 Globally normalized CMRgl from Cingulum_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMIDL01 Globally normalized CMRgl from Cingulum_Mid_L NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMID11 Cingulum_Post_R/Cingulum_Mid_R NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMID06 Cingulum_Mid NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMID05 Cingulum_Mid NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMID04 Cingulum_Mid NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
CINGMID03 Cingulum_Mid NA N/A BAINMRC Banner Alzheimer's Institute NMRC Summaries
LONIUID LONI Unique Image Identifier N/A N/A BAIPETNMRCAV45 Banner Alzheimer's Institute PET NMRC AV45 Summaries
RID Participant roster ID N/A N/A BAIPETNMRCAV45 Banner Alzheimer's Institute PET NMRC AV45 Summaries
LONIUID LONI Unique Image Identifier N/A N/A BAIPETNMRCFDG Banner Alzheimer's Institute PET NMRC FDG Summaries
RID Participant roster ID N/A N/A BAIPETNMRCFDG Banner Alzheimer's Institute PET NMRC FDG Summaries
LONIUID LONI Unique Image Identifier N/A N/A BAIPETNMRCFTP Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries
RID Participant roster ID N/A N/A BAIPETNMRCFTP Banner Alzheimer's Institute PET NMRC Flortaucipir (F-AV1451) Summaries
ACI amyloid convergence index for AV-45 subjects N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMID03 Cingulum_Mid N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMID04 Cingulum_Mid N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMID05 Cingulum_Mid N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMID06 Cingulum_Mid N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMID11 Cingulum_Post_R/Cingulum_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMIDL01 Globally normalized CMRgl from Cingulum_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMIDL02 Globally normalized CMRgl from Cingulum_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMIDR01 Globally normalized CMRgl from Cingulum_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGMIDR02 Globally normalized CMRgl from Cingulum_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
CINGPSTR12 Cingulum_Post_R/Cingulum_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDL01 Globally normalized CMRgl from Frontal_mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDL02 Globally normalized CMRgl from Frontal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDL03 Frontal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDL04 Frontal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDL05 Frontal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDL06 Frontal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDOL02 Globally normalized CMRgl from Frontal_Mid_Orb_Right N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDOR02 Globally normalized CMRgl from Frontal_Mid_Orb_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDR01 Globally normalized CMRgl from Frontal_mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDR02 Globally normalized CMRgl from Frontal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDR03 Frontal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDR04 Frontal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDR05 Frontal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
FRTMIDR06 Frontal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
INDGLBNDX Individualized Global Index N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
INDTEPNDX Individualized Temporal index N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
LONIUID LONI Unique Image Identifier N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL01 Globally normalized CMRgl from Occipital_mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL02 Globally normalized CMRgl from Occipital_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL03 Occipital_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL04 Occipital_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL05 Occipital_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL06 Occipital_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDL11 Occipital_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDR01 Globally normalized CMRgl from Occipital_mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDR02 Globally normalized CMRgl from Occipital_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDR03 Occipital_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDR04 Occipital_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDR05 Occipital_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
OCCMIDR06 Occipital_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
RID Participant roster ID N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL01 Globally normalized CMRgl from Temporal _mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL02 Globally normalized CMRgl from Temporal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL03 Temporal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL04 Temporal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL05 Temporal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL06 Temporal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDL07 Temporal_Mid_L N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR01 Globally normalized CMRgl from Temporal_mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR02 Globally normalized CMRgl from Temporal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR03 Temporal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR04 Temporal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR05 Temporal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR06 Temporal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
TMPMIDR08 Temporal_Mid_R N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
SROI statistical region of interest (sROI) developed and validated for optimal longitudinal FDG-PET CMRgl changes N/A N/A BAIPETNMRC Banner Alzheimer's Institute PET NMRC Summaries
ASSAY Experiment file name N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
ASSAY_FLUID Main biological matrix of experiment "Plasma; CSF" N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
ASSAY_IP_PROTOCOL Sample processing protocol N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
BATCH_N Indicates the batch in which the sample was processed (prepped) for LC-MSMS N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
Box_Number -4 -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
EXAMDATE Examination Date -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
FILE_NAME_NE Exact file name of LC-MSMS rum without extention N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
Global_Spec_ID -4 -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
INJECTION injection (technical replicate) 1-st denoted as 'a'; second as 'b' ei. "a; b; c; d" N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
INSTRUMENT Masspectrometer "Lumos; Altis; Xevo; Fusion" N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
LC_MS_SAMPLE_ID Internal ID of LS_MS sample to control for technical replicates. It serves as internal blinding ID and for QC purpocess N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
MS_RUN_DATE date when sequense get started to run on LC-MSMS N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA38_N14_B07 Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from endogenous A38 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA38_N14_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A38 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA38_N14_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A38 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA38_N15_B07 Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from 15N labled A38 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA38_N15_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A38 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA38_N15_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A38 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_B05 Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN C-terminal peptide from endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_B07 Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_B10 Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_B11 Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N14_TOUSE Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to endogenous A40 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_B05 Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN C-terminal peptide from 15N labled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_B07 Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from 15N labled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_B10 Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from 15N labled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_B11 Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from 15N labled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA40_N15_TOUSE Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to 15N labeled A40 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_B10 Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_B11 Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_B12 Integrated Peak Area for chromatograms derived from MS/MS transition ion b12 for the LysN C-terminal peptide from endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_B13 Integrated Peak Area for chromatograms derived from MS/MS transition ion b13 for the LysN C-terminal peptide from endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N14_TOUSE Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to endogenous A42 N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_B10 Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from 15N labled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_B11 Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from 15N labled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_B12 Integrated Peak Area for chromatograms derived from MS/MS transition ion b12 for the LysN C-terminal peptide from 15N labled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_B13 Integrated Peak Area for chromatograms derived from MS/MS transition ion b13 for the LysN C-terminal peptide from 15N labled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETA42_N15_TOUSE Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to 15N labeled A42 internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B04 Integrated Peak Area for chromatograms derived from MS/MS transition ion b4 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B05 Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B06 Integrated Peak Area for chromatograms derived from MS/MS transition ion b6 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B07 Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B10 Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N14_B11 Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN Mid-Domain from endogenous A N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B04 Integrated Peak Area for chromatograms derived from MS/MS transition ion b4 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B05 Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B06 Integrated Peak Area for chromatograms derived from MS/MS transition ion b6 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B07 Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B08 Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B09 Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B10 Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
PEAK_AREA_ABETAMD_N15_B11 Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN Mid-Domain from 15N labled A internal standard N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
Position -4 -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
QC_FLAGS None or one or many QC flags assigned by QC comitte when sample does not meet respective quality criterias "00 No Ab signal; 01 Signal Intensity; 02 Backpressure; 03 Retention Time; 04 Inter-assay variance; 05 Intra-assay variance; 06 Spectral noise; 07 Unusual TIC; 08 Chromatogram noise; 09 Re-injected; 10 Masspec issue; 11 Wrong sample preparation; 12 Different injection scheme" N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
QC_STATUS Status of samples assign by quality control comitte (Passed; Failed). If failed, samples should not be used for further analysis "Passed; FAIL" N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
RATIO_ABETA42_40_BY_ISTD_TOUSE Final Calculated 42/40 Ratio N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
RID Participant roster ID -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
SAMPLE_TYPE Type of LC_MS sample "External calibrator; QC Calibrator; Clinical plasma" N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
SUBJECT Subject or biosample ID or blinded ID. For Clinical samples this column should be key for unblinding N/A N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
VID -4 -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
VISCODE Visit code -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
VISCODE2 Translated visit code -4 N/A BATEMANLAB Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis
RID Participant roster ID -4 N/A BLENNOWCSFNFL Blennow Lab ADNI1 CSF NFL
RID Participant roster ID N/A N/A BLENNOWCSFNG Blennow Lab ADNI1 CSF Ng
RID Participant roster ID N/A N/A BLENNOWPLASMANFLLONG Blennow Lab ADNI1-2 Plasma neurofilament light (NFL) longitudinal
RID Participant roster ID -4 N/A BLENNOWPLASMANFL Blennow Lab ADNI1 Plasma neurofilament light (NFL)
RID Participant roster ID -4 N/A BLENNOWPLASMATAU Blennow Lab ADNI1 Plasma Tau
RID Participant roster ID -4 N/A BLENNOW_LAB_CSF_GAP_43 Blennow Lab CSF GAP 43
SAMPLE_ID Participant ID ADNI N/A N/A BLENNOW_LAB_CSF_GAP_43 Blennow Lab CSF GAP 43
UGOT_NUMBER Participant ID Blennow Lab N/A N/A BLENNOW_LAB_CSF_GAP_43 Blennow Lab CSF GAP 43
TG_56_6_NL_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ID N/A "indexes","adni_bsi_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" N/A BSI Boundary Shift Integral Summaries (Nick Fox's lab)
IMAGEUID imageUID N/A N/A BSI Boundary Shift Integral Summaries (Nick Fox's lab)
KMNDBCBBSI An improved version of the Differential Bias Corrected Boundary Shift Integral from baseline, which: a) Has a new intensity normalisation step that normalises scan intensity by matching the intensities by tissue type (cerebrospinal fluid, grey matter, white mater) instead of being just based on the average whole brain intensity. This helps reduce artefactual change in the BSI that might be caused by change in contrasts between scans (e.g scanner changes) b) Automatically calculates the BSI window based on k-means clustering of tissue intensities for each scan pair N/A N/A BSI Boundary Shift Integral Summaries (Nick Fox's lab)
RID N/A N/A N/A BSI Boundary Shift Integral Summaries (Nick Fox's lab)
SITEID N/A N/A N/A BSI Boundary Shift Integral Summaries (Nick Fox's lab)
TG_54_5_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_54_6_NL_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
VENTACCEPT A boolean to indicate whether or not we have confidence in the VBSI value. Similar purpose to the REGRATING. 0=Vent not accepted; 1=Vent accepted N/A BSI Boundary Shift Integral Summaries (Nick Fox's lab)
RID N/A -4 N/A CONVERSIONS Conversions Confirmed by Conversion Committee
TG_54_4_NL_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_54_4_NL_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
RID Participant roster ID -4 N/A CSFALPHASYN CSF Alpha-synuclein, Jing Zhang Lab, University of Washington
RID Participant roster ID -4 N/A CSFC3FH CSF Complement 3 & Factor H, Jing Zhang Lab, University of Washington
A1AT_AVLTIDEK Alpha-1-antitrypsin -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
A4_LVFFAEDVGSNK Amyloid beta A4 protein -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
A4_THPHFVIPYR Amyloid beta A4 protein -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
A4_WYFDVTEGK Amyloid beta A4 protein -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
AMD_IPVDEEAFVIDFKPR Peptidyl-glycine alpha-amidating monooxygenase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
AMD_IVQFSPSGK Peptidyl-glycine alpha-amidating monooxygenase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
AMD_NGQWTLIGR Peptidyl-glycine alpha-amidating monooxygenase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
APLP2_HYQHVLAVDPEK Amyloid-like protein 2 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
APLP2_WYFDLSK Amyloid-like protein 2 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
B3GN1_EPGEFALLR N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
B3GN1_TALASGGVLDASGDYR N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
B3GN1_YEAAVPDPR N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
BASP1_ETPAATEAPSSTPK Brain acid soluble protein 1 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
BTD_LSSGLVTAALYGR Biotinidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
BTD_SHLIIAQVAK Biotinidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CERU_IYHSHIDAPK Ceruloplasmin -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CH3L1_VTIDSSYDIAK Chitinase-3-like protein 1 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CLUS_IDSLLENDR Clusterin -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CNDP1_ALEQDLPVNIK Beta-Ala-His dipeptidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CNDP1_VFQYIDLHQDEFVQTLK Beta-Ala-His dipeptidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CNDP1_WNYIEGTK Beta-Ala-His dipeptidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
ENPP2_SYPEILTLK Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
ENPP2_WWGGQPLWITATK Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
FABPH_SIVTLDGGK Fatty acid-binding protein, heart -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
FABPH_SLGVGFATR Fatty acid-binding protein, heart -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
FETUA_HTLNQIDEVK Alpha-2-HS-glycoprotein -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
GFAP_ALAAELNQLR Glial fibrillary acidic protein -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
KPYM_LDIDSPPITAR Pyruvate kinase isozymes M1/M2 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
NRX1A_DLFIDGQSK Neurexin-1 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
PGRP2_AGLLRPDYALLGHR N-acetylmuramoyl-L-alanine amidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
PGRP2_TFTLLDPK N-acetylmuramoyl-L-alanine amidase -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
PRDX2_GLFIIDGK Peroxiredoxin-2 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
PRDX3_HLSVNDLPVGR Thioredoxin-dependent peroxide reductase, mitochondrial -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
PRDX6_LIALSIDSVEDHLAWSK Peroxiredoxin-6 -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
RID Participant roster ID -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
SODC_GDGPVQGIINFEQK Superoxide dismutase [Cu-Zn] -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
SODC_HVGDLGNVTADK Superoxide dismutase [Cu-Zn] -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
SODC_TLVVHEK Superoxide dismutase [Cu-Zn] -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
SODE_AGLAASLAGPHSIVGR Extracellular superoxide dismutase [Cu-Zn] -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
SODE_AVVVHAGEDDLGR Extracellular superoxide dismutase [Cu-Zn] -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
SODE_VTGVVLFR Extracellular superoxide dismutase [Cu-Zn] -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
TTHY_VEIDTK Transthyretin -4 N/A CSFMRM Biomarkers Consortium CSF Proteomics MRM data set
CIR Cummulative Incidence Rate -4 N/A DESIKANLAB Desikan Lab Polygenic Hazard Score (PHS)
RID Participant roster ID -4 N/A DESIKANLAB Desikan Lab Polygenic Hazard Score (PHS)
Global_Specimen_ID Global Specimen ID -4 N/A DIADEM -4
RID Patient ID -4 N/A DIADEM -4
LONIUID_1 LONI Image ID for FA N/A N/A DTIROI DTI ROI summary measures
LONIUID_2 LONI Image ID for MD N/A N/A DTIROI DTI ROI summary measures
LONIUID_3 LONI Image ID for RD N/A N/A DTIROI DTI ROI summary measures
LONIUID_4 LONI Image ID for AD N/A N/A DTIROI DTI ROI summary measures
RID Participant roster ID -4 N/A DTIROI DTI ROI summary measures
AD_MCP Middle cerebellar peduncle (mean) -4 N/A DTIROI_MEAN_V2 USC - DTI ROI Summary Measures v2 (Mean)
FA_MCP Middle cerebellar peduncle (mean) -4 N/A DTIROI_MEAN_V2 USC - DTI ROI Summary Measures v2 (Mean)
IMAGEUID IMAGE ID of the raw diffusion scan -4 N/A DTIROI_MEAN_V2 USC - DTI ROI Summary Measures v2 (Mean)
MD_MCP Middle cerebellar peduncle (mean) -4 N/A DTIROI_MEAN_V2 USC - DTI ROI Summary Measures v2 (Mean)
RD_MCP Middle cerebellar peduncle (mean) -4 N/A DTIROI_MEAN_V2 USC - DTI ROI Summary Measures v2 (Mean)
RID Participant roster ID -4 N/A DTIROI_MEAN_V2 USC - DTI ROI Summary Measures v2 (Mean)
AD_MCP Middle cerebellar peduncle (robust mean) -4 N/A DTIROI_ROBUSTMEAN_V2 USC - DTI ROI Summary Measures v2 (Robust Mean)
FA_MCP Middle cerebellar peduncle (robust mean) -4 N/A DTIROI_ROBUSTMEAN_V2 USC - DTI ROI Summary Measures v2 (Robust Mean)
IMAGEUID IMAGE ID of the raw diffusion scan -4 N/A DTIROI_ROBUSTMEAN_V2 USC - DTI ROI Summary Measures v2 (Robust Mean)
MD_MCP Middle cerebellar peduncle (robust mean) -4 N/A DTIROI_ROBUSTMEAN_V2 USC - DTI ROI Summary Measures v2 (Robust Mean)
RD_MCP Middle cerebellar peduncle (robust mean) -4 N/A DTIROI_ROBUSTMEAN_V2 USC - DTI ROI Summary Measures v2 (Robust Mean)
RID Participant roster ID -4 N/A DTIROI_ROBUSTMEAN_V2 USC - DTI ROI Summary Measures v2 (Robust Mean)
LONIUID_1 LONI Image ID for FA N/A N/A DTIROI_V1 USC - DTI ROI Summary Measures v1
LONIUID_2 LONI Image ID for MD N/A N/A DTIROI_V1 USC - DTI ROI Summary Measures v1
LONIUID_3 LONI Image ID for RD N/A N/A DTIROI_V1 USC - DTI ROI Summary Measures v1
LONIUID_4 LONI Image ID for AD N/A N/A DTIROI_V1 USC - DTI ROI Summary Measures v1
RID Participant roster ID -4 N/A DTIROI_V1 USC - DTI ROI Summary Measures v1
EID -4 -4 N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LINK_ID -4 -4 N/A EMORY_PEPTIDERATIOS Emory University CSF Targeted MS
PEPTIDE Targeted peptide sequence N/A N/A EMORY_PEPTIDERATIOS Emory University CSF Targeted MS
RID Participant roster ID. RID 999999 indicates pooled or other sample not associated with any ADNI participant. -4 N/A EMORY_PEPTIDERATIOS Emory targeted proteomics assay
TOTAL_AREA_RATIO Light/Heavy peptide ratio N/A N/A EMORY_PEPTIDERATIOS Emory University CSF Targeted MS
VID -4 -4 N/A EMORY_PEPTIDERATIOS Emory University CSF Targeted MS
BETA_AMYLOID_1_40 Beta-Amyloid 1-40 N/A N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
BETA_AMYLOID_1_42 Beta-Amyloid 1-42 N/A N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
BETA_AMYLOID_42_40 Beta-Amyloid 1-42/1-40 ratio N/A N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
COMMENTS Version date N/A N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
DRAWTIME -4 -4 N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
EXAMDATE Examination Date -4 N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
POOL -4 -4 N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
RID Participant roster ID -4 N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
VISCODE Visit code -4 N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
VISCODE2 Translated visit code -4 N/A EUROIMMUN EUROIMMUN CSF Beta-Amyloid
RID Participant roster ID -4 N/A FAGANLAB Fagan lab summaries
HBSI_L Left side hippocampal BSI N/A N/A FOXLABBSI Fox Lab BSI measures
HBSI_R Right side hippocampal BSI N/A N/A FOXLABBSI Fox Lab BSI measures
HIPPOVOL_L Left side hippocampal volume N/A N/A FOXLABBSI Fox Lab BSI measures
HIPPOVOL_R Right side hippocampal volume N/A N/A FOXLABBSI Fox Lab BSI measures
HPACCEPT_L Left side hippocampal QC rating 0=FAIL; 1=PASS N/A FOXLABBSI Fox Lab BSI measures
HPACCEPT_R Right side hippocampal QC rating 0=FAIL; 1=PASS N/A FOXLABBSI Fox Lab BSI measures
LONIUID UID of fully pre-processed scan for which results are provided N/A N/A FOXLABBSI Fox Lab BSI measures
LONIUID_BASE UID of fully pre-processed baseline scan for longitudinal results N/A N/A FOXLABBSI Fox Lab BSI measures
RID Participant roster ID -4 N/A FOXLABBSI Fox Lab BSI measures
ABETA42 Beta-Amyloid 1-42 N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
ABETA40 Beta-Amyloid 1-40 N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
ABETA42_40 Beta-Amyloid 1-42/1-40 ratio N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
COMMENTS Comments N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
DER -4 -4 N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
DRAWDTE -4 -4 N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
EXAMDATE Examination Date N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
GUSPECID Specimen ID N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
RECDTE N/A N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
RID Participant roster ID -4 N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
RUN Run N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
RUNDATE Run date N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
SITE Site N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
STORDTE N/A N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
VID Visit ID N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
VISCODE Visit code N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
VISCODE2 Translated visit code N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
VOL Volume N/A N/A FUJIREBIOABETA Fujirebio Beta-Amyloid Ratio
RID Participant roster ID -4 N/A HAASS_WASHU_LAB Haass and Wash U lab summaries
RID Participant roster ID -4 N/A HULAB ADNI Data Hu Lab
RID N/A N/A N/A ISOPROSTANE Baseleine isoprostanes data. ADNI Biomarker Core laboratory
SITEID N/A N/A N/A ISOPROSTANE Baseleine isoprostanes data. ADNI Biomarker Core laboratory
ADAS_Q5b_Middle ADAS 0 = No; 1 = Yes; NULL = Missing or N/A N/A ITEM Item Level Data
ADAS_Q8_WL2_REC_W24_acid ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. REC means these columns store responses as to whether the participant recalled the word 0 = No; 1 = Yes; NULL = Missing or N/A N/A ITEM Item Level Data
ADAS_Q8_WL2_Reminder_W24_acid ADAS: ADAS Q8. WL1-WL3 - indicates which wordlist was used (dependent on timepoint). W1-W14 followed by the word indicates the actual word and its position in the list. Reminder menas these columsn store whether or not a participant was given a reminder 0 = No; 1 = Yes; NULL = Missing or N/A N/A ITEM Item Level Data
RID Participant roster ID ADNI code N/A UCD_ADNI1_WMH Univerity of California Davis White Matter Hyperintensity Volumes (ADNI1)
RID N/A N/A N/A ITEM Item Level Data
TG_54_3_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_54_2_NL_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_54_1_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_54_0_NL_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_53_2_NL_17_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_52_4_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_52_4_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_52_3_NL_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_52_3_NL_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_52_2_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_52_1_NL_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_51_2_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_51_2_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_51_2_NL_15_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_51_1_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_51_0_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_4_NL_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_3_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_3_NL_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_3_NL_14_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_2_NL_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_2_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_2_NL_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_1_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_1_NL_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_50_0_NL_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_49_1_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_49_1_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_49_1_NL_15_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_3_NL_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_3_NL_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_2_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_2_NL_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_2_NL_14_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_2_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_1_NL_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
TG_48_0_NL_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE_D18_1_24_1_OH_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE_D18_1_24_0_OH_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE_D18_1_16_0_OH_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D19_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_23_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_17_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_2_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_23_0_SM_D17_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_20_0_SM_D16_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_22_0_SM_D16_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_18_0_SM_D16_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_17_0_SM_D17_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_14_0_SM_D16_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_0_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_0_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D17_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D17_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D17_1_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D16_1_23_0_SM_D17_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D16_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D16_1_19_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_43_2_C_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_43_2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_43_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_41_1_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_41_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_37_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_35_2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_34_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
RID Participant roster ID -4 N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
QCID -4 -4 N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_40_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_40_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_38_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_38_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_38_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_36_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PS_36_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_39_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_38_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_38_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_38_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_37_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_36_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_34_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_20_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_22_5_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_22_5_N3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_18_0_20_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_16_0_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_16_0_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_16_0_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_16_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_15_MHDA_20_4_PI_17_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_15_MHDA_18_2_PI_17_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_15_MHDA_18_1_PI_17_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PG_36_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PG_36_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PG_34_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PG_34_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_20_1_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_20_1_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_20_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_20_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_20_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_20_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_19_0_20_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_19_0_20_4_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_22_6_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_22_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_22_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_22_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_20_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_20_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_20_4_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_20_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_18_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_18_2_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_18_2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_22_5_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_22_5_N3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_18_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_18_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_17_0_22_6_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_17_0_22_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_17_0_20_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_17_0_20_4_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_22_5_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_22_5_N3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_18_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_16_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_15_0_22_6_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_15_0_22_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_15_0_20_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_P_15_0_20_4_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_38_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_38_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_34_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_36_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_18_1_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_18_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_18_0_22_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_16_0_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_16_0_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_38_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_O_16_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_38_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_36_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_20_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_1_22_6_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_1_22_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_22_5_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_22_5_N3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_18_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_17_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_17_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_17_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_17_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_1_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_18_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_18_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_16_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_15_MHDA_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_15_MHDA_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_15_MHDA_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PE_15_MHDA_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_38_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_38_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_36_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_20_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_18_1_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_18_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_18_0_22_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_18_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_17_0_20_4_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_17_0_20_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_18_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_16_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_15_0_20_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_P_15_0_20_4_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_40_7_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_40_7_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_40_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_38_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_36_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_36_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_35_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_34_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_34_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_32_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_34_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_32_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_18_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_18_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_18_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_18_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_16_0_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_O_16_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_40_8_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_40_7_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_39_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_39_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_38_7_C_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_38_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_38_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_38_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_38_4_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_38_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_36_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_36_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_35_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_34_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_33_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_33_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_33_0_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_33_0_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_32_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_31_0_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_32_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_31_0_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_28_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_2_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_20_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_2_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_1_22_6_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_1_22_6_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_1_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_22_5_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_22_5_N3_PC_20_1_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_17_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_17_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_17_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_17_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_17_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_1_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_1_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_20_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_20_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_18_3_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_18_3_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_16_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_MHDA_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_MHDA_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_MHDA_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_MHDA_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_15_0_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_14_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_14_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_14_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_20_4_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_20_4_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_18_2_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_18_2_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_18_1_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_18_1_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_18_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPI_18_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_P_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_P_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_P_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_P_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_22_6_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_22_6_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_20_4_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_20_4_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_18_2_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_18_2_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_18_1_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_18_1_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_18_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_18_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_17_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_17_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_16_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPE_16_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_P_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_P_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_P_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_P_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_24_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_22_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_20_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_O_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_26_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_26_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_24_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_24_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_6_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_6_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_5_SN2_N3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_5_SN1_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_5_SN1_N3_LPC_22_5_SN2_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_4_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_4_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_1_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_1_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_5_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_5_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_4_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_4_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_3_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_3_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_2_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_2_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_1_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_1_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_20_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_19_0_SN2_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_19_0_SN1_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_19_0_SN1_A_LPC_19_0_SN2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_19_0_A_SN1_104_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_3_SN2_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_3_SN1_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_3_SN1_A_LPC_18_3_SN2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_2_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_2_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_1_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_1_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_1_SN2_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_1_SN1_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_1_SN1_A_LPC_17_1_SN2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_1_A_SN1_104_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_16_1_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_16_1_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_16_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_16_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_15_MHDA_SN1_LPC_17_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_15_MHDA_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_15_MHDA_SN1_104_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_15_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_15_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_14_0_SN1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_14_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEXCER_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEXCER_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEXCER_D18_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEXCER_D18_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEXCER_D18_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEXCER_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX3CER_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX3CER_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX3CER_D18_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX3CER_D18_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX3CER_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX3CER_D18_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX2CER_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX2CER_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX2CER_D18_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX2CER_D18_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX2CER_D18_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
HEX2CER_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM3_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM3_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM3_D18_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM3_D18_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM3_D18_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM3_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
GM1_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DHCER_D18_0_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DHCER_D18_0_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DHCER_D18_0_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DHCER_D18_0_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DHCER_D18_0_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DHCER_D18_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_2_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_2_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_1_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_1_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_1_18_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_1_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_18_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_1_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_22_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_16_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_14_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DG_14_0_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DE_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DE_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DE_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DE_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DE_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
DE_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
COH Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_24_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_24_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_24_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_22_5_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_22_5_N3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_22_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_22_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_20_5_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_20_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_20_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_20_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_18_3_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_17_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_17_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_16_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_15_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CE_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D20_1_26_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D20_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D20_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D20_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_26_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D19_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_26_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_17_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_2_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_26_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_17_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D18_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D17_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D17_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D17_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D17_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D17_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D17_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D16_1_24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D16_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D16_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D16_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
CER_D16_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ANALYSIS_START_DATE -4 -4 N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
APOA1 N/A N/A N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
APOE N/A N/A N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
CHOL N/A N/A N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
COLPROT Study protocol of data collection -4 N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
HDL N/A N/A N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
ORIGPROT Original study protocol -4 N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
RID Participant roster ID -4 N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
TG N/A N/A N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
VISCODE Visit code -4 N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
VISCODE2 Translated visit code -4 N/A ADNI1LIPIDOMICSRADER Rader Lab ADNI 1 Lipids CAD ALZ
ABETA38 Amyloid beta pepetide (x-38) -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
ABETA40 Amyloid peptide beta (x-40) -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
ABETA42 Amyloid beta peptide (x-42) -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
DRAWDTE -4 -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
DRAWTIME -4 -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
EXAMDATE Examination Date -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
RECDTE -4 -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
RID Participant roster ID -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
TAU total Tau protein -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
VISCODE Visit code -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
VISCODE2 Translated visit code -4 N/A MESOSCALE Meso Scale Diagnostics Analysis of Residual CSF Samples
RID Participant roster ID -4 N/A MRI_INFARCTS MRI Infarcts
SIDE Side of Infarct, if detected R/L or - N/A MRI_INFARCTS MRI Infarcts
NPAMY e2. Cerebral amyloid angiopathy (Check One) 0=0 None; 1=1 Mild; 2=2 Moderate; 3=3 Severe; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPCSFANT Is banked postmotem cerebrospinal fluid (CSF) accessible? 1=Yes; 2=No N/A NEUROPATH NACC Neuropathology Data Form
NPDIFF e1. CERAD semi-quantitative score for diffuse plaques (plaques with non-compact amyloid and no apparent dystrophic neurites). Score from the neocortical field with the highest plaque density and without respect to age or diagnosis. (Check One) 0=0 No diffuse plaques; 1=1 Sparse diffuse plaques; 2=2 Moderate diffuse plaques; 3=3 Frequent diffuse plaques; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPNEUR c. CERAD score for density of neocortical neuritic plaque (plaques with argrophilic dystrophic neurities, with or without dense amyloid cores). Score without respect to age or diagnosis. (C score - Check One) 0=0 No neuritic plaques (C0); 1=1 Sparse neuritic plaques (C1); 2=2 Moderate neuritic plaques (C2); 3=3 Frequent neuritic plaques (C3); 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPPICK b1. FTLD-tau (PiD) 0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
RID Participant roster ID -4 N/A NEUROPATH NACC Neuropathology Data Form
ADCID center id 27 N/A NEUROPATH NACC Neuropathology Data Form
NACCAMY Cerebral amyloid angiopathy 0=None;1=Mild;2=Moderate;3=Severe;8=Not assessed;9=Missing/unknown; .=skipped N/A NEUROPATH NACC Neuropathology Data Form
NACCPICK FTLD-tau subtype Pick's (PID) 0=No;1=Yes;8=Not assessed;9=Missing/unknown; .=skipped N/A NEUROPATH NACC Neuropathology Data Form
NPABAN b. Amyloid beta antibody (Check One) 1=1 4G8; 2=2 10D5; 7=7 Other (Specify); 8=8 Not assessed N/A NEUROPATH NACC Neuropathology Data Form
GLOBAL.SPEC.ID -4 -4 N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
FAW6.FA Ratio of omega-6 fatty acids to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
FAW6 Omega-6 fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
NPHEMO1 b1. Subdural or epidural hemorrhage 0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
FAW3.FA Ratio of omega-3 fatty acids to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
FAW3 Omega-3 fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
DHA.FA Ratio of 22:6 docosahexaenoic acid to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
DHA 22:6, docosahexaenoic acid N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
NPLBOD Is there evidence of Lewy body pathology? (Check One) 0=0 No; 1=1 Brainstem predominant; 2=2 Limbic (transitional); 3=3 Neocortical (diffuse); 4=4 Amygdala predominant; 5=5 Olfactory bulb; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPOFTD2 f2. NIFID (neuronal intermediate filament inclusions disease) 0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPPDXA a. Pigment-spheroid degeneration/NBIA 0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPPDXD d. Trinucleotide disease (Huntington disease, SCA, other) 0=0 No; 1=1 Yes; 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
NPTHAL a. Thal phase for amyloid plaques by immunohisto-chemistry (IHC) (A score - Check One) 0=0 Phase 0 (A0); 1=1 Phase 1 (A1); 2=2 Phase 2 (A1); 3=3 Phase 3 (A2); 4=4 Phase 4 (A3); 5=5 Phase 5 (A3); 8=8 Not assessed; 9=9 Missing/unknown N/A NEUROPATH NACC Neuropathology Data Form
GP Glycoprotein acetyls, mainly a1-acid glycoprotein N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
HDL.TG Triglycerides in HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
HIS Histidine N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.C Total cholesterol in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.CE Cholesterol esters in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.CE_. Cholesterol esters to total lipids ratio in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.C_. Total cholesterol to total lipids ratio in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.FC Free cholesterol in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.FC_. Free cholesterol to total lipids ratio in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.L Total lipids in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.P Concentration of IDL particles N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.PL Phospholipids in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.PL_. Phospholipids to total lipds ratio in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.TG Triglycerides in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
IDL.TG_. Triglycerides to total lipids ratio in IDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.CE_. Cholesterol esters to total lipids ratio in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.C_. Total cholesterol to total lipids ratio in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.FC_. Free cholesterol to total lipids ratio in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.L Total lipids in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.PL Phospholipids in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.PL_. Phospholipids to total lipds ratio in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.TG Triglycerides in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.HDL.TG_. Triglycerides to total lipids ratio in large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.CE_. Cholesterol esters to total lipids ratio in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.C_. Total cholesterol to total lipids ratio in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.FC_. Free cholesterol to total lipids ratio in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.L Total lipids in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.PL Phospholipids in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.PL_. Phospholipids to total lipds ratio in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.TG Triglycerides in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.LDL.TG_. Triglycerides to total lipids ratio in large LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.CE_. Cholesterol esters to total lipids ratio in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.C_. Total cholesterol to total lipids ratio in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.FC_. Free cholesterol to total lipids ratio in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.L Total lipids in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.PL Phospholipids in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.PL_. Phospholipids to total lipds ratio in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.TG Triglycerides in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
L.VLDL.TG_. Triglycerides to total lipids ratio in large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
LA 18:2, linoleic acid N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
LA.FA Ratio of 18:2 linoleic acid to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
LDL.TG Triglycerides in LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.CE_. Cholesterol esters to total lipids ratio in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.C_. Total cholesterol to total lipids ratio in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.FC_. Free cholesterol to total lipids ratio in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.L Total lipids in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.PL Phospholipids in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.PL_. Phospholipids to total lipds ratio in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.TG Triglycerides in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.HDL.TG_. Triglycerides to total lipids ratio in medium HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.CE_. Cholesterol esters to total lipids ratio in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.C_. Total cholesterol to total lipids ratio in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.FC_. Free cholesterol to total lipids ratio in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.L Total lipids in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.PL Phospholipids in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.PL_. Phospholipids to total lipds ratio in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.TG Triglycerides in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.LDL.TG_. Triglycerides to total lipids ratio in medium LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.CE_. Cholesterol esters to total lipids ratio in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.C_. Total cholesterol to total lipids ratio in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.FC_. Free cholesterol to total lipids ratio in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.L Total lipids in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.PL Phospholipids in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.PL_. Phospholipids to total lipds ratio in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.TG Triglycerides in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
M.VLDL.TG_. Triglycerides to total lipids ratio in medium VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
MUFA Monounsaturated fatty acids; 16:1, 18:1 N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
MUFA.FA Ratio of monounsaturated fatty acids to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
PC Phosphatidylcholine and other cholines N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
PUFA Polyunsaturated fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
PUFA.FA Ratio of polyunsaturated fatty acids to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
RID Participant roster ID -4 N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.CE_. Cholesterol esters to total lipids ratio in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.C_. Total cholesterol to total lipids ratio in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.FC_. Free cholesterol to total lipids ratio in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.L Total lipids in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.PL Phospholipids in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.PL_. Phospholipids to total lipds ratio in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.TG Triglycerides in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.HDL.TG_. Triglycerides to total lipids ratio in small HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.CE_. Cholesterol esters to total lipids ratio in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.C_. Total cholesterol to total lipids ratio in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.FC_. Free cholesterol to total lipids ratio in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.L Total lipids in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.PL Phospholipids in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.PL_. Phospholipids to total lipds ratio in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.TG Triglycerides in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.LDL.TG_. Triglycerides to total lipids ratio in small LDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.CE_. Cholesterol esters to total lipids ratio in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.C_. Total cholesterol to total lipids ratio in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.FC_. Free cholesterol to total lipids ratio in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.L Total lipids in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.PL Phospholipids in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.PL_. Phospholipids to total lipds ratio in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.TG Triglycerides in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
S.VLDL.TG_. Triglycerides to total lipids ratio in small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
SAMPLEID Sample ID N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
SERUM.TG Serum total triglycerides N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
SFA Saturated fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
SFA.FA Ratio of saturated fatty acids to total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
TAG_UNEXPECTED_AMINO_ACID_SIGNALS Unexpected amino acid signals N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
TG.PG Ratio of triglycerides to phosphoglycerides N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
TOTFA Total fatty acids N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
TOTPG Total phosphoglycerides N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
VLDL.TG Triglycerides in VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.CE_. Cholesterol esters to total lipids ratio in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.C_. Total cholesterol to total lipids ratio in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.FC_. Free cholesterol to total lipids ratio in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.L Total lipids in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.PL Phospholipids in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.PL_. Phospholipids to total lipds ratio in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.TG Triglycerides in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.HDL.TG_. Triglycerides to total lipids ratio in very large HDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.CE_. Cholesterol esters to total lipids ratio in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.C_. Total cholesterol to total lipids ratio in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.FC_. Free cholesterol to total lipids ratio in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.L Total lipids in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.PL Phospholipids in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.PL_. Phospholipids to total lipds ratio in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.TG Triglycerides in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XL.VLDL.TG_. Triglycerides to total lipids ratio in very large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.CE_. Cholesterol esters to total lipids ratio in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.C_. Total cholesterol to total lipids ratio in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.FC_. Free cholesterol to total lipids ratio in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.L Total lipids in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.PL Phospholipids in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.PL_. Phospholipids to total lipds ratio in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.TG Triglycerides in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XS.VLDL.TG_. Triglycerides to total lipids ratio in very small VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.CE_. Cholesterol esters to total lipids ratio in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.C_. Total cholesterol to total lipids ratio in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.FC_. Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.L Total lipids in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.PL Phospholipids in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.PL_. Phospholipids to total lipds ratio in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.TG Triglycerides in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
XXL.VLDL.TG_. Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL N/A N/A ADNINIGHTINGALE ADMC Nightingale Platform NMR Analysis of Lipoproteins and Metabolites [ADNI 1, GO, 2]
AMINOCAPROIC_ACID Aminocaproic acid detected in the sample; this compound is an antifibrinolytic agent. In higher concentrations, it prohibits the quantification of acetone, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
BELOW_LIMIT_OF_QUANTIFICATION Below Limit-Of-Quantification (LOQ) means that the concentration of the given biomarker is smaller than the range where the Nightingale platform offers highly accurate quantification. For instance, the LOQ for lipoprotein lipid measures is < 0.01 mmol/L. The estimated biomarker concentration is reported for use in certain epidemiological analyses, but it may be advisable to conduct sensitivity analyses with all values below LOQ excluded. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
DHA Docosahexaenoic acid -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
DHA_PCT Ratio of docosahexaenoic acid to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
GLOBAL.SPEC.ID -4 -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
GLUCONOLACTONE Gluconolactone is an oxidation product of glucose and is not normally detected in samples. Interferes with the quantification of creatinine. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HDL_L Total lipids in HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HDL_PL Phospholipids in HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HDL_TG Triglycerides in HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HIGH_ETHANOL This arises potentially due to disinfectant contaminations in the blood donation/collection process and/or contamination in air from lab handling, such as cleaning of well-plates. In higher concentrations, ethanol prohibits the quantification of glycerol, 3-hydroxybutyrate and valine, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glycerol, 3-hydroxybutyrate and valine and result in artificially distorted glycerol, 3-hydroxybutyrate and valine levels. We recommend caution when interpreting absolute glycerol, 3-hydroxybutyrate and valine concentrations. It is also good to note that high alcohol in the sample might artificially increase the acetate concentration. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HIGH_LACTATE Low glucose is tagged since the physiological concentration is commonly well controlled, particularly in the low concentration end. However, glucose is metabolised to pyruvate and lactate if the blood sample is kept with the cells during the sample collection process, in particular at room temperature but also to some extent at fridge temperature. The low glucose tag thus commonly reflects extended time periods prior to preparation to serum/plasma. As a result of the glycolysis, high lactate and/or high pyruvate is commonly observed along with low glucose levels. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HIGH_PYRUVATE Low glucose is tagged since the physiological concentration is commonly well controlled, particularly in the low concentration end. However, glucose is metabolised to pyruvate and lactate if the blood sample is kept with the cells during the sample collection process, in particular at room temperature but also to some extent at fridge temperature. The low glucose tag thus commonly reflects extended time periods prior to preparation to serum/plasma. As a result of the glycolysis, high lactate and/or high pyruvate is commonly observed along with low glucose levels. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
HIS Histidine -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_C Cholesterol in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_CE Cholesteryl esters in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_CE_PCT Cholesteryl esters to total lipids ratio in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_C_PCT Cholesterol to total lipids ratio in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_FC Free cholesterol in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_FC_PCT Free cholesterol to total lipids ratio in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_L Total lipids in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_P Concentration of IDL particles -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_PL Phospholipids in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_PL_PCT Phospholipids to total lipids ratio in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_TG Triglycerides in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
IDL_TG_PCT Triglycerides to total lipids ratio in IDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
ISOPROPYL_ALCOHOL Isopropyl alcohol signals detected. In higher concentrations, this compound prohibits the quantification of creatinine, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of creatinine and result in artificially distorted creatinine levels. We recommend caution when interpreting absolute creatinine concentrations. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LA Linoleic acid -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LA_PCT Ratio of linoleic acid to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LDL_L Total lipids in LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LDL_PL Phospholipids in LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LDL_TG Triglycerides in LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LOW_ETHANOL This arises potentially due to disinfectant contaminations in the blood donation/collection process and/or contamination in air from lab handling, such as cleaning of well-plates. In higher concentrations, ethanol prohibits the quantification of glycerol, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glycerol and result in artificially distorted glycerol levels. We recommend caution when interpreting absolute glycerol concentrations. It is also good to note that high alcohol in the sample might artificially increase the acetate concentration. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LOW_GLUCOSE Low glucose is tagged since the physiological concentration is commonly well controlled, particularly in the low concentration end. However, glucose is metabolised to pyruvate and lactate if the blood sample is kept with the cells during the sample collection process, in particular at room temperature but also to some extent at fridge temperature. The low glucose tag thus commonly reflects extended time periods prior to preparation to serum/plasma. As a result of the glycolysis, high lactate and/or high pyruvate is commonly observed along with low glucose levels. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LOW_GLUTAMINE_OR_HIGH_GLUTAMATE In these samples most of the glutamine appears to have degraded into glutamate. This can take place, e.g. during the sample collection process, if the sample is kept at room temperature for a prolonged period of time, there are multiple freeze-thaw cycles, or there are oxidative conditions / oxidation occurs in the sample. In these samples glutamine is not quantified. In higher concentrations, glutamate prohibits the quantification of pyruvate, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, glutamate may interfere with the reliable quantification of pyruvate and result in artificially distorted pyruvate levels. We recommend caution when interpreting absolute pyruvate concentrations. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LOW_PROTEIN Unexpected protein features have been identified during the analysis. This quality observation is related to unexpectedly low total protein concentration in the sample and may be an indication of potential sample dilution. Sample dilution may occur due to water contamination, or prolonged storage in freezer in combination with loosely closed tube caps, which exposes the sample to collect ice and increases the chances of dilution. In case there is reason to assume sample dilution, we recommend caution when analyzing absolute concentrations. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_CE_PCT Cholesteryl esters to total lipids ratio in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_C_PCT Cholesterol to total lipids ratio in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_FC_PCT Free cholesterol to total lipids ratio in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_L Total lipids in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_PL Phospholipids in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_PL_PCT Phospholipids to total lipids ratio in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_TG Triglycerides in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_HDL_TG_PCT Triglycerides to total lipids ratio in large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_CE_PCT Cholesteryl esters to total lipids ratio in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_C_PCT Cholesterol to total lipids ratio in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_FC_PCT Free cholesterol to total lipids ratio in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_L Total lipids in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_PL Phospholipids in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_PL_PCT Phospholipids to total lipids ratio in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_TG Triglycerides in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_LDL_TG_PCT Triglycerides to total lipids ratio in large LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_CE_PCT Cholesteryl esters to total lipids ratio in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_C_PCT Cholesterol to total lipids ratio in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_FC_PCT Free cholesterol to total lipids ratio in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_L Total lipids in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_PL Phospholipids in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_PL_PCT Phospholipids to total lipids ratio in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_TG Triglycerides in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
L_VLDL_TG_PCT Triglycerides to total lipids ratio in large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
MEDIUM_ETHANOL This arises potentially due to disinfectant contaminations in the blood donation/collection process and/or contamination in air from lab handling, such as cleaning of well-plates. In higher concentrations, ethanol prohibits the quantification of glycerol and 3-hydroxybutyrate, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glycerol and 3-hydroxybutyrate and result in artificially distorted glycerol and 3-hydroxybutyrate levels. We recommend caution when interpreting absolute glycerol and 3-hydroxybutyrate concentrations. It is also good to note that high alcohol in the sample might artificially increase the acetate concentration. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
MUFA Monounsaturated fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
MUFA_PCT Ratio of monounsaturated fatty acids to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_CE_PCT Cholesteryl esters to total lipids ratio in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_C_PCT Cholesterol to total lipids ratio in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_FC_PCT Free cholesterol to total lipids ratio in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_L Total lipids in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_PL Phospholipids in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_PL_PCT Phospholipids to total lipids ratio in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_TG Triglycerides in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_HDL_TG_PCT Triglycerides to total lipids ratio in medium HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_CE_PCT Cholesteryl esters to total lipids ratio in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_C_PCT Cholesterol to total lipids ratio in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_FC_PCT Free cholesterol to total lipids ratio in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_L Total lipids in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_PL Phospholipids in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_PL_PCT Phospholipids to total lipids ratio in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_TG Triglycerides in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_LDL_TG_PCT Triglycerides to total lipids ratio in medium LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_CE_PCT Cholesteryl esters to total lipids ratio in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_C_PCT Cholesterol to total lipids ratio in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_FC_PCT Free cholesterol to total lipids ratio in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_L Total lipids in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_PL Phospholipids in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_PL_PCT Phospholipids to total lipids ratio in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_TG Triglycerides in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
M_VLDL_TG_PCT Triglycerides to total lipids ratio in medium VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
N_METHYL_2_PYRROLIDONE A compound that can be used in sample collection processes. In higher concentrations, it prohibits the quantification of glutamine, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of glutamine and result in artificially distorted glutamine levels. We recommend caution when interpreting absolute glutamine concentrations. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
OMEGA_3 Omega-3 fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
OMEGA_3_PCT Ratio of omega-3 fatty acids to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
OMEGA_6 Omega-6 fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
OMEGA_6_BY_OMEGA_3 Ratio of omega-6 fatty acids to omega-3 fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
OMEGA_6_PCT Ratio of omega-6 fatty acids to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
PHOSPHATIDYLC Phosphatidylcholines -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
PHOSPHOGLYC Phosphoglycerides -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
POLYSACCHARIDES Polysaccharide or some other type of carbohydrate signals detected. Most commonly observed along with other signs of suboptimal sample quality, but may also indicate presence of heparin. In higher concentrations, this compound prohibits the quantification of creatinine, and therefore the sample has been flagged with a "TAG", and no concentration has been provided for the sample. In lower concentrations, it may interfere with the reliable quantification of creatinine and result in artificially distorted creatinine levels. We recommend caution when interpreting absolute creatinine concentrations. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
PUFA Polyunsaturated fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
PUFA_BY_MUFA Ratio of polyunsaturated fatty acids to monounsaturated fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
PUFA_PCT Ratio of polyunsaturated fatty acids to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
RID Participant roster ID -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
SAMPLEID -4 -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
SFA Saturated fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
SFA_PCT Ratio of saturated fatty acids to total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_CE_PCT Cholesteryl esters to total lipids ratio in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_C_PCT Cholesterol to total lipids ratio in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_FC_PCT Free cholesterol to total lipids ratio in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_L Total lipids in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_PL Phospholipids in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_PL_PCT Phospholipids to total lipids ratio in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_TG Triglycerides in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_HDL_TG_PCT Triglycerides to total lipids ratio in small HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_CE_PCT Cholesteryl esters to total lipids ratio in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_C_PCT Cholesterol to total lipids ratio in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_FC_PCT Free cholesterol to total lipids ratio in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_L Total lipids in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_PL Phospholipids in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_PL_PCT Phospholipids to total lipids ratio in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_TG Triglycerides in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_LDL_TG_PCT Triglycerides to total lipids ratio in small LDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_CE_PCT Cholesteryl esters to total lipids ratio in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_C_PCT Cholesterol to total lipids ratio in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_FC_PCT Free cholesterol to total lipids ratio in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_L Total lipids in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_PL Phospholipids in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_PL_PCT Phospholipids to total lipids ratio in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_TG Triglycerides in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
S_VLDL_TG_PCT Triglycerides to total lipids ratio in small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
TG_BY_PG Ratio of triglycerides to phosphoglycerides -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
TOTAL_BCAA Total concentration of branched-chain amino acids (leucine + isoleucine + valine) -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
TOTAL_FA Total fatty acids -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
TOTAL_L Total lipids in lipoprotein particles -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
TOTAL_PL Total phospholipids in lipoprotein particles -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
TOTAL_TG Total triglycerides -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
UNEXPECTED_AMINO_ACID_SIGNALS These are signals that we do not typically observe in normal samples. It is likely that they relate to protein breakage due to non optimal storage. Interferes with the reliable quantification of citrate and glycerol, and may result in artificially distorted metabolite concentrations. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
UNIDENTIFIED_MACROMOLECULES Signals from abnormal macromolecule(s)/protein(s). Interferes with the quantification of phenylalanine, acetate, acetone, glutamine and pyruvate. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
UNIDENTIFIED_SMALL_MOLECULE_A Untypical signals from unknown small molecule(s); potentially xenobiotics. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
UNIDENTIFIED_SMALL_MOLECULE_B Untypical signals from unknown small molecule(s); potentially xenobiotics. Interferes with the quantification of acetate. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
UNIDENTIFIED_SMALL_MOLECULE_C Unidentified signals at 2.27 ppm and various other spectral areas. Interferes with the reliable quantification of albumin, creatinine, glycerol, glycine and acetone. -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
VLDL_L Total lipids in VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
VLDL_PL Phospholipids in VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
VLDL_TG Triglycerides in VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_CE_PCT Cholesteryl esters to total lipids ratio in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_C_PCT Cholesterol to total lipids ratio in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_FC_PCT Free cholesterol to total lipids ratio in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_L Total lipids in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_PL Phospholipids in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_PL_PCT Phospholipids to total lipids ratio in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_TG Triglycerides in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_HDL_TG_PCT Triglycerides to total lipids ratio in very large HDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_CE_PCT Cholesteryl esters to total lipids ratio in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_C_PCT Cholesterol to total lipids ratio in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_FC_PCT Free cholesterol to total lipids ratio in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_L Total lipids in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_PL Phospholipids in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_PL_PCT Phospholipids to total lipids ratio in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_TG Triglycerides in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XL_VLDL_TG_PCT Triglycerides to total lipids ratio in very large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_CE_PCT Cholesteryl esters to total lipids ratio in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_C_PCT Cholesterol to total lipids ratio in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_FC_PCT Free cholesterol to total lipids ratio in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_L Total lipids in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_PL Phospholipids in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_PL_PCT Phospholipids to total lipids ratio in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_TG Triglycerides in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XS_VLDL_TG_PCT Triglycerides to total lipids ratio in very small VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_CE_PCT Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_C_PCT Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_FC_PCT Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_L Total lipids in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_PL Phospholipids in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_PL_PCT Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_TG Triglycerides in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
XXL_VLDL_TG_PCT Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL -4 N/A ADNINIGHTINGALE2 ADMC Nightingale Platform NMR Post-Unblinding Re-Analysis of Lipoproteins and Metabolites
LONIUID LONI Image ID N/A N/A NYUFDGHIP NYU FDG-PET Hippocampus (pons normalized)
PTID Participant ID N/A N/A NYUFDGHIP NYU FDG-PET Hippocampus (pons normalized)
RID Participant ID N/A N/A NYUFDGHIP NYU FDG-PET Hippocampus (pons normalized)
SERIESID LONI PET series ID N/A N/A NYUFDGHIP NYU FDG-PET Hippocampus (pons normalized)
SITEID ADNI site ID N/A N/A NYUFDGHIP NYU FDG-PET Hippocampus (pons normalized)
STUDYID LONI PET study ID N/A N/A NYUFDGHIP NYU FDG-PET Hippocampus (pons normalized)
IMAGEUID -4 N/A N/A PIBPETSUVR U Pitt PIB PET Analysis
LONISID -4 N/A N/A PIBPETSUVR U Pitt PIB PET Analysis
LONIUID -4 N/A N/A PIBPETSUVR U Pitt PIB PET Analysis
RID -4 N/A N/A PIBPETSUVR U Pitt PIB PET Analysis
MRIDATE MRI date N/A N/A PICSLASHS ASHS volume data
RID Participant roster ID N/A N/A PICSLASHS ASHS volume data
RID Participant roster ID -4 N/A PLASMAABETA ABeta40 and ABeta42 quantification in plasma using ABtest40 and ABtest42
GFAP Calibrated plasma glial fibrillary acidic protein (GFAP) concentration in pg/mL -4 N/A PLASMA_ABETA_PROJECT_ADX_VUMC FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc
GUSPECID -4 -4 N/A PLASMA_ABETA_PROJECT_ADX_VUMC FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc
RID Participant roster ID -4 N/A PLASMA_ABETA_PROJECT_ADX_VUMC FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc
VID -4 -4 N/A PLASMA_ABETA_PROJECT_ADX_VUMC FNIH Biomarkers Consortium Plasma Abeta Project: ADx VUmc
GUSPECID -4 -4 N/A PLASMA_ABETA_PROJECT_QUANTERIX FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix
RID Participant roster ID -4 N/A PLASMA_ABETA_PROJECT_QUANTERIX FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix
SAMPLE_ID -4 -4 N/A PLASMA_ABETA_PROJECT_QUANTERIX FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix
VID -4 -4 N/A PLASMA_ABETA_PROJECT_QUANTERIX FNIH Biomarkers Consortium Plasma Abeta Project: Quanterix
GUSPECID -4 -4 N/A PLASMA_ABETA_PROJECT_ROCHE FNIH Biomarkers Consortium Plasma Abeta Project: Roche
RBARCODE Identifer for run sequence -4 N/A PLASMA_ABETA_PROJECT_ROCHE FNIH Biomarkers Consortium Plasma Abeta Project: Roche
RID Participant roster ID -4 N/A PLASMA_ABETA_PROJECT_ROCHE FNIH Biomarkers Consortium Plasma Abeta Project: Roche
STUDYID -4 -4 N/A PLASMA_ABETA_PROJECT_ROCHE FNIH Biomarkers Consortium Plasma Abeta Project: Roche
VID -4 -4 N/A PLASMA_ABETA_PROJECT_ROCHE FNIH Biomarkers Consortium Plasma Abeta Project: Roche
GUSPECID -4 -4 N/A PLASMA_ABETA_PROJECT_SHIMADZU FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu
RID Participant roster ID -4 N/A PLASMA_ABETA_PROJECT_SHIMADZU FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu
VID -4 -4 N/A PLASMA_ABETA_PROJECT_SHIMADZU FNIH Biomarkers Consortium Plasma Abeta Project: Shimadzu
GUSPECID -4 -4 N/A PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg
RID Participant roster ID -4 N/A PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg
VID -4 -4 N/A PLASMA_ABETA_PROJECT_U_OF_GOTHENBURG FNIH Biomarkers Consortium Plasma Abeta Project: U of Gothenburg
GUSPECID -4 -4 N/A PLASMA_ABETA_PROJECT_WASH_U FNIH Biomarkers Consortium Plasma Abeta Project: Wash U
LC_MS_SAMPLE_ID Internal ID of LS_MS sample to control for technical replicates. It serves as internal blinding ID and for QC purpocess -4 N/A PLASMA_ABETA_PROJECT_WASH_U FNIH Biomarkers Consortium Plasma Abeta Project: Wash U
PLASMAAB4240 Concentration ratio of 42/40 as measured by Di-oxidized C-terminal peptides, based on its relation to respective known concentrations of N15 internal standard -4 N/A PLASMA_ABETA_PROJECT_WASH_U FNIH Biomarkers Consortium Plasma Abeta Project: Wash U
RID Participant roster ID -4 N/A PLASMA_ABETA_PROJECT_WASH_U FNIH Biomarkers Consortium Plasma Abeta Project: Wash U
VID -4 -4 N/A PLASMA_ABETA_PROJECT_WASH_U FNIH Biomarkers Consortium Plasma Abeta Project: Wash U
RID N/A N/A N/A REDOX Redox Reactive Reagents LLC ADNI R-RAA ELISA
COLPROT Study protocol of data collection -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
EXAMDATE -4 -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
GUSPECID Global Specimen ID identifying individual aliquots -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
RECDTE Date of sample receipt at UPenn -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
RID Participant roster ID -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
SITE Hospital/Site ID -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
STORDTE Date of aliquoting and storing -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
VID Visit ID from sample tube -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
VISCODE Visit code -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
VISCODE2 Translated visit code -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
VOL Volume of residual CSF left after analysis -4 N/A RESIDUAL_ALIQUOT_LIST Residual aliquot count in the LDMS database
IMAGEUID_1 IMAGE ID of the screening scan -4 N/A TBM Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1
IMAGEUID_2 IMAGE ID of the follow-up scan; see VISCODE -4 N/A TBM Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1
MEASURE_1 Numerical summary of cumulative temporal lobe atrophy average within a statistically defined region-of-interest (p<0.00001) inside the temporal lobes; see VISCODE; summaries are scaled by 1000 (e.g. 1000: no change, 1200: 20% increase, 800: 20% loss) -4 N/A TBM Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1
RID Participant roster ID -4 N/A TBM Paul Thompson's Lab, Imaging Genetics Center (IGC), University of Southern California - Cross-sectional and longitudinal tensor-based morphometry Versions 2.0 and 2.1
LONIUID Study ID N/A N/A TCV Total Cranial Vault Segmentation
RID Participant ID N/A N/A TCV Total Cranial Vault Segmentation
RID Participant roster ID -4 N/A TS_RATIO_ADJ ADNI Telomere length / Single copy gene (T/S) ratio of DNA from blood, adjusted for confounders
CINGMIDL Cingulum_Mid_L N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
CINGMIDR Cingulum_Mid_R N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
FRONTMIDL Frontal_Mid_L N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
FRONTMIDR Frontal_Mid_R N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
FRTMIDORBL Frontal_Mid_Orb_L N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
FRTMIDORBR Frontal_Mid_Orb_R N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
ID N/A "indexes","adni_uaspmvbm_idx=RID,VISCODE,ENTRY,RECNO","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE,RECNO" N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
IMAGEUID imageUID N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
OCCMIDL N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
OCCMIDR N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
PALLIDUML N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
PALLIDUMR N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
RID N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
SITEID N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
TEMPMIDL N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
TEMPMIDR N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
TEMPPLMIDL N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
TEMPPLMIDR N/A N/A N/A UASPMVBM UA (Gene Alexander) MRI SPM voxel based morphometry (VBM) analysis
CC_MID_ANTERIOR cc-mid-anterior -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_ANTERIOR_SIZE cc-mid-anterior ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_POSTERIOR cc-mid-posterior -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_POSTERIOR_SIZE cc-mid-posterior ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_CAUDALMIDDLEFRONTAL ctx-lh-caudalmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SIZE ctx-lh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_MIDDLETEMPORAL ctx-lh-middletemporal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_MIDDLETEMPORAL_SIZE ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL ctx-lh-rostralmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SIZE ctx-lh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_CAUDALMIDDLEFRONTAL ctx-rh-caudalmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SIZE ctx-rh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_MIDDLETEMPORAL ctx-rh-middletemporal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_MIDDLETEMPORAL_SIZE ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL ctx-rh-rostralmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SIZE ctx-rh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_CHOROID_PLEXUS left-choroid-plexus -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_CHOROID_PLEXUS_SIZE left-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_PALLIDUM left-pallidum -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_PALLIDUM_SIZE left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RID Participant roster ID -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_CHOROID_PLEXUS right-choroid-plexus -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_CHOROID_PLEXUS_SIZE right-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_PALLIDUM right-pallidum -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_PALLIDUM_SIZE right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_ANTERIOR_SUVR cc-mid-anterior -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_ANTERIOR_VOLUME cc-mid-anterior ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_POSTERIOR_SUVR cc-mid-posterior -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CC_MID_POSTERIOR_VOLUME cc-mid-posterior ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SUVR ctx-lh-caudalmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME ctx-lh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_MIDDLETEMPORAL_SUVR ctx-lh-middletemporal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_MIDDLETEMPORAL_VOLUME ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR ctx-lh-rostralmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-lh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SUVR ctx-rh-caudalmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME ctx-rh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_MIDDLETEMPORAL_SUVR ctx-rh-middletemporal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_MIDDLETEMPORAL_VOLUME ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR ctx-rh-rostralmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-rh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_CHOROID_PLEXUS_SUVR left-choroid-plexus -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_CHOROID_PLEXUS_VOLUME left-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_PALLIDUM_SUVR left-pallidum -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
LEFT_PALLIDUM_VOLUME left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_CHOROID_PLEXUS_SUVR right-choroid-plexus -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_CHOROID_PLEXUS_VOLUME right-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_PALLIDUM_SUVR right-pallidum -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
RIGHT_PALLIDUM_VOLUME right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CHOROID Bilateral choroid plexus -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
CHOROID_SIZE Bilateral choroid plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
CTX_LH_MIDDLETEMPORAL ctx-lh-middletemporal -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
CTX_LH_MIDDLETEMPORAL_SIZE ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
CTX_RH_MIDDLETEMPORAL ctx-rh-middletemporal -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
CTX_RH_MIDDLETEMPORAL_SIZE ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
LEFT_MIDDLEFR Left middle frontal ROI -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
LEFT_MIDDLEFR_SIZE Left middle frontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
LEFT_PALLIDUM left-pallidum -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
LEFT_PALLIDUM_SIZE left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
RID Participant roster ID -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
RIGHT_MIDDLEFR Right middle frontal ROI -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
RIGHT_MIDDLEFR_SIZE Right middle frontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
RIGHT_PALLIDUM right-pallidum -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
RIGHT_PALLIDUM_SIZE right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 analysis
CHOROID_SUVR Bilateral choroid plexus -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CHOROID_VOLUME Bilateral choroid plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CTX_LH_MIDDLETEMPORAL_SUVR ctx-lh-middletemporal -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CTX_LH_MIDDLETEMPORAL_VOLUME ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CTX_RH_MIDDLETEMPORAL_SUVR ctx-rh-middletemporal -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CTX_RH_MIDDLETEMPORAL_VOLUME ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
LEFT_MIDDLEFR_SUVR Left middle frontal ROI -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
LEFT_MIDDLEFR_VOLUME Left middle frontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
LEFT_PALLIDUM_SUVR left-pallidum -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
LEFT_PALLIDUM_VOLUME left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
RIGHT_MIDDLEFR_SUVR Right middle frontal ROI -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
RIGHT_MIDDLEFR_VOLUME Right middle frontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
RIGHT_PALLIDUM_SUVR right-pallidum -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
RIGHT_PALLIDUM_VOLUME right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
QID48_9 Select the response that best describes your life.... I am at peace about leading a life as a caregiver 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID48_8 Select the response that best describes your life.... I am able to be happy and satisfied with my life, and be a caregiver 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID48_7 Select the response that best describes your life.... Being a caregiver prevents me from having a fulfilling life 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
ST5SD Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Mid_Posterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST5MIN Min CBF value for FreeSurfer ROI: CC_Mid_Posterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST5MAX Max CBF value for FreeSurfer ROI: CC_Mid_Posterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST5MD Median CBF value for FreeSurfer ROI: CC_Mid_Posterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST5CT Count of CBF voxels in FreeSurfer ROI: CC_Mid_Posterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST5AVG Mean CBF value for FreeSurfer ROI: CC_Mid_Posterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
StudyPartnerID Unique identifier for study partners N/A N/A SP_INITIAL CogState Brief Battery Report
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_STUDY_CONFIRMATION Brain Health Registry SP STUDY CONFIRMATION
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_RELATIONSHIP Brain Health Registry SP RELATIONSHIP
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_FAQ Brain Health Registry SP FAQ
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
StudyPartnerID Unique identifier for study partners N/A N/A BHR_SP_ADL Brain Health Registry SP ADL
QID9 Has YOUR STUDY PARTNER ever been diagnosed with Mild Cognitive Impairment (MCI)? 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
QID9 Has YOUR STUDY PARTNER ever been diagnosed with Mild Cognitive Impairment (MCI)? 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID8 Compared to one year ago, does YOUR STUDY PARTNER show less interest in hobbies and social activities? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID8 Compared to one year ago, does YOUR STUDY PARTNER show less interest in hobbies and social activities? 1=Yes;2=Maybe;3=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID8 Compared to six months ago, how would you rate your mood in general? 1=Much Better;2=Better;3=About the Same;4=Worse;5=Much Worse N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID8 Are you in good spirits most of the time? 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID7 Compared to one year ago, is YOUR STUDY PARTNER having more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID7 Compared to one year ago, is YOUR STUDY PARTNER having more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)? 1=Yes;2=Maybe;3=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID7 Are you in good spirits most of the time? 1=Yes;2=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID7 Compared to one year ago, how would you rate your health in general now? 1=Much Better;2=Better;3=Same;4=Worse;5=Much Worse N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID6 Compared to one year ago, does YOUR STUDY PARTNER need more help from others to remember appointments, family occasions or holidays? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID6 Compared to one year ago, does YOUR STUDY PARTNER need more help from others to remember appointments, family occasions or holidays? 1=Yes;2=Maybe;3=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID6 Compared to six months ago, how would you rate your health in general? 1=Much better;2=Better;3=About the Same;4=Worse;5=Much Worse N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID55 Are you caregiving for more than one person? 1=Yes;3=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID54_4 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... Cooking or working and talking at the same time. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID54_4 Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... Cooking or working and talking at the same time. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID54_3 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... The ability to concentrate on a task without being distracted by external things in the environment. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID54_3 Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... The ability to concentrate on a task without being distracted by external things in the environment. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID54_2 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... Returning to a task after being interrupted. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID54_2 Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... Returning to a task after being interrupted. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID54_1 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: divided attention... The ability to do two things at once. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID54_1 Compared to 10 years ago, has there been any change in... DIVIDED ATTENTION... The ability to do two things at once. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID54 How confident are you with computers? 1=Not confident at all;2=I usually need help;3=It depends on the task;4=Confident N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID53_6 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Using an organized strategy to manage a medication schedule involving multiple medications. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID53_6 Compared to 10 years ago, has there been any change in... ORGANIZATION... Using an organized strategy to manage a medication schedule involving multiple medications. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID53_5 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Keeping mail and papers organized. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID53_5 Compared to 10 years ago, has there been any change in... ORGANIZATION... Keeping mail and papers organized. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID53_4 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Prioritizing tasks by importance. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID53_4 Compared to 10 years ago, has there been any change in... ORGANIZATION... Prioritizing tasks by importance. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID53_3 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Keeping financial records organized. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID53_3 Compared to 10 years ago, has there been any change in... ORGANIZATION... Keeping financial records organized. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID53_2 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Balancing the checkbook without error. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID53_2 Compared to 10 years ago, has there been any change in... ORGANIZATION... Balancing the checkbook without error. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID53_1 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: organization... Keeping living and work space organized. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID53_1 Compared to 10 years ago, has there been any change in... ORGANIZATION... Keeping living and work space organized. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID53 Are you the primary caregiver for YOUR STUDY PARTNER, who needs extra assistance due to a disability, condition, or illness? We define a primary caregiver as the person who is primarily responsible for helping make medical care decisions, is emotionally invested in the person's care, and provides help with daily activities (or almost daily). Daily caregiving activities may include helping with medical or therapeutic treatments, preparing meals, and/or helping with dressing and/or bathing. Caregivers may be caring for a loved one with dementia, or be the parents to a child with developmental delays or burdensome health conditions, for example. 1=Yes, I am a caregiver for MY STUDY PARTNER;2=No, I am not a caregiver for MY STUDY PARTNER;3=I am not a caregiver based on this definition, but I do help MY STUDY PARTNER with some health issues N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID53 How often do you use a computer? 1=Daily;2=Weekly;3=Monthly;4=Almost never N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID52_5 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Thinking ahead. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID52_5 Compared to 10 years ago, has there been any change in... PLANNING... Thinking ahead. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID52_4 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Thinking things through before acting. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID52_4 Compared to 10 years ago, has there been any change in... PLANNING... Thinking things through before acting. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID52_3 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Developing a schedule in advance of anticipated events. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID52_3 Compared to 10 years ago, has there been any change in... PLANNING... Developing a schedule in advance of anticipated events. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID52_2 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella). 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID52_2 Compared to 10 years ago, has there been any change in... PLANNING... The ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella). 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID52_1 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S executive functioning: planning... Planning a sequence of stops on a shopping trip. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID52_1 Compared to 10 years ago, has there been any change in... PLANNING... Planning a sequence of stops on a shopping trip. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_7 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way around a house visited many times. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_7 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way around a house visited many times. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_6 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way around a familiar store. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_6 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way around a familiar store. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_5 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way around a familiar neighborhood. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_5 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way around a familiar neighborhood. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_4 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her way back to a meeting spot in the mall or other location. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_4 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my way back to a meeting spot in the mall or other location. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_3 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Finding his/her car in a parking lot. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_3 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Finding my car in a parking lot. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_2 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Reading a map and helping with directions when someone else is driving. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_2 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Reading a map and helping with directions when someone else is driving. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID51_14 Compared to one year ago ...... Do you have more difficulty using household appliances (such as the washing machine, VCR or computer)? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID51_13 Compared to one year ago ...... Are you more likely to become disoriented, or get lost, for example when traveling to another city? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID51_12 Compared to one year ago ...... Are there any activities (e.g., hobbies, such as card games, crafts) that are substantially more difficult for you now compared to one year ago? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID51_11 Compared to one year ago ...... Do you have more trouble following the news, or the plots of books, movies or TV shows, compared to one year ago? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID51_1 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S visual-spatial and perceptual abilities... Following a map to find a new location. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID51_1 Compared to 10 years ago, has there been any change in...VISUAL-SPATIAL AND PERCEPTUAL ABILITIES... Following a map to find a new location. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_9 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Understanding spoken directions or instructions. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_9 Compared to one year ago ...... Are you less involved in social activities? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID50_9 Compared to 10 years ago, has there been any change in...LANGUAGE... Understanding spoken directions or instructions. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_8 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Describing a program he/she has watched on TV. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_8 Compared to one year ago ...... Compared to one year ago, do you have more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID50_8 Compared to 10 years ago, has there been any change in...LANGUAGE... Describing a program I have watched on TV. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_7 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Remembering the meaning of common words. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_7 Compared to one year ago ...... Do you have more trouble driving (e.g., do you drive more slowly, have more trouble at night, tend to get lost, have accidents)? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID50_7 Compared to 10 years ago, has there been any change in...LANGUAGE... Remembering the meaning of common words. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_6 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Understanding the point of what other people are trying to say. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_6 Compared to one year ago ...... Do you have more trouble recalling names, finding the right word, or completing sentences? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID50_6 Compared to 10 years ago, has there been any change in...LANGUAGE... Understanding the point of what other people are trying to say. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_5 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Following a story in a book or on TV. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_5 Compared to 10 years ago, has there been any change in...LANGUAGE... Following a story in a book or on TV. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_4 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Communicating thoughts in a conversation. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_4 Compared to 10 years ago, has there been any change in...LANGUAGE... Communicating thoughts in a conversation. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_3 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Finding the right words to use in a conversation. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_3 Compared to 10 years ago, has there been any change in...LANGUAGE... Finding the right words to use in a conversation. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_2 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Verbally giving instructions to others. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_2 Compared to 10 years ago, has there been any change in...LANGUAGE... Verbally giving instructions to others. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50_13 Compared to one year ago ...... Has your work performance (paid or volunteer) declined significantly compared to one year ago? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID50_1 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S language... Forgetting the names of objects. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID50_1 Compared to 10 years ago, has there been any change in...LANGUAGE... Forgetting the names of objects. 8=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID50 How confident are you with computers? 1=Not confident at all;2=I usually need help;3=It depends on the task;4=Confident N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID5 Compared to one year ago, does it seem to you that lately YOUR STUDY PARTNER is relying more on written reminders (e.g., shopping lists, calendars)? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID5 Compared to one year ago, does it seem to you that lately YOUR STUDY PARTNER is relying more on written reminders (e.g., shopping lists, calendars)? 1=Yes;2=Maybe;3=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID5 Compared to 10 years ago, would you say there has been a change in your memory? 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID4_5 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Traveling out of the neighborhood, driving, or arranging to take public transportation. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID4_4 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Remembering appointments, family occasions, holidays, medications. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID4_3 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Paying attention to and understanding a TV program, book, or magazine. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID4_2 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Keeping track of current events. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID4_1 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks... Preparing a balanced meal. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID49_9 As a result of being a caregiver, I have experienced the following changes in my life:... I have a stronger religious faith 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID49_8 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering appointments, meetings, or engagements. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_8 As a result of being a caregiver, I have experienced the following changes in my life:... I discovered that I was stronger than I thought I was 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID49_8 Compared to 10 years ago, has there been any change in...MEMORY... Remembering appointments, meetings, or engagements. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_7 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering he/she has already told someone something. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_7 As a result of being a caregiver, I have experienced the following changes in my life:... I established a new path for my life 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID49_7 Compared to 10 years ago, has there been any change in...MEMORY... Remembering I have already told someone something. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_6 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering the current date or day of the week. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_6 As a result of being a caregiver, I have experienced the following changes in my life:... I have a greater sense of closeness with others 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID49_6 Compared to 10 years ago, has there been any change in...MEMORY... Remembering the current date or day of the week. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_5 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Repeating stories and/or questions. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_5 Compared to one year ago ...... Do you need more help from others to remember appointments, family occasions or holidays? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID49_5 Compared to 10 years ago, has there been any change in...MEMORY... Repeating stories and/or questions. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_4 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering where he/she has placed objects. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_4 Compared to one year ago ...... Do you find that lately you are relying more on written reminders (e.g., shopping lists, calendars)? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID49_4 Compared to 10 years ago, has there been any change in...MEMORY... Remembering where I have placed objects. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_3 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Recalling conversations a few days later. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_3 Compared to one year ago ...... Have you been misplacing things more often? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID49_3 Compared to 10 years ago, has there been any change in...MEMORY... Recalling conversations a few days later. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_2 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering things that happened recently (such as recent outings, events in the news). 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_2 Compared to one year ago ...... Do others tell you that you tend to repeat questions over and over? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID49_2 Compared to 10 years ago, has there been any change in...MEMORY... Remembering things that happened recently (such as recent outings, events in the news). 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
QID49_10 As a result of being a caregiver, I have experienced the following changes in my life:... I changed my priorities about what is important in life 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID49_1 Compared to 10 years ago, has there been any change in... YOUR STUDY PARTNER'S memory... Remembering a few shopping items without a list. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
QID49_1 Compared to one year ago ...... Do you feel that your memory has declined substantially? 1=Yes;2=No;3=Maybe N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID49 How often do you use a computer? 1=Daily;2=Weekly;3=Monthly;4=Almost never N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID49_1 Compared to 10 years ago, has there been any change in...MEMORY... Remembering a few shopping items without a list. 1=Better or no change;2=Questionable/ occasionally worse;3=Consistently a little worse;4=Consistently much worse;5=I don't know N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
VISCODE2 N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
VISCODE N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Slope_Standardization N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Sample_volume_UNITS N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Sample_volume Volume of the sample at the beginng of IP process N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Sample_Type N/A "Clinical Plasma; Calibration standard" N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Sample_ID N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
RID N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
QC_Status Status assigned by Quality Control team "Pass; Pass with warnings; Fail" N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
QC_Flags Flags assigned by Quality Control team N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
QC_Comment N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
PROT N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
MS_Run_Date N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
LC_MS_Sample_ID N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Intertcept_Standardization N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Instrument Masspectrometer Identifier "OTF Lumos; TQS Altis" N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Injection N/A "a; b; c; d" N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
File_Name_NE Acquisition file name N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
EXAMDATE N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Batch_N N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Assay_IP_protocol N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Assay_fluid N/A "Plasma; CSF" N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Assay N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_42_N15_ISTD_amount_UNITS N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_42_N15_ISTD_amount N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_42_N14N15 (N14 Area/N15 Area) N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_42_conc_UNITS N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_42_conc ((N14 Area / N15 Area) * ISTD conc. ) / Sample volume N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_4240_Standardized Slope [Standardization]* Abeta 42:40 + Intercept[Standardization] N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_4240 A?42 / A?40 Ratio N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_40_N15_ISTD_amount_UNITS N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_40_N15_ISTD_amount N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_40_N14N15 (N14 Area/N15 Area) N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_40_conc_UNITS N/A N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
Abeta_40_conc ((N14 Area / N15 Area) * ISTD conc. ) / Sample volume N/A N/A BATEMANLAB_ADNI_Plasma_Abeta4240_20221118 Bateman Lab Plasma Abeta42:Abeta40 Ratio as a Predictor of Brain Amyloidosis [ADNI]
SAMPLEID Subject or biosample ID or blinded ID N/A N/A FNIH_PLASMA_PTAU181_PROJECT FNIH Biomarkers Consortium Plasma pTau-181 Project
RID ADNI subject ID N/A N/A FNIH_PLASMA_PTAU181_PROJECT FNIH Biomarkers Consortium Plasma pTau-181 Project
PTAU_181 Calibrated plasma phospho-tau 181 concentration in pg/mL (related to the peptide used as calibrator and not the full-length phosphorylated tau protein) N/A N/A FNIH_PLASMA_PTAU181_PROJECT FNIH Biomarkers Consortium Plasma pTau-181 Project
SEQUENCE_NO Internal sequence Identifier -4 N/A EMORY_PEPTIDERATIOS Emory targeted proteomics assay
SAMPLEID Tube ID assigned by Biorepository -4 N/A EMORY_PEPTIDERATIOS Emory targeted proteomics assay
WHOLECEREBELLUM_VOLUME Reference region - volume of whole cerebellum. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
WHOLECEREBELLUM_SUVR Reference region - florbetaben mean of whole cerebellum. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
SUMMARYSUVR_WHOLECEREBNORM_1.08CUTOFF Amyloid positivity determined by applying a cutoff value of 1.08 to the summary florbetaben cortical SUVR normalized by whole cerebellum -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
SUMMARYSUVR_COMPOSITE_REFNORM_0.74CUTOFF Amyloid positivity determined by applying a cutoff value of 0.74 to the summary florbetaben cortical SUVR normalized by composite ref region -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
RIGHT_PALLIDUM_SUVR right-pallidum -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
RIGHT_PALLIDUM_VOLUME right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
RIGHT_CHOROID_PLEXUS_VOLUME right-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
RIGHT_CHOROID_PLEXUS_SUVR right-choroid-plexus -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
RID Participant roster ID -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
LEFT_PALLIDUM_VOLUME left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
LEFT_PALLIDUM_SUVR left-pallidum -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
LEFT_CHOROID_PLEXUS_VOLUME left-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
LEFT_CHOROID_PLEXUS_SUVR left-choroid-plexus -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
ERODED_SUBCORTICALWM_SUVR Reference region - florbetaben mean of eroded subcortical white matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-rh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR ctx-rh-rostralmiddlefrontal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_RH_MIDDLETEMPORAL_VOLUME ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_RH_MIDDLETEMPORAL_SUVR ctx-rh-middletemporal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME ctx-rh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SUVR ctx-rh-caudalmiddlefrontal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-lh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR ctx-lh-rostralmiddlefrontal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
RID Participant roster ID -4 N/A UCBERKELEYFDG_8MM UC Berkeley - FDG analysis
UID Unique image ID -4 N/A UCBERKELEYFDG_8MM UC Berkeley - FDG analysis
ST55SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST55MIN Min CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST55MD Median CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST55MAX Max CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST55CT Count of CBF voxels in FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST55AVG Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
QID48_6 Select the response that best describes your life.... I accept my negative feelings about caregiving, instead of pushing them away 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID48_10 Select the response that best describes your life.... I tell myself I shouldn't be thinking or feeling the way I am about being a caregiver 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID47_5 Select the response that best describes your life.... I criticize myself for having negative emotions about having to be a caregiver 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID47_4 Select the response that best describes your life.... Being a caregiver is an important role to me 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID47_3 Select the response that best describes your life.... There is great value in what I do everyday for MY STUDY PARTNER 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID47_2 Select the response that best describes your life.... Most of my caregiving activities seem trivial and unimportant 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID47_14 Compared to one year ago ...... Do you have more difficulty using household appliances (such as the washing machine, VCR or computer)? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID47_13 Compared to one year ago ...... Are you more likely to become disoriented, or get lost, for example when traveling to another city? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID47_12 Compared to one year ago ...... Are there any activities (e.g., hobbies, such as card games, crafts) that are substantially more difficult for you now compared to one year ago? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID47_11 Compared to one year ago ...... Do you have more trouble following the news, or the plots of books, movies or TV shows, compared to one year ago? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID47_1 Select the response that best describes your life.... The things I do to take care of MY STUDY PARTNER are worthwhile 11=Strongly disagree (1);12=Disagree (2);13=Neither agree nor disagree (3);14=Agree (4);15=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID46_9 Compared to one year ago ...... Are you less involved in social activities? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID46_8 Compared to one year ago ...... Compared to one year ago, do you have more difficulty managing money (e.g., paying bills, calculating change, completing tax forms)? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID46_7 Compared to one year ago ...... Do you have more trouble driving (e.g., do you drive more slowly, have more trouble at night, tend to get lost, have accidents)? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID46_6 Compared to one year ago ...... Do you have more trouble recalling names, finding the right word, or completing sentences? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID46_13 Compared to one year ago ...... Has your work performance (paid or volunteer) declined significantly compared to one year ago? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID45_6 As a caregiver do YOU feel...... You could do a better job caring for YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID45_5 As a caregiver do YOU feel...... You should be doing more for YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID45_4 As a caregiver do YOU feel...... Uncertain about what to do about YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID45_3 As a caregiver do YOU feel...... That you have lost control of your life since you began providing care for YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID45_2 As a caregiver do YOU feel...... That your social life has suffered because you are caring for YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID45_1 As a caregiver do YOU feel...... That you don't have as much privacy as you would like because of caregiving? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_2_6 How much has this bothered or upset you when it happened?... Arguing, irritability, and/or complaining 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_2_5 How much has this bothered or upset you when it happened?... Comments about feeling like a failure, or about not having any worthwhile accomplishments in life 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_2_4 How much has this bothered or upset you when it happened?... Comments about feeling worthless or being a burden to others 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_2_3 How much has this bothered or upset you when it happened?... Talking about feeling lonely 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_2_2 How much has this bothered or upset you when it happened?... Commenting about death of self or others 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_2_1 How much has this bothered or upset you when it happened?... Crying and tearfulness 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_1_6 Has it occurred in the past week?... Arguing, irritability, and/or complaining 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
BRAIN Whole Brain. A summary measure of total brain parenchyma, including the Cerebral-Cortex, Cerebellum-Cortex, Thalamus-Proper, CaudatePutamen, Pallidum, Hippocampus, Amygdala, Accumbens-area, VentralDC, Cerebral-White-Matter, Cerebellum-White-Matter, and WM-hypointensities. As such, it does not include ventricles or other CSF spaces, and is not intended to be used as a measure of intracranial volume. N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
EICV Estimated Intracranial Volume, aka eTIV. To generate the mask, the baseline image is automatically segmented; all thus-defined brain and ventricular voxels are given the value 1 with all other voxels 0. This binary mask is then repeatedly smoothed with a Gaussian kernel to produce a simply connected uniform mask, covering all sulci, whose boundary tapers smoothly from 1 to 0 over the length of a few voxels. Ideally, the mask would end on the skull and include the brain stem down to where it starts to bend with the neck. The smoothing can be controlled fairly nicely to begin tapering at the skull, so that voxels with a mask value less than 1 can be considered outside the ICV and therefore ignored. N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
LMIDTEMP Left Middle Temporal N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
LONISID LONISID N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
RID N/A N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
RMIDTEMP Right Middle Temporal N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
SITEID N/A N/A N/A UCSDVOL Anders Dale Lab (UCSD) - Derived Volumes
RID Participant roster ID -4 N/A BHR_MEMTRAX Brain Health Registry MEMTRAX
QID36_2 How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID36_1 How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID36_1 How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID35_2 How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID35_2 How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID35_1 How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID35_1 How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID35 Compared to one year ago, does YOUR STUDY PARTNER have more difficulty using household appliances (such as the washing machine, VCR, or computer)? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID35 Did you have to leave your paid job, cut down on your hours, or drop out of school due to your caregiving responsibilities? 1=Yes;2=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID34_2 How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID34_2 How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID34_1 How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID34_1 How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID34 Compared to one year ago, is YOUR STUDY PARTNER more likely to become disoriented, or get lost, for example when traveling to another city?  1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID34 What is your employment status? 1=Employed full-time;2=Employed part-time;3=Full-time student;4=Part-time student;5=Unemployed;6=Retired N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID33_2 How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID33_1 How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID33 Are there any activities (e.g., hobbies, such as card games, crafts) that are substantially more difficult for YOUR STUDY PARTNER now compared to one year ago? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID33 Do you live with YOUR STUDY PARTNER? 1=Yes;2=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID32_3 How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID32_2 How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID32_1 How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID32_1 How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID32 Does YOUR STUDY PARTNER have more trouble following the news, or the plots of books, movies or TV shows, compared to one year ago? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID32 Are you the primary caregiver for more than one person? 1=Yes;2=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID31_2 How long has your current anti-depressant prescription been stable (same medication, frequency, dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID31_2 How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID31_1 How long has your current anti-depressant prescription been stable (same medication, frequency, dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID31_1 How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID31 Do you believe, based on your own observations or comments from YOUR STUDY PARTNER'S co-workers, that YOUR STUDY PARTNER'S work performance (paid or volunteer) has declined significantly, compared to one year ago? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID31 Because you do not identify as a primary caregiver for YOUR STUDY PARTNER, we have no more questions for you. If you become a primary caregiver at a later time, you will have the opportunity to let us know at a future visit. N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID30_TEXT How long has it been in years since you stopped the drug abuse? If you still abuse drugs please write 0. N/A N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID30_2 How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID30_1 How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID30 Compared to one year ago, is YOUR STUDY PARTNER less interested in social activities?  1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID3 Has there been a change in YOUR STUDY PARTNER'S memory in the past 10 years? 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
QID3 Has there been a change in YOUR STUDY PARTNER'S memory in the past 10 years? 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID3 Do you have trouble remembering if you have already told someone something? 1=Yes;2=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID3 Do you have trouble remembering if you have already told someone something? 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID2_8 Please answer the following questions using the responses provided.... Performance at work (paid or volunteer). This may be based on your own observations, or comments from your study partner's coworkers. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_7 Please answer the following questions using the responses provided.... Driving (e.g., drive more slowly, have more trouble at night, tend to get lost, have accidents)? 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_6 Please answer the following questions using the responses provided.... Preparing a balanced meal. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_5 Please answer the following questions using the responses provided.... Heating water, making a cup of coffee, turning off the stove. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_4 Please answer the following questions using the responses provided.... Playing a game of skill such as bridge or chess, or working on a hobby. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_3 Please answer the following questions using the responses provided.... Shopping alone for clothes, household necessities, or groceries. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_2 Please answer the following questions using the responses provided.... Learning how to use a tool, appliance, or gadget. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID2_1 Please answer the following questions using the responses provided.... The ability to make decisions. 1=Normal;2=Never did, but could do now;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_ADL Brain Health Registry SP ADL
QID29_9 Select the response that best describes YOUR life.... MY STUDY PARTNER'S pleasure over little things gives me pleasure 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_8 Select the response that best describes YOUR life.... Nothing I do seems to please MY STUDY PARTNER 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_7 Select the response that best describes YOUR life.... MY STUDY PARTNER shows real appreciation of my care 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_6 Select the response that best describes YOUR life.... I really want to care for MY STUDY PARTNER 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_5 Select the response that best describes YOUR life.... I resent having to care for MY STUDY PARTNER 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_4 Select the response that best describes YOUR life.... I feel privileged to care for MY STUDY PARTNER 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_3 Select the response that best describes YOUR life.... Caring for MY STUDY PARTNER makes me feel good 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_2 Select the response that best describes YOUR life.... I enjoy caring for MY STUDY PARTNER 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_2 How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID29_1 Select the response that best describes YOUR life.... Caring for MY STUDY PARTNER is important to me 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID29_1 How long has your current Tacrine (Cognex) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID29 Please indicate whether you currently have or had experienced drug abuse in the past. 1=Yes;3=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID28_TEXT How long has it been in years since your stopped your alcohol abuse? If you still abuse alcohol please write 0. N/A N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID28_2 How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID28_1 How long has your current Donepezil (Aricept) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID28 Compared to one year ago, is YOUR STUDY PARTNER having more trouble driving (e.g., does he/she drive more slowly, have more trouble at night, tend to get lost, have accidents)? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID27_TEXT How many hours per week do you spend caring for YOUR STUDY PARTNER? We know this may be difficult to estimate, just give your best guess. If this question is not relevant to you, please enter 0. N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID27_3 How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID27_1 How long has your current anti-anxiety prescription been stable (same medication, frequency, dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID27 Compared to one year ago, does YOUR STUDY PARTNER have more trouble recalling names, finding the right word, or completing sentences? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID27 Please indicate whether you currently have or had experienced alcohol abuse in the past. 1=Yes;3=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID26_TEXT In addition to your role as caregiver, how many hours per week do you work at a paid job or attend school? If you do not have a job or go to school, please write 0. N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID26_2 How long has your current anti-depressant prescription been stable (same medication, frequency, dose)? ... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID26_1 How long has your current anti-depressant prescription been stable (same medication, frequency, dose)? ... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID25_2_TEXT For how long have you been caregiving? For example: 1 year, 3 months, 0 years, 7 months, 9 years, 0 months... Months N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID25_1_TEXT For how long have you been caregiving? For example: 1 year, 3 months, 0 years, 7 months, 9 years, 0 months... Years N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID25 Have you dropped many of your activities and interests? 1=Yes;2=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID24_9 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Mental or Psychiatric Illness 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_8 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Brain-related Injury (e.g. tumor, stroke, traumatic brain injury) 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_7 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Dementia 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_6 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Mental Disability or Impairment 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_5 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Physical Disability or Injury 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_4 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other Chronic Illness 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_3 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Heart Disease 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_21 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Intellectual Disability 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_20 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Psychiatric illness (e.g. schizophrenia, depression, bipolar disorder, anxiety disorder) 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_2 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Diabetes 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_19 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Autism 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_18 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Epilepsy 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_1_5 Has it occurred in the past week?... Comments about feeling like a failure, or about not having any worthwhile accomplishments in life 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_1_3 Has it occurred in the past week?... Talking about feeling lonely 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_1_4 Has it occurred in the past week?... Comments about feeling worthless or being a burden to others 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_1_1 Has it occurred in the past week?... Crying and tearfulness 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID44_1_2 Has it occurred in the past week?... Commenting about death of self or others 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_2 How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID43_1 How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID43_2_6 How much has this bothered or upset you when it happened?... Expressing feelings of hopelessness or sadness about the future 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_2_5 How much has this bothered or upset you when it happened?... Appeared sad or depressed 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_2_4 How much has this bothered or upset you when it happened?... Aggressive to others verbally 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_2_3 How much has this bothered or upset you when it happened?... Threatened to hurt others 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_2_2 How much has this bothered or upset you when it happened?... Threatened to hurt oneself 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_2_1 How much has this bothered or upset you when it happened?... Engaging in behavior that is potentially dangerous to self or others 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_1_6 Has it occurred in the past week?... Expressing feelings of hopelessness or sadness about the future 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_1_5 Has it occurred in the past week?... Appeared sad or depressed 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_1_4 Has it occurred in the past week?... Aggressive to others verbally 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_1_3 Has it occurred in the past week?... Threatened to hurt others 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_1_2 Has it occurred in the past week?... Threatened to hurt oneself 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID43_1_1 Has it occurred in the past week?... Engaging in behavior that is potentially dangerous to self or others 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_TEXT How long has it been in years since you stopped the drug abuse? If you still abuse drugs please write 0. N/A N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID42_2 How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID42_1 How long has your current Quetiapine (Seroquel) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID42_2_5 How much has this bothered or upset you when it happened?... Talking loudly and rapidly 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_2_4 How much has this bothered or upset you when it happened?... Waking you or other family members up at night 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_2_3 How much has this bothered or upset you when it happened?... Doing things that embarrass you 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_2_25 How much has this bothered or upset you when it happened?... Appeared anxious or worried 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_2_2 How much has this bothered or upset you when it happened?... Destroying property 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_2_1 How much has this bothered or upset you when it happened?... Difficulty concentrating on a task 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_1_5 Has it occurred in the past week?... Talking loudly and rapidly 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_1_4 Has it occurred in the past week?... Waking you or other family members up at night 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_1_3 Has it occurred in the past week?... Doing things that embarrass you 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_1_25 Has it occurred in the past week?... Appeared anxious or worried 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_1_2 Has it occurred in the past week?... Destroying property 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID42_1_1 Has it occurred in the past week?... Difficulty concentrating on a task 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID41_2 How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID41_1 How long has your current Olanzapine (Zyprexa) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID41 Please indicate whether you currently have or had experienced drug abuse in the past. 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID40_2 How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID40_1 How long has your current Paliperidone (Invega) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID4 Does YOUR STUDY PARTNER have trouble remembering whether he/she told someone something? 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
QID4 Does YOUR STUDY PARTNER have trouble remembering whether he/she told someone something? 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID4 Compared to six months ago, do you have more or less trouble remembering if you have already told someone something? 1=Much more trouble;2=More trouble;3=About the same;4=Less trouble;5=Much less trouble N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID4 Have your children, your sibling(s), or parent(s) ever been diagnosed with Alzheimer's Disease? 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID3_5 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Heating water, making a cup of coffee, turning off the stove. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID3_4 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Playing a game of skill such as bridge or chess, working on a hobby. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID3_3 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Shopping alone for clothes, household necessities, or groceries. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID3_2 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Assembling tax records, business affairs, or other papers. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID3_1 Select the most accurate representation of YOUR STUDY PARTNER'S level of ability to perform each activity over the preceding four weeks.... Writing checks, paying bills, or balancing checkbook. 1=Normal;2=Never did, but could now do;3=Never did, would have difficulty now;4=Has difficulty, but does by self;5=Requires assistance;6=Dependent N/A BHR_SP_FAQ Brain Health Registry SP FAQ
QID39_5 Compared to one year ago ...... Do you need more help from others to remember appointments, family occasions or holidays? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID39_4 Compared to one year ago ...... Do you find that lately you are relying more on written reminders (e.g., shopping lists, calendars)? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID39_3 Compared to one year ago ...... Have you been misplacing things more often? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID39_2 How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID39_2 Compared to one year ago ...... Do others tell you that you tend to repeat questions over and over? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID39_1 How long has your current Risperidone (Risperdal) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID39_1 Compared to one year ago ...... Do you feel that your memory has declined substantially? 1=Yes;2=No;3=Maybe N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID38_2 How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID38_1 How long has your current Galantamine (Razadyne) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID38_2_6 How much has this bothered or upset you when it happened?... Starting, but not finishing, things 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_2_5 How much has this bothered or upset you when it happened?... Forgetting what day it is 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_2_4 How much has this bothered or upset you when it happened?... Losing or misplacing things 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_2_3 How much has this bothered or upset you when it happened?... Trouble remembering significant past events 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_2_2 How much has this bothered or upset you when it happened?... Trouble remembering recent events (i.e. items in newspaper or TV) 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_2_1 How much has this bothered or upset you when it happened?... Asking the same question over and over 0=Not At All (0);1=A Little (1);2=Moderately (2);3=Very Much (3);4=Extremely (4);5=Has NOT occurred in the past week N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_1_6 Has it occurred in the past week?... Starting, but not finishing, things 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_1_5 Has it occurred in the past week?... Forgetting what day it is 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_1_4 Has it occurred in the past week?... Losing or misplacing things 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_1_3 Has it occurred in the past week?... Trouble remembering significant past events 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_1_2 Has it occurred in the past week?... Trouble remembering recent events (i.e. items in newspaper or TV) 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38_1_1 Has it occurred in the past week?... Asking the same question over and over 2=No;1=Yes N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID38 Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say you experienced: 1=A lot of stress;2=A moderate amount of stress;3=Relatively little stress;4=Almost no stress at all N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID37_2 How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID37_2 How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID37_1 How long has your current Memantine (Namenda) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID37_1 How long has your current Aripiprazole (Abilify) prescription been stable (same frequency and dose)?... Years 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID36_2 How long has your current Rivastigmine (Exelon) prescription been stable (same frequency and dose)?... Months 1=0;2=0 ~ 0;3=0 ~ 1;4=0 ~ 2;5=0 ~ 3;6=0 ~ 4;7=0 ~ 5;8=0 ~ 6;9=0 ~ 7;10=0 ~ 8;11=0 ~ 9;12=0 ~ 10;13=0 ~ 11;14=1;15=1 ~ 0;16=1 ~ 1;17=1 ~ 2;18=1 ~ 3;19=1 ~ 4;20=1 ~ 5;21=1 ~ 6;22=1 ~ 7;23=1 ~ 8;24=1 ~ 9;25=1 ~ 10;26=1 ~ 11;27=2;28=2 ~ 0;29=2 ~ 1;30=2 ~ 2;31=2 ~ 3;32=2 ~ 4;33=2 ~ 5;34=2 ~ 6;35=2 ~ 7;36=2 ~ 8;37=2 ~ 9;38=2 ~ 10;39=2 ~ 11;40=3;41=3 ~ 0;42=3 ~ 1;43=3 ~ 2;44=3 ~ 3;45=3 ~ 4;46=3 ~ 5;47=3 ~ 6;48=3 ~ 7;49=3 ~ 8;50=3 ~ 9;51=3 ~ 10;52=3 ~ 11;53=4;54=4 ~ 0;55=4 ~ 1;56=4 ~ 2;57=4 ~ 3;58=4 ~ 4;59=4 ~ 5;60=4 ~ 6;61=4 ~ 7;62=4 ~ 8;63=4 ~ 9;64=4 ~ 10;65=4 ~ 11;66=5;67=5 ~ 0;68=5 ~ 1;69=5 ~ 2;70=5 ~ 3;71=5 ~ 4;72=5 ~ 5;73=5 ~ 6;74=5 ~ 7;75=5 ~ 8;76=5 ~ 9;77=5 ~ 10;78=5 ~ 11;79=6;80=6 ~ 0;81=6 ~ 1;82=6 ~ 2;83=6 ~ 3;84=6 ~ 4;85=6 ~ 5;86=6 ~ 6;87=6 ~ 7;88=6 ~ 8;89=6 ~ 9;90=6 ~ 10;91=6 ~ 11;92=7;93=7 ~ 0;94=7 ~ 1;95=7 ~ 2;96=7 ~ 3;97=7 ~ 4;98=7 ~ 5;99=7 ~ 6;100=7 ~ 7;101=7 ~ 8;102=7 ~ 9;103=7 ~ 10;104=7 ~ 11;105=8;106=8 ~ 0;107=8 ~ 1;108=8 ~ 2;109=8 ~ 3;110=8 ~ 4;111=8 ~ 5;112=8 ~ 6;113=8 ~ 7;114=8 ~ 8;115=8 ~ 9;116=8 ~ 10;117=8 ~ 11;118=9;119=9 ~ 0;120=9 ~ 1;121=9 ~ 2;122=9 ~ 3;123=9 ~ 4;124=9 ~ 5;125=9 ~ 6;126=9 ~ 7;127=9 ~ 8;128=9 ~ 9;129=9 ~ 10;130=9 ~ 11;131=10;132=10 ~ 0;133=10 ~ 1;134=10 ~ 2;135=10 ~ 3;136=10 ~ 4;137=10 ~ 5;138=10 ~ 6;139=10 ~ 7;140=10 ~ 8;141=10 ~ 9;142=10 ~ 10;143=10 ~ 11;144=11;145=11 ~ 0;146=11 ~ 1;147=11 ~ 2;148=11 ~ 3;149=11 ~ 4;150=11 ~ 5;151=11 ~ 6;152=11 ~ 7;153=11 ~ 8;154=11 ~ 9;155=11 ~ 10;156=11 ~ 11;157=12;158=12 ~ 0;159=12 ~ 1;160=12 ~ 2;161=12 ~ 3;162=12 ~ 4;163=12 ~ 5;164=12 ~ 6;165=12 ~ 7;166=12 ~ 8;167=12 ~ 9;168=12 ~ 10;169=12 ~ 11;170=13;171=13 ~ 0;172=13 ~ 1;173=13 ~ 2;174=13 ~ 3;175=13 ~ 4;176=13 ~ 5;177=13 ~ 6;178=13 ~ 7;179=13 ~ 8;180=13 ~ 9;181=13 ~ 10;182=13 ~ 11;183=14;184=14 ~ 0;185=14 ~ 1;186=14 ~ 2;187=14 ~ 3;188=14 ~ 4;189=14 ~ 5;190=14 ~ 6;191=14 ~ 7;192=14 ~ 8;193=14 ~ 9;194=14 ~ 10;195=14 ~ 11;196=15;197=15 ~ 0;198=15 ~ 1;199=15 ~ 2;200=15 ~ 3;201=15 ~ 4;202=15 ~ 5;203=15 ~ 6;204=15 ~ 7;205=15 ~ 8;206=15 ~ 9;207=15 ~ 10;208=15 ~ 11;209=16;210=16 ~ 0;211=16 ~ 1;212=16 ~ 2;213=16 ~ 3;214=16 ~ 4;215=16 ~ 5;216=16 ~ 6;217=16 ~ 7;218=16 ~ 8;219=16 ~ 9;220=16 ~ 10;221=16 ~ 11;222=17;223=17 ~ 0;224=17 ~ 1;225=17 ~ 2;226=17 ~ 3;227=17 ~ 4;228=17 ~ 5;229=17 ~ 6;230=17 ~ 7;231=17 ~ 8;232=17 ~ 9;233=17 ~ 10;234=17 ~ 11;235=18;236=18 ~ 0;237=18 ~ 1;238=18 ~ 2;239=18 ~ 3;240=18 ~ 4;241=18 ~ 5;242=18 ~ 6;243=18 ~ 7;244=18 ~ 8;245=18 ~ 9;246=18 ~ 10;247=18 ~ 11;248=19;249=19 ~ 0;250=19 ~ 1;251=19 ~ 2;252=19 ~ 3;253=19 ~ 4;254=19 ~ 5;255=19 ~ 6;256=19 ~ 7;257=19 ~ 8;258=19 ~ 9;259=19 ~ 10;260=19 ~ 11;261=20+;262=20+ ~ N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
IMAGEUID1 N/A N/A N/A UCSFATRPHY UCSF (Colin Studholme) Regional Atrophy Rates
IMAGEUID2 N/A N/A N/A UCSFATRPHY UCSF (Colin Studholme) Regional Atrophy Rates
RID N/A N/A N/A UCSFATRPHY UCSF (Colin Studholme) Regional Atrophy Rates
SITEID N/A N/A N/A UCSFATRPHY UCSF (Colin Studholme) Regional Atrophy Rates
RID Participant roster ID -4 N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
LONISID The LONI study UID for the image processed N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
RID Participant roster ID N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST101SV Subcortical Volume (aseg.stats) of RightPallidum N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST114CV Cortical Volume (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST114SA Surface Area (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST114TA Thickness Average (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST114TS Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST15CV Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST15SA Surface Area (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST15TA Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST15TS Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST21SV Subcortical Volume (aseg.stats) of LeftChoroidPlexus N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST40CV Cortical Volume (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST40SA Surface Area (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST40TA Thickness Average (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST40TS Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST42SV Subcortical Volume (aseg.stats) of LeftPallidum N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST4SV Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST55CV Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST55SA Surface Area (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST55TA Thickness Average (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST55TS Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST5SV Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST74CV Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST74SA Surface Area (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST74TA Thickness Average (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST74TS Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST80SV Subcortical Volume (aseg.stats) of RightChoroidPlexus N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST99CV Cortical Volume (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST99SA Surface Area (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST99TA Thickness Average (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
ST99TS Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) Pass/Fail N/A UCSFFSL51ALL Longitudinal FreeSurfer (5.1) - All Available Base Image
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
LONISID The LONI study UID for the image processed N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
RID Participant roster ID N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST101SV Subcortical Volume (aseg.stats) of RightPallidum N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST114CV Cortical Volume (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST114SA Surface Area (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST114TA Thickness Average (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST114TS Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST15CV Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST15SA Surface Area (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST15TA Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST15TS Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST21SV Subcortical Volume (aseg.stats) of LeftChoroidPlexus N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST40CV Cortical Volume (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST40SA Surface Area (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST40TA Thickness Average (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST40TS Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST42SV Subcortical Volume (aseg.stats) of LeftPallidum N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST4SV Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST55CV Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST55SA Surface Area (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST55TA Thickness Average (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST55TS Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST5SV Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST74CV Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST74SA Surface Area (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST74TA Thickness Average (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST74TS Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST80SV Subcortical Volume (aseg.stats) of RightChoroidPlexus N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST99CV Cortical Volume (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST99SA Surface Area (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST99TA Thickness Average (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
ST99TS Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) Pass/Fail N/A UCSFFSL51Y1 Longitudinal FreeSurfer (5.1) - Year 1 Base Image
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
LONISID The LONI study UID for the image processed N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
RID Participant roster ID N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST101SV Subcortical Volume (aseg.stats) of RightPallidum N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST114CV Cortical Volume (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST114SA Surface Area (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST114TA Thickness Average (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST114TS Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST15CV Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST15SA Surface Area (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST15TA Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST15TS Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST21SV Subcortical Volume (aseg.stats) of LeftChoroidPlexus N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST40CV Cortical Volume (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST40SA Surface Area (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST40TA Thickness Average (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST40TS Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST42SV Subcortical Volume (aseg.stats) of LeftPallidum N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST4SV Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST55CV Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST55SA Surface Area (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST55TA Thickness Average (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST55TS Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST5SV Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST74CV Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST74SA Surface Area (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST74TA Thickness Average (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST74TS Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST80SV Subcortical Volume (aseg.stats) of RightChoroidPlexus N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST99CV Cortical Volume (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST99SA Surface Area (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST99TA Thickness Average (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
ST99TS Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) Pass/Fail N/A UCSFFSL51 Longitudinal FreeSurfer (5.1) - Final Run w/ All A
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
LONISID The LONI study UID for the image processed N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
RID Participant roster ID N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST101SV Volume (WM Parcellation) of RightPallidum N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST114CV Volume (Cortical Parcellation) of RightRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST114SA Surface Area of RightRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST114TA Cortical Thickness Average of RightRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST114TS Cortical Thickness Standard Deviation of RightRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST15CV Volume (Cortical Parcellation) of LeftCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST15SA Surface Area of LeftCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST15TA Cortical Thickness Average of LeftCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST15TS Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST21SV Volume (WM Parcellation) of LeftChoroidPlexus N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST40CV Volume (Cortical Parcellation) of LeftMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST40SA Surface Area of LeftMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST40TA Cortical Thickness Average of LeftMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST40TS Cortical Thickness Standard Deviation of LeftMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST42SV Volume (WM Parcellation) of LeftPallidum N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST4SV Volume (WM Parcellation) of CorpusCallosumMidAnterior N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST55CV Volume (Cortical Parcellation) of LeftRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST55SA Surface Area of LeftRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST55TA Cortical Thickness Average of LeftRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST55TS Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST5SV Volume (WM Parcellation) of CorpusCallosumMidPosterior N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST74CV Volume (Cortical Parcellation) of RightCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST74SA Surface Area of RightCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST74TA Cortical Thickness Average of RightCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST74TS Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST80SV Volume (WM Parcellation) of RightChoroidPlexus N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST99CV Volume (Cortical Parcellation) of RightMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST99SA Surface Area of RightMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST99TA Cortical Thickness Average of RightMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
ST99TS Cortical Thickness Standard Deviation of RightMiddleTemporal N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) N/A N/A UCSFFSL Longitudinal FreeSurfer (FreeSurfer Version 4.4)
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
LONISID The LONI study UID for the image processed N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
RID Participant roster ID N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST101SV Volume (aseg.stat) of RightPallidum N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST114CV Volume (aparc.stat) of RightRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST114SA Surface Area of RightRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST114TA Cortical Thickness Average of RightRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST114TS Cortical Thickness Standard Deviation of RightRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST15CV Volume (aparc.stat) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST15SA Surface Area of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST15TA Cortical Thickness Average of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST15TS Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST21SV Volume (aseg.stat) of LeftChoroidPlexus N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST40CV Volume (aparc.stat) of LeftMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST40SA Surface Area of LeftMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST40TA Cortical Thickness Average of LeftMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST40TS Cortical Thickness Standard Deviation of LeftMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST42SV Volume (aseg.stat) of LeftPallidum N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST4SV Volume (aseg.stat) of CorpusCallosumMidAnterior N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST55CV Volume (aparc.stat) of LeftRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST55SA Surface Area of LeftRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST55TA Cortical Thickness Average of LeftRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST55TS Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST5SV Volume (aseg.stat) of CorpusCallosumMidPosterior N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST74CV Volume (aparc.stat) of RightCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST74SA Surface Area of RightCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST74TA Cortical Thickness Average of RightCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST74TS Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST80SV Volume (aseg.stat) of RightChoroidPlexus N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST99CV Volume (aparc.stat) of RightMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST99SA Surface Area of RightMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST99TA Cortical Thickness Average of RightMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
ST99TS Cortical Thickness Standard Deviation of RightMiddleTemporal N/A N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) Pass/Fail N/A UCSFFSX51_ADNI1_3T ADNI-1 3T Cross-Sectional FreeSurfer (5.1)
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
LONISID The LONI study UID for the image processed N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
RID Participant roster ID N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST101SV Subcortical Volume (aseg.stats) of RightPallidum N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST114CV Cortical Volume (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST114SA Surface Area (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST114TA Thickness Average (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST114TS Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST15CV Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST15SA Surface Area (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST15TA Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST15TS Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST21SV Subcortical Volume (aseg.stats) of LeftChoroidPlexus N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST40CV Cortical Volume (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST40SA Surface Area (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST40TA Thickness Average (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST40TS Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST42SV Subcortical Volume (aseg.stats) of LeftPallidum N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST4SV Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST55CV Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST55SA Surface Area (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST55TA Thickness Average (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST55TS Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST5SV Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST74CV Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST74SA Surface Area (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST74TA Thickness Average (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST74TS Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST80SV Subcortical Volume (aseg.stats) of RightChoroidPlexus N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST99CV Cortical Volume (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST99SA Surface Area (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST99TA Thickness Average (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
ST99TS Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) Pass/Fail N/A UCSFFSX51 Cross-Sectional FreeSurfer (5.1)
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
HIPPOQC QC rating of the hippocampus. Fail affects the following regions: RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
IMAGEUID N/A N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
LONIUID N/A N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
RID Participant roster ID N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST101SV Subcortical Volume (aseg.stats) of RightPallidum N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST114CV Cortical Volume (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST114SA Surface Area (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST114TA Thickness Average (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST114TS Thickness Stardard Deviation (aparc.stats) of RightRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST15CV Cortical Volume (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST15SA Surface Area (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST15TA Thickness Average (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST15TS Thickness Stardard Deviation (aparc.stats) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST21SV Subcortical Volume (aseg.stats) of LeftChoroidPlexus N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST40CV Cortical Volume (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST40SA Surface Area (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST40TA Thickness Average (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST40TS Thickness Stardard Deviation (aparc.stats) of LeftMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST42SV Subcortical Volume (aseg.stats) of LeftPallidum N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST4SV Subcortical Volume (aseg.stats) of CorpusCallosumMidAnterior N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST55CV Cortical Volume (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST55SA Surface Area (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST55TA Thickness Average (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST55TS Thickness Stardard Deviation (aparc.stats) of LeftRostralMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST5SV Subcortical Volume (aseg.stats) of CorpusCallosumMidPosterior N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST74CV Cortical Volume (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST74SA Surface Area (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST74TA Thickness Average (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST74TS Thickness Stardard Deviation (aparc.stats) of RightCaudalMiddleFrontal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST80SV Subcortical Volume (aseg.stats) of RightChoroidPlexus N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST99CV Cortical Volume (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST99SA Surface Area (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST99TA Thickness Average (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
ST99TS Thickness Stardard Deviation (aparc.stats) of RightMiddleTemporal N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) N/A N/A UCSFFSX6 Cross-Sectional FreeSurfer (6.0)
BGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) Pass/Fail N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
FRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) Pass/Fail N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
IMAGEUID The ImageUID for the image processed. N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
LONISID The LONI study UID for the image processed N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
LONIUID The LONI series UID for the image processed. N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
RID Participant roster ID N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST101SV Volume (WM Parcellation) of RightPallidum N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST114CV Volume (Cortical Parcellation) of RightRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST114SA Surface Area of RightRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST114TA Cortical Thickness Average of RightRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST114TS Cortical Thickness Standard Deviation of RightRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST15CV Volume (Cortical Parcellation) of LeftCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST15SA Surface Area of LeftCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST15TA Cortical Thickness Average of LeftCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST15TS Cortical Thickness Standard Deviation of LeftCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST21SV Volume (WM Parcellation) of LeftChoroidPlexus N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST40CV Volume (Cortical Parcellation) of LeftMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST40SA Surface Area of LeftMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST40TA Cortical Thickness Average of LeftMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST40TS Cortical Thickness Standard Deviation of LeftMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST42SV Volume (WM Parcellation) of LeftPallidum N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST4SV Volume (WM Parcellation) of CorpusCallosumMidAnterior N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST55CV Volume (Cortical Parcellation) of LeftRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST55SA Surface Area of LeftRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST55TA Cortical Thickness Average of LeftRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST55TS Cortical Thickness Standard Deviation of LeftRostralMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST5SV Volume (WM Parcellation) of CorpusCallosumMidPosterior N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST74CV Volume (Cortical Parcellation) of RightCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST74SA Surface Area of RightCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST74TA Cortical Thickness Average of RightCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST74TS Cortical Thickness Standard Deviation of RightCaudalMiddleFrontal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST80SV Volume (WM Parcellation) of RightChoroidPlexus N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST99CV Volume (Cortical Parcellation) of RightMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST99SA Surface Area of RightMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST99TA Cortical Thickness Average of RightMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
ST99TS Cortical Thickness Standard Deviation of RightMiddleTemporal N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
TEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) Pass/Fail N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
VENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) N/A N/A UCSFFSX Cross-Sectional FreeSurfer (FreeSurfer Version 4.3)
IMAGEUID imageUID N/A N/A UCSFSNTVOL UCSF SNT Hippocampal Volumes
LONISID LONI Study ID N/A N/A UCSFSNTVOL UCSF SNT Hippocampal Volumes
LONIUID LONI Unique Series ID N/A N/A UCSFSNTVOL UCSF SNT Hippocampal Volumes
RID N/A N/A N/A UCSFSNTVOL UCSF SNT Hippocampal Volumes
SITEID N/A N/A N/A UCSFSNTVOL UCSF SNT Hippocampal Volumes
RID Participant roster ID -4 N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
RID Participant roster ID -4 N/A UGOTPTAU181 University of Gothenburg Longitudinal plasma P-tau181
VID UPENN Visit Code -4 N/A UGOTPTAU181 University of Gothenburg Longitudinal plasma P-tau181
RID Participant roster ID -4 N/A UPENNBIOMK10 UPENN CSF Biomarkers Elecsys [ADNI3, batch I]
RID Participant roster ID N/A N/A UPENNBIOMK12_2020 UPENN CSF Biomarkers Elecsys
RID -4 -4 N/A UPENNBIOMK2 UPENN Longitudinal Biomarker Data
SITEID -4 -4 N/A UPENNBIOMK2 UPENN Longitudinal Biomarker Data
RID -4 -4 N/A UPENNBIOMK3 UPENN Longitudinal Biomarker Data (3 yr)
SITEID -4 -4 N/A UPENNBIOMK3 UPENN Longitudinal Biomarker Data (3 yr)
RID Participant roster ID -4 N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
RID RID -4 N/A UPENNBIOMK4 UPENN Longitudinal Biomarker Data (4 yr)
RID Participant roster ID -4 N/A UPENNBIOMK5 ADNI GO and ADNI 2: first batch analysis of CSF biomarkers
RID Participant roster ID -4 N/A UPENNBIOMK6 ADNI 2: second batch analysis of CSF biomarkers
RID Participant roster ID -4 N/A UPENNBIOMK7 UPENN-Third batch analysis of CSF biomarkers
RID Participant roster ID -4 N/A UPENNBIOMK8 UPENN - Fourth Batch Analyses of CSF Biomarkers
RID Participant roster ID -4 N/A UPENNBIOMK_ADNIDIAN_ES_2017 UPENN - ADNI/DIAN study CSF Elecsys results
STUDY Identifies ADNI and DIAN samples -4 N/A UPENNBIOMK_ADNIDIAN_ES_2017 UPENN - ADNI/DIAN study CSF Elecsys results
RID Participant roster ID N/A N/A UPENNBIOMK_MASTER UPENN CSF Biomarkers
ABETA38 Amyloid Beta 1-38 -4 N/A UPENNMSMSABETA2CRM -4
ABETA40 Amyloid Beta 1-40 -4 N/A UPENNMSMSABETA2CRM -4
ABETA42 Amyloid Beta 1-42 -4 N/A UPENNMSMSABETA2CRM -4
ABETA42CRM Amyloid Beta 1-42 -4 N/A UPENNMSMSABETA2CRM -4
RID Participant roster ID -4 N/A UPENNMSMSABETA2CRM -4
VID Visit code -4 N/A UPENNMSMSABETA2CRM -4
ABETA38 Amyloid Beta 1-38 -4 N/A UPENNMSMSABETA2 -4
ABETA40 Amyloid Beta 1-40 -4 N/A UPENNMSMSABETA2 -4
ABETA42 Amyloid Beta 1-42 -4 N/A UPENNMSMSABETA2 -4
RID Participant roster ID -4 N/A UPENNMSMSABETA2 -4
VID Visit number from sample tube -4 N/A UPENNMSMSABETA2 -4
ABETA38 Amyloid Beta 1-38 -4 N/A UPENNMSMSABETA -4
ABETA40 Amyloid Beta 1-40 -4 N/A UPENNMSMSABETA -4
ABETA42 Amyloid Beta 1-42 -4 N/A UPENNMSMSABETA -4
RID Participant roster ID -4 N/A UPENNMSMSABETA -4
RID Patient number N/A N/A UPENNPLASMA UPENN Plasma Biomarker Data
LEFT_MCGG_MIDDLE_CINGULATE_GYRUS Left MCgG middle cingulate gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
LEFT_MFG_MIDDLE_FRONTAL_GYRUS Left MFG middle frontal gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
LEFT_MOG_MIDDLE_OCCIPITAL_GYRUS Left MOG middle occipital gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
LEFT_MTG_MIDDLE_TEMPORAL_GYRUS Left MTG middle temporal gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
LEFT_PALLIDUM Left Pallidum -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
RID Participant roster ID -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
RIGHT_MCGG_MIDDLE_CINGULATE_GYRUS Right MCgG middle cingulate gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
RIGHT_MFG_MIDDLE_FRONTAL_GYRUS Right MFG middle frontal gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
RIGHT_MOG_MIDDLE_OCCIPITAL_GYRUS Right MOG middle occipital gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
RIGHT_MTG_MIDDLE_TEMPORAL_GYRUS Right MTG middle temporal gyrus -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
RIGHT_PALLIDUM Right Pallidum -4 N/A UPENN_ROI_MARS Hierarchical Parcellation of MRI using multi-atlas labeling methods
CBICA_ID -4 -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
IMAGE_UID -4 -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R138 Right MCgG middle cingulate gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R139 Left MCgG middle cingulate gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R142 Right MFG middle frontal gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R143 Left MFG middle frontal gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R144 Right MOG middle occipital gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R145 Left MOG middle occipital gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R154 Right MTG middle temporal gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R155 Left MTG middle temporal gyrus -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R55 Right Pallidum -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
R56 Left Pallidum -4 N/A UPENN_ROI_MARS UPENN - Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods
CBICA_ID -4 -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
IMAGE_UID -4 -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R138 Right MCgG middle cingulate gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R139 Left MCgG middle cingulate gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R142 Right MFG middle frontal gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R143 Left MFG middle frontal gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R144 Right MOG middle occipital gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R145 Left MOG middle occipital gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R154 Right MTG middle temporal gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R155 Left MTG middle temporal gyrus -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R55 Right Pallidum -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
R56 Left Pallidum -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
RID Participant roster ID -4 N/A UPENNSBIAROI University of Pennsylvania Section of Biomedical Image Analysis (SBIA) Volumes
RID Participant roster ID -4 N/A UPENNSPARE_AD Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.
CBICA_ID Subject ID used at CBICA -4 N/A UPENNSPARE_AD Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.
IMAGE_UID N/A -4 N/A UPENNSPARE_AD Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD). C. Davatzikos. U. Penn.
RID Participant roster ID -4 N/A UPENNSPARE_MCI Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.
CBICA_ID Subject ID used at CBICA -4 N/A UPENNSPARE_MCI Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.
IMAGE_UID N/A -4 N/A UPENNSPARE_MCI Spatial Pattern of Abnormalities for Recognition of Early MCI to AD conversion (SPARE-MCI). C. Davatzikos. U. Penn.
IMAGEUID ImageUID -4 N/A UUCACIR UU PET Analysis
RID Participant roster ID -4 N/A UUCACIR UU PET Analysis
RID Participant roster ID -4 N/A UWNPSYCHSUM Crane Lab (UW) Neuropsych Summary Scores
GUSPECID -4 -4 N/A UWPLASMAEVAPOGEE University of Washington - Plasma EV Apogee
RID Participant roster ID -4 N/A UWPLASMAEVAPOGEE University of Washington - Plasma EV Apogee
UW_ASSAY_ID University of Washington Sample (Assay) ID -4 N/A UWPLASMAEVAPOGEE University of Washington - Plasma EV Apogee
VID UPENN Visit Code -4 N/A UWPLASMAEVAPOGEE University of Washington - Plasma EV Apogee
RID Participant roster ID -4 N/A ZHANG CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)
SHIPMENT Respository shipment identifier -4 N/A ZHANG CSF Hemoglobin ELISA and PS129 Luminex Assays (Zhang Lab, University of Washington)
IMAGEUID The LONI Image UID for the image reviewed. N/A N/A UCSFASLQC ASL Perfusion Raw QC
LONIUID The LONI Series UID for the image reviewed. N/A N/A UCSFASLQC ASL Perfusion Raw QC
PTID Subject Identifier N/A N/A UCSFASLQC ASL Perfusion Raw QC
QID24_17 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Brain disease that affects movement (e.g. Parkinson's, Huntington's, ALS, Motor Neuron Disease, Multiple Sclerosis) 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_16 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other dementia (e.g. Vascular dementia, Dementia with Lewy Bodies) 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_13 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Alzheimer's disease 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_10 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other, please specify: 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24 In general, would you say your health is: 1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID23_TEXT How long has it been in years since you stopped your alcohol abuse? If you still abuse alcohol please write 0. N/A N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID23 Compared to one year ago, does YOUR STUDY PARTNER tend to ask the same question over and over?  1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID24_15 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Frontotemporal Dementia 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_14 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Mild Cognitive Impairment (MCI) 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_10_TEXT What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Other, please specify: 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID22 Please answer the following questions about YOUR STUDY PARTNER, thinking about his or her ability to perform certain tasks as compared to one year ago.  In other words, try to remember how he/she was doing one year ago and indicate any change you have seen.

Do you feel YOUR STUDY PARTNER has had a significant decline in memory compared to one year ago?
 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID22 Please indicate whether you currently have or had experienced alcohol abuse in the past. 1=Yes;3=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID21_3 Select the response that best describes YOUR life.... I wish I could just run away 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly Agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID21_2 Select the response that best describes YOUR life.... I feel trapped by MY STUDY PARTNER'S condition 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly Agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID21_1 Select the response that best describes YOUR life.... I wish I were free to lead a life of my own 1=Strongly disagree (1);2=Disagree (2);3=Neither agree nor disagree (3);4=Agree (4);5=Strongly Agree (5) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID20_4 As a caregiver, do YOU feel...... I'm physically tired 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID20_5 As a caregiver, do YOU feel...... I have headaches or other pains 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID21 Have you dropped many of your activities and interests? 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID20_1 As a caregiver, do YOU feel...... I'm not getting enough sleep 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID20_2 As a caregiver, do YOU feel...... My health has suffered 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID20_3 As a caregiver, do YOU feel...... Caregiving has made me physically sick 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24_11 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Age-Related Issues 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID24 Compared to one year ago, has YOUR STUDY PARTNER been misplacing things more often? 1=Yes;2=Maybe;3=No N/A SP_INITIAL CogState Brief Battery Report
QID24_1 What is the primary condition that requires YOUR STUDY PARTNER to need your care? If YOUR STUDY PARTNER has multiple conditions, please select all that apply.... Cancer 1=Yes;=No N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID20 In general, would you say your health is: 1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID20 Have YOU ever been diagnosed with Alzheimer's disease? 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID20 Have YOU ever been diagnosed with Alzheimer's disease? 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
MATERIAL For this study the samples are serum -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
Phase ADNI Cohort ID; ADNI 1 or 2 N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
PLATE_ID Plate bar code number from which the sample was injected -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
PLATFORM_ID BILEACID: Biocrates Bile Acid Kit -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
RID Participant roster ID -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
Run_Number Generated by the Biocrates MetIDQ software for every plate indicating the run number for a particular plate. For this study, all plates were injected only once. Therefore, all Run Numbers are 1. N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
SAMPLE_VOLUME The volume of sample injected in microliters -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
SPECIES Species of sample -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
SUBJECT_FLAG A flag shows whether a sample were excluded during preprocessing steps; 0: sample were not excluded. 1: sample were excluded -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TCA Taurocholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TCA_LOGTRANSFORMFLAG Flag showing whether Taurocholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TCDCA Taurochenodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TCDCA_LOGTRANSFORMFLAG Flag showing whether Taurochenodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TDCA Taurodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TDCA/CA TDCA:CA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
TDCA/CA_LogTransformFlag Flag showing whether TDCA:CA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
TDCA/DCA TDCA:DCA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
TDCA/DCA_LogTransformFlag Flag showing whether TDCA:DCA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
TDCA_LOGTRANSFORMFLAG Flag showing whether Taurodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TLCA Taurolithocholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TLCA/CDCA TLCA:CDCA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
TLCA/CDCA_LogTransformFlag Flag showing whether TLCA:CDCA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
TLCA_LOGTRANSFORMFLAG Flag showing whether Taurolithocholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TMCA_A_B -4 -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TMCA_A_B_LOGTRANSFORMFLAG -4 -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TUDCA Tauroursodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TUDCA_LOGTRANSFORMFLAG Flag showing whether Tauroursodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
UDCA Ursodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
UDCA_LOGTRANSFORMFLAG Flag showing whether Ursodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
Visit_ID Visit ID for the subjects. Used along with RID to merge data with clinical variables N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
WELL_POSITION Well number in the 96-well plate from which the sample was injected -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
CA_CDCA CA:CDCA ratio -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
CA_CDCA_LOGTRANSFORMFLAG Flag showing whether CA:CDCA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
DCA_CA DCA:CA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
DCA_CA_LOGTRANSFORMFLAG Flag showing whether DCA:CA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA_CA GDCA:CA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA_CA_LOGTRANSFORMFLAG Flag showing whether GDCA:CA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA_DCA GDCA:DCA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA_DCA_LOGTRANSFORMFLAG Flag showing whether GDCA:DCA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GLCA_CDCA GLCA:CDCA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GLCA_CDCA_LOGTRANSFORMFLAG Flag showing whether GLCA:CDCA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TDCA_CA_LOGTRANSFORMFLAG Flag showing whether TDCA:CA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TDCA_DCA TDCA:DCA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TDCA_DCA_LOGTRANSFORMFLAG Flag showing whether TDCA:DCA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TLCA_CDCA TLCA:CDCA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TLCA_CDCA_LOGTRANSFORMFLAG Flag showing whether TLCA:CDCA ratio values were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
VISCODE Visit code -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
RID Participant roster ID -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_CAUDALMIDDLEFRONTAL ctx-lh-caudalmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SIZE ctx-lh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_MIDDLETEMPORAL ctx-lh-middletemporal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_MIDDLETEMPORAL_SIZE ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL ctx-lh-rostralmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SIZE ctx-lh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_CAUDALMIDDLEFRONTAL ctx-rh-caudalmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SIZE ctx-rh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_MIDDLETEMPORAL ctx-rh-middletemporal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_MIDDLETEMPORAL_SIZE ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL ctx-rh-rostralmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SIZE ctx-rh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
SUMMARYSUVR_COMPOSITE_REFNORM_0.79CUTOFF Amyloid positivity determined by applying a cutoff value of 0.79 to the summary florbetapir cortical SUVR normalized by composite ref region -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
SUMMARYSUVR_WHOLECEREBNORM_1.11CUTOFF Amyloid positivity determined by applying a cutoff value of 1.11 to the summary florbetapir cortical SUVR normalized by whole cerebellum -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_ANTERIOR cc-mid-anterior -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_ANTERIOR_SIZE cc-mid-anterior ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_POSTERIOR cc-mid-posterior -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_POSTERIOR_SIZE cc-mid-posterior ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_CHOROID_PLEXUS left-choroid-plexus -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_CHOROID_PLEXUS_SIZE left-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_PALLIDUM left-pallidum -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_PALLIDUM_SIZE left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_CHOROID_PLEXUS right-choroid-plexus -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_CHOROID_PLEXUS_SIZE right-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_PALLIDUM right-pallidum -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_PALLIDUM_SIZE right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_ANTERIOR_SUVR cc-mid-anterior -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_ANTERIOR_VOLUME cc-mid-anterior ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_POSTERIOR_SUVR cc-mid-posterior -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CC_MID_POSTERIOR_VOLUME cc-mid-posterior ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CEREBELLUMGREYMATTER_SUVR Reference region - florbetapir mean of cerebellar grey matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CEREBELLUMGREYMATTER_VOLUME Reference region - volume of cerebellar grey matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
COMPOSITE_REF_SUVR Reference region - florbetapir mean of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM). Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SUVR ctx-lh-caudalmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME ctx-lh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_MIDDLETEMPORAL_SUVR ctx-lh-middletemporal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_MIDDLETEMPORAL_VOLUME ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR ctx-lh-rostralmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-lh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SUVR ctx-rh-caudalmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME ctx-rh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_MIDDLETEMPORAL_SUVR ctx-rh-middletemporal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_MIDDLETEMPORAL_VOLUME ctx-rh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR ctx-rh-rostralmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-rh-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
ERODED_SUBCORTICALWM_SUVR Reference region - florbetapir mean of eroded subcortical white matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_CHOROID_PLEXUS_SUVR left-choroid-plexus -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_CHOROID_PLEXUS_VOLUME left-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_PALLIDUM_SUVR left-pallidum -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
LEFT_PALLIDUM_VOLUME left-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_CHOROID_PLEXUS_SUVR right-choroid-plexus -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_CHOROID_PLEXUS_VOLUME right-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_PALLIDUM_SUVR right-pallidum -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
RIGHT_PALLIDUM_VOLUME right-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
WHOLECEREBELLUM_SUVR Reference region - florbetapir mean of whole cerebellum. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
WHOLECEREBELLUM_VOLUME Reference region - volume of whole cerebellum. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
BRAINSTEM_SUVR Reference region - florbetapir mean of brainstem. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
SUMMARYSUVR_COMPOSITE_REFNORM_0.78CUTOFF Amyloid positivity determined by applying a cutoff value of 0.78 to the summary florbetapir cortical SUVR normalized by composite ref region -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
ST4AVG Mean CBF value for FreeSurfer ROI: CC_Mid_Anterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST4CT Count of CBF voxels in FreeSurfer ROI: CC_Mid_Anterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST4MAX Max CBF value for FreeSurfer ROI: CC_Mid_Anterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST4MD Median CBF value for FreeSurfer ROI: CC_Mid_Anterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST4MIN Min CBF value for FreeSurfer ROI: CC_Mid_Anterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST4SD Standard Deviation of Mean CBF value for FreeSurfer ROI: CC_Mid_Anterior N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST42SD Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST42MIN Min CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST42MD Median CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST42MAX Max CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST42CT Count of CBF voxels in FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST42AVG Mean CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST40SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST40MIN Min CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST40MD Median CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST40MAX Max CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST40AVG Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST40CT Count of CBF voxels in FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST21SD Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST21MIN Min CBF value for FreeSurfer ROI: Left-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST21MD Median CBF value for FreeSurfer ROI: Left-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST21MAX Max CBF value for FreeSurfer ROI: Left-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST21CT Count of CBF voxels in FreeSurfer ROI: Left-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST21AVG Mean CBF value for FreeSurfer ROI: Left-choroid-plexus N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST15SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST15MIN Min CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST15MD Median CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST15MAX Max CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST15CT Count of CBF voxels in FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST15AVG Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST114SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST114MIN Min CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST114MD Median CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST114MAX Max CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST114CT Count of CBF voxels in FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST114AVG Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST101SD Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST101MIN Min CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST101MD Median CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST101MAX Max CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST101AVG Mean CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST101CT Count of CBF voxels in FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
LONIUID N/A N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
RID Participant roster ID N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
IMAGEUID N/A N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST99SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST99MAX Max CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST99MIN Min CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST99CT Count of CBF voxels in FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST99AVG Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST74SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST74MIN Min CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST74MAX Max CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST74CT Count of CBF voxels in FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST74AVG Mean CBF value for FreeSurfer ROI: ctx-rh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST55SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST55MIN Min CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST55MAX Max CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST55CT Count of CBF voxels in FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST55AVG Mean CBF value for FreeSurfer ROI: ctx-lh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST42SD Standard Deviation of Mean CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST42MIN Min CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST42MAX Max CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST42CT Count of CBF voxels in FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST42AVG Mean CBF value for FreeSurfer ROI: Left-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST40MIN Min CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST40SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST40MAX Max CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST40CT Count of CBF voxels in FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST40AVG Mean CBF value for FreeSurfer ROI: ctx-lh-middletemporal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_ADL Brain Health Registry SP ADL
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_FAQ Brain Health Registry SP FAQ
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_RELATIONSHIP Brain Health Registry SP RELATIONSHIP
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A BHR_SP_STUDY_CONFIRMATION Brain Health Registry SP STUDY CONFIRMATION
AboutPTID Code obtained from CBB CRF report of subject about whom the study partner provided responses N/A N/A SP_INITIAL CogState Brief Battery Report
PTID Subject code obtained from the CogState Brief Battery CRF report N/A N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
PTID Subject code obtained from the CogState Brief Battery CRF report N/A N/A BHR_EVERYDAY_COGNITION Brain Health Registry EVERYDAY COGNITION
PTID Subject code obtained from the CogState Brief Battery CRF report N/A N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
PTID Subject code obtained from the CogState Brief Battery CRF report N/A N/A BHR_MEMTRAX Brain Health Registry MEMTRAX
QID1 Are you concerned that you have a memory problem? 1=Yes;2=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID1 Do you currently serve as the study partner in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study? 1=Yes;2=No N/A BHR_SP_STUDY_CONFIRMATION Brain Health Registry SP STUDY CONFIRMATION
QID10 Compared to six months ago, are you pursuing fewer or more activities and interests? 1=Much fewer;2=Fewer;3=About the same;4=More;5=Much more N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID10 Has YOUR STUDY PARTNER ever been diagnosed with Alzheimer's disease? 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID10 Has YOUR STUDY PARTNER ever been diagnosed with Alzheimer's disease? 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
QID11 Are you concerned that YOU have a memory problem? 1=Yes;2=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID11 Are you concerned that YOU have a memory problem? 1=Yes;2=No N/A SP_INITIAL CogState Brief Battery Report
QID12 Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say you experienced: 1=A lot of stress;3=A moderate amount of stress;4=Relatively little stress;5=Almost no stress at all N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID12 Do YOU have trouble remembering if YOU have already told someone something? 1=Yes;2=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID12 Do YOU have trouble remembering if YOU have already told someone something? 1=Yes;2=No N/A SP_INITIAL CogState Brief Battery Report
QID13 Are you the primary caregiver for YOUR STUDY PARTNER, who needs extra assistance due to a disability, condition, or illness? We define a primary caregiver as the person who is primarily responsible for helping make medical care decisions, is emotionally invested in the person's care, and provides help with daily activities (almost daily). Daily caregiving activities may include helping with medical or therapeutic treatment, preparing meal, and/or helping with dressing and/or bathing. Caregivers may be caring for a loved with dementia, or be the parent to a child with development delays or burdensome health conditions, for example. 1=Yes, I am a caregiver;2=No, I am not a caregiver;3=I am not a caregiver based on this definition, but I do help someone with age-related issues N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID13 Compared to 10 years ago, would you say that there has been a change in YOUR memory? 1=Yes;2=No N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID13 Compared to 10 years ago, would you say that there has been a change in YOUR memory? 1=Yes;2=No N/A SP_INITIAL CogState Brief Battery Report
QID14 In general, would you say YOUR health is: 1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID14 In general, would you say YOUR health is: 1=Excellent;2=Very Good;3=Good;4=Fair;5=Poor N/A SP_INITIAL CogState Brief Battery Report
QID15 Compared to one year ago, how would you rate YOUR health in general now? 1=Much Better;2=Better;3=Same;4=Worse;5=Much Worse N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID15 Compared to one year ago, how would you rate YOUR health in general now? 1=Much Better;2=Better;3=Same;4=Worse;5=Much Worse N/A SP_INITIAL CogState Brief Battery Report
QID15_1 Are you currently taking any of the following types of medications? (Select all that apply)... Anti-depressant medication 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID15_2 Are you currently taking any of the following types of medications? (Select all that apply)... Anti-anxiety medication 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16 Over the last two months, how often have YOU been bothered by having little interest or pleasure in doing things? 1=Not at all;2=Several days;3=More than half the days;4=Nearly every day N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID16 Over the last two months, how often have YOU been bothered by having little interest or pleasure in doing things? 1=Not at all;2=Several days;3=More than half the days;4=Nearly every day N/A SP_INITIAL CogState Brief Battery Report
QID16_1 Are you currently taking any of the following medications? (Select all that apply)... Donepezil (Aricept) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_10 Are you currently taking any of the following medications? (Select all that apply)... Aripiprazole (Abilify) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_2 Are you currently taking any of the following medications? (Select all that apply)... Tacrine (Cognex) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_3 Are you currently taking any of the following medications? (Select all that apply)... Rivastigmine (Exelon) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_4 Are you currently taking any of the following medications? (Select all that apply)... Memantine (Namenda) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_5 Are you currently taking any of the following medications? (Select all that apply)... Galantamine (Razadyne) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_6 Are you currently taking any of the following medications? (Select all that apply)... Risperidone (Risperdal) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_7 Are you currently taking any of the following medications? (Select all that apply)... Paliperidone (Invega) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_8 Are you currently taking any of the following medications? (Select all that apply)... Olanzapine (Zyprexa) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID16_9 Are you currently taking any of the following medications? (Select all that apply)... Quetiapine (Seroquel) 1=Yes;=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID17 Over the last two months, how often have YOU been bothered by feeling down, depressed, or hopeless? 1=Not at all;2=Several days;3=More than half the days;4=Nearly every day N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID17 Over the last two months, how often have YOU been bothered by feeling down, depressed, or hopeless? 1=Not at all;2=Several days;3=More than half the days;4=Nearly every day N/A SP_INITIAL CogState Brief Battery Report
QID18 Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say YOU experienced: 1=A lot of stress;2=A moderate amount of stress;3=Relatively little stress;4=Almost not stress at all N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID18 Stress means a situation in which a person feels tense, restless, nervous or anxious or is unable to sleep at night because his/her mind is troubled all the time. During the past 12 months, would you say YOU experienced: 1=A lot of stress;2=A moderate amount of stress;3=Relatively little stress;4=Almost not stress at all N/A SP_INITIAL CogState Brief Battery Report
QID18_1 Are you currently taking any of the following types of medications? (Select all that apply)... Anti-depressant medication 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID18_2 Are you currently taking any of the following types of medications? (Select all that apply)... Anti-anxiety medication 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19 Have YOU ever been diagnosed with Mild Cognitive Impairment (MCI). 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID19 Have YOU ever been diagnosed with Mild Cognitive Impairment (MCI). 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
QID19_1 Are you currently taking any of the following medications? (Select all that apply)... Donepezil (Aricept) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_1 As a caregiver do YOU feel...... That because of the time you spend caregiving that you don't have enough time for yourself? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID19_10 Are you currently taking any of the following medications? (Select all that apply)... Aripiprazole (Abilify) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_2 Are you currently taking any of the following medications? (Select all that apply)... Tacrine (Cognex) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_2 As a caregiver do YOU feel...... Stressed between caregiving and trying to meet other responsibilities (work/ family)? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID19_3 Are you currently taking any of the following medications? (Select all that apply)... Rivastigmine (Exelon) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_3 As a caregiver do YOU feel...... Angry when you are around YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID19_4 Are you currently taking any of the following medications? (Select all that apply)... Memantine (Namenda) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_4 As a caregiver do YOU feel...... That YOUR STUDY PARTNER currently affects your relationship with family members in a negative way? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID19_5 Are you currently taking any of the following medications? (Select all that apply)... Galantamine (Razadyne) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_5 As a caregiver do YOU feel...... Strained when you are around YOUR STUDY PARTNER? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID19_6 Are you currently taking any of the following medications? (Select all that apply)... Risperidone (Risperdal) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_6 As a caregiver do YOU feel...... That your health has suffered because of caregiving? 0=Never (0);1=Rarely (1);2=Sometimes (2);3=Quite Frequently (3);4=Nearly Always (4) N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
QID19_7 Are you currently taking any of the following medications? (Select all that apply)... Paliperidone (Invega) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_8 Are you currently taking any of the following medications? (Select all that apply)... Olanzapine (Zyprexa) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID19_9 Are you currently taking any of the following medications? (Select all that apply)... Quetiapine (Seroquel) 1=Yes;=No N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID2 Are you concerned that you have a memory problem? 1=Yes;2=No N/A BHR_BASELINE_QUESTIONNAIRE Brain Health Registry BASELINE QUESTIONNAIRE
QID2 Compared to six months ago, how would you rate your memory in general? 1=Much Better;2=Better;3=About the same;4=Worse;5=Much Worse N/A BHR_LONGITUDINAL_QUESTIONNAIRE Brain Health Registry LONGITUDINAL QUESTIONNAIRE
QID2 Are you concerned that YOUR STUDY PARTNER has a memory problem? 1=Yes;2=No;3=I don't know N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
QID2 Are you concerned that YOUR STUDY PARTNER has a memory problem? 1=Yes;2=No;3=I don't know N/A SP_INITIAL CogState Brief Battery Report
GUDCA Glycoursodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GUDCA_LOGTRANSFORMFLAG Flag showing whether Glycoursodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA/DCA_LogTransformFlag Flag showing whether GDCA:DCA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
GDCA_LOGTRANSFORMFLAG Flag showing whether Glycodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GLCA Glycolithocholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GLCA/CDCA GLCA:CDCA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
GLCA/CDCA_LogTransformFlag Flag showing whether GLCA:CDCA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
GLCA_LOGTRANSFORMFLAG Flag showing whether Glycolithocholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
ORIGPROT Original study protocol -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
TDCA_CA TDCA:CA ratio [unitless] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
DCA Deoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
DCA/CA DCA:CA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
DCA/CA_LogTransformFlag Flag showing whether DCA:CA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
DCA_LOGTRANSFORMFLAG Flag showing whether Deoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GCA Glycocholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GCA_LOGTRANSFORMFLAG Flag showing whether Glycocholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GCDCA Glycochenodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GCDCA_LOGTRANSFORMFLAG Flag showing whether Glycochenodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA Glycodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
GDCA/CA GDCA:CA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
GDCA/CA_LogTransformFlag Flag showing whether GDCA:CA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
GDCA/DCA GDCA:DCA ratio [unitless] N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
CDCA_LOGTRANSFORMFLAG Flag showing whether Chenodeoxycholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
CDCA Chenodeoxycholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
CA_LOGTRANSFORMFLAG Flag showing whether Cholic acid levels were log2 transformed -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
CA Cholic acid [M] -4 N/A ADMCBAPP AD Metabolomics Consortium Bile Acids - Post-processed
CA/CDCA CA:CDCA ratio N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
CA/CDCA_LogTransformFlag Flag showing whether CA:CDCA ratio values were log2 transformed N/A N/A ADMCBAPP AD Metabolomics Consortium Bile Acids
SCANDATE Scan acquisition date N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
DIAN_ID -4 N/A N/A ADNI_DIAN_COMPARISON The DIAN-ADNI Comparison Study
RID Participant roster ID N/A N/A ADNI_DIAN_COMPARISON The DIAN-ADNI Comparison Study
AVID_STAGE_4_ANTERIOR_CINGULATE_SUVR anterior cingulate normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
AVID_STAGE_4_FRONTAL_MEDIAL_ORBITAL_SUVR medial orbital frontal normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
AVID_STAGE_4_GLOBAL_SUVR Average six region SUVr normalized by entire cerebellmu for florbetapir (AV-45) images calcualted using AVID semi-automated quantification. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
AVID_STAGE_4_PARIETAL_SUVR parietal normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
AVID_STAGE_4_POSTERIOR_CINGULATE_SUVR s -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
AVID_STAGE_4_PRECUNEUS_SUVR precuneus normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
AVID_STAGE_4_TEMPORAL_SUVR lateral temporal normalized to entire cerebellum using Avid semi-automated method. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
DIAGRP2 clinical diagnosis close to the AV45 scan available during the data download in August 2012 -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
EXAMDATE -4 -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
RID Participant roster ID -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_ANTERIOR_CINGULATE_SUVR anterior cingulate normalized to entire cerebellum in sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_FRONTAL_SUVR medial orbital frontal normalized to entire cerebellum in sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_GLOBAL_SUVR Average six region SUVr normalized by entire cerebellum for flroetbapir (AV-45) images calcualted using sPAP software. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_PARIETAL_SUVR parietal region normalized to entire cerebellum is sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_POSTERIOR_CINGULATE_SUVR posterior cingulate normalized to entire cerebellum is sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_PRECUNEUS_SUVR precuneus region normalized to entire cerebellum is sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
SPAP_TEMPORAL_SUVR lateral temporal normalized to entire cerebellum in sPAP. Refer to sPAP_Avid_Florbetapir_Analysis_Methods PDF on LONI for details -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
VISCODE Visit code -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
VISCODE2 Translated visit code -4 N/A SPAP_AVID_FLORBETAPIR sPAP Avid ADNI Florbetapir summaries
RID Participant roster ID -4 N/A ADSP_PHC_COGN ADSP Phenotype Harmonization Consortium (PHC) - Composite Cognitive Scores
IMAGEUID LONI Image ID -4 N/A MAYOADIRL_MRI_FMRI Jack Lab - Default Mode Network connectivity
RID Participant roster ID -4 N/A MAYOADIRL_MRI_FMRI Jack Lab - Default Mode Network connectivity
RID Participant roster ID The 4 digit roster ID (RID) should be used to merge data N/A N/A MAYOADIRL_MRI_FMRI_NFQ Jack Lab - fMRI Network Failure Quotient (NFQ)
LONI_SERIES LONI Series ID -4 N/A MAYOADIRL_MRI_ADNI3 Jack Lab - ADNI GO/2/3 MRI QC
RID Participant roster ID -4 N/A MAYOADIRL_MRI_IMAGEQC Jack Lab - ADNI GO/2 MRI QC
LONI_STUDY LONI Study ID -4 N/A MAYOADIRL_MRI_IMAGEQC Jack Lab - ADNI GO/2 MRI QC
LONI_SERIES LONI Series ID -4 N/A MAYOADIRL_MRI_IMAGEQC Jack Lab - ADNI GO/2 MRI QC
LONI_IMG_ID LONI Image ID N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
LONI_SERIES LONI Series ID N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
LONI_STUDY LONI Study ID N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
RID The 4 digit roster ID (RID) should be used to merge data N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
SERIES_UID Individual Dicom Image String N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
UNIQUEID Unique ID of MCH N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
LONIUID LONI Unique ID -4 N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONIUIDBL LONI Unique ID Baseline Scan -4 N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
RID Participant roster ID The 4 digit roster ID (RID) should be used to merge data N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONI_IMAGEID LONI Image ID N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONI_IMAGEID_BL LONI Image ID baseline N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONI_SERIESID LONI Series ID N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONI_SERIESID_BL LONI Series ID baseline N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONI_STUDYID LONI Study ID N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
LONI_STUDYID_BL LONI Study ID baseline N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
SERIESINSTANCEUID DICOM SeriesInstanceUID N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
SERIESINSTANCEUID_BL DICOM SeriesInstanceUID baseline N/A N/A MAYOADIRL_MRI_TBMSYN Jack Lab - TBM-SyN Based Scores
C181N9 C18:1 n-9 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C181N7 C18:1 n-7 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C180 C18:0 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C161N7 C16:1 n-7 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C160 C16:0 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
C140 C14:0 (% of total fatty acids) -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
BOX_NAME Box Name -4 N/A AGROCAMPUS Institut Agro-ecole interne Agrocampus Ouest lipids in red blood cells
ST15SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST15MIN Min CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST15MAX Max CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST15CT Count of CBF voxels in FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST15AVG Mean CBF value for FreeSurfer ROI: ctx-lh-caudalmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST114SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST114MIN Min CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST114MAX Max CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST114CT Count of CBF voxels in FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST114AVG Mean CBF value for FreeSurfer ROI: ctx-rh-rostralmiddlefrontal N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST101SD Standard Deviation of Mean CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST101MIN Min CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST101MAX Max CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST101CT Count of CBF voxels in FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST101AVG Mean CBF value for FreeSurfer ROI: Right-Pallidum N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
RID Participant roster ID N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
LONIUID N/A N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
IMAGEUID N/A N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
FSVENTQC QC rating of the ventricles. Fail affects the following regions: LeftLateralVentricle (ST37); RightLateralVentricle (ST96); LeftInferiorLateralVentricle (ST30); RightInferiorLateralVentricle (ST89); ThirdVentricle (ST127); FourthVentricle (ST9); FifthVentrical (ST8); LeftChoroidPlexus (ST21); RightChoroidPlexus (ST80) N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
FSTEMPQC QC rating of temporal lobe. Fail affects the following regions: LeftTemporalPole (ST60); RightTemporalPole (ST119); LeftFusiform (ST26); RightFusiform (ST85); LeftSuperiorTemporal (ST58); RightSuperiorTemporal (ST117); LeftInferiorTemporal (ST32); RightInferiorTemporal (ST91); LeftMiddleTemporal (ST40); RightMiddleTemporal (ST99) N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
FSFRONTQC QC rating of the frontal lobe. Fail affects the following regions: LeftFrontalPole (ST25); RightFrontalPole (ST84); LeftPrecentral (ST51); RightPrecentral (ST110); LeftSuperiorFrontal (ST56); RightSuperiorFrontal (ST115); LeftCaudalMiddleFrontal (ST15); RightCaudalMiddleFrontal (ST74); LeftRostralMiddleFrontal (ST55); RightRostralMiddleFrontal (ST114); LeftMedialOrbitofrontal (ST39); RightMedialOrbitofrontal (ST98) N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
FSBGQC QC rating of the basal ganglia. Fail affects the following regions: LeftPutamen (ST53); RightPutamen (ST112); LeftCaudate (ST16); RightCaudate (ST75); LeftPallidum (ST42); RightPallidum (ST101) N/A N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
CBFQC Checks the qCBF overlaid on the PD image 0=Fail;1=Pass N/A UCSFASLFSCBF ASL Perfusion CBF by FreeSurfer ROI
ST99AVG Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST99CT Count of CBF voxels in FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST99MAX Max CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST99MD Median CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST99MIN Min CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
ST99SD Standard Deviation of Mean CBF value for FreeSurfer ROI: ctx-rh-middletemporal N/A N/A UCSFASLFS ASL Perfusion CBF by FreeSurfer ROI
RID Participant roster ID ADNI code N/A UCD_ADNI2_WMH Univerity of California Davis White Matter Hyperintensity Volumes (ADNI2)
RID Participant roster ID -4 N/A UCD_WMH UCD - White Matter Hyperintensity Volumes
CEREBRUM_TCC Total Cerebrum Cerebrospinal Fluid Volume -4 N/A UCD_WMH UCD - White Matter Hyperintensity Volumes
TOTAL_CSF Total Brain Cerebrospinal Fluid Volume -4 N/A UCD_WMH UCD - White Matter Hyperintensity Volumes
CTX_LH_MIDDLETEMPORAL_VOLUME ctx-lh-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_LH_MIDDLETEMPORAL_SUVR ctx-lh-middletemporal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME ctx-lh-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SUVR ctx-lh-caudalmiddlefrontal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
COMPOSITE_REF_SUVR Reference region - florbetaben mean of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM). Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CEREBELLUMGREYMATTER_VOLUME Reference region - volume of cerebellar grey matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CEREBELLUMGREYMATTER_SUVR Reference region - florbetaben mean of cerebellar grey matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CC_MID_POSTERIOR_VOLUME cc-mid-posterior ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CC_MID_POSTERIOR_SUVR cc-mid-posterior -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CC_MID_ANTERIOR_VOLUME cc-mid-anterior ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CC_MID_ANTERIOR_SUVR cc-mid-anterior -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
BRAINSTEM_SUVR Reference region - florbetaben mean of brainstem. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
ID Record ID N/A N/A MAYOADIRL_MRI_MCH Jack Lab - ADNI MRI MCH
LONI_STUDY LONI Study ID -4 N/A MAYOADIRL_MRI_ADNI3 Jack Lab - ADNI GO/2/3 MRI QC
RID Participant roster ID -4 N/A MAYOADIRL_MRI_ADNI3 Jack Lab - ADNI GO/2/3 MRI QC
SERIESINSTANCEUID -4 -4 N/A MAYOADIRL_MRI_ADNI3 Jack Lab - ADNI GO/2/3 MRI QC
STUDYINSTANCEUID -4 -4 N/A MAYOADIRL_MRI_ADNI3 Jack Lab - ADNI GO/2/3 MRI QC
PTID Subject Identifier N/A N/A MAYOADIRL_MRI_ADNI3 Jack Lab - ADNI GO/2/3 MRI QC
TG_58_8_NL_22_6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_17_0_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_17_0_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_16_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_15_0_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_15_0_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_14_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_14_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_14_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_13_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ACYLCARNITINE_12_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
AboutRID Participant roster ID -4 N/A BHR_SP_STUDY_CONFIRMATION Brain Health Registry SP STUDY CONFIRMATION
AboutRID Participant roster ID -4 N/A BHR_SP_RELATIONSHIP Brain Health Registry SP RELATIONSHIP
AboutRID Participant roster ID -4 N/A BHR_SP_INITIAL Brain Health Registry SP INITIAL
AboutRID Participant roster ID -4 N/A BHR_SP_FAQ Brain Health Registry SP FAQ
AboutRID Participant roster ID -4 N/A BHR_SP_EVERYDAY_COGNITION Brain Health Registry SP EVERYDAY COGNITION
AboutRID Participant roster ID -4 N/A BHR_SP_CAREGIVER_BURDEN Brain Health Registry SP CAREGIVER BURDEN
AboutRID Participant roster ID -4 N/A BHR_SP_ADL Brain Health Registry SP ADL
LPC_15_MHDA_SN1__LPC_17_0_SN2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_1_SN1_A__LPC_17_1_SN2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_17_1__SN2_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_18_3_SN1_A__LPC_18_3_SN2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_19_0_SN1_A__LPC_19_0_SN2_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
LPC_22_5_SN1_N3__LPC_22_5_SN2_N6_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC_18_0_22_5_N3__PC_20_1_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC__39_5_A_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PC__39_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_15_MHDA_18_1__PI_17_0_18_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_15_MHDA_18_2__PI_17_0_18_2_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI_15_MHDA_20_4__PI_17_0_20_4_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
PI__38_5_B_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SAMPLE_ID -4 -4 N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D16_1_23_0__SM_D17_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_14_0__SM_D16_1_16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_17_0__SM_D17_1_18_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_18_0__SM_D16_1_20_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_20_0__SM_D16_1_22_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_22_0__SM_D16_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SM_D18_1_23_0__SM_D17_1_24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE__D18_1__16_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE__D18_1__16_0_OH__ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE__D18_1__24_0_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE__D18_1__24_0_OH__ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE__D18_1__24_1_ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
SULFATIDE__D18_1__24_1_OH__ Measured Lipid N/A N/A LIPIDOMICSDATABASE_MEIKLELAB ADMC Lipidomics Meikle Lab Baseline Data Matrix [ADNI1]
ID Record ID "crfname","ApoE Genotyping - Results","indexes","adni_apoeres_idx=RID,VISCODE,ENTRY","notnullcols","ID,RID,SITEID,VISCODE,ENTRY,USERID,USERDATE" N/A APOEGO2 ADNI GO & 2 APOE Genotypes
RID Participant roster ID N/A N/A APOEGO2 ADNI GO & 2 APOE Genotypes
SITEID Site ID N/A N/A APOEGO2 ADNI GO & 2 APOE Genotypes
USERID N/A N/A N/A APOEGO2 ADNI GO & 2 APOE Genotypes
USERID2 N/A N/A N/A APOEGO2 ADNI GO & 2 APOE Genotypes
SUBJID Subject ID used in NIAGADS for the whole genome sequencing data files generated by the AD Sequencing Project. -4 N/A ADSP_PHC_BIOMARKER ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores
RID Participant roster ID -4 N/A ADSP_PHC_BIOMARKER ADSP Phenotype Harmonization Consortium (PHC) - Composite Biomarker Scores
RID Participant roster ID -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
VISCODE Record time of visit -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
VISCODE2 Record time of visit by month -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
EXAMDATE Record time of visit by date -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
SPECIMEN_TYPE Specimen sample type - plasma -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
ANALYTE Biomarker analyte tested -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
COUNT Sample count -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
CONCENTRATION Concentration of biomarker in pg/ml -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
MM_NUMBER For samples tested in duplicate sample test 1 or 2 -4 N/A FUJIREBIOABETAPLASMA Plasma Amyloid Beta (1-42/1-40) Ratio Biomarker Feasibility Study - Fujirebio Lumipulse
CENTILOIDS Summary florbetapir cortical SUVR normalized by whole cerebellum and transformed to Centiloids (CL=188.22xSUMMARY_SUVR-189.16). All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CHOROID_PLEXUS_SUVR bilateral-choroid-plexus -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CHOROID_PLEXUS_VOLUME bilateral-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
COMPOSITE_REF_VOLUME Reference region - volume of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM). Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_CAUDALMIDDLEFRONTAL_SUVR ctx-bilateral-caudalmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_CAUDALMIDDLEFRONTAL_VOLUME ctx-bilateral-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_MIDDLETEMPORAL_SUVR ctx-bilateral-middletemporal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_MIDDLETEMPORAL_VOLUME ctx-bilateral-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_ROSTRALMIDDLEFRONTAL_SUVR ctx-bilateral-rostralmiddlefrontal -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CTX_ROSTRALMIDDLEFRONTAL_VOLUME ctx-bilateral-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
ERODED_SUBCORTICALWM_VOLUME Reference region - volume of eroded subcortical white matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
PALLIDUM_SUVR bilateral-pallidum -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
PALLIDUM_VOLUME bilateral-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
SUMMARY_SUVR Summary florbetapir cortical SUVR normalized by whole cerebellum. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYAV45_8MM UC Berkeley - AV45 analysis
CHOROID_PLEXUS_SUVR bilateral-choroid-plexus -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CHOROID_PLEXUS_VOLUME bilateral-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_CAUDALMIDDLEFRONTAL_SUVR ctx-bilateral-caudalmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_CAUDALMIDDLEFRONTAL_VOLUME ctx-bilateral-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_MIDDLETEMPORAL_SUVR ctx-bilateral-middletemporal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_MIDDLETEMPORAL_VOLUME ctx-bilateral-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_ROSTRALMIDDLEFRONTAL_SUVR ctx-bilateral-rostralmiddlefrontal -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_ROSTRALMIDDLEFRONTAL_VOLUME ctx-bilateral-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
PALLIDUM_SUVR bilateral-pallidum -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
PALLIDUM_VOLUME bilateral-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_8MM UC Berkeley - AV1451 analysis
CTX_MIDDLETEMPORAL_SUVR ctx-bilateral-middletemporal -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CTX_MIDDLETEMPORAL_VOLUME ctx-bilateral-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
MIDDLEFR_SUVR Bilateral middle frontal ROI -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
MIDDLEFR_VOLUME Bilateral middle frontal ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
PALLIDUM_SUVR Bilateral-pallidum -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
PALLIDUM_VOLUME Bilateral-pallidum ROI size in mm^3 -4 N/A UCBERKELEYAV1451_PVC_8MM UC Berkeley - AV1451 PVC analysis
CENTILOIDS Summary florbetaben cortical SUVR normalized by whole cerebellum and transformed to Centiloids Summary florbetapir cortical SUVR normalized by whole cerebellum and transformed to Centiloids (CL=157.15xSUMMARY_SUVR-151.87). All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CHOROID_PLEXUS_SUVR bilateral-choroid-plexus -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CHOROID_PLEXUS_VOLUME bilateral-choroid-plexus ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
COMPOSITE_REF_VOLUME Reference region - volume of composite ref region (avg of whole cerebellum, pons/brainstem, eroded WM). Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_CAUDALMIDDLEFRONTAL_SUVR ctx-bilateral-caudalmiddlefrontal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_CAUDALMIDDLEFRONTAL_VOLUME ctx-bilateral-caudalmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_MIDDLETEMPORAL_SUVR ctx-bilateral-middletemporal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_MIDDLETEMPORAL_VOLUME ctx-bilateral-middletemporal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_ROSTRALMIDDLEFRONTAL_SUVR ctx-bilateral-rostralmiddlefrontal -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
CTX_ROSTRALMIDDLEFRONTAL_VOLUME ctx-bilateral-rostralmiddlefrontal ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
ERODED_SUBCORTICALWM_VOLUME Reference region - volume of eroded subcortical white matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
PALLIDUM_SUVR bilateral-pallidum -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
PALLIDUM_VOLUME bilateral-pallidum ROI size in mm^3 -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
SUMMARY_SUVR Summary florbetaben cortical SUVR normalized by whole cerebellum. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. -4 N/A UCBERKELEYFBB_8MM UC Berkeley - FBB analysis
BioFluid_Type Biofluid being assayed, either CSF or Plasma N/A N/A UPENNMIRNA UPENN CSF Plasma miRNA Data
Cq_Conf Quality flag: indicates that the calculated confidence for the Cq (Ct or Crt) value of the well is less than the minimum value defined in the analysis, typical cutoff is 0.8. Samples falling below the 0.8 threshold are flagged as low confidence. N/A N/A UPENNMIRNA UPENN CSF Plasma miRNA Data
Experiment_Name Biofluid assayed, internal PCR ID and Custom Taqman Low Density Array Card Barcode N/A N/A UPENNMIRNA UPENN CSF Plasma miRNA Data
Global_Specimen_ID_x ID of donor participant associated with a specific biofluid (CSF or Plasma) N/A N/A UPENNMIRNA UPENN CSF Plasma miRNA Data
RID ADNI ID N/A N/A UPENNMIRNA UPENN CSF Plasma miRNA Data
Sample_ID ID of donor participant N/A N/A UPENNMIRNA UPENN CSF Plasma miRNA Data
FLUID Type of fluid N/A N/A UPENNBIOMK_MASTER UPENN CSF Biomarkers
1-Met-His 1-Methylhistidine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
RID Participant roster ID N/A N/A UPENNBIOMK_MASTER_OLD UPENN CSF Biomarker Master
3-IAA Indoleacetic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
3-IPA Indolepropionic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
3-Met-His 3-Methylhistidine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
5-AVA 5-Aminovaleric acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
AA Arachidonic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
AABA Alpha-Aminobutyric acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
AbsAcid Abscisic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Ac-Orn Acetylornithine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
AconAcid Aconitic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
ADMA Asymmetric dimethylarginine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Ala Alanine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
alpha-AAA alpha-Aminoadipic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Anserine L-Anserine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Arg Arginine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Asn Asparagine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Asp Aspartic Acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
BABA beta-Aminobutyric acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
beta-Ala beta-Alanine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Betaine Betaine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
c4-OH-Pro cis-4-Hydroxyproline -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
CA Cholic Acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Carnosine Carnosine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
CDCA Chenodeoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Choline Choline -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Cit Citrulline -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Cortisol Cortisol -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Cortisone Cortisone -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Creatinine Creatinine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Customer Sample Identification Customer Sample Identification -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Cys Cysteine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Cystine Cystine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
DCA Deoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
DHA Docosahexaenoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
DHEAS Dehydroepiandrosterone sulfate -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
DiCA(12:0) Dodecanedioic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
DiCA(14:0) Tetradecanedioic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
DOPA Dihydroxyphenylalanine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Dopamine Dopamine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
EPA Eicosapentaenoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
EXAMDATE The date sample is collected -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(12:0) Dodecanoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(14:0) Myristic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(16:0) Palmitic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(18:0) Stearic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(18:1) Octadecenoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(18:2) Octadecadienoate -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(20:1) Eicosenoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(20:2) Eicosadienoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
FA(20:3) Eicosatrienoic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GABA gamma-Aminobutyric acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GCA Glycocholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GCDCA Glycochenodeoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GDCA Glycodeoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GLCA Glycolithocholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GLCAS Glycolithocholic acid sulfate -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Gln Glutamine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Glu Glutamic Acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Gly Glycine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
GUDCA Glycoursodeoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
HArg Homoarginine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
HCys Homocysteine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
HipAcid Hippuric acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
His Histidine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Histamine Histamine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Hypoxanthine Hypoxanthine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Ile Isoleucine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Ind-SO4 Indoxyl sulfate -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Indole Indole -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Injection Number Injection Number -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Kynurenine Kynurenine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Lac Lactic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Leu Leucine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Lys Lysine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Material For this study the samples are serum -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Met Methionine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Met-SO Methionine-Sulfoxide -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Nitro-Tyr Nitrotyrosine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
OH-GlutAcid Hydroxyglutaric acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Orn Ornithine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
p-Cresol-SO4 p-Cresol sulfate -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
PAG Phenylacetylglycine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
PEA Phenylethylamine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Phe Phenylalanine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
PheAlaBetaine Phenylalanine betaine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Plate Bar Code Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Pro Proline -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
ProBetaine Proline betaine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Putrescine Putrescine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
RID Participant roster ID. NOTE: 9999999 denotes pooled sample. -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Run Number Run Number -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Sample Bar Code Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Sample Identification Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System. -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Sample Type Sample Type -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Sample Volume The volume of sample injected in microliters -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Sarcosine Sarcosine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
SDMA Symmetric dimethylarginine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Ser Serine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Serotonin Serotonin -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Species Species of sample origin -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Spermidine Spermidine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Spermine Spermine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Suc Succinic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
t4-OH-Pro trans-4-Hydroxyproline -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Taurine Taurine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TCA Taurocholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TCDCA Taurochenodeoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TDCA Taurodeoxycholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Thr Threonine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TLCA Taurolithocholic acid -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TMAO Trimethylamine N-oxide -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TMCA Tauro-muricholic acids -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Trigonelline Trigonelline -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Trp Tryptophan -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
TrpBetaine Tryptophan betaine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Tyr Tyrosine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Val Valine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
VISCODE How many month between the baseline and visit -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Well Position Well number in the 96-well plate from which the sample was injected -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Xanthine Xanthine -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
Cer(d16:1/18:0) Ceramide(d16:1/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d16:1/20:0) Ceramide(d16:1/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d16:1/22:0) Ceramide(d16:1/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d16:1/23:0) Ceramide(d16:1/23:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d16:1/24:0) Ceramide(d16:1/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/16:0) Ceramide(d18:0/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/18:0(OH)) Dihydroceramide(d18:0/18:0(OH)) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/18:0) Dihydroceramide(d18:0/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/20:0) Dihydroceramide(d18:0/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/22:0) Dihydroceramide(d18:0/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/24:0) Dihydroceramide(d18:0/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/24:1) Dihydroceramide(d18:0/24:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:0/26:1(OH)) Dihydroceramide(d18:0/26:1(OH)) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/14:0) Ceramide(d18:1/14:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/16:0) Ceramide(d18:1/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/18:0(OH)) Ceramide(d18:1/18:0(OH)) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/18:0) Ceramide(d18:1/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/18:1) Ceramide(d18:1/18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/20:0(OH)) Ceramide(d18:1/20:0(OH)) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/20:0) Ceramide(d18:1/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/22:0) Ceramide(d18:1/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/23:0) Ceramide(d18:1/23:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/24:0) Ceramide(d18:1/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/24:1) Ceramide(d18:1/24:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/25:0) Ceramide(d18:1/25:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/26:0) Ceramide(d18:1/26:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:1/26:1) Ceramide(d18:1/26:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/14:0) Ceramide(d18:2/14:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/16:0) Ceramide(d18:2/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/18:0) Ceramide(d18:2/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/18:1) Ceramide(d18:2/18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/20:0) Ceramide(d18:2/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/22:0) Ceramide(d18:2/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/23:0) Ceramide(d18:2/23:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/24:0) Ceramide(d18:2/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Cer(d18:2/24:1) Ceramide(d18:2/24:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Customer Sample Identification Customer Sample Identification -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(14:0_14:0) Diacylglyceride(14:0_14:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(14:0_18:1) Diacylglyceride(14:0_18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(14:0_18:2) Diacylglyceride(14:0_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(14:0_20:0) Diacylglyceride(14:0_20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(14:1_18:1) Diacylglyceride(14:1_18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(14:1_20:2) Diacylglyceride(14:1_20:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_16:0) Diacylglyceride(16:0_16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_16:1) Diacylglyceride(16:0_16:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_18:1) Diacylglyceride(16:0_18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_18:2) Diacylglyceride(16:0_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_20:0) Diacylglyceride(16:0_20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_20:3) Diacylglyceride(16:0_20:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:0_20:4) Diacylglyceride(16:0_20:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:1_18:0) Diacylglyceride(16:1_18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:1_18:1) Diacylglyceride(16:1_18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(16:1_18:2) Diacylglyceride(16:1_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(17:0_17:1) Diacylglyceride(17:0_17:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(17:0_18:1) Diacylglyceride(17:0_18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:0_20:4) Diacylglyceride(18:0_20:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_18:1) Diacylglyceride(18:1_18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_18:2) Diacylglyceride(18:1_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_18:3) Diacylglyceride(18:1_18:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_18:4) Diacylglyceride(18:1_18:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_20:1) Diacylglyceride(18:1_20:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_20:2) Diacylglyceride(18:1_20:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_20:3) Diacylglyceride(18:1_20:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_20:4) Diacylglyceride(18:1_20:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_22:5) Diacylglyceride(18:1_22:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:1_22:6) Diacylglyceride(18:1_22:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:2_18:2) Diacylglyceride(18:2_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:2_18:3) Diacylglyceride(18:2_18:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:2_18:4) Diacylglyceride(18:2_18:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:2_20:0) Diacylglyceride(18:2_20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:2_20:4) Diacylglyceride(18:2_20:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:3_18:3) Diacylglyceride(18:3_18:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(18:3_20:2) Diacylglyceride(18:3_20:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(21:0_22:6) Diacylglyceride(21:0_22:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG(22:1_22:2) Diacylglyceride(22:1_22:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG-O(14:0_18:2) Diacylglyceride O-(14:0_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG-O(16:0_20:4) Diacylglyceride O-(16:0_20:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
DG-O(18:2_18:2) Diacylglyceride O-(18:2_18:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/14:0) Dihexosylceramide(d18:1/14:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/16:0) Dihexosylceramide(d18:1/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/18:0) Dihexosylceramide(d18:1/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/20:0) Dihexosylceramide(d18:1/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/22:0) Dihexosylceramide(d18:1/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/24:0) Dihexosylceramide(d18:1/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/24:1) Dihexosylceramide(d18:1/24:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/26:0) Dihexosylceramide(d18:1/26:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex2Cer(d18:1/26:1) Dihexosylceramide(d18:1/26:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex3Cer(d18:1/16:0) Trihexosylceramide(d18:1/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex3Cer(d18:1/18:0) Trihexosylceramide(d18:1/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex3Cer(d18:1/24:1) Trihexosylceramide(d18:1/24:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex3Cer(d18:1/26:1) Trihexosylceramide(d18:1/26:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex3Cer(d18:1_20:0) Trihexosylceramide(d18:1_20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Hex3Cer(d18:1_22:0) Trihexosylceramide(d18:1_22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d16:1/22:0) Hexosylceramide(d16:1/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d16:1/24:0) Hexosylceramide(d16:1/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/14:0) Hexosylceramide(d18:1/14:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/16:0) Hexosylceramide(d18:1/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/18:0) Hexosylceramide(d18:1/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/18:1) Hexosylceramide(d18:1/18:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/20:0) Hexosylceramide(d18:1/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/22:0) Hexosylceramide(d18:1/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/23:0) Hexosylceramide(d18:1/23:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/24:0) Hexosylceramide(d18:1/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/24:1) Hexosylceramide(d18:1/24:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/26:0) Hexosylceramide(d18:1/26:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:1/26:1) Hexosylceramide(d18:1/26:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:2/16:0) Hexosylceramide(d18:2/16:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:2/18:0) Hexosylceramide(d18:2/18:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:2/20:0) Hexosylceramide(d18:2/20:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:2/22:0) Hexosylceramide(d18:2/22:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:2/23:0) Hexosylceramide(d18:2/23:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
HexCer(d18:2/24:0) Hexosylceramide(d18:2/24:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C14:0 Lysophosphatidylcholine a C14:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C16:0 Lysophosphatidylcholine a C16:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C16:1 Lysophosphatidylcholine a C16:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C17:0 Lysophosphatidylcholine a C17:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C18:0 Lysophosphatidylcholine a C18:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C18:1 Lysophosphatidylcholine a C18:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C18:2 Lysophosphatidylcholine a C18:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C20:3 Lysophosphatidylcholine a C20:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C20:4 Lysophosphatidylcholine a C20:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C24:0 Lysophosphatidylcholine a C24:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C26:0 Lysophosphatidylcholine a C26:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C26:1 Lysophosphatidylcholine a C26:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C28:0 Lysophosphatidylcholine a C28:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
lysoPC a C28:1 Lysophosphatidylcholine a C28:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C24:0 Phosphatidylcholine aa C24:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C26:0 Phosphatidylcholine aa C26:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C28:1 Phosphatidylcholine aa C28:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C30:0 Phosphatidylcholine aa C30:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C32:0 Phosphatidylcholine aa C32:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C32:1 Phosphatidylcholine aa C32:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C32:2 Phosphatidylcholine aa C32:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C32:3 Phosphatidylcholine aa C32:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C34:1 Phosphatidylcholine aa C34:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C34:2 Phosphatidylcholine aa C34:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C34:3 Phosphatidylcholine aa C34:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C34:4 Phosphatidylcholine aa C34:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:0 Phosphatidylcholine aa C36:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:1 Phosphatidylcholine aa C36:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:2 Phosphatidylcholine aa C36:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:3 Phosphatidylcholine aa C36:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:4 Phosphatidylcholine aa C36:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:5 Phosphatidylcholine aa C36:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C36:6 Phosphatidylcholine aa C36:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C38:0 Phosphatidylcholine aa C38:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C38:3 Phosphatidylcholine aa C38:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C38:4 Phosphatidylcholine aa C38:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C38:5 Phosphatidylcholine aa C38:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C38:6 Phosphatidylcholine aa C38:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C40:1 Phosphatidylcholine aa C40:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C40:2 Phosphatidylcholine aa C40:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C40:3 Phosphatidylcholine aa C40:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C40:4 Phosphatidylcholine aa C40:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C40:5 Phosphatidylcholine aa C40:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C40:6 Phosphatidylcholine aa C40:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C42:0 Phosphatidylcholine aa C42:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C42:1 Phosphatidylcholine aa C42:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C42:2 Phosphatidylcholine aa C42:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C42:4 Phosphatidylcholine aa C42:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C42:5 Phosphatidylcholine aa C42:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC aa C42:6 Phosphatidylcholine aa C42:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C30:0 Phosphatidylcholine ae C30:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C30:1 Phosphatidylcholine ae C30:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C30:2 Phosphatidylcholine ae C30:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C32:1 Phosphatidylcholine ae C32:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C32:2 Phosphatidylcholine ae C32:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C34:0 Phosphatidylcholine ae C34:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C34:1 Phosphatidylcholine ae C34:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C34:2 Phosphatidylcholine ae C34:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C34:3 Phosphatidylcholine ae C34:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C36:0 Phosphatidylcholine ae C36:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C36:1 Phosphatidylcholine ae C36:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C36:2 Phosphatidylcholine ae C36:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C36:3 Phosphatidylcholine ae C36:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C36:4 Phosphatidylcholine ae C36:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C36:5 Phosphatidylcholine ae C36:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:0 Phosphatidylcholine ae C38:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:1 Phosphatidylcholine ae C38:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:2 Phosphatidylcholine ae C38:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:3 Phosphatidylcholine ae C38:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:4 Phosphatidylcholine ae C38:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:5 Phosphatidylcholine ae C38:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C38:6 Phosphatidylcholine ae C38:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C40:1 Phosphatidylcholine ae C40:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C40:2 Phosphatidylcholine ae C40:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C40:3 Phosphatidylcholine ae C40:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C40:4 Phosphatidylcholine ae C40:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C40:5 Phosphatidylcholine ae C40:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C40:6 Phosphatidylcholine ae C40:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C42:0 Phosphatidylcholine ae C42:0 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C42:1 Phosphatidylcholine ae C42:1 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C42:2 Phosphatidylcholine ae C42:2 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C42:3 Phosphatidylcholine ae C42:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C42:4 Phosphatidylcholine ae C42:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C42:5 Phosphatidylcholine ae C42:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C44:3 Phosphatidylcholine ae C44:3 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C44:4 Phosphatidylcholine ae C44:4 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C44:5 Phosphatidylcholine ae C44:5 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
PC ae C44:6 Phosphatidylcholine ae C44:6 -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Plate Bar Code Unique identifier for every plate generated by the Biocrates MetIDQ software -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
RID Participant roster ID. NOTE: 9999999 denotes pooled sample. -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Sample Bar Code Unique identifier for every sample registered in the Biocrates MetIDQ software -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
Sample Identification Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System. -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_32:2) Triacylglyceride(14:0_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_34:0) Triacylglyceride(14:0_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_34:1) Triacylglyceride(14:0_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_34:2) Triacylglyceride(14:0_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_34:3) Triacylglyceride(14:0_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_35:1) Triacylglyceride(14:0_35:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_35:2) Triacylglyceride(14:0_35:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_36:1) Triacylglyceride(14:0_36:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_36:2) Triacylglyceride(14:0_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_36:3) Triacylglyceride(14:0_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_36:4) Triacylglyceride(14:0_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_38:4) Triacylglyceride(14:0_38:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_38:5) Triacylglyceride(14:0_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(14:0_40:5) Triacylglyceride(14:0_40:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_28:1) Triacylglyceride(16:0_28:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_28:2) Triacylglyceride(16:0_28:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_30:2) Triacylglyceride(16:0_30:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_32:0) Triacylglyceride(16:0_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_32:1) Triacylglyceride(16:0_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_32:2) Triacylglyceride(16:0_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_32:3) Triacylglyceride(16:0_32:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_33:1) Triacylglyceride(16:0_33:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_33:2) Triacylglyceride(16:0_33:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_34:0) Triacylglyceride(16:0_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_34:1) Triacylglyceride(16:0_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_34:2) Triacylglyceride(16:0_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_34:3) Triacylglyceride(16:0_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_34:4) Triacylglyceride(16:0_34:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_35:1) Triacylglyceride(16:0_35:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_35:2) Triacylglyceride(16:0_35:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_35:3) Triacylglyceride(16:0_35:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_36:2) Triacylglyceride(16:0_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_36:3) Triacylglyceride(16:0_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_36:4) Triacylglyceride(16:0_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_36:5) Triacylglyceride(16:0_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_36:6) Triacylglyceride(16:0_36:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_37:3) Triacylglyceride(16:0_37:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:1) Triacylglyceride(16:0_38:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:2) Triacylglyceride(16:0_38:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:3) Triacylglyceride(16:0_38:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:4) Triacylglyceride(16:0_38:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:5) Triacylglyceride(16:0_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:6) Triacylglyceride(16:0_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_38:7) Triacylglyceride(16:0_38:7) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_40:6) Triacylglyceride(16:0_40:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_40:7) Triacylglyceride(16:0_40:7) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:0_40:8) Triacylglyceride(16:0_40:8) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_28:0) Triacylglyceride(16:1_28:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_30:1) Triacylglyceride(16:1_30:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_32:0) Triacylglyceride(16:1_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_32:1) Triacylglyceride(16:1_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_32:2) Triacylglyceride(16:1_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_33:1) Triacylglyceride(16:1_33:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_34:0) Triacylglyceride(16:1_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_34:1) Triacylglyceride(16:1_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_34:2) Triacylglyceride(16:1_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_34:3) Triacylglyceride(16:1_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_36:1) Triacylglyceride(16:1_36:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_36:2) Triacylglyceride(16:1_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_36:3) Triacylglyceride(16:1_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_36:4) Triacylglyceride(16:1_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_36:5) Triacylglyceride(16:1_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_38:3) Triacylglyceride(16:1_38:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_38:4) Triacylglyceride(16:1_38:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(16:1_38:5) Triacylglyceride(16:1_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:0_32:1) Triacylglyceride(17:0_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:0_34:1) Triacylglyceride(17:0_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:0_34:2) Triacylglyceride(17:0_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:0_34:3) Triacylglyceride(17:0_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:0_36:3) Triacylglyceride(17:0_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:0_36:4) Triacylglyceride(17:0_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_32:1) Triacylglyceride(17:1_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_34:1) Triacylglyceride(17:1_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_34:2) Triacylglyceride(17:1_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_34:3) Triacylglyceride(17:1_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_36:3) Triacylglyceride(17:1_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_36:4) Triacylglyceride(17:1_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_36:5) Triacylglyceride(17:1_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_38:5) Triacylglyceride(17:1_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_38:6) Triacylglyceride(17:1_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:1_38:7) Triacylglyceride(17:1_38:7) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_34:2) Triacylglyceride(17:2_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_34:3) Triacylglyceride(17:2_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_36:2) Triacylglyceride(17:2_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_36:3) Triacylglyceride(17:2_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_36:4) Triacylglyceride(17:2_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_38:5) Triacylglyceride(17:2_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_38:6) Triacylglyceride(17:2_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(17:2_38:7) Triacylglyceride(17:2_38:7) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_30:0) Triacylglyceride(18:0_30:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_30:1) Triacylglyceride(18:0_30:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_32:0) Triacylglyceride(18:0_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_32:1) Triacylglyceride(18:0_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_32:2) Triacylglyceride(18:0_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_34:2) Triacylglyceride(18:0_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_34:3) Triacylglyceride(18:0_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_36:1) Triacylglyceride(18:0_36:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_36:2) Triacylglyceride(18:0_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_36:3) Triacylglyceride(18:0_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_36:4) Triacylglyceride(18:0_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_36:5) Triacylglyceride(18:0_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_38:6) Triacylglyceride(18:0_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:0_38:7) Triacylglyceride(18:0_38:7) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_26:0) Triacylglyceride(18:1_26:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_28:1) Triacylglyceride(18:1_28:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_30:0) Triacylglyceride(18:1_30:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_30:1) Triacylglyceride(18:1_30:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_30:2) Triacylglyceride(18:1_30:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_31:0) Triacylglyceride(18:1_31:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_32:0) Triacylglyceride(18:1_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_32:1) Triacylglyceride(18:1_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_32:2) Triacylglyceride(18:1_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_32:3) Triacylglyceride(18:1_32:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_33:0) Triacylglyceride(18:1_33:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_33:1) Triacylglyceride(18:1_33:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_33:2) Triacylglyceride(18:1_33:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_33:3) Triacylglyceride(18:1_33:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_34:1) Triacylglyceride(18:1_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_34:2) Triacylglyceride(18:1_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_34:3) Triacylglyceride(18:1_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_34:4) Triacylglyceride(18:1_34:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_35:2) Triacylglyceride(18:1_35:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_35:3) Triacylglyceride(18:1_35:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:0) Triacylglyceride(18:1_36:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:1) Triacylglyceride(18:1_36:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:2) Triacylglyceride(18:1_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:3) Triacylglyceride(18:1_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:4) Triacylglyceride(18:1_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:5) Triacylglyceride(18:1_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_36:6) Triacylglyceride(18:1_36:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_38:5) Triacylglyceride(18:1_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_38:6) Triacylglyceride(18:1_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:1_38:7) Triacylglyceride(18:1_38:7) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_28:0) Triacylglyceride(18:2_28:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_30:0) Triacylglyceride(18:2_30:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_30:1) Triacylglyceride(18:2_30:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_31:0) Triacylglyceride(18:2_31:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_32:0) Triacylglyceride(18:2_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_32:1) Triacylglyceride(18:2_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_32:2) Triacylglyceride(18:2_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_33:0) Triacylglyceride(18:2_33:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_33:1) Triacylglyceride(18:2_33:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_33:2) Triacylglyceride(18:2_33:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_34:0) Triacylglyceride(18:2_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_34:1) Triacylglyceride(18:2_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_34:2) Triacylglyceride(18:2_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_34:3) Triacylglyceride(18:2_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_34:4) Triacylglyceride(18:2_34:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_35:1) Triacylglyceride(18:2_35:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_35:2) Triacylglyceride(18:2_35:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_35:3) Triacylglyceride(18:2_35:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_36:0) Triacylglyceride(18:2_36:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_36:1) Triacylglyceride(18:2_36:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_36:2) Triacylglyceride(18:2_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_36:3) Triacylglyceride(18:2_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_36:4) Triacylglyceride(18:2_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_36:5) Triacylglyceride(18:2_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_38:4) Triacylglyceride(18:2_38:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_38:5) Triacylglyceride(18:2_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:2_38:6) Triacylglyceride(18:2_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_30:0) Triacylglyceride(18:3_30:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_32:0) Triacylglyceride(18:3_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_32:1) Triacylglyceride(18:3_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_33:2) Triacylglyceride(18:3_33:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_34:0) Triacylglyceride(18:3_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_34:1) Triacylglyceride(18:3_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_34:2) Triacylglyceride(18:3_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_34:3) Triacylglyceride(18:3_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_35:2) Triacylglyceride(18:3_35:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_36:1) Triacylglyceride(18:3_36:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_36:2) Triacylglyceride(18:3_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_36:3) Triacylglyceride(18:3_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_36:4) Triacylglyceride(18:3_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_38:5) Triacylglyceride(18:3_38:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(18:3_38:6) Triacylglyceride(18:3_38:6) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:0_32:3) Triacylglyceride(20:0_32:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:0_32:4) Triacylglyceride(20:0_32:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:0_34:1) Triacylglyceride(20:0_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_24:3) Triacylglyceride(20:1_24:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_26:1) Triacylglyceride(20:1_26:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_30:1) Triacylglyceride(20:1_30:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_32:0) Triacylglyceride(20:1_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_32:1) Triacylglyceride(20:1_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_32:2) Triacylglyceride(20:1_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_32:3) Triacylglyceride(20:1_32:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_34:0) Triacylglyceride(20:1_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_34:1) Triacylglyceride(20:1_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_34:2) Triacylglyceride(20:1_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:1_34:3) Triacylglyceride(20:1_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_32:0) Triacylglyceride(20:2_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_32:1) Triacylglyceride(20:2_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_34:1) Triacylglyceride(20:2_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_34:2) Triacylglyceride(20:2_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_34:3) Triacylglyceride(20:2_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_34:4) Triacylglyceride(20:2_34:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:2_36:5) Triacylglyceride(20:2_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_32:0) Triacylglyceride(20:3_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_32:1) Triacylglyceride(20:3_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_32:2) Triacylglyceride(20:3_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_34:0) Triacylglyceride(20:3_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_34:1) Triacylglyceride(20:3_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_34:2) Triacylglyceride(20:3_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_34:3) Triacylglyceride(20:3_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_36:3) Triacylglyceride(20:3_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_36:4) Triacylglyceride(20:3_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:3_36:5) Triacylglyceride(20:3_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_30:0) Triacylglyceride(20:4_30:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_32:0) Triacylglyceride(20:4_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_32:1) Triacylglyceride(20:4_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_32:2) Triacylglyceride(20:4_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_33:2) Triacylglyceride(20:4_33:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_34:0) Triacylglyceride(20:4_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_34:1) Triacylglyceride(20:4_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_34:2) Triacylglyceride(20:4_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_34:3) Triacylglyceride(20:4_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_35:3) Triacylglyceride(20:4_35:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_36:2) Triacylglyceride(20:4_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_36:3) Triacylglyceride(20:4_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_36:4) Triacylglyceride(20:4_36:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:4_36:5) Triacylglyceride(20:4_36:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:5_34:0) Triacylglyceride(20:5_34:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:5_34:1) Triacylglyceride(20:5_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:5_34:2) Triacylglyceride(20:5_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:5_36:2) Triacylglyceride(20:5_36:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(20:5_36:3) Triacylglyceride(20:5_36:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:0_32:4) Triacylglyceride(22:0_32:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:1_32:5) Triacylglyceride(22:1_32:5) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:2_32:4) Triacylglyceride(22:2_32:4) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:3_30:2) Triacylglyceride(22:3_30:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:4_32:0) Triacylglyceride(22:4_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:4_32:2) Triacylglyceride(22:4_32:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:4_34:2) Triacylglyceride(22:4_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:5_32:0) Triacylglyceride(22:5_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:5_32:1) Triacylglyceride(22:5_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:5_34:1) Triacylglyceride(22:5_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:5_34:2) Triacylglyceride(22:5_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:5_34:3) Triacylglyceride(22:5_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:6_32:0) Triacylglyceride(22:6_32:0) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:6_32:1) Triacylglyceride(22:6_32:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:6_34:1) Triacylglyceride(22:6_34:1) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:6_34:2) Triacylglyceride(22:6_34:2) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
TG(22:6_34:3) Triacylglyceride(22:6_34:3) -4 N/A ADMC_DUKE_Q500_FIA ADMC Duke Biocrates MxP Quant 500 Flow injection analysis Longitudinal ADNI-1, -GO, -2
VISCODE2 How many month between the baseline and visit -4 N/A ADMC_DUKE_Q500_UPLC ADMC Duke Biocrates MxP Quant 500 Ultra Performance Liquid Chromatography Longitudinal ADNI -1, -GO, -2
ACCUMBENS_AREA_SUVR bilateral-accumbens-area N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
ACCUMBENS_AREA_VOLUME bilateral-accumbens-area ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
AMYGDALA_SUVR bilateral-amygdala N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
AMYGDALA_VOLUME bilateral-amygdala ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
AMYLOID_STATUS Amyloid positivity determined by applying thresholds to cortical summary SUVR normalized by whole cerebellum; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
AMYLOID_STATUS_COMPOSITE_REF Amyloid positivity determined by applying thresholds to cortical summary SUVR normalized by composite ref region; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
BRAINSTEM_SUVR Reference region - mean SUVR of brainstem. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
BRAINSTEM_VOLUME brain-stem ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CAUDATE_SUVR bilateral-caudate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CAUDATE_VOLUME bilateral-caudate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_ANTERIOR_SUVR cc-anterior N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_ANTERIOR_VOLUME cc-anterior ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_CENTRAL_SUVR cc-central N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_CENTRAL_VOLUME cc-central ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_MID_ANTERIOR_SUVR cc-mid-anterior N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_MID_ANTERIOR_VOLUME cc-mid-anterior ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_MID_POSTERIOR_SUVR cc-mid-posterior N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_MID_POSTERIOR_VOLUME cc-mid-posterior ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_POSTERIOR_SUVR cc-posterior N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_POSTERIOR_VOLUME cc-posterior ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CENTILOIDS Summary cortical SUVR normalized by whole cerebellum and transformed to Centiloids. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CEREBELLUM_CORTEX_SUVR Reference region - mean SUVR of bilateral-cerebellum-cortex defined by Freesurfer (previously CEREBELLUMGREYMATTER_SUVR); See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CEREBELLUM_CORTEX_VOLUME Reference region - volume of bilateral-cerebellum-cortex defined by Freesurfer (previously CEREBELLUMGREYMATTER_VOLUME); See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CEREBELLUM_WHITE_MATTER_SUVR bilateral-cerebellum-white-matter N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CEREBELLUM_WHITE_MATTER_VOLUME bilateral-cerebellum-white-matter ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CEREBRAL_WHITE_MATTER_SUVR bilateral-cerebral-white-matter N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CEREBRAL_WHITE_MATTER_VOLUME bilateral-cerebral-white-matter ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CHOROID_PLEXUS_SUVR bilateral-choroid-plexus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CHOROID_PLEXUS_VOLUME bilateral-choroid-plexus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
COMPOSITE_REF_SUVR Reference region - mean SUVR of composite ref region (avg of whole cerebellum, brainstem, eroded WM). Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
COMPOSITE_REF_VOLUME Reference region - volume of composite ref region (avg of whole cerebellum, brainstem, eroded WM). Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CSF_SUVR csf N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CSF_VOLUME csf ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_BANKSSTS_SUVR ctx-bilateral-bankssts N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_BANKSSTS_VOLUME ctx-bilateral-bankssts ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_CAUDALANTERIORCINGULATE_SUVR ctx-bilateral-caudalanteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_CAUDALANTERIORCINGULATE_VOLUME ctx-bilateral-caudalanteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_CAUDALMIDDLEFRONTAL_SUVR ctx-bilateral-caudalmiddlefrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_CAUDALMIDDLEFRONTAL_VOLUME ctx-bilateral-caudalmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_CUNEUS_SUVR ctx-bilateral-cuneus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_CUNEUS_VOLUME ctx-bilateral-cuneus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ENTORHINAL_SUVR ctx-bilateral-entorhinal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ENTORHINAL_VOLUME ctx-bilateral-entorhinal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_FRONTALPOLE_SUVR ctx-bilateral-frontalpole N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_FRONTALPOLE_VOLUME ctx-bilateral-frontalpole ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_FUSIFORM_SUVR ctx-bilateral-fusiform N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_FUSIFORM_VOLUME ctx-bilateral-fusiform ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_INFERIORPARIETAL_SUVR ctx-bilateral-inferiorparietal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_INFERIORPARIETAL_VOLUME ctx-bilateral-inferiorparietal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_INFERIORTEMPORAL_SUVR ctx-bilateral-inferiortemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_INFERIORTEMPORAL_VOLUME ctx-bilateral-inferiortemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_INSULA_SUVR ctx-bilateral-insula N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_INSULA_VOLUME ctx-bilateral-insula ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ISTHMUSCINGULATE_SUVR ctx-bilateral-isthmuscingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ISTHMUSCINGULATE_VOLUME ctx-bilateral-isthmuscingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LATERALOCCIPITAL_SUVR ctx-bilateral-lateraloccipital N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LATERALOCCIPITAL_VOLUME ctx-bilateral-lateraloccipital ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LATERALORBITOFRONTAL_SUVR ctx-bilateral-lateralorbitofrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LATERALORBITOFRONTAL_VOLUME ctx-bilateral-lateralorbitofrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_BANKSSTS_SUVR ctx-lh-bankssts N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_BANKSSTS_VOLUME ctx-lh-bankssts ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_CAUDALANTERIORCINGULATE_SUVR ctx-lh-caudalanteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_CAUDALANTERIORCINGULATE_VOLUME ctx-lh-caudalanteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SUVR ctx-lh-caudalmiddlefrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME ctx-lh-caudalmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_CUNEUS_SUVR ctx-lh-cuneus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_CUNEUS_VOLUME ctx-lh-cuneus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ENTORHINAL_SUVR ctx-lh-entorhinal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ENTORHINAL_VOLUME ctx-lh-entorhinal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_FRONTALPOLE_SUVR ctx-lh-frontalpole N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_FRONTALPOLE_VOLUME ctx-lh-frontalpole ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_FUSIFORM_SUVR ctx-lh-fusiform N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_FUSIFORM_VOLUME ctx-lh-fusiform ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_INFERIORPARIETAL_SUVR ctx-lh-inferiorparietal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_INFERIORPARIETAL_VOLUME ctx-lh-inferiorparietal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_INFERIORTEMPORAL_SUVR ctx-lh-inferiortemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_INFERIORTEMPORAL_VOLUME ctx-lh-inferiortemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_INSULA_SUVR ctx-lh-insula N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_INSULA_VOLUME ctx-lh-insula ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ISTHMUSCINGULATE_SUVR ctx-lh-isthmuscingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ISTHMUSCINGULATE_VOLUME ctx-lh-isthmuscingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_LATERALOCCIPITAL_SUVR ctx-lh-lateraloccipital N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_LATERALOCCIPITAL_VOLUME ctx-lh-lateraloccipital ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_LATERALORBITOFRONTAL_SUVR ctx-lh-lateralorbitofrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_LATERALORBITOFRONTAL_VOLUME ctx-lh-lateralorbitofrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_LINGUAL_SUVR ctx-lh-lingual N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_LINGUAL_VOLUME ctx-lh-lingual ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_MEDIALORBITOFRONTAL_SUVR ctx-lh-medialorbitofrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_MEDIALORBITOFRONTAL_VOLUME ctx-lh-medialorbitofrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_MIDDLETEMPORAL_SUVR ctx-lh-middletemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_MIDDLETEMPORAL_VOLUME ctx-lh-middletemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARACENTRAL_SUVR ctx-lh-paracentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARACENTRAL_VOLUME ctx-lh-paracentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARAHIPPOCAMPAL_SUVR ctx-lh-parahippocampal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARAHIPPOCAMPAL_VOLUME ctx-lh-parahippocampal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARSOPERCULARIS_SUVR ctx-lh-parsopercularis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARSOPERCULARIS_VOLUME ctx-lh-parsopercularis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARSORBITALIS_SUVR ctx-lh-parsorbitalis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARSORBITALIS_VOLUME ctx-lh-parsorbitalis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARSTRIANGULARIS_SUVR ctx-lh-parstriangularis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PARSTRIANGULARIS_VOLUME ctx-lh-parstriangularis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PERICALCARINE_SUVR ctx-lh-pericalcarine N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PERICALCARINE_VOLUME ctx-lh-pericalcarine ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_POSTCENTRAL_SUVR ctx-lh-postcentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_POSTCENTRAL_VOLUME ctx-lh-postcentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_POSTERIORCINGULATE_SUVR ctx-lh-posteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_POSTERIORCINGULATE_VOLUME ctx-lh-posteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PRECENTRAL_SUVR ctx-lh-precentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PRECENTRAL_VOLUME ctx-lh-precentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PRECUNEUS_SUVR ctx-lh-precuneus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_PRECUNEUS_VOLUME ctx-lh-precuneus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ROSTRALANTERIORCINGULATE_SUVR ctx-lh-rostralanteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ROSTRALANTERIORCINGULATE_VOLUME ctx-lh-rostralanteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR ctx-lh-rostralmiddlefrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-lh-rostralmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPERIORFRONTAL_SUVR ctx-lh-superiorfrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPERIORFRONTAL_VOLUME ctx-lh-superiorfrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPERIORPARIETAL_SUVR ctx-lh-superiorparietal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPERIORPARIETAL_VOLUME ctx-lh-superiorparietal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPERIORTEMPORAL_SUVR ctx-lh-superiortemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPERIORTEMPORAL_VOLUME ctx-lh-superiortemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPRAMARGINAL_SUVR ctx-lh-supramarginal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_SUPRAMARGINAL_VOLUME ctx-lh-supramarginal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_TEMPORALPOLE_SUVR ctx-lh-temporalpole N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_TEMPORALPOLE_VOLUME ctx-lh-temporalpole ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_TRANSVERSETEMPORAL_SUVR ctx-lh-transversetemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LH_TRANSVERSETEMPORAL_VOLUME ctx-lh-transversetemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LINGUAL_SUVR ctx-bilateral-lingual N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_LINGUAL_VOLUME ctx-bilateral-lingual ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_MEDIALORBITOFRONTAL_SUVR ctx-bilateral-medialorbitofrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_MEDIALORBITOFRONTAL_VOLUME ctx-bilateral-medialorbitofrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_MIDDLETEMPORAL_SUVR ctx-bilateral-middletemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_MIDDLETEMPORAL_VOLUME ctx-bilateral-middletemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARACENTRAL_SUVR ctx-bilateral-paracentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARACENTRAL_VOLUME ctx-bilateral-paracentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARAHIPPOCAMPAL_SUVR ctx-bilateral-parahippocampal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARAHIPPOCAMPAL_VOLUME ctx-bilateral-parahippocampal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARSOPERCULARIS_SUVR ctx-bilateral-parsopercularis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARSOPERCULARIS_VOLUME ctx-bilateral-parsopercularis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARSORBITALIS_SUVR ctx-bilateral-parsorbitalis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARSORBITALIS_VOLUME ctx-bilateral-parsorbitalis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARSTRIANGULARIS_SUVR ctx-bilateral-parstriangularis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PARSTRIANGULARIS_VOLUME ctx-bilateral-parstriangularis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PERICALCARINE_SUVR ctx-bilateral-pericalcarine N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PERICALCARINE_VOLUME ctx-bilateral-pericalcarine ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_POSTCENTRAL_SUVR ctx-bilateral-postcentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_POSTCENTRAL_VOLUME ctx-bilateral-postcentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_POSTERIORCINGULATE_SUVR ctx-bilateral-posteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_POSTERIORCINGULATE_VOLUME ctx-bilateral-posteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PRECENTRAL_SUVR ctx-bilateral-precentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PRECENTRAL_VOLUME ctx-bilateral-precentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PRECUNEUS_SUVR ctx-bilateral-precuneus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_PRECUNEUS_VOLUME ctx-bilateral-precuneus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_BANKSSTS_SUVR ctx-rh-bankssts N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_BANKSSTS_VOLUME ctx-rh-bankssts ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_CAUDALANTERIORCINGULATE_SUVR ctx-rh-caudalanteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_CAUDALANTERIORCINGULATE_VOLUME ctx-rh-caudalanteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SUVR ctx-rh-caudalmiddlefrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME ctx-rh-caudalmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_CUNEUS_SUVR ctx-rh-cuneus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_CUNEUS_VOLUME ctx-rh-cuneus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ENTORHINAL_SUVR ctx-rh-entorhinal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ENTORHINAL_VOLUME ctx-rh-entorhinal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_FRONTALPOLE_SUVR ctx-rh-frontalpole N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_FRONTALPOLE_VOLUME ctx-rh-frontalpole ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_FUSIFORM_SUVR ctx-rh-fusiform N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_FUSIFORM_VOLUME ctx-rh-fusiform ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_INFERIORPARIETAL_SUVR ctx-rh-inferiorparietal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_INFERIORPARIETAL_VOLUME ctx-rh-inferiorparietal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_INFERIORTEMPORAL_SUVR ctx-rh-inferiortemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_INFERIORTEMPORAL_VOLUME ctx-rh-inferiortemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_INSULA_SUVR ctx-rh-insula N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_INSULA_VOLUME ctx-rh-insula ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ISTHMUSCINGULATE_SUVR ctx-rh-isthmuscingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ISTHMUSCINGULATE_VOLUME ctx-rh-isthmuscingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_LATERALOCCIPITAL_SUVR ctx-rh-lateraloccipital N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_LATERALOCCIPITAL_VOLUME ctx-rh-lateraloccipital ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_LATERALORBITOFRONTAL_SUVR ctx-rh-lateralorbitofrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_LATERALORBITOFRONTAL_VOLUME ctx-rh-lateralorbitofrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_LINGUAL_SUVR ctx-rh-lingual N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_LINGUAL_VOLUME ctx-rh-lingual ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_MEDIALORBITOFRONTAL_SUVR ctx-rh-medialorbitofrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_MEDIALORBITOFRONTAL_VOLUME ctx-rh-medialorbitofrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_MIDDLETEMPORAL_SUVR ctx-rh-middletemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_MIDDLETEMPORAL_VOLUME ctx-rh-middletemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARACENTRAL_SUVR ctx-rh-paracentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARACENTRAL_VOLUME ctx-rh-paracentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARAHIPPOCAMPAL_SUVR ctx-rh-parahippocampal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARAHIPPOCAMPAL_VOLUME ctx-rh-parahippocampal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARSOPERCULARIS_SUVR ctx-rh-parsopercularis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARSOPERCULARIS_VOLUME ctx-rh-parsopercularis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARSORBITALIS_SUVR ctx-rh-parsorbitalis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARSORBITALIS_VOLUME ctx-rh-parsorbitalis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARSTRIANGULARIS_SUVR ctx-rh-parstriangularis N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PARSTRIANGULARIS_VOLUME ctx-rh-parstriangularis ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PERICALCARINE_SUVR ctx-rh-pericalcarine N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PERICALCARINE_VOLUME ctx-rh-pericalcarine ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_POSTCENTRAL_SUVR ctx-rh-postcentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_POSTCENTRAL_VOLUME ctx-rh-postcentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_POSTERIORCINGULATE_SUVR ctx-rh-posteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_POSTERIORCINGULATE_VOLUME ctx-rh-posteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PRECENTRAL_SUVR ctx-rh-precentral N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PRECENTRAL_VOLUME ctx-rh-precentral ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PRECUNEUS_SUVR ctx-rh-precuneus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_PRECUNEUS_VOLUME ctx-rh-precuneus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ROSTRALANTERIORCINGULATE_SUVR ctx-rh-rostralanteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ROSTRALANTERIORCINGULATE_VOLUME ctx-rh-rostralanteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR ctx-rh-rostralmiddlefrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-rh-rostralmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPERIORFRONTAL_SUVR ctx-rh-superiorfrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPERIORFRONTAL_VOLUME ctx-rh-superiorfrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPERIORPARIETAL_SUVR ctx-rh-superiorparietal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPERIORPARIETAL_VOLUME ctx-rh-superiorparietal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPERIORTEMPORAL_SUVR ctx-rh-superiortemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPERIORTEMPORAL_VOLUME ctx-rh-superiortemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPRAMARGINAL_SUVR ctx-rh-supramarginal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_SUPRAMARGINAL_VOLUME ctx-rh-supramarginal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_TEMPORALPOLE_SUVR ctx-rh-temporalpole N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_TEMPORALPOLE_VOLUME ctx-rh-temporalpole ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_TRANSVERSETEMPORAL_SUVR ctx-rh-transversetemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_RH_TRANSVERSETEMPORAL_VOLUME ctx-rh-transversetemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ROSTRALANTERIORCINGULATE_SUVR ctx-bilateral-rostralanteriorcingulate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ROSTRALANTERIORCINGULATE_VOLUME ctx-bilateral-rostralanteriorcingulate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ROSTRALMIDDLEFRONTAL_SUVR ctx-bilateral-rostralmiddlefrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_ROSTRALMIDDLEFRONTAL_VOLUME ctx-bilateral-rostralmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPERIORFRONTAL_SUVR ctx-bilateral-superiorfrontal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPERIORFRONTAL_VOLUME ctx-bilateral-superiorfrontal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPERIORPARIETAL_SUVR ctx-bilateral-superiorparietal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPERIORPARIETAL_VOLUME ctx-bilateral-superiorparietal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPERIORTEMPORAL_SUVR ctx-bilateral-superiortemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPERIORTEMPORAL_VOLUME ctx-bilateral-superiortemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPRAMARGINAL_SUVR ctx-bilateral-supramarginal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_SUPRAMARGINAL_VOLUME ctx-bilateral-supramarginal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_TEMPORALPOLE_SUVR ctx-bilateral-temporalpole N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_TEMPORALPOLE_VOLUME ctx-bilateral-temporalpole ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_TRANSVERSETEMPORAL_SUVR ctx-bilateral-transversetemporal N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CTX_TRANSVERSETEMPORAL_VOLUME ctx-bilateral-transversetemporal ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
ERODED_SUBCORTICALWM_SUVR Reference region - mean SUVR of eroded subcortical white matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
ERODED_SUBCORTICALWM_VOLUME Reference region - volume of eroded subcortical white matter. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
EXAMDATE Examination Date N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
HIPPOCAMPUS_SUVR bilateral-hippocampus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
HIPPOCAMPUS_VOLUME bilateral-hippocampus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
IMAGE_RESOLUTION Spatial resolution in mm^3 FWHM of Step4 Preprocessed PET image. See UCBERKELEY PET 8mm-to-6mm Transformation Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
INF_LAT_VENT_SUVR bilateral-inf-lat-vent N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
INF_LAT_VENT_VOLUME bilateral-inf-lat-vent ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LATERAL_VENTRICLE_SUVR bilateral-lateral-ventricle N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LATERAL_VENTRICLE_VOLUME bilateral-lateral-ventricle ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_ACCUMBENS_AREA_SUVR left-accumbens-area N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_ACCUMBENS_AREA_VOLUME left-accumbens-area ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_AMYGDALA_SUVR left-amygdala N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_AMYGDALA_VOLUME left-amygdala ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CAUDATE_SUVR left-caudate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CAUDATE_VOLUME left-caudate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CEREBELLUM_CORTEX_SUVR left-cerebellum-cortex N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CEREBELLUM_CORTEX_VOLUME left-cerebellum-cortex ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CEREBELLUM_WHITE_MATTER_SUVR left-cerebellum-white-matter N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CEREBELLUM_WHITE_MATTER_VOLUME left-cerebellum-white-matter ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CEREBRAL_WHITE_MATTER_SUVR left-cerebral-white-matter N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CEREBRAL_WHITE_MATTER_VOLUME left-cerebral-white-matter ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CHOROID_PLEXUS_SUVR left-choroid-plexus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_CHOROID_PLEXUS_VOLUME left-choroid-plexus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_HIPPOCAMPUS_SUVR left-hippocampus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_HIPPOCAMPUS_VOLUME left-hippocampus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_INF_LAT_VENT_SUVR left-inf-lat-vent N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_INF_LAT_VENT_VOLUME left-inf-lat-vent ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_LATERAL_VENTRICLE_SUVR left-lateral-ventricle N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_LATERAL_VENTRICLE_VOLUME left-lateral-ventricle ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_PALLIDUM_SUVR left-pallidum N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_PALLIDUM_VOLUME left-pallidum ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_PUTAMEN_SUVR left-putamen N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_PUTAMEN_VOLUME left-putamen ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_THALAMUS_PROPER_SUVR left-thalamus-proper N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_THALAMUS_PROPER_VOLUME left-thalamus-proper ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_VENTRALDC_SUVR left-ventraldc N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_VENTRALDC_VOLUME left-ventraldc ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_VESSEL_SUVR left-vessel N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LEFT_VESSEL_VOLUME left-vessel ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
LONIUID LONI Image ID N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
NON_WM_HYPOINTENSITIES_SUVR non-wm-hypointensities N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
NON_WM_HYPOINTENSITIES_VOLUME non-wm-hypointensities ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
OPTIC_CHIASM_SUVR optic-chiasm N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
OPTIC_CHIASM_VOLUME optic-chiasm ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
PALLIDUM_SUVR bilateral-pallidum N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
PALLIDUM_VOLUME bilateral-pallidum ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
PROCESSDATE Date quantification pipeline was run N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
PTID ADNI Participant ID consisting of 3-digit "SITEID" and 4-digit "RID" N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
PUTAMEN_SUVR bilateral-putamen N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
PUTAMEN_VOLUME bilateral-putamen ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
qc_flag Quality control flag based on visual inspection: 2=Pass;1=Partial pass; 0=Fail; -1=Not assessed; -2=Cannot be processed; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RID Participant roster ID (unique participant identifier that should be used to merge data) N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_ACCUMBENS_AREA_SUVR right-accumbens-area N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_ACCUMBENS_AREA_VOLUME right-accumbens-area ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_AMYGDALA_SUVR right-amygdala N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_AMYGDALA_VOLUME right-amygdala ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CAUDATE_SUVR right-caudate N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CAUDATE_VOLUME right-caudate ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CEREBELLUM_CORTEX_SUVR right-cerebellum-cortex N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CEREBELLUM_CORTEX_VOLUME right-cerebellum-cortex ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CEREBELLUM_WHITE_MATTER_SUVR right-cerebellum-white-matter N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CEREBELLUM_WHITE_MATTER_VOLUME right-cerebellum-white-matter ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CEREBRAL_WHITE_MATTER_SUVR right-cerebral-white-matter N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CEREBRAL_WHITE_MATTER_VOLUME right-cerebral-white-matter ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CHOROID_PLEXUS_SUVR right-choroid-plexus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_CHOROID_PLEXUS_VOLUME right-choroid-plexus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_HIPPOCAMPUS_SUVR right-hippocampus N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_HIPPOCAMPUS_VOLUME right-hippocampus ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_INF_LAT_VENT_SUVR right-inf-lat-vent N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_INF_LAT_VENT_VOLUME right-inf-lat-vent ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_LATERAL_VENTRICLE_SUVR right-lateral-ventricle N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_LATERAL_VENTRICLE_VOLUME right-lateral-ventricle ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_PALLIDUM_SUVR right-pallidum N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_PALLIDUM_VOLUME right-pallidum ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_PUTAMEN_SUVR right-putamen N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_PUTAMEN_VOLUME right-putamen ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_THALAMUS_PROPER_SUVR right-thalamus-proper N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_THALAMUS_PROPER_VOLUME right-thalamus-proper ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_VENTRALDC_SUVR right-ventraldc N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_VENTRALDC_VOLUME right-ventraldc ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_VESSEL_SUVR right-vessel N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
RIGHT_VESSEL_VOLUME right-vessel ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
SITEID Site ID N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
SUMMARY_SUVR Summary cortical SUVR normalized by whole cerebellum. All SUVRs in this file are normalized to the whole cerebellum unless otherwise noted. See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
SUMMARY_VOLUME Summary cortical ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
THALAMUS_PROPER_SUVR bilateral-thalamus-proper N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
THALAMUS_PROPER_VOLUME bilateral-thalamus-proper ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
TRACER PET Radiotracer N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRALDC_SUVR bilateral-ventraldc N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRALDC_VOLUME bilateral-ventraldc ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRICLE_3RD_SUVR 3rd-ventricle N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRICLE_3RD_VOLUME 3rd-ventricle ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRICLE_4TH_SUVR 4th-ventricle N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRICLE_4TH_VOLUME 4th-ventricle ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRICLE_5TH_SUVR 5th-ventricle N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VENTRICLE_5TH_VOLUME 5th-ventricle ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VESSEL_SUVR bilateral-vessel N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
VESSEL_VOLUME bilateral-vessel ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
WHOLECEREBELLUM_SUVR Reference region - mean SUVR of whole cerebellum. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
WHOLECEREBELLUM_VOLUME Reference region - volume of whole cerebellum. Regions defined by Freesurfer; See UCBERKELEY Amyloid Processing Methods PDF on LONI for details. N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
WM_HYPOINTENSITIES_SUVR wm-hypointensities N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
WM_HYPOINTENSITIES_VOLUME wm-hypointensities ROI size in mm^3 N/A N/A UCBERKELEY_AMY_6MM UC Berkeley - Amyloid PET 6mm Res analysis
CC_MID_ANTERIOR_SUVR cc-mid-anterior N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CC_MID_ANTERIOR_VOLUME cc-mid-anterior ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CC_MID_POSTERIOR_SUVR cc-mid-posterior N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CC_MID_POSTERIOR_VOLUME cc-mid-posterior ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CHOROID_PLEXUS_SUVR bilateral-choroid-plexus N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CHOROID_PLEXUS_VOLUME bilateral-choroid-plexus ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_CAUDALMIDDLEFRONTAL_SUVR ctx-bilateral-caudalmiddlefrontal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_CAUDALMIDDLEFRONTAL_VOLUME ctx-bilateral-caudalmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_LH_CAUDALMIDDLEFRONTAL_SUVR ctx-lh-caudalmiddlefrontal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_LH_CAUDALMIDDLEFRONTAL_VOLUME ctx-lh-caudalmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_LH_MIDDLETEMPORAL_SUVR ctx-lh-middletemporal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_LH_MIDDLETEMPORAL_VOLUME ctx-lh-middletemporal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_SUVR ctx-lh-rostralmiddlefrontal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_LH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-lh-rostralmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_MIDDLETEMPORAL_SUVR ctx-bilateral-middletemporal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_MIDDLETEMPORAL_VOLUME ctx-bilateral-middletemporal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_RH_CAUDALMIDDLEFRONTAL_SUVR ctx-rh-caudalmiddlefrontal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_RH_CAUDALMIDDLEFRONTAL_VOLUME ctx-rh-caudalmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_RH_MIDDLETEMPORAL_SUVR ctx-rh-middletemporal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_RH_MIDDLETEMPORAL_VOLUME ctx-rh-middletemporal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_SUVR ctx-rh-rostralmiddlefrontal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_RH_ROSTRALMIDDLEFRONTAL_VOLUME ctx-rh-rostralmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_ROSTRALMIDDLEFRONTAL_SUVR ctx-bilateral-rostralmiddlefrontal N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
CTX_ROSTRALMIDDLEFRONTAL_VOLUME ctx-bilateral-rostralmiddlefrontal ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
LEFT_CHOROID_PLEXUS_SUVR left-choroid-plexus N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
LEFT_CHOROID_PLEXUS_VOLUME left-choroid-plexus ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
LEFT_PALLIDUM_SUVR left-pallidum N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
LEFT_PALLIDUM_VOLUME left-pallidum ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
LONIUID LONI Image ID N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
PALLIDUM_SUVR bilateral-pallidum N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
PALLIDUM_VOLUME bilateral-pallidum ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
PTID ADNI Participant ID consisting of 3-digit "SITEID" and 4-digit "RID" N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
RID Participant roster ID (unique participant identifier that should be used to merge data) N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
RIGHT_CHOROID_PLEXUS_SUVR right-choroid-plexus N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
RIGHT_CHOROID_PLEXUS_VOLUME right-choroid-plexus ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
RIGHT_PALLIDUM_SUVR right-pallidum N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
RIGHT_PALLIDUM_VOLUME right-pallidum ROI size in mm^3 N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
SITEID Site ID N/A N/A UCBERKELEY_TAU_6MM UC Berkeley - Tau PET 6mm Res analysis
KITID Specimen Collection Kit Identifier -4 N/A ADNI3_URMC_LABDATA ADNI3 URMC Lab Data
RID Participant roster ID -4 N/A ADNI3_URMC_LABDATA ADNI3 URMC Lab Data
TESTID Individual Test Identifier -4 N/A ADNI3_URMC_LABDATA ADNI3 URMC Lab Data
TESTNAME Individual Test Name -4 N/A ADNI3_URMC_LABDATA ADNI3 URMC Lab Data
LONIUID LONI Image UID N/A N/A ADSP_PHC_ADNI_T1_1.0_MetaData ADNI Meta Data for U24 Phase 1 T1 Release
RID Participant ID N/A N/A ADSP_PHC_ADNI_T1_1.0_MetaData ADNI Meta Data for U24 Phase 1 T1 Release
ID Unique Global Specimen ID for each sample N/A N/A SELKOELAB_NT1TAU Plasma NT1-tau in ADNI
RID Patient ID N/A N/A SELKOELAB_NT1TAU Plasma NT1-tau in ADNI